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Abstract 
Background: Finding effective ways to care for people with palliative care needs is a 
national priority. A primary care locality has developed and implemented an Integrated 
Care Pathway (ICP) for those with life limiting illnesses. It focuses on identifying patients 
early, regardless of disease type, and uses proactive and patient centred interventions to 
plan for a good death. Although palliative care pathways present a promising practice 
framework, the literature does not allow for an assessment of how and when they work 
best. This thesis aimed to explain which parts of the ICP worked best, for whom and in 
what circumstances. Design: Realist evaluation was used to guide the analysis of multiple 
data strands: quantitative data from the GP practices; interviews with palliative care 
patients and bereaved relatives; bereaved relatives and matched health care professional 
questionnaires; focus groups with health care professionals; consultation recordings with 
palliative care patients and their GPs. Results: The results of this study are multifaceted, 
and focus on the conditions of successful implementation, such as the presence of a 
champion; palliative care registration decisions for all diagnoses and the importance of 
leadership and peer support; advance care planning, including the roles of mental capacity 
and time constraints; communication in consultations and the role of patient and GP 
traits; and using open multicomponent communication strategies to facilitate home 
deaths. Discussion: A realist approach has exposed how the ICP implementation has led 
to positive practice and patient level outcomes. The ICP can be construed as a 
translational tool, which enables the operationalisation of policy directives on shared 
decision making, proactivity and patient centeredness in primary care. In the context of 
palliative care, this study allows important reconceptualisations of shared decision 
making and advance care planning to be presented.  
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Introduction 
 
"Life is pleasant. Death is peaceful. It's the transition that's troublesome." 
– Isaac Asimov, American science fiction novelist and scholar (1920 - 1992). 
 
Background 
When initially facing the prospect of working within the palliative care domain I was 
undoubtedly nervous. My background was in psychology (Psychology BSc and Health 
Psychology MSc) so immigrating into health care was daunting, let alone the palliative 
care domain. People often asked me “won’t it be depressing?” and I was not sure of the 
answer. But something intrigued me; the opportunity to make a difference in an area 
that affects every person. What I have found is that the palliative care domain is not 
depressing; it is actually somewhat the opposite. In the course of the three years of this 
PhD I have never felt upset or disheartened by the area I work in or by the people I have 
had the privilege to interview. They have shown me that palliative care is inspiring; it 
can change lives and can also aid people in their unavoidable fate. I feel as a result of 
this realisation I now know that previously I was affected by the death and dying taboo 
that western society faces and throughout this PhD that taboo has been broken down 
from within me. Thus, the need for death and dying to be discussed in society, I now 
feel, is pivotal. As the quote above from Issac Asimov demonstrates, the transition from 
life to death is difficult, but palliative care is a way to manage this transition. It will 
never be easy but it should always be attempted.  
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I came to this PhD, as aforementioned, from my MSc, with no formal training or 
expertise in primary or palliative care. I came to find that this was actually an 
advantage. Although learning the infrastructures, tools, and relationships within primary 
care, and understanding the service I have been evaluating was not easy, I have had no 
biases throughout this study. Instead I understood all health care professionals’ roles 
and the difficulties that come with them. I have no allegiances to any group. This makes 
this thesis a very impartial and balanced account of a service implemented to improve 
primary care.  
Having a background in the social sciences I was very drawn to realist evaluation 
(Pawson and Tilley 1997) for several reasons. The first was its underlying wariness of 
strong claims for evidence, drawing on a Popperian philosophy of science (Popper 
1959). Throughout my psychology undergraduate training it became clear that all 
scientific data is peppered with ambiguity. The accumulation of explanation leads to an 
increased scientific knowledge and investigation often stops when researchers are 
satisfied that there is enough scientific evidence to support the claim. However, this 
accumulation of evidence could be falsified by new evidence in the future and thus 
nothing is absolute truth (Popper 1959). The second notion that drew me to realist 
evaluation was its embrace of the human mind and how the fate of a social programme 
lies in the reasoning of its stakeholders (Pawson 2013). Having a background based in 
psychology I was aware of individual differences and the uniqueness of individuals and 
their reasoning. To see this embraced and linked to context in a methodology that 
sought explanation of data was very attractive to me. Thirdly, I wished to pursue a 
methodology that explained real life issues, encompassing the difficult phenomena that 
can affect outcomes; realist evaluation aims to include and explain confounding 
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variables as opposed to eradicate them, an aspect that lends it to complex real life 
evaluation. Fourth and finally, one of realist evaluation’s foundations is the explicit 
generation and testing of theory. I am a great believer in science and logical scientific 
principles, to see a methodology that allows the use of theory in a flexible way that does 
not have a sole focus on outcome was refreshing.  
In summary, I faced two new challenges when I started this PhD: palliative care and 
realist evaluation, both of which I was drawn to and both of which I have been lucky 
enough to embrace and enjoy.  
 
Formulation of the research questions  
As described, my previous academic and professional life had not been in palliative or 
end-of-life care, thus I came to this PhD ravenous to explore the domain. Integration 
into the locality, the field of palliative and end-of-life care in general, and delving into 
realist evaluation gave me a greater understanding which prompted the formulation of 
the research questions. Understanding these domains made it clear that a lot is known 
about palliative and end-of-life care – it cannot be considered as a sparsely researched 
topic. However, there is little research on palliative and end-of-life care using realist 
methodology. This gave me a great breadth of research paths to follow in this thesis. I 
not only wanted to generate research that was relevant to the locality as a result of the 
Integrated Care Pathway (ICP), but also generate research that had a larger scope and 
relevance to palliative and end-of-life care across the nation. Considering this with 
realist evaluation I wanted to know if the ICP worked, how it worked, for whom it 
worked for and in what circumstances. These were the initial questions that guided the 
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inquiry and the formulation of the research questions, which are described within the 
methodology (Chapter three, pg. 72).  
 
Protocol publication  
Whilst formulating the research questions I began to write the protocol of this study 
(Dalkin, Jones et al. 2012). Realist evaluation is a relatively new method of inquiry and 
thus I found it difficult to know where to start – how do you find programme theories, 
what sort of data should you collect? The literature offers some exploration of this but 
putting this into practice is not always easy. Despite the research questions and project 
moving on somewhat from the publication, it provides a statement of how I started the 
evaluation. Realist evaluation is very difficult to ‘capture’ at the beginning of the project 
but I felt this protocol may help others when starting realist evaluations and thus felt it 
was important to publish.  
 
Flow of the thesis  
The thesis is divided into nine chapters. Chapters one and two introduce and use 
existing literature to contextualise the research in terms of palliative and end-of-life 
care. It also provides a description of the ICP that was implemented in the locality 
including commissioning aspects and specific tools used (palliative care registration, the 
traffic light system, the surprise question). Chapter three introduces realism and realist 
evaluation, provides an understanding of how the findings of the research will be 
presented and describes the data collection framework. The chapter also provides the 
reader with the research questions and programme theories that were developed from 
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this. The programme theories are then tested and refined in chapters four to eight 
through interpretation of the findings alongside existing literature. Each findings chapter 
begins with an initial programme theory which is refined using data from several 
sources; a refined programme theory is then presented at the end of each chapter. 
Chapter nine provides a discussion of the findings, bringing together all the programme 
theories to form an overall programme theory of the ICP. This chapter also includes a 
critical self-appraisal of the research commenting on limitations and future research.  
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Chapter 1: Key issues in palliative and 
end-of-life care 
 
This chapter examines some of the key issues that affect palliative and end-of-life care 
both in the UK and internationally.  A description of the history of palliative care is 
provided with implications for practice. Following this, preferences for end-of-life care 
in the UK and the societal taboo of death and dying are discussed due to their pertinence 
and palliative and end-of-life policies addressing these concerns will be explored. 
Important philosophies identified in relevant palliative care policies will be highlighted 
and discussed in further detail. Practicalities of using these philosophies in palliative 
care and primary care will then be addressed.  The diffusion of innovation and 
Normalisation Process Theory (NPT) literature is then explored to help understand how 
philosophies from palliative care policy can be translated into practice.  
 
Palliative care: historically and in practice  
In the late 1950s, there was little published research focusing on care of the dying 
(Clark 1999); the modern hospice movement was not underway (Clark, Small et al. 
2005); the term ‘palliative care’ was not in common use (Clark and Seymour 1999); no 
professional societies had formed to promote interest in palliative care (Clark 1998, 
Clark 2004); and there were only a few hospices which were managed by religious 
foundations (Humphreys 2001). In 1967 the St. Christopher’s hospice opened and ‘the 
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modern hospice movement’ began (Saunders 1996). A crucial decision from the hospice 
was that it would only admit terminally ill cancer patients, due to limited resources and 
the necessity to limit who was treated and to track clinical outcomes. This pioneering 
work from Dame Cicely Saunders was pivotal in drawing attention to the end-of-life 
care needs of patients’ with advanced cancer diseases (Clark 2007). Although cancer 
causes a large number of people globally to suffer extreme distress at the end of life, 
this decision meant the exclusion of patients with equally distressing and symptomatic 
conditions – those with non-cancer illnesses. This was despite reports in the 1950s that 
identified a need for improvement of services for terminally ill cancer and non-cancer 
patients (Bean 1961) and arguments for the UK’s NHS to make terminal care, 
regardless of disease type, a priority (Clark 1999). Additionally, evidence of the time 
indicated that non-cancer patients experienced the same, if not more, distress as cancer 
patients (Exton Smith 1961). Despite this, the modern hospice movement was focused 
on cancer. This may have been because Dame Cicely Saunders’ research focused on 
cervical or breast cancer patients aged between forty and sixty (Clark 1999). 
Additionally, a cancer focus reduced the strain on new services and made a clear 
distinction between palliative care and geriatric care (Addington-Hall and Hunt 2012). 
Furthermore, cancer had replaced infectious disease as the leading cause of early death 
(Brower 2005). Following the hospice movement, in the 1970s, palliative care began to 
be defined and came to be construed as the physical, social, psychological, and spiritual 
support of patients with life-limiting illness, delivered by a multidisciplinary team 
(MDT) (Clark 2007). Since the 1970s palliative care has been closely related to 
oncology (Clark 2007). The international need for palliative care remains much larger 
than the actual available provision, yet there are signs of acknowledgment by policy 
makers and influential bodies (referred to in the policy section of this chapter) and 
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interest in palliative care has never been so great (Clark 2007). In only four decades the 
care of cancer patients has evolved completely – patients with advanced cancer and the 
management of their symptoms has moved from being on the periphery of oncological 
care to being at the centre of modern cancer care (Clark 2007). However, patients with 
progressive diseases other than cancer (for example, chronic obstructive pulmonary 
disorder, heart failure, motor neurone disease, herein referred to as non-cancer diseases) 
have not been offered the same palliative services in the past, despite having similar 
physical and psychosocial symptoms (Eve, Smith et al. 1997, Addington-Hall 1998). 
Yet recent policies (described below) have stated that palliative care should be provided 
for all, regardless of diagnosis (Department of Health 2008). However, the historical 
focus on cancer has had a lasting effect on provision of health care services, resulting in 
inequality in the provision of services for those with a non-cancer diagnosis.  
This injustice can be seen in practice, as until 2008 cancer registers were used in 
practice regardless of palliative or curative status. Yet there was no equivalent for 
patients with non-cancer diagnoses. Only recently were palliative care registers 
developed that are for all patients with a terminal diagnosis.  
Doyle and Woodruff (2008) have reviewed barriers to providing palliative care which 
can relate to access issues, social factors, the patient or the health care professional. 
Access to palliative care can be an issue – the high cost of care, treatments and 
medications in developing countries, and laws and regulations restricting or prohibiting 
the use of opioids can have an effect on the palliative care provided (Doyle and 
Woodruff 2008). Social factors that prevent the delivery of palliative care include ethnic 
minorities and language barriers, rural communities and underprivileged communities 
(Doyle and Woodruff 2008). The patient can also be a barrier to providing palliative 
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care; they may have unrealistic expectations or believe their prognosis is better than 
expected by professionals. There can also be disagreements between the patient and the 
family about treatment options. There may also be no advance care planning (ACP) 
(Doyle and Woodruff 2008), delaying the onset of palliative care. This can be due to the 
health care professional’s poor prognostication, resulting in curative care proceeding for 
too long or lack of communication skills to address palliative and end-of-life care 
issues. Alternatively, the health care professional may not believe in the use of palliative 
care or may not have high palliative care standards in their institution (Doyle and 
Woodruff 2008).  
The literature identifies health care professionals’ poor prognostication as a barrier to 
palliative care, as well as the fact that little is known about the potentially complex 
transition to palliative care (Gardiner, Ingleton et al. 2011). This transition can be 
defined as “a change of focus in the goals of a patient’s care from ‘active treatment,’ 
where the focus is on cure or management of a chronic disease, to a ‘palliative care’ 
approach, where the focus is on maximising quality of life” (Gott, Ingleton et al. 2011, 
p.1). The boundaries between palliation and curative care are blurred and becoming 
increasingly so, this is due to advances in medical technology (Payne, Seymour et al. 
2004). Evidence suggests that continuity of care and MDT collaboration are crucial in 
order to improve patient experience of the transition. Incorporating palliative care 
earlier in the patient’s illness trajectory and implementing a stepped transition could be 
vital factors of high quality care (Gardiner, Ingleton et al. 2011), however this is seldom 
evident in UK secondary care (Gott, Ingleton et al. 2011). Adopting a stepped transition 
from curative to palliative care may be difficult as it requires a change in health care 
professionals’
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to cure. These issues are discussed further throughout this chapter. In order to provide 
palliative care that is based on patient preferences the barriers to providing palliative 
care need to be overcome and a change in ethos needs to occur.  
 
Preferences in end-of-life care addressed through palliative care 
The North East, where the new palliative care ICP under investigation has been 
implemented, had the highest percentage of those who would prefer to die in their own 
home in 2010 (67%), with the average across government office regions being 60% 
(Gomes, Calanzani et al. 2011). The preference of a hospice death was second choice 
across the UK ranging from 26-32% across England. 89% of people would prefer to die 
in their own home or a hospice (Gomes, Calanzani et al. 2011). Hospital was the least 
preferred place of death across all government office regions apart from in the North 
East, where it was the second least preferred place of death for 31% of people (Gomes, 
Calanzani et al. 2011). A care home was the least preferred place of death (34%) in the 
North East in this study. However, this survey was of younger adults unlikely to be 
situated in care homes so might not be representative of the adult population as a whole. 
Data from the locality under study indicates that those asked who are current palliative 
care patients would prefer to die in their own care home as opposed to hospital.  
It is important that patient preferences are discussed in advance of end-of-life care as 
patients who lack capacity and have not previously stated their preferences may receive 
unwanted, futile, aggressive and costly medical treatment (Detering, Hancock et al. 
2010, Silveira, Kim et al. 2010). Alternatively, they may experience the withdrawal of 
treatments that they would have desired (Detering, Hancock et al. 2010, Silveira, Kim et 
al. 2010). If these decisions are not made by the individual in advance they cannot be 
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adhered to. This not only causes distress to the patient but also to their family and carers 
as they may be required to make decisions if capacity is diminished and may disagree 
with one another (Breen, Abernethy et al. 2001).   
Across the country, there is a substantial gap between the amount of people who would 
prefer to die at home and those who actually do die at home. This gap is larger in the 
North East (46%) when compared to the government office regions as a whole (Gomes, 
Calanzani et al. 2011). This may be because as end-of-life approaches the use of 
hospital care rises very significantly, particularly via unplanned admissions (Van den 
Block, Deschepper et al. 2007, Pot, Portrait et al. 2009, Maddams, Utley et al. 2011, 
Rosenwax, McNamara et al. 2011, Bardsley, Georghiou et al. 2012). Unplanned 
admissions are expensive to the NHS and often not desired by patients and their 
families. Research has shown that ACP is effective in helping patients to achieve their 
preferred place of death by stating preferences and avoiding unplanned admissions 
(Detering, Hancock et al. 2010, Arnold, Finucane et al. 2012).  
 
Difficulties in discussing death and dying   
As discussed above, stating preferences is essential in order to achieve patient 
centeredness. However, in modern society people often do not wish to discuss death and 
dying, a fact that is often attributed to the death taboo (Lee 2008). The first publication 
about death was by Groer (1955); his essay ‘The Pornography of Death’ opened the 
door for others to publish on this topic. He argued that death had replaced sex as 
society’s major taboo topic (Leming and Dickinson 2010). The 1960s sexual revolution 
made advances in overcoming sex as a taboo subject. However, there has been no such 
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revolution for death and dying. The origin of the social taboo of death and dying is 
complex and multifaceted, including historical, cultural and demographical 
considerations. Historically, priests cared for terminally ill patients at the end-of-life. 
This has been supplanted by medical experts who traditionally see death as failure due 
to the curative culture which is enforced by ever developing medical advances (Walter 
1991). Adults are living longer in the UK (Caley and Sidhu 2011) and since 1945 
hospitalisation of dying people has been promoted with death in the community 
becoming rarer (Walter 1991, Leming and Dickinson 2010), despite the curative culture 
that dominates hospital settings. The dying person can be seen to be banished from 
mainstream society with individuals seeing fewer corpses (Leming and Dickinson 2010, 
Meier, Isaacs et al. 2010). This change in location has made death invisible to the public 
(Walter 1991). Additionally, personnel in the media and medical domain who are part 
of institutions who have the most power in interpreting death have strong anxieties 
about death and dying (Walter 1991). The controversy and media storm surrounding the 
Liverpool Care Pathway for the Dying Patient (LCP) is a direct, recent example of this. 
Regardless of its origins or terminology, death is still a subject that many find difficulty 
in facing or discussing frankly. It is a social taboo that is present in the media and the 
medical domain:  
“But whereas death was much more of a part of everyday life for 
previous generations, in Britain today death is becoming a social 
taboo.” (BBC News 2011, p. 1) 
 
“Death has become too closed off, too much behind hospital doors and 
altogether too sanitised.” (Yorkshire Post 2013, p. 1) 
 
 “We know, the physician and nurse know and the patient knows 
(whether told or not) when the condition is terminal but we often exist 
in anything but an open awareness context. No one lets the other know 
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that he or she knows. Death talk remains taboo.” (Leming and 
Dickinson 2010, p. 180). 
 
Death has been discussed as a social taboo for many years (Simpson 1987, Walter 
1991), meaning that it is not a new phenomenon, yet little has been done in the past to 
address this. Although the social taboo of death and dying may not be as strong as it 
was in the 1980s, it is deeply rooted and is unlikely to be overcome in just a few years 
(Leming and Dickinson 2010), despite some writers considering the social taboo of 
death and dying to be in its twilight years (Lee 2008). The results of this are that both 
patients and health care professionals can feel uncomfortable discussing death and 
dying or caring for a person who is dying. This makes early identification and 
preference discussions difficult, which in turn makes planning a good, preference-based 
death problematic. 
 
The political mandate 
Recently the public, policy makers, hospice movement and individual case studies have 
been seen to attempt to break down the social taboo of death and dying, with reports of 
death cafes (MSN News 2013) and festivals (Cardiff University 2013), hospice care 
providing a greater awareness about care for the dying (Lee 2008), the Dying Matters 
campaign (The National Council for Palliative Care 2009), high profile end-of-life 
euthanasia cases such as Terri Schiavo in the USA and Tony Nicholson in the UK and 
publications such as the End of Life Care Strategy (Department of Health 2008) and 
Deciding Right (NHS North East 2012). Palliative and end-of-life care has recently 
become a local, regional, national and international priority (Brennan 2007, Department 
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of Health 2008, The National Council for Palliative Care 2009, The National Gold 
Standards Framework Centre 2009, NHS North East 2012). A short description of all 
relevant policy follows in order to frame the political context of the research and 
highlight important concepts in providing high quality palliative care.  
The Gold Standards Framework (GSF) (2009) was originally developed in the UK from 
within primary care as an initiative to improve palliative care. It is a systematic 
approach to improving the quality and organisation of care for people approaching the 
end of their life. It aims to improve patient outcomes that match the patient’s needs and 
preferences, alongside better cost-efficiency through avoiding unnecessary hospital 
admissions.  The GSF has three essential elements:  
1. Identify patients and what stage they are in their illness. 
2. Assess current and future clinical needs and personal needs. 
3. Plan (anticipate needs) (The National Gold Standards Framework Centre 2009). 
The five goals of the GSF are to provide for patients with any final illness: consistent 
high quality care; alignment of patients’ preferences to actual care (person centred care 
which can be achieved through shared decision making); pre-planning and anticipation 
of needs (proactive care); improved staff confidence and teamwork; more home based 
and less hospital based care (proactive and patient centred care) (The National Gold 
Standards Framework Centre 2009). The GSF is recommended as best practice by the 
End of Life Care Strategy published by the Department of Health (2008). This strategy 
identified a number of significant issues affecting dying and death in England. This 
included: discussions as the end-of-life approaches, assessment, care planning and 
review, coordination of individual patient care, delivery of high quality services in a 
range of settings, care in the last days of life and care after death (Department of Health 
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2008). All of these issues affecting death and dying can be addressed through the use of 
proactive and patient centred care using shared decision making. The strategy promotes 
high quality care for all adults at the end-of-life by providing people with more choice 
about where they would like to live and die. This document also defined what a ‘good 
death’ could be considered as:  
• Being treated as an individual, with dignity and respect. 
• Being without pain and other symptoms.  
• Being in familiar surroundings.  
• Being in the company of close family and/or friends.  
As part of the End of Life Care Strategy (Department of Health 2008) the Dying 
Matters campaign (The National Council for Palliative Care 2009) was created to 
support the implementation of the strategy, focusing on increasing public awareness and 
aiming to support changing attitudes and behaviours in society towards dying, death and 
bereavement. Echoing this national policy is local policy, such as Deciding Right for the 
North East of England (NHS North East 2012). This is an integrated approach to 
making care decisions in advance with children, young people and adults and provides 
information and instruction on how to implement a proactive, integrated approach to 
palliative and end-of-life care that results in a good death, adhering to patient 
preferences. This is done through use of shared decision making, the Mental Capacity 
Act (Department of Health 2005), ACP, generic form use across the North of England 
and use of the LCP (Ellershaw and Ward 2003). Deciding Right uses The Mental 
Capacity Act (MCA) (Justice 2007), which is important for caring for those with 
palliative care needs, assuring that decisions that are made in advance, which can 
concern patient preferences, are valid. It states that a person lacks capacity in relation to 
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a matter if at that specific time he or she is unable to make a decision for her or himself 
in relation to the matter due to an impairment of, or a disturbance in the functioning of 
the mind or brain (Justice 2007).  A person is not to be treated as unable to make a 
decision unless all feasible steps to help him or her to do so have been taken without 
success. Furthermore, an unwise decision should not be considered as a lack of capacity 
either (NHS North East 2012). Issues surrounding capacity are prominent in palliative 
and end-of-life care, for example, ACP should always be done with someone who has 
capacity for the decisions it involves.  
 
Important concepts from palliative care policies  
Patient centred care, shared decision making and proactive care are all highlighted as 
pivotal concepts in the recent policies related to palliative and end-of-life care that are 
discussed above and are explored in greater depth below.  
 
Proactive care  
The primary role of the GP is listening and offering appropriate treatment and advice, 
and is perceived as such by the public (Spence 1960). It is wholly attuned with high 
quality, contemporary primary care and encompasses the bulk of a GP’s workload 
(Spence 1960). Thus the primary role of the GP is a reactive role.  Spence (1960) 
defines reactive care in the following way:  
“The essential unit of medical practice is the occasion when, in the 
intimacy of the consulting room, a person who is ill, or who believes 
himself to be ill, seeks the advice of a doctor whom he trusts. This is a 
consultation, and all else in medicine derives from it.” (Spence 1960, 
p. 273).  
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However, proactive care has become a prominent focus in the health care domain and 
emphasises the anticipation of needs. Gillies, Baird et al. (1995) describe proactive care 
as:  
“Care that attempts to prevent illness by intervention in asymptomatic 
individuals.” (Gillies, Baird et al. 1995, p. 16).  
 
However, in palliative care this term is refined. The patient is already ill with a 
condition that can only be managed. The health care professional needs to be proactive 
in terms of care planning. This is holistic and thus addresses physical needs 
(anticipating required increases in medication to alleviate pain), emotional needs 
(discussing end-of-life issues and fears), and practical needs (place of death). The World 
Health Organisation (WHO) define palliative care as:  
“An approach that improves the quality of life of patients and their 
families facing the problems associated with life-threatening illness, 
through the prevention and relief of suffering by means of early 
identification and impeccable assessment and treatment of pain and 
other problems, physical, psychosocial and spiritual.” (World Health 
Organisation 2014, p. 1) 
 
This definition highlights the inherent need for palliative care to be proactive through 
early identification and impeccable assessment and treatment; this means that to deliver 
high quality palliative care, as stated in the policies discussed above, proactive care 
must be central.  Supporting this, the academic literature indicates that proactive care is 
pivotal in providing high quality palliative care (Froggatt and Hoult 2002, Norton, 
Hogan et al. 2007, Burns, Johnson et al. 2008). Integrating palliative care into curative 
care or combining palliative care with illness-oriented management earlier in the disease 
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trajectory resulted in increased satisfaction with care, less acute interventions, and an 
increased likelihood to die at home in chronically ill patients nearing the end-of-life 
(Brumley, Enguidanos et al. 2003, Abarshi, Onwuteaka-Philipsen et al. 2009). The first 
proactive action a health care professional must take to begin providing proactive 
palliative care is to identify patients that require it. Identifying patients early enough to 
work within a palliative care framework as opposed to in crises would encompass a 
proactive approach. The early identification of palliative care is a key concept in the UK 
End of Life Care Strategy (Department of Health 2008). Early identification of 
palliative care patients means that they can build longer term, stronger relationships 
with health care professionals, especially community nurses who will provide the 
majority of end-of-life care if a home death is the patient’s preference. By building 
trusting relationships prior to problematic symptoms patients and their families can be 
offered access to timely and appropriate support (Agar, Currow et al. 2008). This is 
important, as often a precursor to patients needing to be cared for in a location other 
than their own home is linked to receiving ‘unwanted’ physical help from relatives, such 
as with incontinence (McCall and Rice 2005) or due to carer/relative fatigue in relation 
to providing emotional and physical support to loved ones (Grande, Todd et al. 1997). 
UK policy guidance on treatment and care towards the end-of-life has identified a need 
to better recognise patients who are likely to be in the last 12 months of life (Gardiner, 
Ingleton et al. 2011). This means that people with life limiting illnesses who require 
palliative care should be identified as early as possible (via proactive actions from 
health care professionals) in the course of their progressive illness.  
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Patient centred care 
Patient centred care can be construed in different ways (Wagner, Bennett et al. 2005). 
Yet regardless of perspective all definitions are a reaction to the perceived inadequacies 
of traditional care and its focus on the biomedical model and the domination of the 
health care professional (Mead and Bower 2000).  To many, patient centred care means 
focusing on the whole person and not only their health care needs (Wagner, Bennett et 
al. 2005, Manley, Hills et al. 2011). This includes consideration of their feelings and 
experience of illness and psychological and social factors in order to direct the patient’s 
care (Wagner, Bennett et al. 2005). Thus patient centred care can also be thought of as 
‘the person in the patient’ (Goodrich and Cornwall 2008) and is a desired feature in 
modern health care. The Fourth Principle of Nursing Practice, Principle D, refers to 
patient centred care, stating:  
“Nurses and nursing staff provide and promote care that puts people 
at the centre, involves patients, service users, their families and their 
carers in decisions, and helps them make informed choices about their 
treatment and care” (Manley, Hills et al. 2011, p. 35).  
 
Patient centred care should acknowledge individual patient preferences, needs, and 
perspectives and ensure that patient principles guide clinical decisions (McCormack, 
Treiman et al. 2011).  
 
There is a consensus that patient centred care equates with high quality care (Innes, 
Macpherson et al. 2006, Royal College of Nursing 2009). Chronic conditions which can 
be likened to palliative care indicate that high quality care of this population includes a 
fuller understanding  of the patient’s life and preferences, tailoring of management to 
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the patient’s preferences (Wagner, Bennett et al. 2005) and the activation (Hibbard, 
Stockard et al. 2004) or empowerment (Anderson 1995) of patients. These are all 
concepts that are often associated with the term patient centred care. Achieving patient 
centred care consistently entails specific knowledge and abilities, a shared philosophy 
that is practised by the multidisciplinary health care team, a positive workplace culture, 
and organisational support (Manley, Hills et al. 2011). In addition, health care 
professionals need to be able to use different processes to develop patient centred care, 
including working with patients’ values and beliefs, engaging patients, having a 
sympathetic presence, sharing decision making and accommodating patients’ physical 
needs (McCormack and McCance 2010). Shared decision making is required to provide 
patient centred care and will be discussed below.  
 
Shared decision making  
Policy makers perceive shared decision making as necessary due to its potential to 
sustain the health care system (Coulter 2006) and promote the right of patients to be 
involved in decisions concerning their health (Straub, Nebling et al. 2008, Légaré, Ratté 
et al. 2010). It has been referred to as the crux of patient centred care (Godolphin 2009). 
It can be described as a middle ground between paternalism and rampant consumerism, 
with a medical encounter perceived as the meeting of two experts - the patient as an 
expert in his or her own life, values, and circumstances, and the health care professional 
as an expert in medicine (Tuckett, Boulton et al. 1985, Godolphin 2009). In order for 
shared decision making to take place the health care professional must search for and 
offer choices, as without choices there is no decision to be made (Godolphin 2009). The 
health care professional must then inform patients of the choices in order to engage 
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them in shared decision making. Godolphin (2009) identifies eight abilities a health care 
professional needs to successfully use shared decision making. These are the ability to:  
1. Develop a partnership with a patient  
2. Establish and review a patient’s preference for the amount and format of 
information they receive 
3. Establish and review the patient’s preferences for their role in decision making 
(including their preferred degree of involvement) 
4. Determine and act in response to patients’ ideas, concerns and expectations  
5. Identify relevant choices and evaluate research evidence in relation to the 
individual patient 
6. Present or direct the patient to relevant evidence 
7. Make or negotiate a decision in partnership and resolve conflict 
8. Agree on an action plan and complete arrangements for follow up (Godolphin 
2009) 
Health care professionals should aim to relieve suffering and increase autonomy 
(Godolphin 2009) to allow the patient to feel more independent and self-reliant post 
consultation, as opposed to disempowered and dependent on the health care professional 
or system (Godolphin 2009). However, shared decision making is not always in 
isolation between the patient and the health care professional. It may also involve a 
team of health care professionals working collaboratively or significant others including 
family members and carers (Godolphin 2009). 
Involving patients in care decisions makes a potentially significant and lasting 
difference to health care outcomes (Stewart 1995, Elwyn, Edwards et al. 2000). Despite 
this, the literature indicates that quality shared decision making only occurs about 10% 
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of the time (Braddock, Edwards et al. 1999, Godolphin 2009) and that generally shared 
decision making in practice is poor (Campion, Foulkes et al. 2002, Elwyn, Edwards et 
al. 2003, Towle, Godolphin et al. 2006, Young, Bell et al. 2008). However, it is 
envisaged that it will improve as the health care professional-patient relationship is 
changing due to a more consumerist society with greater public involvement in health 
care (Coulter 2002, Godolphin 2009). Furthermore, shared decision making is now an 
international philosophy that features in guidelines from Canada, the United States of 
America, Australia and the UK (Australian Council for Safety and Quality in Health 
Care 2005) and is incorporated into training programs and good practice (Godolphin 
2009). The General Medical Council in the UK declares shared decision making as an 
“over riding duty or principle” and that “serious or persistent failure to follow this 
guidance will put your registration at risk” (General Medical Council 2008, p.5). 
 
Difficulties in translating policy in to practice  
An ageing population  
The annual number of deaths in England and Wales is predicted to rise by 17% per cent 
from 2012 to 2030, and the average age at death is also set to substantially increase 
(Gomes and Higginson 2008). In 2012, cancer was the most common cause of death in 
England and Wales (29% of all registered deaths) but this was closely followed by 
circulatory diseases, such as heart disease and strokes (28% of all deaths registered) 
(Office for National Statistics 2013). Information was not available for other non-cancer 
deaths (frailty and dementia, organ failure). Since 2002, death rates for cancer have 
fallen by 14% for males and 10% for females (Office for National Statistics 2013); the 
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prevalence of non-cancer illnesses such as dementia are expected to increase, from 
800,000 in 2012 to 1,000,000 in 2021 in the UK (Alzheimer's Society 2013). This 
evidence, alongside the knowledge that the population is ageing (Caley and Sidhu 2011) 
and cancer treatment is advancing (Costanzo, Ryff et al. 2009), suggests that cancer 
deaths will continue to decrease and non-cancer deaths will increase in the future. Due 
to the ageing population (Forder and Fernandez 2011, Gomes, Calanzani et al. 2011) the 
level of frailty, impairment and needs of people admitted to care homes is now higher 
than it was 10-15 years ago (Forder and Fernandez 2011). A Bupa report recently found 
that over 50% of care home residents were over 85 years of age in 2011 (53.9%), this 
figure was similar to findings from the Department of Health for 2008 for residents over 
85 (55%) (Forder and Fernandez 2011). Bupa figures are largely representative of 
England averages in relation to age and sex. In 2011, the average length of stay in Bupa 
care homes was 801 days; half of residents had died by 464 days. Older adults had a 
shorter length of stay in care homes as they had a higher death rate (Forder and 
Fernandez 2011). Thus, care home residents are often elderly and frail with non-cancer 
diagnoses. The literature and statistics indicate that non-cancer illnesses will increase, 
however this poses difficulties in providing proactive care as prognosis can be difficult 
to determine (Murray, Boyd et al. 2005). Differences in the trajectories of cancer and 
non-cancer illnesses have been recognised as far back as 1968 (Glaser and Strauss 
1968). Three typical illness trajectories have been defined for patients with progressive 
palliative illness: cancer, organ failure, and the frail elderly or dementia trajectory 
(Murray, Boyd et al. 2005, The National Gold Standards Framework Centre 2009). 
Individuals who have cancer do not have serious debilitation or restriction in activity 
until the final stages of the illness, when anti-cancer treatments are no longer effective 
(Murtagh, Preston et al. 2004). This means that for most the illness trajectory is 
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commonly a slow overall decline until anti-cancer treatments cease to be effective. 
Therefore, people with cancer diagnoses have a predictable terminal phase, similar to 
that described by McCusker (1984). By contrast, organ failure trajectories are erratic; 
they have sudden acute deteriorations followed by substantial improvement, but with an 
underlying downward trend in function and ability (Murtagh, Preston et al. 2004). 
However, not all non-cancer illnesses stemming from organ failure follow this 
trajectory; for example, end stage renal failure may be that of a steady decline, at a rate 
that varies with pathology and individual factors. However, renal disease has a high 
level of co-morbidity with cardiovascular and cerebrovascular disease, making this non-
cancer illness also difficult to predict (Murtagh, Preston et al. 2004). Individuals who 
have dementia or general frailty have a much lower baseline level of functioning, with a 
declining but variable downward course towards death (Murtagh, Preston et al. 2004). 
Sudden deteriorations may lead to hospitalisation and intensive active treatment being 
more often associated with non-cancer (organ failure and frail elderly or dementia) than 
with cancer diagnoses (Murtagh, Preston et al. 2004). Thus the different trajectories 
make providing palliative care for those with non-cancer illnesses much more difficult 
and this affects health care professionals’ ability to be proactive. This in turn means that 
health care professionals will have difficulties being patient centred and engaging in 
palliative care based shared decision making.  
 
Time constraints  
Over the past several decades major transformations have occurred in health care in the 
more developed world; this has affected the way health care professionals perform, 
experience, and evaluate their own clinical work (Konrad, Link et al. 2010). Health care 
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professionals are increasingly pressured to be proactive, deliver patient centred care, 
engage in shared decision making, follow guidelines and engage in evidence based 
practice. Thus, time is very important in designing national health care systems that 
operate efficiently (Konrad, Link et al. 2010). Health care professionals often struggle 
with how much control they have over their time in terms of hours of service and 
minutes of patient contact. This can affect patient centred care which requires the ability 
to develop good relationships, a process that can be time consuming. The relationship 
between the patient and front line worker is crucial to the experience of high quality, 
patient centred care and support (Innes, Macpherson et al. 2006). Transient experiences 
with patients in primary care that has high demands and time constraints may prevent 
health care professionals from providing patient centred care and engaging in shared 
decision making (Elwyn, Edwards et al. 1999). A recent systematic review identified 
longer health care professional visits were associated with more positive outcomes such 
as more attention to psychosocial problems, lower prescribing rates, lower return 
consultation rates and higher patient satisfaction indicators suggesting patient 
centeredness was higher (Wilson and Childs 2002). Furthermore, longer visits may 
decrease malpractice litigation risk (Levinson, Roter et al. 1997). American health care 
professionals reported that they scheduled more time for consultations with patients 
than health care professionals in the UK or Germany (Konrad, Link et al. 2010). 
American and German health care professionals had similar perceptions of control over 
their time; in comparison UK health care professionals felt that they had less control 
over time. Health care professionals from the UK are scheduled more tightly and appear 
to work more rapidly than their American colleagues (Konrad, Link et al. 2010). Thus 
health care professionals in the UK have shorter consultations, feel that they have less 
control over time and are scheduled more tightly and work faster than their associates in 
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America and Germany. However, with longer consultations having positive outcomes 
for patients and health care professionals as well as reducing risk of malpractice 
litigation (Levinson, Roter et al. 1997, Wilson and Childs 2002), feeling time pressured 
and working rapidly are not beneficial to patients or health care professionals and may 
compromise patient centred care and shared decision making. 
 
Communication surrounding death and dying  
The UK General Medical Council guidance on end-of-life care, which came into effect 
in July 2010 (General Medical Council 2010), states that health care professionals must 
ensure that death becomes “an explicit discussion point when patients are likely to die 
within 12 months, and that medical paternalism on the subject, however benignly 
intended, must be replaced by patient choice” (Bell 2010, p. 1). This is in line with 
policy initiatives to identify patients in the last twelve months of their life (Department 
of Health 2008). However, awkwardness, embarrassment and fear can mean that people 
avoid connecting with those who are dying (The National Council for Palliative Care 
2009), making proactive care, patient centred care and shared decision making difficult. 
Both a palliative diagnosis and information about palliative care can be classed as 
distressing health threatening information which is difficult for the doctor to deliver and 
for the patient to receive (Buckman 1984, Ptacek and Eberhardt 1996, Ptacek and Ptacek 
2001). The literature suggests conversations about death occur infrequently and that this 
may be due to professionals not feeling at ease with broaching the subject (The 
SUPPORT Principal Investigators 1995, Hoffman, Wenger et al. 1997, National End of 
Life Programme 2011). It has been proposed that in such health related risk situations 
individuals utilise distinctive attentional processing styles which allows them to be 
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classified as a ‘monitor’ or ‘blunter’ (Miller 1995). When faced with a health related 
risk, monitors generally seek information, magnify disease related cues and display 
greater dissatisfaction about the amount of information provided. Alternatively, blunters 
psychologically distract themselves from health related risk information and desire less 
knowledge. People can be classified as (high or low) monitors and (high or low) 
blunters using the Miller Behavioural Style Scale (MBSS) and this scale could have 
explanatory potential in terms of why some consultations about death and dying work 
better than others.  
Communicating realistic information about different treatment options and the 
likelihood of successful treatment or adverse effects and symptoms is also difficult 
(Matsuyama, Reddy et al. 2006). The literature indicates that patients who have cancer 
would choose chemotherapy for much smaller improvements in outcome than would 
health care professionals (Matsuyama, Reddy et al. 2006). This makes supportive and 
holistic palliative care that is patient centred, proactive and based on shared decisions 
extremely difficult. If a patient wishes to continue with aggressive treatment, it could be 
that they are unlikely to engage in end-of-life care preference discussions. However, 
patient autonomy and choice should always be valued and thus patients’ treatment 
options should always be presented in a balanced manner (Earle 2006), and preference 
discussions and a palliative approach should be entered into mutually. However, there is 
a subjective discrepancy in how aggressive palliative treatment is viewed by patients, 
bereaved relatives and health care professionals. Both bereaved relatives and health care 
professionals who have experienced aggressive treatment for palliative care patients 
would avoid it, giving more time to plan hospice and end-of-life care (Earle 2006). 
However, in focus groups, terminally ill cancer patients who by virtue of still being 
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alive had not experienced the whole course of their illness were more inclined to 
consider aggressive palliative treatment (Earle 2006). This discrepancy suggests that 
there is a gap between the informed opinions of bereaved relatives and health care 
professionals, and the decisions of patients’. Slevin, Stubbs et al. (1990) makes this 
more explicit, stating that 53% of cancer patients are willing to contemplate aggressive 
chemotherapy if chances of a cure were increased by as little as 1%. Furthermore, 
patients have stated that they would accept chemotherapy or radiotherapy despite being 
aware that it would have no clinical benefit and no gain in survival chances (Palda, 
Llewellyn et al. 1997, Jansen, Kievit et al. 2001). This could be due to explanations 
from those providing the treatment being unclear or due to a fear of death. A quote from 
de Haes and Koedoot (2003) suggests that oncologists prefer to give treatment as 
opposed to deny it, despite doubtful expectations about a positive result.  
“Giving chemotherapy, rather than watchful waiting, is what I have 
been educated to do; that’s what I have to sell in my shop.” (de Haes 
and Koedoot 2003, p. 45).  
 
Earle (2006) suggested that primary care health care professionals may feel 
uncomfortable in communications about palliative care due to a lack of tools in 
conveying pros and cons; the subject being too emotionally distressing to discuss; 
patients being unable to comprehend the realistic outcomes; and attempt to not be 
totally honest in order to preserve hope (Earle 2006). However, if these discussions do 
not take place it is difficult for proactive care, patient centred care and shared decision 
making to occur.  
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Litigation in palliative care  
Around 3,800 years ago, the Code of Hammurabi stated that health care professionals 
who harmed their patients would have their hands cut off (Selkin 2011). Since then, 
health care professional-patient relationship has produced potential civil, criminal and 
administrative liability (Selkin 2011). Often physicians learn the law as defendants in 
malpractice claims, thus the systems are adversarial (Selkin 2011). Few health care 
professionals know the different factors that constitute negligence and can be confused 
about informed consent; this can lead to inappropriate defensive medicine, such as 
cardiopulmonary resuscitation (CPR) in palliative care patients, where it is unlikely to 
succeed (Selkin 2011). Furthermore, it is not only health care professionals who face 
litigation but also those who care for palliative care patients outside of the medical 
domain, such as care home workers. Due to the litigious society in which we reside it is 
difficult for health care professionals and carers to make decisions surrounding 
palliative care, with caveats needed in terms of CPR, capacity, autonomy and patients’ 
best wishes. This makes patient centred care difficult, as despite the knowledge of 
patients’ wishes, supporting documentation may be required to avoid litigation. If this 
documentation cannot be produced (for example, is lost) or is not valid (for example, 
not signed) in a crisis, patient centred care cannot be carried out due to the health care 
professional or carer’s self-preservation (to avoid litigation).  
 
Definitions of palliative and end-of-life care  
The terms palliative and end-of-life care are often used interchangeably in practice and 
the literature, preference in terms has changed in the last 30-40 years, specific meanings 
of terms have changed and definitions vary by organisation and country (Izumi, Nagae 
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et al. 2012). In the UK curative care is care that is focused on ultimately preserving life: 
remission and stabilisation of illness. As stated earlier, palliative care is defined as:  
“An approach that improves the quality of life of patients and their 
families facing the problem associated with life-threatening illness, 
through the prevention and relief of suffering by means of early 
identification and impeccable assessment and treatment of pain and 
other problems, physical, psychosocial and spiritual” (World Health 
Organisation 2014) 
 
End of life care is considered by the General Medical Council as focussed on patients 
who are likely to die within the next twelve months. This includes patients who are: 
expected to die within the next few hours or days; those with advanced incurable 
conditions, those with general frailty and co-existing conditions; those with existing 
conditions who are at risk from dying due to a sudden crisis in their condition; life-
threatening acute conditions caused by sudden events such as accident or stroke (NHS 
Choices 2013). Thus, palliative care is considered as a more holistic form of care. 
However, there is great variation not only in practice but also in the literature in terms 
of definitions for end-of-life care, especially in relation to time. Lunney, Lynn et al. 
(2003) and Chan and Webster (2010) state end-of-life care focuses on the last days and 
hours of life, as opposed to the last twelve months. Confusion about and between 
palliative care and end-of-life care may make it difficult for shared decision making to 
take place with patients. They may become distressed if a health care professional 
attempts to be proactive by suggesting a palliative approach. Furthermore, palliative 
care does not mean that a patient does not require active care. A frail elderly patient 
who health care professionals view as appropriate for palliative care may fall and break 
her wrist; being a palliative care patient does not mean that this person should not 
receive appropriate, patient centred medical attention for this injury.   
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Aids to translating policy into practice  
There has been a drastic increase in literature about research-practice-policy links in 
recent decades (Nutley, Morton et al. 2010). Despite this, there remains a well-
recognised and significant translational gap between these domains. As discussed 
above, there are issues in implementing conceptual notions from the political mandate 
(such as proactive care, patient centred care and shared decision making) into practice. 
However, there are techniques (Continuous Quality Improvement) and theories 
(Diffusion of Innovation and Normalisation Process Theory) that may aid the 
implementation of these concepts into practice.  
 
Continuous Quality Improvement  
Quality improvement is not a new feature in health care. It dates back to the nineteenth 
century, with Ignaz Semmelweis introducing hand washing to medical care and 
Florence Nightingale identifying that poor living conditions were a leading cause of 
death (Chassin and Leob 2011). However, quality improvement in health care has 
developed significantly, with a systems approach used to describe and improve existing 
services termed Continuous Quality Improvement (CQI) (Radawski 1999). Thus CQI 
can aid the translation of national policy into practice. It is a philosophy of continual 
improvement of the processes associated with providing a service that meets or exceeds 
customer expectation (Shortell, Bennett et al. 1998). The basis of CQI is the assumption 
that problems in producing a quality outcome arise commonly due to poor job design, 
failure of leadership or unclear purpose, as opposed to lack of will, skill, or malign 
intention from those involved in the process (Graham 1995). Another premise of CQI is 
that of a blameless culture; establishing trust and respect and avoiding retribution are 
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advocated (Radawski 1999). Honest communication and collaboration about 
implementation and use of an intervention as well as flexibility to make changes to 
these procedures is also important in CQI. This gives health care professionals 
responsibility and empowerment in relation to an intervention. The NHS is now tasked 
to ensure that services are driven by a cycle of CQI that includes clinical aspects of care 
(Ferlie and Shortell 2001), making CQI an important factor for new services and 
palliative care in general.  In order to undertake CQI, revision of the way an 
intervention is performed is executed through examination of outcome data (Radawski 
1999). The goal of CQI is to understand and improve the underlying work processes and 
systems in order to add value, as opposed to correct individuals mistakes (Shortell, 
Bennett et al. 1998). Most studies evaluating CQI in clinical practice have reported 
favourable results, with quality and outcomes of care being improved (Shortell, Bennett 
et al. 1998). Thus CQI can be an aid to health care professionals using a new service 
that is implemented due to national policy and can be seen as a facilitator to new service 
diffusion in practice. 
 
Diffusion of Innovation  
Diffusion is a process where an innovation is communicated over time to and amongst 
the members of a social system (Rogers 1995) and can be thought of as a way to bridge 
the gap between policy and practice. It can be considered as a special type of 
communication as it is concerned with the spread of messages that are perceived as new 
and ideal. Diffusion is distinctive because of the novel idea in the message content, thus 
in health care some uncertainty and perceived risk must be associated with the new 
innovation that is to be diffused in practice (Rogers 1995). 
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New services or interventions require diffusion into practice in order to be successful, 
and the health care domain and its ability to implement and diffuse innovations has 
created great research interest (Greenhalgh, Robert et al. 2004, Länsisalmi, Kivimäki et 
al. 2006). The need for innovation in service delivery has been highlighted since the 
early 1980s (Hunter 1983), but the implementation of innovations still presents 
significant challenges (Barnett, Konstantina et al. 2011), regardless of their potential 
benefits. This is also despite the perception of health care organisations as the most 
knowledgeable and scientific based institutions (Barnett, Konstantina et al. 2011).   
The innovation decision process gives informative insight into how and why individuals 
adopt a new innovation. This process consists of five stages:  
1. Knowledge - when the individual is exposed to the innovation and understands 
how it operates.  
2. Persuasion - when the individual forms a positive or negative view of the 
innovation.  
3. Decision - when the individual engages in activities that lead to a choice to 
accept or reject the innovation.  
4. Implementation - when the individual puts an innovation into use. 
5. Confirmation - when the individual seeks confirming evidence for an 
innovation-decision already made. The individuals may change their decision if 
they are exposed to conflicting evidence about the innovation (Rogers 1995). 
This process highlights how individuals adopt new services, and thus how national 
policy can be adopted by front line staff. However, there are some criticisms of 
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diffusion research including the pro-innovation bias (Rogers 1995). This is the 
suggestion of most diffusion research that an innovation should be rapidly diffused to 
and adopted by all members of a social system, and that the innovation should not be re-
invented or rejected. This ethos is therefore counter to CQI which enforces that new 
services can be implemented differently and yield better (or potentially worse) results.  
Factors that can aid innovation diffusion can be perceived attributes of the innovation 
itself, such as relative advantage (Rogers 1995). Alternatively, innovation diffusion can 
be facilitated by key individuals, such as champions or opinion leads (Greenhalgh, 
Robert et al. 2004). Both perceived attributes of the innovation or key individuals may 
enhance the translation of national policy into practice.  
 
The five perceived attributes of innovations  
Rogers (1995) names five attributes of innovations that make it more likely to be 
adopted: relative advantage, compatibility, complexity, trialability, and observability.  
Compatibility is the degree to which an innovation is perceived as consistent with the 
pre-existing values, past experiences, and needs of potential users (Rogers 1995). An 
innovation can be compatible or incompatible with - sociocultural beliefs and values; 
formerly introduced ideas; or client prerequisites for the innovation (Rogers 1995). 
Complexity is the perceived difficulty of the innovation (Rogers 1995). Any new 
intervention can be situated on the complexity-simplicity continuum – some new 
innovations are clear to the potential users whereas others are not (Rogers 1995). 
Trialability is the degree to which an innovation may be experimented with on a limited 
basis (Rogers). An intervention that lends itself to a trial can be adopted more rapidly 
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than one that does not (Rogers). Observability is the extent to which the results of an 
innovation are visible to others (Rogers 1995). Finally, the last perceived attribute of an 
innovation is its relative advantage, which is the degree to which an innovation is 
perceived as being better than the preceding idea (Rogers 1995). Innovations that have a 
clear, unambiguous advantage in either effectiveness or cost effectiveness are 
implemented and adopted more easily (Greenhalgh, Robert et al. 2004). Thus for a new 
service to be implemented, health care professionals and other associated organisations 
who are involved with it will have to believe that it will make a difference to the care 
they provide to their patients. Greenhalgh, Robert et al. (2004) describe relative 
advantage as ‘sine qua non’ for adoption, without which potential users will not 
consider it further. Therefore it is a corner stone of any new innovation and can be 
considered as an aid when implementing new services or interventions. However, 
relative advantage in isolation is not enough to ensure the adoption of an innovation 
(Greenhalgh, Robert et al. 2004). 
The perceived attributes of an innovation state that if an innovation is comparable to the 
norms of those who use it, simple to use, trialable, observable and advantageous then it 
is more likely to be adopted into practice. Thus interventions aiming to diffuse key 
concepts from policies into practice may be more successful if they have these 
characteristics.  
 
Champions and opinion leads  
Greenhalgh, Robert et al. (2004) state that peer and expert opinion leaders and 
champions can have a particular influence on the beliefs and actions of their colleagues. 
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An opinion leader exerts influence through their representativeness and credibility and 
can have a positive or negative influence on how a new innovation is adopted (diffused 
into routine practice). A champion can aid innovation diffusion as they exert influence 
on others. A champion can be: 
1. The organisational maverick, who provides health care professionals with 
freedom from the organisations rules, processes, and systems in order to 
generate innovative solutions to current problems.  
2. The transformational leader, who creates support from other members of the 
organisation.  
3. The organisational buffer, who forms a flexible monitoring system to ensure that 
innovators properly use the organisation’s resources while still allowing them to 
act inventively.  
4. The network facilitator, who develops cross-functional partnerships within the 
organisation (Greenhalgh, Robert et al. 2004).  
Champions and opinion leads therefore could be pivotal in translating national policy 
into practice through new interventions or services. They provide support for others and 
could facilitate enhanced team work, coordination or communication.  
Both CQI and innovation diffusion literature highlights that these two roles could aid 
the translation of national policy into practice through the support they provide to health 
care professionals using a new service. They could therefore potentially contribute to 
overcoming some of the difficulties referred to in the previous section.  
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Normalisation Process Theory  
The Normalisation Process Theory (NPT) (May and Finch 2009) is a sociological 
theory that has been extensively promoted as a way to understand implementation, 
embedding and integration of innovations, especially in health care settings (McEvoy, 
Ballini et al. 2014). Thus it has been advocated as a means of bridging the translational 
gap between policy and practice (Murray, Treweek et al. 2010, Morrison and Mair 
2012, McEvoy, Ballini et al. 2014). The NPT emphasises the fluid, vigorous and 
interactive processes between context, actors and objects and is consequent of studies 
aiming to understand implementation of complex interventions in health care settings 
(McEvoy, Ballini et al. 2014). The NPT has four main theoretical constructs – 
coherence, cognitive participation, collective action, and reflexive monitoring.  
Coherence refers to the development understanding that individuals and organisations 
must work to achieve in order to promote or inhibit the routine embedding of a practice 
(Finch, Mair et al. 2012). Cognitive participation refers to the work that individuals and 
organisations have to do for individuals to register and engage with the new practice 
(Finch, Mair et al. 2012). Collective action is the work that individuals and 
organisations have to do to enact the new practice (Finch, Mair et al. 2012). Finally, 
reflexive monitoring is the appraisal of a new practice once it is in use, to assess its 
advantages and disadvantages.  
NPT is not concerned with the relationships between individual attitudes and intentions 
and behavioural outcomes and thus does not focus on how knowledge is created within 
or across professional groups (McEvoy, Ballini et al. 2014). However, similar to the 
Diffusion of Innovation (Rogers 1995), the NPT focuses on the legitimacy of the 
intervention and the role of opinion leads. Thus it explores understanding, trust and 
  
38 
 
interpersonal relationships within social networks as they impact on the implementation 
of an intervention (Doumit, Wright et al. 2011, Harris, Provan et al. 2012). 
 
Summary of aids to translate policy into practice  
CQI, diffusion of innovation and NPT are all concepts that can explain, and in some 
cases, aid the diffusion of policy into practice. They offer explanatory potential as to 
why some interventions are not adopted by practice or why they are only adopted by 
some organisations and not others.  
 
Chapter Summary 
Palliative care has been termed since the 1970s and is gaining increasing significance in 
health care. However, there are still prominent barriers to the implementation of 
palliative care in practice related to disease type (cancer or non-cancer), health care 
professional ethos and the constraints of systems created to ‘cure’ people. This is 
understandable given the complexities of palliative and end-of-life care (Vissers, van 
den Brand et al. 2013). It is currently not explicitly known how these barriers affect the 
care that is provided in practice. However, in order to provide preference based 
palliative care, these barriers must be overcome. The literature indicates that most 
patients would prefer to die at home. However, a home death requires discussions and 
planning, which are often stunted by the societal taboo of death and dying. Efforts have 
and are still being made in breaking down this taboo by the public, through the media 
and policies related to palliative and end-of-life care. National guidance strongly 
advocates the use of proactive care, patient centred care and shared decision making to 
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provide high quality, preference based palliative and end-of-life care. Although these 
philosophies are of good standing and can result in positive outcomes for patients, they 
can be difficult to implement in primary care. There are some theories and tools that can 
be used to understand and, in some cases, improve, the implementation of interventions 
into practice including CQI, diffusion of innovation and NPT.  
The next chapter describes how ICPs can structure palliative and end-of-life care and 
aim to provide proactive, patient centred care using shared decision making. The 
chapter will describe an ICP and explore one of the most well-known ICPs related to 
end-of-life care. ICPs in palliative care will be described and the ICP under study in this 
thesis will be explored in detail.  
 
 
  
40 
 
 
Chapter 2: Integrated Care Pathways 
 
A detailed explanation of ICPs will be provided including how they are defined and 
described in the literature. Following this, the ICP implemented in the locality will be 
described in full, including the locality and GP practices’ characteristics, the 
commissioning process and all the tools that can be used within the pathway. Published 
research will then be used to highlight what is known about ICPs in palliative care and 
identify a clear gap in the literature regarding underlying generative mechanisms.  
 
What is an integrated care pathway?  
To meet patients' needs as stated in national policy, a whole-systems approach is 
required which co-ordinates care across professional and organisational boundaries 
(Addicott and Ross 2010). ICPs offer a system of multidisciplinary care planning based 
around the principle of clinical audit and on the understanding and practice of clinical 
staff, which facilitate the management of defined patient groups with a specific clinical 
problem (Hotchkiss 1997, Campbell, Hotchkiss et al. 1998, Atwal and Caldwell 2002). 
They have been formulated as a strategy, thus provide a potential link between the 
publication of national guidelines and their implementation in  local clinical practice 
(Campbell, Hotchkiss et al. 1998). Therefore an ICP can reasonably be expected to 
constitute an effective tool for the translation of proactive care, patient centred care and 
shared decision making into practice.  
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ICPs aim to: reach or exceed existing quality standards; improve multidisciplinary 
communication, health care professional-patient communication and patient 
satisfaction; reduce unwanted practice variation; and enable new staff to learn key 
interventions for specific conditions quickly (Campbell, Hotchkiss et al. 1998). 
Furthermore, they are a strategy for improving the collection and analysis of clinical 
data from practice in order to promote change (De Luc 2001).  ICPs are primarily 
considered to be tools for designing care procedures, implementing clinical governance, 
unifying delivered care, improving the quality of clinical care, and ensuring that clinical 
care is based on current evidence (Riley 1998, De Luc 2001). They can consist of one 
document acting as a care plan, detailing the essential steps in the care of patients with a 
specific clinical problem, and offering description of expected progress (Campbell, 
Hotchkiss et al. 1998, Chan and Webster 2010). However, a palliative care ICP of this 
format would be very difficult to formulate for all palliative care patients due to the 
great variety of conditions and needs. Yet all palliative care patients have underlying 
similarities in needs that require attention from health care professionals; most 
prominently the need to plan for a good death which can be achieved through the use of 
proactive care that is patient centred through use of shared decision making. Thus the 
ICP studied here uses an advance care plan as one of a number of potential resources (as 
described in full later in this chapter). Although it is not validated, Croucher’s work 
(2005) provides a helpful set of criteria to frame the service provided in this study. To 
be considered an ICP a service must be:  
•  A plan of expected clinical care – this is in all the documentation and 
information in the service being evaluated 
•  On some form of timeline, whether that is days, hours or stages.   
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• A multidisciplinary document. 
• The actual clinical record.  
• Based on evidence-based guidelines.  
• A system to review performance.   
• Able to cross organizational boundaries.  
• An evolutionary and dynamic tool that is therefore never cast in stone (Croucher 
2005).  
Thus the palliative care ICP in this study is a long term integrated service that includes 
aspects of the traditional ICP but has been edited to work with the palliative care patient 
population. Due to meeting most of the criteria described by Croucher (2005) and the 
term ICP encompassing the general approach of the service this study evaluates, the 
service will be referred to as an ICP throughout the thesis.  
ICPs provide benefits which lead to patient centred care, increased patient satisfaction, a 
reduction in documentation and inappropriate lengths of stay in secondary care 
(Kitchiner and Bundred 1996, Hotchkiss 1997). Use of ICPs can reduce errors and 
ineffective clinical practice, therefore improving outcomes (Kitchiner and Bundred 
1996). However, there are concerns about ICPs and barriers to their implementation. 
These include discouragement of clinical judgement of individual cases, restriction of 
innovation, and the requirement of guidance, energy, high quality communication and 
time for successful implementation (Campbell, Hotchkiss et al. 1998). Other barriers to 
implementation include reluctance to change, lack of suitable evidence based 
guidelines, inadequate resources to develop guidelines locally, disruptive interpersonal 
politics, lack of recognition of the need for improvements in the quality of care, 
difficulty in identifying cost savings, insufficiently informed leader or a leader who is 
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not of high enough standing within the organisation (Campbell, Hotchkiss et al. 1998). 
ICPs for palliative and end-of-life care management are used widely around the world 
and have been regarded as the gold standard (Chan and Webster 2010). They have also 
been set as the main part of the End of Life Care Strategy in the UK (Department of 
Health 2008) and are part of the NHS’s GSF (Thomas 2003). ICPs provide a key tool in 
translating policy into practice but practitioners nevertheless have been reported to face 
some implementation barriers (Campbell, Hotchkiss et al. 1998).  
 
 
The Liverpool Care Pathway for the Dying Patient  
Historically dying patients received insufficient attention from senior medical staff and 
nursing staff, and experienced inadequate symptom control (Mills, Davies et al. 1994). 
This prompted the development of the LCP, the most well-known ICP in palliative and 
end-of-life care in the UK for the dying phase of palliation (Chan and Webster 2010). 
The LCP was developed by the Royal Liverpool University Trust and the Marie Curie 
Centre Liverpool to transfer the high standard of hospice care to secondary care 
(Ellershaw, Foster et al. 1997, Ellershaw and Ward 2003). It is a standardised approach 
to care for dying people which is intended to ensure that consistently good care is given 
to everyone considered to be dying within a maximum of three days, regardless of 
location (hospital, nursing homes, own home) (Ellershaw and Murphy 2005, Neuberger, 
Aaronovitch et al. 2013). The LCP monitors not only the physical care of a dying 
patient, but also addresses their psychosocial and spiritual needs such as the religious 
and spiritual aspects of care (Ellershaw, Gambles et al. 2007, Veerbeek, van Zuylen et 
al. 2008) Other objectives of the LCP are to encourage cost-effective health care 
through appropriate prescribing, and avoiding crisis interventions and inappropriate 
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hospital admissions (Chan and Webster 2010). The document was developed from 
surveys, focus groups, expert opinion and consensus on best practice, with an aim of 
being patient centred and addressing holistic care needs. The LCP defines nineteen 
goals considered essential in the management of dying patients and for the care of their 
relatives and carers after death (Ellershaw, Foster et al. 1997, Ellershaw and Ward 
2003).  After the development of the LCP numerous other groups developed ICPs for 
the dying based on similar principles (Pooler, McCrory et al. 2003, Fowell, Russell et 
al. 2004, Bookbinder, Blank et al. 2005). Due to substantial criticism including claims 
of premature diagnosis of imminent death, the LCP masking signs of improvement in 
patients, and dissatisfaction from carers and family members (Delvin 2009, Smith 
2009), the LCP was subject to an independent review in 2013 (Neuberger, Aaronovitch 
et al. 2013). This report concluded that there was poor understanding among health care 
professionals of existing guidance in care for the dying and a need for improved skills 
and competencies was identified. Furthermore, there was a reluctance to discuss the 
prospect of death and its clinical uncertainties with patients, their relatives and carers 
(Neuberger, Aaronovitch et al. 2013) due to a lack of openness and candour among 
clinical staff. A lack of compassion was also highlighted, and a need to put the patient, 
their relatives and carers first, treating them with dignity and respect was elected as 
pivotal for future care of the dying. This echoes the principles explored in the previous 
chapter (Chapter 1, p.6) regarding the difficulties of translating policy and evidence in 
to practice due to difficulties surrounding communication in palliative and end-of-life 
care.  
The difficulties described resulted in the decision to ‘phase out’ the LCP across the 
NHS, with a replacement service for end-of-life care currently being developed. The 
  
45 
 
national and regional guidance for the care of patients in the last three days of life is that 
the ‘proper’ use of the LCP (or its equivalent) should continue until new care planning 
tools are introduced (Appendix 1). Thus, the locality health care professionals now 
explain the pros and cons of the LCP to patients and their family members and they 
make a decision as to whether they would like to have the LCP or not. If the patient or 
their family members (making a decision through best interests) chooses not to have the 
LCP, health care professionals ensure that the patient still receives the same standard of 
care (that identified within the LCP) and discuss all relevant care decisions with 
relatives. This illustrates the highly sensitive national debates which form the backdrop 
to this study.  
One limitation of the LCP is its usability only in the three days prior to death; this 
doesn’t sufficiently fulfil the need for proactive care, which should occur much earlier 
in the illness trajectory. However, it is important that end-of-life care is given unique 
attention, which the LCP, or other end-of-life ICPs which focus on the last three days of 
life, can do. They are part of palliative care, which includes the end-of-life phase and 
thus many palliative care ICPs use the LCP for end-of-life care. A Cochrane systematic 
review aimed to assess the effects of end-of-life care ICPs (including the LCP) in 
comparison to usual care or care guided by another ICP (Chan and Webster 2010). The 
study aim was to focus on the impacts of end-of-life care ICPs on symptom severity and 
quality of life for the patient, their family and carers, and health care professionals. The 
authors planned to include randomised controlled trials (RCTs), cluster RCTs and quasi-
RCTs. The initial literature search identified 920 potentially relevant titles, but no 
studies met criteria for inclusion in the review. The review concluded that there was 
insufficient evidence to make recommendations regarding the use of such end-of-life 
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care pathways for the dying. However, the inclusion and exclusion criteria for this study 
were very stringent, and the study focussed on whether these interventions work. 
Furthermore, there are ethical issues associated with RCT designs when focusing on 
patients at the end-of-life; randomising patients to a study arm that does not include an 
intervention which many clinicians believe to be effective (Chan and Webster 2010). 
The LCP is an inherently complex intervention, with human factors playing an 
important part that are difficult to control for. The outcome measures in the study were 
physical symptom severity, memorial symptom assessment, psychological symptom 
severity, quality of life, and harms, all of which are extremely difficult to assess during 
the end-of-life phase, especially as the patient can be unconscious or sedated. The 
traditional RCT design has not yielded the outcomes needed to make informative 
decisions about end-of-life care ICPs effectiveness or worth.  
Studies using research designs which do not match Cochrane review inclusion criteria 
can however provide informative results - Bailey, Burgio et al. (2005) implemented an 
end-of-life care intervention in a tertiary care Veterans Affairs medical centre. The 
intervention included staff education and support to identify dying patients and 
implement care plans for the last days or hours of life. The study found the intervention 
resulted in significant increases in the mean number of symptoms documented, the 
mean number of care plans, opioid medication availability and Do Not Attempt 
Cardiopulmonary Resuscitation (DNACPR) forms. This palliative care intervention 
improved outcomes for those with end-of-life care needs. Similarly, Veerbeek, van der 
Heide et al. (2008) investigated the effect of the LCP on the documentation of care, 
symptom control and communication, in hospitals, patients’ homes and nursing homes. 
The study found that in comparison to the baseline period, when the LCP was used the 
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documentation of care was more comprehensive and symptom burden was significantly 
lower. Thus both studies found that end-of-life ICPs have the potential to improve 
symptom management. Other studies assessing end-of-life ICPs found improvements in 
clinical documentation and assessment (Bookbinder, Blank et al. 2005, Luhrs, Meghani 
et al. 2005, Veerbeek, van der Heide et al. 2008), knowledge of end-of-life care 
amongst internal medicine students (Okon, Evans et al. 2004), prescription of 
medications for end-of-life (Bailey, Burgio et al. 2005, Mirando, Davies et al. 2005) and 
bereavement levels for relatives (Veerbeek, van Zuylen et al. 2008). Whilst these do not 
provide irrefutable proof of ICPs effectiveness at the end-of-life, they nevertheless 
present themselves as promising. 
 
The Integrated Care Pathway under study 
The locality that the primary care based palliative care ICP is implemented in covers a 
predominantly semi-rural and rural geographical area in the North East of England. The 
business cases initially proposed in 2008 and 2009 for the ICP by the Locality Practice 
Based Commissioning Group were developed and delivered in line with the national 
strategies on ACP and end-of-life care (Department of Health 2008). This strategy 
encourages all health and social care services to acknowledge and value high quality 
care in the final years of life. It also emphasises a co-ordinated pathway approach. Key 
components in the palliative and end-of-life care journey should be: to identify 
individuals approaching end-of-life; to assess and agree how needs and preferences of 
patients can be met through use of ACP; well planned and coordinated care; provision 
of high quality services regardless of location; managing the last days of life; supporting 
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families and carers. The eleven point action plan developed by the locality was as 
follows:  
1. Palliative care registers needed to be developed that were meaningful and 
resulted in actions.  
2. Planning (ACP) needed to define patients’ preferences. 
3. Capacity to provide home care needs to increase.  
4. 20% of deaths in the locality occur in care homes, the care is currently reactive 
but needs to be proactive (‘care home’ will be used as a collective term to refer 
to nursing homes, care homes and residential homes, from here on in this thesis. 
This is because the data used in analysis does not allow for differentiation 
between the different types of care homes). 
5. Deaths in hospital are at around 47% which is suboptimal. 
6. OOH services need to be integrated.  
7. Ambulance services need to be integrated.  
8. Standards should adhere to the GSF. 
9. Data on performance was required which could be feedback to practices.  
10. Education and training was needed for all health care professionals using the 
ICP.  
11. A pathway must be created through commissioning to allow capacity & 
alternatives in providing palliative care.  
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In line with the End of Life Care Strategy (Department of Health 2008), the aim of the 
ICP business case (prompted by the eleven point plan) was to provide proactive and 
patient centred care. This was via an improved range of services which result in the 
early identification of those with terminal conditions, the opportunity to discuss and 
plan care, thus resulting in high-quality palliative and end-of-life care across all terminal 
conditions, regardless of diagnosis.  Previously in the locality, palliative care had 
focused on people with cancer diagnoses and palliative care registers were poorly 
developed and not used in a purposeful way. This was due to a number of reasons: 
terminal cancer diseases are easier to identify, cancer trajectory has a more predictable 
course (than in non-cancer conditions), and cancer registers were available in some 
practices that allowed these patients to be closely monitored. The premise of the ICP 
developed was that patients with life limiting illnesses should be identified early and at 
a point in their illness when active treatment is no longer likely to extend their life, but 
while their need for medical, nursing and social care input is relatively low. These 
patients should then be placed on the practice palliative care register, which should 
trigger the offer of ACP. This ACP should result in shared decision making about 
preferences for the end-of-life, which can then be documented, thereby encouraging 
choice, implementing planning and making home, care home and palliative care unit 
deaths more viable. This ICP is thus an implementation of the three key concepts 
identified in the palliative care policies: proactivity, patient centeredness and shared 
decision making.  
Once the ICP was designed a large multidisciplinary education event was held, at which 
the theory and practicalities of ACP in relation to end-of-life care were discussed. 
Feedback regarding the proposed ICP and documentation was collated and utilised to 
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refine the ICP, meaning that it was tailored to local needs and therefore there was a 
strong sense of ownership of the ICP from those who were going to implement it. The 
event was attended by sixty individuals representing members of primary health care 
teams, secondary care, voluntary sector organisations, patients and carers. The ACP 
document designed by the locality was passed to the Medical Protection Society for 
medico-legal comment. Further development of the ICP through feedback from the 
various stakeholders was also sought. The local urgent care services and local 
ambulance service were both informed about the ICP.  
Initially, twelve primary care practices agreed to implement the ICP in April 2009. Two 
additional practices joined at a later date, thus the ICP involved a total of fourteen 
primary care practices. This meant that the population covered increased from 60,000 in 
2009 to 78,000 in 2010. A Local Enhanced Service (LES) was developed to encourage 
GP practices to take part in the project. This LES rewarded practices for setting up the 
necessary systems, allocating more time to visiting patients in their own homes, for 
attending education sessions and for agreeing to return practice information and 
feedback questionnaires. Each GP practice was paid an initial sum of £750 to sign up to 
participate in the ICP.  The ICP is still in place and still coordinated by a 
multidisciplinary steering group that has service user involvement.  
The new ICP for those with life limiting illnesses requiring palliative care involved six 
newly commissioned services: advance palliative care registration, palliative care 
incentive scheme, ‘Hospice at Home’ care (from a local registered charity), three 
community palliative care beds in a local care home, two sessions of medical cover per 
week for these beds, support from a local charity to provide complementary therapies to 
those in the community palliative care beds. The three community palliative care beds 
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were commissioned as an alternative to hospital admission, to widen choice and to offer 
a pragmatic hospice, as all hospice provision prior to this was approximately eighteen 
miles away from the locality. A wide range of appropriate services is pivotal in 
maintaining patients’ quality of life (Ellershaw and Ward 2003, Agar, Currow et al. 
2008). 
Unfortunately the two-year pilot was not fully funded to continue. The third sector 
organisations (Hospice at Home charitable organisation and complementary therapy 
local charity) and the three community palliative care beds at the local palliative care 
unit were not initially re-commissioned. However, public campaigning led to the re-
commissioning of two of the palliative care beds with reduced funding for these beds; 
medical cover for these beds; the charitable organisation providing Hospice at Home 
support had its funding cut from pilot level but would remain above baseline for the 
following year. Advance palliative care registration and the palliative care incentive 
scheme were continued. This highlights how the ICP is not a static intervention; it 
evolved in response to local commissioning stimuli. The palliative care incentive 
scheme includes several interventions: preference discussions, ACP, OOH notifications, 
MDT meetings, the traffic light system of wellbeing (adapted by the ICP founder for the 
locality from the GSF), use of anticipatory medication, and use of the LCP. All of which 
are described in detail below. Additionally, Palliative Care Quality Visits (PCQVs) to 
GP practices were carried out by the founder of the ICP, to ensure ICP diffusion and 
implementation. Thus the ICP has multiple components and is implemented by many 
different people in different job roles and is inherently complex.  
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Advance palliative care registration  
Palliative care registrations consist of a confidential list in each GP practice, which 
details the patients who require palliative care. A patient should be considered as 
requiring palliative care if they have a life limiting illness and active treatment is no 
longer likely to extend their life. Health care professionals from the locality assess this 
by using ‘the surprise question’, adapted from the GSF as part of their prognostic 
indictor (Department of Health 2008, The National Council for Palliative Care 2009, 
The National Gold Standards Framework Centre 2009, NHS North East 2012). The 
surprise question asks, “Would you be surprised if the patient were to die in next six 
months?” Use of the palliative care register has resulted in early identification 
(proactive care), planning and co-ordinated care nationally (Omega: the National 
Association of End of Life Care 2010). Ideally, advance palliative care registration 
should occur when the patient’s need for medical, nursing and social care is still 
relatively low and whilst their symptoms are not severe. By strengthening practice 
palliative care registers, patients who require palliative care can be identified and health 
care professionals can plan with the patient in a more effective and efficient way for the 
future when their care needs increase. Palliative care registrations should trigger 
preference discussions and ACP.   
 
Preference discussions and advance care planning  
Preference discussions are carried out using shared decision making and elicit patients’ 
preferences for care when they have been identified as requiring palliative care. As part 
of the palliative care incentive scheme, these preference discussions should be recorded 
formally. At the start of this PhD the advance care plan was one document that was 
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developed by the locality. Throughout data collection this has changed, according to the 
local Deciding Right (2012) documentation. ACP is now used as an umbrella term and 
refers to the process of documenting preferences which can include the use of four 
independent documents: the advance statement, the DNACPR form, the advance 
decision to refuse treatment (ADRT) and the emergency health care plan (EHCP) or 
Personal Welfare Lasting Power of Attorney (PW-LPA) including health (all described 
below). ACP is now centred on shared decision-making, with these documents as an 
outcome of a preference discussion between a patient and a health care professional. 
Regardless of the outcome of ACP (advance statement, DNACPR form, ADRT or 
EHCP) it should be a process of voluntary discussion and review to help an individual 
anticipate how their condition might affect them in the future and identify their 
preferences in different situations (NHS North East 2012). It is important to note that all 
of the outcomes from these documents are invalid whilst the person retains capacity for 
those decisions, and none of these documents can be used with individuals who do not 
have capacity according to the Mental Capacity Act (Justice 2007, NHS North East 
2012). Furthermore, an automatic and rigid approach to ACP should be avoided; the 
patient should be willing to engage in ACP for it to be successful and to avoid distress.  
 Advance statement 
The advance statement is a document that is written by the patient to clarify and 
document their wishes, feelings, beliefs and values about their future care (Deciding 
Right, 2012). This document is not legally binding but will be taken into account by 
health care professionals and carers if the person is to lose capacity in the future.  
 Do Not Attempt Cardiopulmonary Resuscitation form  
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The DNACPR form is a document that a person can have if they do not wish to have 
CPR. It is the most frequently used document in ACP and has the advantage of 
simplicity as it only addresses one decision. However, this also means that the 
document is inflexible in complex situations (NHS North East 2012). The form needs to 
be from the Deciding Right documentation to be accepted by the North East Ambulance 
Service and must be present in the person’s home and valid (in date, signed and 
witnessed). CPR decisions should only be made for those whom they are appropriate 
for; those who have capacity for that decision where an arrest is anticipated and CPR 
could be successful.  
 Advance Decision to Refuse Treatment  
The ADRT is a legally binding document that states the refusal of a specific treatment 
regarding a person’s future care if they should lose capacity to make this decision. To be 
legally binding it must be valid and applicable to the circumstances. Because of the time 
needed to evaluate the validity and applicability of an ADRT, they are not always 
supportive in acute emergencies that require immediate treatment, but must be adhered 
to when time allows (Deciding Right, 2012). The ADRT has now replaced the Living 
will.  
 Emergency Healthcare Plan 
The EHCP is a care plan covering the management of an anticipated emergency 
(Deciding Right, 2012).  
 Personal Welfare Lasting Power of Attorney including health 
A PW-LPA including health is also an outcome of ACP. A PW-LPA including health 
acts according to a patient’s best interests, which is the bringing together of health or 
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social care professionals’ and the individual’s understanding and opinion of the 
proposed care. For those who do not have capacity the MCA (2007) provides 
information on how a best interest decision should be made.  It can be used in life 
sustaining treatment decisions, but only supersedes the ADRT if it was appointed after 
the ADRT was made by the individual and if the conditions of the PW-LPA including 
health cover the same issues as stated in the ADRT (Deciding Right, 2012).  
 
Home and hospice care 
Three community palliative care beds were commissioned as part of the ICP in a local 
care home as an alternative to hospital admission, to widen choice and to offer hospice 
care in a palliative care unit, as the nearest hospice prior to this was approximately 
eighteen miles away from the locality. Two medical cover sessions per week for these 
beds were also commissioned with support from a local voluntary organisation to those 
in the community palliative care beds. Increased capacity to support home care was also 
commissioned from a Hospice at Home organisation. This charity includes a team of 
registered nurses and health support workers who fill gaps in care, provide respite sitters 
and night care. The ICP ensured the appointment of a lead nurse to assure that clinical 
governance issues were being identified and managed. 
 
Out of Hours notifications  
OOH notifications are alerts that are sent to the local GP OOH service to make them 
aware that a person is on the palliative care register.  
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Traffic light system 
The traffic light system of wellness was created by the locality to encourage patient 
centred, appropriate and timely care, taking inspiration from the GSF needs based 
coding that consists of five colours. The locality traffic light system has only three 
colours: green, amber and red. A patient is considered within the green section of the 
system when they are thought of by health care professionals as being at a point where 
active treatment is no longer likely to extend their life, even if they appear to be 
relatively well and have few symptoms. The amber section of the system is for patients 
who have begun to deteriorate. The red section of the system is for the final days and 
hours of life. The traffic light system also acts as a prompt to health care professionals 
to ensure that additional measures such as facilitating access to financial benefits 
(green), providing anticipatory medication (amber) and initiation of the LCP (red) are 
implemented (when data was collected the LCP was nationally used, currently the 
patient or their family decide on the care the patient receives. See the section above on 
the LCP, p.43).  
 
Multidisciplinary Team Meetings 
A MDT within the ICP consists of professionals who work in the community and the 
GP practice. A MDT meeting will involve the discussion of palliative care patients 
identified using the palliative care register and manage complex problems associated 
with palliative care guided by the traffic light system of wellness. A palliative and end-
of-life care MDT team meeting should occur regularly to discuss progress with patient 
care and treatment options. Most practices include this as part of their general clinical 
meeting.  
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Anticipatory care medication  
This is medication that can be used to aid end-of-life symptom control; it is provided 
proactively prior to actual need so that these medicines can be administered to the 
patient if required without delay, especially at night, at weekends or over bank holiday 
periods. Anticipatory medication can be provided for patients who are currently being 
cared for at home, in a care home or in a community palliative care bed and can be 
administered subcutaneously by health care professionals for nausea, sickness, pain, 
respiratory secretions or agitation (Pellett 2009). 
 
The Liverpool Care Pathway for the Dying Patient  
In the UK, the LCP was created to transfer the high standard of hospice care to 
secondary care (Ellershaw, Foster et al. 1997). The LCP is a standardised method to 
monitor the care of a dying person, considering their physical, psychosocial and 
spiritual needs (Veerbeek, van Zuylen et al. 2008). As previously discussed, the LCP is 
now being phased out in the NHS as a result of the government’s acceptance of an 
independent report (Neuberger, Aaronovitch et al. 2013). However, data collection for 
this study began in February 2012, thus preceding the publication of this report. 
Therefore this thesis will refer to the LCP and report outcomes related to it.  
 
Palliative Care Quality Visits – Continuous Quality Improvement  
PCQVs promote CQI and are carried out by the ICP’s founder. These clinical 
governance visits consist of a visit to the GP practices’ MDT meetings to feedback data, 
discuss the practice’s performance, discuss how the practice staff would manage a 
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fictional palliative care patient from diagnosis to death, talk about difficult issues 
experienced when using the ICP and identify and provide potential solutions for 
common problems. Thirteen out of fourteen GP practices involved in the ICP have 
received a PCQV. Additionally it allows for insight into how each individual GP 
practice interprets, adapts to and uses the ICP. 
The service delivered in the locality and evaluated in this study qualifies for the title of 
ICP in all domains but that of it being one document. The ICP facilitates the 
introduction of multidisciplinary guidelines into routine practice and is based on clinical 
experience from recently treated patients with the same condition (Kitchiner and 
Bundred 1996). Members of the health care team using the ICP may stray from it, but 
this must be justified clinically. This encourages adherence to the ICP and its supporting 
national guidelines therefore decreasing variations in the care that is provided (Kitchiner 
and Bundred 1996). The ICP has a founder who developed and facilitated the 
introduction, implementation, professional education and review of patients’ progress. 
The founder also analysed variations from the ICP implementation modes in order to 
make appropriate revisions, ensuring it had flexibility to integrate best practice 
exemplars (Kitchiner and Bundred 1996). Furthermore, the ICP under study meets the 
criteria stated on the ICP key elements checklist, developed by Croucher (2005) and 
detailed above (p.41). The creation of this ICP also avoids the ‘tick box’ criticisms that 
some ICPs face, such as the LCP (Stocker and Close 2013). 
This concludes the description of the ICP and its component parts. The next section 
focuses on the current literature surrounding ICPS in palliative care.   
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Evidence of Integrated Care Pathway effectiveness in palliative care 
While end-of-life care is concerned with the last days and hours of life (Lunney, Lynn et 
al. 2003), palliative care focuses on "the quality of life of patients and families who face 
life-threatening illness, by providing pain and symptom relief, spiritual and 
psychosocial support from diagnosis to the end of life and bereavement" (Chan and 
Webster 2010, World Health Organisation 2014). Palliative care ICPs are less visible in 
the literature than end-of-life ICPs (such as the LCP), due to the unpredictable nature of 
palliative care and variability in diagnosis and prognosis. Several searches of the 
literature databases CINAHL (CINAHL 2013) and Web of Knowledge (Web of 
Knowledge 2013) were conducted to identify palliative care ICP evaluations. The core 
terms ‘palliative care’, ‘service*’, ‘pathway*’, ‘integrated care pathway*’, ‘preferred 
place of care’, ‘home death*’, ‘communit*’, and ‘evaluat*’ were entered either 
singularly or in combination. Titles and abstracts were screened for original research 
with adult palliative care patients in Western contexts evaluating an ICP, service or 
pathway implemented by primary care or a care home. The following discussion is 
based on these literature searches, snowballing searches of bibliographies and reference 
lists as well as RSS feeds of relevant journals.  
Smith (2012) found that the palliative care needs of patients with advanced heart failure 
were not being adequately addressed in the locality through use of a baseline audit of 
services. The audit included the number of patients who had been referred to specialist 
palliative care services, had discussions around anticipatory care planning, had a 
documented preferred place of care and had a documented actual place of death. A 
MDT process mapping event highlighted issues with the current service provision and 
identified the aims and scopes for the project: the development of a palliative care 
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pathway for end-stage heart failure patients, collaboration between clinicians, managers, 
commissioners and patients to enable patient choice and access to palliative care 
services both in hospital and the community. A steering group was established including 
clinicians, managers, patient representatives, ambulance service representatives, local 
palliative care teams and the cardiac network. Secured funding allowed a palliative care 
clinical nurse specialist to work collaboratively on the service with the heart failure 
nurse specialist. Outcomes of this collaboration were joint visits to patients and an 
increased understanding of job roles. Several tools were created for the new service. 
The GSF (The National Gold Standards Framework Centre 2009) was used to develop a 
‘cause for concern’ trigger tool that aided community heart failure nurses to identify 
patients with advanced diseases who may require palliative care. This is similar to the 
surprise question used in the ICP under study. The health care professionals in the study 
could then discuss these patients who they were concerned about at the newly 
established advanced heart failure multidisciplinary forum, with a view to improving 
patient care and reducing hospital admissions. A patient and carer assessment (PACA) 
tool was developed from the GSF (The National Gold Standards Framework Centre 
2009) for use by community heart failure nurses to facilitate holistic assessment. This 
tool also contained referral criteria for specialist palliative care. An aide-mémoire was 
developed to trigger conversations with patients and assist symptom management or 
end-of-life care.  Out of Hours (OOH), GP and Ambulance Service palliative care or 
end-of-life forms were used to highlight identified patients to the services. A regular 
collaborative cardiorespiratory and palliative care nurses meeting was established that 
included teaching sessions as a forum to improve communication and discuss complex 
cases. A red folder containing relevant information for all of the services involved in the 
patient’s care (when being cared for in the community) was left in each patient's home. 
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Finally, the heart failure nurse specialist assumed the role of key worker, liaising with 
other health care professionals involved in the patient’s care.  
The introduction of these tools into clinical practice was expected to improve 
coordination between acute and community clinicians and palliative care nurses. A 
second audit (of the same criteria as the first) executed eighteen months post 
implementation identified: improved access to palliative care for advanced heart failure 
patients; improved choices at the end-of-life (more patients dying in their preferred 
place of care); provision of holistic heart failure service spanning referral to palliative 
care and then end-of-life. The main difficulties highlighted within this study were the 
challenge of working collaboratively across services and job roles, and ensuring 
patients’ wishes were communicated to all relevant health care professionals. However, 
this study highlights that improvements in communication and multidisciplinary 
collaboration have resulted in better access to palliative care services for patients and 
more choice with an increased number of patients dying in their preferred place of care. 
Although the study identifies positive outcomes, it does not explain why they might 
have occurred. The aim of the intervention was to increase coordination between 
services, but this is highlighted as one of the challenges, thus this may not be the 
explanation for the outcomes observed. The resources used in this ICP need to be 
identified in order to understand why the health care professionals involved changed 
their behaviour, resulting in the outcome of improved access to palliative care services 
and increased home deaths.  
Reymond, Israel et al. (2011) implemented the residential aged care end-of-life care 
pathway (RAC EoLCP). This care pathway involved the promotion of: ACP, proactive 
care, multidisciplinary management of residents (patients) and their family members, 
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death in current residence (care home), optimal symptom management and increased 
competence in managing palliative care cases. Those working in the care home were 
also given palliative care training to enhance their care capacity. The implementation of 
the RAC EoLCP resulted in 98.3% of residents dying in their place of choice (the care 
home) and significantly less hospital admissions in comparison to those not on the RAC 
EoLCP. Staff perceived an improvement in their satisfaction with, and quality of, 
palliative and end-of-life care provided by the care home after the introduction of the 
RAC EoLCP. One staff member reported that, “before (RAC EoLCP implementation) 
staff had little training in palliative care and sometimes were very scared of caring for 
the dying” (Reymond, Israel et al. 2011). Bereaved relatives evaluations of palliative 
and end-of-life care did not increase from the pre-implementation to post-
implementation phase; satisfaction remained consistently high. Thus, Reymond, Israel 
et al. (2011) highlight that training leads to increased use of ACP and LCP, however 
they do not explicitly identify the tools (although it could be assumed to be ACP and 
LCP) or thought processes of individuals implementing the new service. Furthermore, 
they do not refer to the context of this intervention. The same positive outcomes may 
not have been achieved if this were an intervention outside of a care home or if the 
recipients of the training had not seen the relative advantage of the new service. 
However, outcomes of this study indicate that palliative care ICPs that have a focus on 
ACP and multidisciplinary working can facilitate death in the patients’ current place of 
residence.  
A three year non-blinded randomised controlled trial took place to compare the effects 
of early palliative care integrated with a standard oncology care service in comparison 
to standard oncology care alone, for newly diagnosed metastatic non-small cell lung 
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cancer patients (Temel, Greer et al. 2010). Patients assigned to the early palliative care 
integrated with standard oncology care service met with a member of the palliative care 
team within three weeks of enrolment and at least monthly thereafter in an outpatient 
setting till death. Additional visits were scheduled at the discretion of the patient. 
Meetings focused on the assessment of physical and psychological symptoms, founding 
goals of care, helping with individual decision making regarding treatment and 
coordinating care. Patients in the palliative care integrated group had a higher quality of 
life in comparison to the control group (standard oncology care), as measured by the 
Functional Assessment of Cancer Therapy–Lung (FACT-L) scale. Of the patients who 
died, those in the standard oncology care group had more aggressive treatment. Despite 
receiving less aggressive treatment palliative care group patients survived longer. 
Finally, more patients in the palliative care group had resuscitation preferences 
documented. Again, this palliative care ICP documents positive outcomes for those in 
the intervention group. However, the study does not identify what factors explain the 
choice of patients in the intervention group to have less aggressive treatment.  
Bakitas, Lyons et al. (2009) conducted a RCT for nearly 5 years with patients who had 
advanced cancer. It is rare to find an RCT in this domain that is so long term; this is an 
asset to the study. Patients were randomly allocated to receive either standard care 
(n=161) or a multicomponent, psycho-educational intervention: Project ENABLE 
(Educate, Nurture, Advise, Before Life Ends) (n=161), implemented by advanced 
practice nurses. The intervention consisted of four weekly educational sessions and 
monthly follow-up sessions until death, which encouraged patient activation, self-
management, and empowerment. Patients who received the intervention had higher 
scores for quality of life and mood than those receiving usual care. However, they did 
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not have improvements in symptom intensity scores or reduced days in hospital visits. 
No details are provided as to why intervention group patients’ quality of life or mood 
improved apart from that they had educational sessions. The content of these sessions is 
described but no description of what elevated mood or quality of life specifically is 
provided.  
 
Implementation of the Gold Standards Framework to enhance palliative care 
services 
Many studies describe implementation of the GSF; a systematic, evidence-based 
approach to aid health care professionals in identifying patients in the final years of life, 
assessing their needs, symptoms and preferences and planning care on that basis and 
empowering patients to live and die where they choose (The National Gold Standards 
Framework Centre 2009). It supports care pathways that are patient and carer centred 
(Thomas 2003, Pellett 2009). Hockley, Watson et al. (2010) implemented the Gold 
Standards Framework for Care Homes (GSFCH) and the LCP over eighteen months.  
Significant in-house training was provided for staff with GSFCH facilitators visiting the 
care homes every ten to fourteen days. Residents’ (n=228) notes were reviewed and 
qualitative interviews with bereaved relatives were conducted pre and post 
implementation of the pathway (GSFCH and LCP). Use of DNACPR forms, ACP and 
LCP (which are all also used in the ICP under study) increased significantly and 
hospital deaths were reduced from 15% pre ICP implementation to 8% post 
implementation. Therefore, it can be concluded that the GSFCH was successful in 
improving outcomes for care home residents with palliative care needs who died.  
However, similar to all of the studies described, this study does not explain why these 
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outcomes occurred; it only provides the outcomes and tools used, and an assumption of 
causality between the two. Hall, Goddard et al. (2011) also implemented the GSFCH. 
Nine care homes were involved and semi-structured interviews were conducted with all 
care home managers, eight nurses, nine care assistants, eleven residents and seven 
family members. Perceived benefits of the GSFCH were improved symptom control, 
team communication, staff confidence and adhering to patients’ preferences.  However, 
there were some perceived barriers to the GSFCH as well. These included lack of 
understanding about end-of-life care and an increase in paperwork (Hall, Goddard et al. 
2011). Several of the tools in the GSFCH focus on improving communication in 
palliative care (The National Gold Standards Framework Centre 2009). Hall, Goddard 
et al. (2011) found that the GSFCH improved communication within homes and with 
external providers including GPs and specialists in palliative care. Tools created to 
improve communication were similar to those used in the ICP under study and included 
palliative care registers, coding predicted stages of illness and ACP. These tools were 
perceived as beneficial in the study however some participants felt they required more 
experience of using these. There were also concerns about discussing death and dying 
(Hall, Goddard et al. 2011). Hall, Goddard et al. (2011) suggest that the use of the 
GSFCH tools have improved communication, but they do not explicitly state how this 
increase might have occurred – stronger team cohesion or improved multidisciplinary 
collaboration, for example. Furthermore, they highlight barriers to implementing the 
GSFCH but do not state explicitly if or how these barriers have affected the 
implementation or outcomes.  
Bower, Roderick et al. (2010) evaluated the use of the GSF in two GP practices, one 
rural and one urban, with the aim of improving integrated team working to facilitate 
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death in the patients’ place of choice. Despite the use of the GSF increasing health care 
professionals’ workload, through early identification of patients, they were able to work 
with patients prior to a crisis in the last few weeks of life.  Additionally, community 
nurses, practice nurses and GPs all felt empowered to identify patients with any illness 
requiring palliative care who may have been in their last year of life, despite a previous 
focus on cancer patients. Increased and structured MDT meetings allowed patients to be 
monitored and individualised care plans to be altered to meet care needs. A lead GP was 
allocated to each patient to ensure continuity of care. Recent deaths were reflected on in 
MDT meetings to facilitate practical learning. Once identified at the MDT meeting, 
relevant information about palliative care patients (medication, next of kin, current 
input, potential risks) was faxed to OOH services in order to create an advanced service. 
The patient’s notes (at home) provided information for all health care professionals to 
use and provided information for patients and their relatives about who to contact (GP 
or nurse) during the day and at night; this relieved feelings of anxiety that can occur due 
to isolation from services out of normal working hours. Health care professionals 
worked closely with patients to assess the need and timely implementation of 
anticipatory medication (a tool used in the ICP under study). An audit of twenty-one 
patients who died with community nurse involvement indicated that high quality MDT 
working with the GSF is effective in supporting patients to die in their place of choice 
(90% of patients died in their place of choice). However, limitations of the intervention 
were reported by health care professionals who stated that completing notes in the 
patient’s home and then duplicating these notes electronically at the practice was time 
consuming. There were also already strong working links between GPs and nurses; 
specialist palliative care expertise in the community nursing team; and an ‘open to 
change’ ethos in both practices. This questions whether the same service would work as 
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effectively in a practice where the context was not as favourable; changes in practice 
may have taken longer to implement and have been faced with more barriers. It must 
also be noted that this study had a small sample size (n = 21); larger scale 
implementation may have created issues. However, small-scale findings indicate that 
implementation of palliative care tools promoted by the GSF result in improved 
outcomes.  
 
What is known so far?  
Some overlaps can be seen between the palliative care ICP under study and those in the 
literature. They all aim to increase patient centeredness and have a focus on providing 
proactive care. Some use shared decision making in the form of ACP or educational 
sessions that promote decision making about the patient’s care. Decision aids and cause 
for concern trigger tools have similar properties to the surprise question and the traffic 
light system in the ICP under study. The GSF studies use many similar tools to the ICP 
under study including palliative care registers, the traffic light system, ACP and the 
LCP. Many of the studies have working collaboratively or enhanced communication as 
an aim in the implicit expectation that this will allow patients better access to palliative 
care services. MDT working was perceived to integrate team work and enhance patient 
centred care. However, it is highlighted that working collaboratively can be a challenge. 
Confidence was highlighted as important in providing high quality palliative care and 
the perceived ability to provide palliative care may be important in ICPs. Health care 
professionals may also need to feel empowered in order to identify palliative care 
patients regardless of diagnosis (cancer or non-cancer). Many of the ICPs and GSF 
studies aimed to reduce hospital deaths and increase home deaths which they did 
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successfully. Again, this highlights how health care professionals in these studies are 
operating within a patient centred framework. However, barriers to using palliative care 
ICPs were also identified in the literature including understanding about palliative and 
end-of-life care, increases in paper work and time constraints, and difficulties discussing 
death and dying.  
It is acknowledged that the ICP under study is not always congruent with the ICPs 
reviewed in the literature. For example, the ICP under study does not use regular 
meetings with palliative care experts or educational sessions with patients, as Temel, 
Greer et al. (2010) and Bakitas, Lyons et al. (2009) did. However, consultations can be 
seen as meetings with experts (health care professionals) and thus some learning can 
still be taken from these studies.  
However, in all of the studies reviewed the causality between the introduction of 
practice tools and improved outcomes is at present assumed rather than understood in 
depth. Studies evaluating palliative care ICPs state that an intervention that promotes 
early identification of patients in need of palliative care and the use of ACP, 
collaborative working and specialist palliative care services have positive effects in 
terms of quality of life, place of death and resuscitation orders. However, although the 
palliative care intervention studies described have shown improvements in care, they 
report these favourable outcomes but do not identify why they occur. All of the 
interventions described have one thing in common: they involve multiple tools and 
professionals. It is therefore very difficult, within the research designs employed, to 
decipher any detail on the causality chains which might have led to favourable 
outcomes. Furthermore, the studies discussed pay no attention to context such as 
location, population, disease type, socioeconomic factors, or understanding of palliative 
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care. The interventions all show promising outcomes, but none go in to much depth to 
explain which components of the inherently complex and multifactorial interventions 
might have worked best for whom, and in what circumstances. 
The studies reported leave a clear gap in knowledge: what actually works, for whom 
and in what circumstances? Thus, this thesis will investigate whether a palliative care 
ICP using care planning principles for those with life limiting illnesses leads to positive 
outcomes, how, for whom and in what circumstances.  
Currently, there is no specific way to provide palliative or end-of-life care in the UK. 
Studies focusing on palliative care interventions are limited and difficult to identify in 
the literature and thus an evaluation providing information on context, underlying 
mechanisms and related outcomes is warranted. This is important not only to policy 
makers and health care professionals in order to deliver a high standard of care, but also 
to patients, who wish to die in their current place of residency.  
ICPs in palliative care provide promising results in terms of translating policy into 
practice. They indicate that they increase proactive care, patient centeredness and shared 
decision making which results in a good death that is often in the patient’s place of 
choice. However, the complexity of these multicomponent interventions means that it is 
not clear which tool worked best for whom (for example, professionals, patients, 
primary or secondary care, care homes) and in what circumstances (type of illness, 
timing of patient identification as terminal prior to death). Furthermore, the assumptions 
made in most of these studies between intervention strategies and outcomes pose a 
significant challenge to implementation in other contexts.  
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Chapter Summary  
The ICP has been developed in line with national and local policy that identifies 
palliative and end-of-life care as a local regional and national priority and continues to 
develop (Department of Health 2008, The National Council for Palliative Care 2009, 
The National Gold Standards Framework Centre 2009, NHS North East 2012). It aims 
to translate national policy and guidelines about proactive care, patient centred care and 
shared decision making into practice.  
The facets of the ICP have been described and issues with funding and changes in 
commissioning have been discussed. The changes made in the re-commissioning of 
services has resulted in the ICP functioning differently now in comparison to when it 
was initially implemented. However, use of the core tools (palliative care registration, 
ACP, anticipatory medication use) that are based on proactive care, patient centred care 
and shared decision making have remained unchanged despite this, as recommended by 
regional and national policy. Publication of regional policy, Deciding Right (NHS North 
East 2012), has the same underlying principles as the ICP and therefore it should be an 
enforcing factor to the proper use of the interventions of the ICP, including ACP. 
However, undoubtedly, these changes will all have had an effect on the ICP, the way it 
functions, those who implement it and those who are in receipt of care. Yet, 
development of an ICP is a dynamic process, which is likely to be affected by change 
which can come from local or national policy, or due to economic factors, especially in 
the current economic climate which is resulting in significant changes to the NHS. 
The introduction of Deciding Right (NHS North East 2012) has meant that some of the 
documentation used in the ICP has changed (the advance care plan form has become the 
advance statement, with ACP now acknowledged as an umbrella term for a process 
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which results in several formal outcomes of preference discussions in the form of 
documents). Workshops have been run in the locality to further explain and implement 
Deciding Right (NHS North East 2012) which has the same underlying principles as the 
ICP. 
Individual case studies from the pilot before limited re-commissioning have shown that 
the ICP improved patient experience, avoided hospital admissions in individual cases, 
informed the OOH GPs’ decision making, and facilitated patients’ wishes around end-
of-life care decisions (Locality North East Clinical Commissioning Group 2012). 
However, the ICP required more formal evaluation, investigating if the ICP worked, 
how it worked and in what circumstances.  
The complexity highlighted in this chapter means that the ICP does not lend itself easily 
to a quasi-experimental design, and indeed, the literature has demonstrated the 
limitations of such designs to evaluate multifactorial ICPs. The next chapter will explain 
the methodology used to evaluate such a complex ICP, realist evaluation. The principles 
of realism, realist evaluation and realist inquiry will be explored alongside the data 
collection tools. The research question will be formulated which will aid in the design 
of the programme theories that will be tested in order to guide the evaluation.  
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Chapter 3: Methodology 
 
This chapter will begin with an exploration of realism that will address questions of 
ontology, epistemology and methodology. An introduction to realist evaluation will 
then be provided with the realist logic of inquiry explained, to help understand how the 
ICP will be evaluated in terms of Context, Mechanism and Outcome Configurations 
(CMOCs). The research question will be stated which prompted the development of 
programme theories to be tested through data collection. Following this, a data 
collection and analysis framework will be presented which has been developed 
specifically to meet the needs of this research, using both quantitative and qualitative 
data tools.  
Policy, such as the End of Life Care Strategy (Department of Health 2008) is delivered 
through active social programmes, such as the ICP, to active subjects (health care 
professionals and patients) and this has major implications for research methodology. In 
clinical trials human volition is regarded as a contaminator and the aim is to minimise 
its impact, hence the use of placebos, blinding and randomisation. However, social 
programmes work through the reasoning of subjects and knowledge of that reasoning is 
integral to understanding a programme’s outcomes. Since the ICP is such a complex 
system that includes many people providing and receiving services, it must be 
investigated using a methodology that embraces human volition, as well as this 
complexity, rather than minimises it.  
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Realism 
Realism is not a research method but a methodological orientation; an approach to 
constructing and selecting research methods (Pawson, Greenhalgh et al. 2005). It is a 
logic of investigation that is grounded in the philosophy of science and social science 
(Bhaskar 1978, Harre 1978, Bhaskar 1979, Putnam and Conant 1990, Collier 1994). In 
these writings, realism is considered as the principal post-positivist perspective and 
provides an explanation of phenomena that sits between empiricist and constructivist 
accounts of scientific explanation (Pawson 2006). Realism regards social change as 
transformational as opposed to linear, it values both qualitative and quantitative research 
methods and is not nomothetic or idiographic (Sayer 1992, Archer 1995, Sayer 2000). 
Realism is a methodological orientation due to its understanding of causation, the 
constitution of the social world, and the stratification of social reality (Pawson 2006), all 
of which are questions of ontology, epistemology and methodology and are developed 
further below.  
There are two streams of realism in social science: critical realism (Archer, Bhaskar et 
al. 1998, Bhaskar 2002) and empirical realism (Pawson 1989, Hedstom and Swedberg 
1998, Williams 2000, Carter and New 2004), also known as scientific realism, emergent 
realism, analytic realism, ‘realism pane e burro’ and middle-range realism (Pawson 
2006), although no consistent nomenclature has been assigned to this school of thought. 
It shall be referred to as empirical realism for the purpose of this thesis. The schism 
between critical realism and empirical realism is due to the open systems nature of 
social explanation. Critical realism assumes that there will always be an excess of 
explanatory possibilities, some of which will be mistaken (Pawson 2006). It is therefore 
the primary task of the critical realist to be critical of the lay thought and actions that lie 
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behind false explanations (Bhaskar 2002). Empirical realism assumes that a researcher 
should still aim to decide between alternative explanations, despite the knowledge that 
further explanatory potentials remain without investigation in the open systems in which 
people live (Pawson 2006). Furthermore, empirical realism suggests that classic 
apparatus, including clear hypothesis making, critical comparisons and empirical 
patterns, are of use in research underpinned by realism. Empirical realism is embraced 
by realistic evaluation, the methodology used in this study.  
 
Questions of ontology, epistemology and methodology in realism  
Ontology questions the form and nature of reality and therefore what can be known 
about it (Guba and Lincoln 1994). Realism suggests that there is a real world within 
which people interact and that individuals construct meaning in this world. Whilst 
theories, concepts and perspectives may generate a valid understanding of a phenomena, 
they cannot and do not exhaust it, as all knowledge is contextual and partial; other 
conceptual schemas and perspectives are always possible and theories, concepts and 
findings are grounded in values and perspectives (Altheide and Johnson 2011). For 
example, whilst death is an inescapable reality, its meaning is mediated by individuals’ 
understanding and experiences of it. Two separate individuals who experience the death 
of a grandparent may have differing reactions due to context, resources and reasoning. 
Additionally the way in which an individual reacts to their grandmother’s death may be 
very different to the way they react to a sibling’s death. Therefore a theory on relatives’ 
experiences of a loved one’s death will generate understanding of this topic, but is not 
definitive as all knowledge is contextual and partial. The current literature focusing on 
palliative care ICP evaluations generates understanding but does not acknowledge that it 
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is contextual, or that the findings are grounded in values and perspectives. For example, 
Smith (2012) states that a holistic heart failure service increases choice for palliative 
care patients. However, this does not mean that the same holistic heart failure service 
implemented in another locality would achieve the same outcomes. The findings may be 
different due to the differing values and perspectives of those implementing and 
receiving the service.  
From a societal or organisational perspective, death is a process that needs to be 
managed and the ICP, a complex system in itself, is one way of implementing this 
management. Realism suggests that regularities in the ICP are attributable to the 
underlying mechanism that is constituted by people’s reasoning and the resources they 
have in a specific context (Pawson and Tilley 1997). Realists state that the 
embeddedness of all human action within a wider range of social processes is the 
stratified nature of social reality (Pawson and Tilley 1997). Even the most repetitive and 
commonplace actions are only understandable because they contain innate assumptions 
about a wider set of rules and institutions (Pawson and Tilley 1997). For example, the 
act of visiting a GP is routinely accepted as what most people would do if they felt 
unwell for a significant period of time. However, this is only because it is known that 
visiting the GP is part of a wider institution (the NHS) within which Hippocratic rules 
dictate that efforts are deployed to manage patients’ illnesses. The causal power 
between visiting the GP and managing the illness does not reside in the GP themselves 
or the drugs they prescribe but in the organisational structures which they form. One 
action leads to another due to their accepted place in the whole (Pawson and Tilley 
1997); the patient makes an appointment with the GP, the GP prescribes medication if 
appropriate, the pharmacist dispenses the drug and the patient adheres to the drug 
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regime. Therefore human action and understanding is not linear and is understood in 
terms of its location within different layers of social reality. This explains why realists 
shun the secessionist view of causation (Pawson and Tilley 1997).  
Epistemology considers the nature of the relationship between the knower or the would-
be knower and what can be known (Guba and Lincoln 1994). The answer to the 
epistemological question is always constrained by the answer to the ontological 
question. What can be known about any social programme is not definitive. For 
example, the heart failure service described by Smith (2012) may not achieve the same 
results in a different locality and is thus not a definitive finding. This is due to the 
complexity of social reality meaning that people have different understanding, values 
and meanings and thus a social programme is never exactly replicated. However a 
decision can be made between opposing explanatory theories (the heart failure service 
may have worked due to improved communication between the clinical team, as Smith 
(2012) suggest, however they do not unpack explicitly how improved communication 
has led to the outcomes achieved). Realist evaluation begins with a theory of causal 
explanation known as a CMOC, which is based on the idea of the generative mechanism 
exposed further here (Pawson and Tilley 1997). The researcher searches for causal 
powers within objects or agents or structures under investigation and expresses them in 
terms of CMOC (Pawson 2006). It requires complex and systematic understanding of 
causal powers which takes into account the underlying constructs that connect two 
events, and the context in which that relationship occurs (Pawson 2006). Generative 
mechanisms explain the causal link between social programmes and outcomes. Using 
Smith (2012) as an example again, if improved communication between the team has 
led to more home deaths, the generative mechanism explains why this is, in relation to 
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resources and reasoning. Thus it could be hypothesised that the mechanism could be the 
key worker identified for each patient (resource), who liaises with all other health care 
professionals involved in the patient’s care to improve communication (reasoning), 
which has led to more home deaths (outcome) in the context of improved access to 
palliative care services. In another hypothetical example grounded in primary care, the 
mechanism could be information provided by a GP in a consultation (resource), which 
set in the context of a long standing and trusting GP-patient relationship, results in a 
reasoning of trusting the information provided, absorbing it and leads to an outcome of 
acting on it. However, there are often cases that go against the trend, which realism 
embraces, and our understanding of the causal link (content of consultations) may 
survive even in the face of irregularities; patients may have researched their condition 
using the internet as opposed to receiving the information in the consultation or the GP 
and patient may not have the aforementioned long standing and trusting relationship. 
Put simply, what causes something to happen has nothing to do with the number of 
times it is observed happening (Sayer 2000). Therefore gathering data on regularities is 
misguided, however these may suggest where to look for causal mechanisms (Sayer 
2000), one of the integral concepts in realist evaluation. 
Individuals may be aware of patterns of regularities into which their lives are shaped, 
the choices that channel their activities and the wider social forces that limit their 
opportunities (Pawson and Tilley 1997). This can result in individuals wishing to 
change the pattern. This change may or may not happen as the individual may or may 
not have the resources to do so, or their efforts may be overcome by an opposing group 
who have more resources. Furthermore, individuals have incomplete knowledge of the 
contextual conditions in which they reside and these contextual conditions may limit 
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their actions, and the proposed change mechanism itself may have unanticipated 
consequences (Pawson and Tilley 1997). For example, recently medication availability 
has been affected by locality in the UK. Patients may wish to have a course of 
medication but cannot due to this contextual factor. Social programmes or interventions 
are an attempt to change the current regularity in a domain through generative 
mechanisms.  
Methodology considers how the would-be knower can go about finding whatever he or 
she thinks can be known (Guba and Lincoln 1994). This question is constrained by the 
answer given to the first two questions. Realist evaluation (Pawson and Tilley 1997) has 
been created for researchers to investigate the world from a realist perspective and 
focuses on the development and refinement of CMOCs. Realism and realist evaluation 
have further explanatory potential in relation to death and dying and palliative care 
ICPs. They can offer an understanding that is grounded in the locality but provides more 
macro knowledge about death and dying and palliative care ICPs. It opens up the ‘black 
box’ and links outcomes to explanations that are mindful of contextual factors and the 
individuals who implement and receive social programmes. Previously the management 
of death has been considered in a very causal way; improved communication will lead 
to more home deaths (Smith 2012). Realist evaluation allows for a deeper understanding 
that embraces human volition and the complex social systems in which people reside. 
Realist evaluation of this palliative care ICP will therefore provide novel insights.  
 
Theoretical framework: realist evaluation  
The conceptual approach in this study is realist evaluation (Dalkin, Jones et al. 2012) 
(Appendix 2), as it enables in-depth analysis of interventions through the means of 
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realist programme theories, embracing both qualitative and quantitative research 
(Pawson, 2013). Programme theories have been developed and iteratively refined for 
each section of analysis. Analysis will highlight what Contexts (C) need to be present so 
that the relevant mechanisms (M) are likely to be triggered to cause observed outcomes 
(O). The purpose of this is to generate understanding of how resources provided by the 
ICP interact with contexts to trigger the necessary mechanisms to produce positive 
outcomes. Social programmes, realist logic, and CMOCs are explained in detail below.  
 
Social Programmes 
To understand realist evaluation, an understanding of social programmes or 
interventions must be developed. Social programmes are active, they do not operate in 
laboratories, they are affected by contexts which are changeable and thus although two 
social programmes may have the same name, they will never behave in exactly the same 
way. The ICP can and will thus be considered as social programmes in this thesis.  
‘Realistic Evaluation’ (Pawson and Tilley 1997) is the main text for realist evaluation. 
The subject matter of a realist evaluator is a social programme (intervention), otherwise 
understood as social systems. They consist of the complex interactions between 
individuals and institutions and of micro and macro social processes (Pawson and Tilley 
1997). A realist approach states that social programmes are theories incarnate; this is 
plural as one social programme is likely to have several theories. Social programmes are 
delivered under the hypothesis that if the programme is delivered in a certain way it will 
improve outcomes (Pawson 2006). This means that whenever a social programme is 
implemented, it has an underlying theory about what might cause change, which is 
being tested. However, this theory is not always explicit. It is the role of the realist 
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evaluator to make these theories explicit, and ensure that the right questions are asked of 
the data. For example, the underlying theory in ACP may be that planning for a good 
death results in more patients dying in their location of choice.  
Interventions are implemented into existing social systems that are believed to account 
for a particular problem, such as difficulty talking about death or issues identifying 
palliative care patients. The fresh input the social programme gives to the system is 
expected to improve patterns of behaviour, events or conditions via changing and 
rebalancing the system (Pawson 2006). The underlying theories of the ICP are discussed 
later in this chapter (Research questions section, p.88). In order to describe a social 
system or programme, realists use three predominant concepts: context, mechanism and 
outcome. These three concepts produce a generative mechanism to explain causality. 
 
• Context  
In realist evaluation, mechanisms work in partnership with context to lead to outcomes 
in a causal way (Pawson 2006). In other words, the relationship between causal 
mechanisms and their effects (outcomes) is not fixed, but contingent on context (Sayer 
1984). Thus realist approaches make explicit use of broader insights in order to explain 
the impacts of interventions in context, as will be done in the analysis in this thesis.  All 
social programmes/interventions are introduced into pre-existing social contexts, 
therefore there is sometimes a struggle for them to prevail in these contextual 
conditions, hence, they are contingent. It is impossible to establish a straightforward 
relationship between intervention and outcome without identifying pre-existing 
contexts. Each social programme implemented has a great number of different 
contextual constraints and facilitators and the interrelationships, institutions and 
  
81 
 
structures in which it is embedded all affect its success (Pawson 2006). Context refers to 
not just the physical, but to the culture and drivers (professional cultures, power 
dynamics within GP practices, cost effectiveness, disease specific clinical reasoning), 
institutional features (patient list sizes in GP practices, shared nursing teams, staffing 
levels in care homes) and ethical issues (equality of care, capacity to make a decision).  
Context works by constraining the choices of stakeholders in a social programme. 
Stakeholders in the ICP can be programme leaders, programme policy makers, clinical 
staff, social care staff, voluntary organisations, palliative care patients and bereaved 
relatives. The subjects of a social programme are always faced with a choice about 
whether to participate (Pawson 2006). Subjects have different pre-developed or pre-
given characteristics that leave some well prepared and some badly prepared for the 
programme theory, resulting in varying success for individuals, whether this is those 
implementing the social programme or those receiving it. They also have different pre-
existing relationships, which means that some are well placed and some are ill placed to 
use the opportunities provided by the social programme (Pawson 2006). For example, 
the ICP has a focus on being patient centred. However, the policy context encouraging 
proactivity and patient centredness may compete with pre-existing systems. 
Alternatively, from the patients’ point of view, a patient who is less familiar with their 
GP may be less likely to engage with the ICP (through, for example, ACP), than a 
patient who has built a relationship with their GP over their life-time. Additionally, on a 
more macro level, some GP practices may have more flexible systems that make 
explicit allowances for patient involvement. On an even higher level, societal taboos 
about death and dying can be a prominent context, meaning that death is often not 
discussed and is shrouded in mystery. Currently there is an effort to change this taboo 
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through the National End of Life Care Strategy (Department of Health 2008) and 
documentation such as Deciding Right (NHS North East 2012). Although these 
documents are tailored for, and aimed at, health care professionals, they encourage early 
discussions about death and dying with patients. This social change in the way GPs 
regard and discuss death and dying is a social change that will have effects on any social 
programme in palliative and end-of-life care. Despite this, it could be that some GPs and 
patients may be reluctant to talk about death and dying due to this societal taboo. This 
would make the resources of the social programme, such as ACP, very difficult to use. 
The context thus has clear implications for the successes and failures resulting from a 
social programme.  
It is not expected that massive contextual change will occur during a programme or as a 
result of a programme; a social programme does not aspire to cause the downfall of 
existing cultural and social order (Pawson and Tilley 1997). However, an 
accommodating context is crucial for implementation of a successful social programme 
that aims to change behaviour. If a context is inhospitable, the programme mechanisms 
are unlikely to be activated and therefore will not combat or neutralise the original 
problem mechanisms that were sustaining the bad outcome pattern. A physical analogy 
of this could refer to gunpowder; a spark causes an explosion. However, there will be no 
explosion if the conditions are not right – damp, insufficient gunpowder, inadequately 
compact, no oxygen present, or no heat applied (Pawson and Tilley 1997). Thus in 
research it is necessary to identify the social and cultural conditions necessary for 
change mechanisms to operate.  
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• Mechanism 
The explanatory mechanism is the most characteristic tool of realist evaluation and is 
often referred to as underlying mechanism or generative mechanism (Pawson and Tilley 
1997, Pawson 2006). The term ‘mechanism’ relates to causation. Processes that produce 
events, or patterns of events, can be seen as causal mechanisms. Mechanisms explain 
causal relations by describing the powers built in to a system, including the reasoning of 
stakeholders (such as health care professionals, patients, carers or bereaved relatives), 
and resources of the social programme (such as ACP, palliative care registration, peer 
support from MDT meetings) (Pawson 2006). Yet in all cases, it is something about 
context and a combination of resource and reasoning which form a mechanism with 
explanatory potential for the observed outcome. Therefore the mechanism explains what 
it is about the system that makes things change (Pawson 2006). Mechanisms can often 
not be directly observed, and the evaluator must hypothesise which mechanism is likely 
to have ‘fired’ and then test this theory with data. For example, if it is thought that the 
number of patients who have anticipatory medication is higher (outcome) in practices 
(context) where the ICP is more embedded and adopted as routine practice 
(mechanism), then the degree of how embedded the ICP is must be investigated by the 
evaluator, despite embeddedness not being an explicitly measurable factor. The 
evaluator can also investigate whether there are any other practices where the ICP is not 
as embedded. Scientific knowledge begins to accumulate when the same mechanism is 
commonly attributed to the same outcome or the absence of a mechanism is linked to 
the lack of an observable outcome. For example, if more regular use of anticipatory 
medication (outcome) is commonly attributed to practices where the ICP is more 
embedded (mechanism), then scientific knowledge starts to build that purports that there 
is a relationship between anticipatory medication and how embedded the ICP is.   
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It is also important to note that social programmes offer resources, however it is the 
reasoning of the subjects in combination with the resources provided by the social 
programme that result in outcomes (Pawson and Tilley 1997, Pawson 2006). Social 
programmes only work if the people involved choose to make them work by adhering to 
the programme theory (reasoning) and using the resources as intended (Pawson 2006). 
The acknowledgement of reasoning is one of the key strengths of using realist 
evaluation (together with the importance of context), as most other evaluations assume a 
relation of straightforward causality between the resources introduced by an 
intervention and the outcomes observed. However, as with most practice development 
efforts, interpersonal relationships between health care professionals and patients 
embody the intervention. They are the resource that is intended to bring about change 
(Entwistle and Cribb 2013). Thus, in order to help understand the mechanisms of the 
ICP in detail they will be unpacked in terms of reasoning and resources throughout the 
thesis. This is represented in Figure 1 below, as well as throughout the findings. Taking 
the example about how embedded the ICP is, we can now ask what are the resources 
and reasoning of this mechanism? Resources could be informed practitioners who have 
access to anticipatory medication. The reasoning is the decision to provide the 
anticipatory medication in advance of a decline in health requiring the medication, and 
the outcome would be an increase in the use of anticipatory medication.  
 
• Outcome 
In realist evaluation outcomes are not a sufficient base for establishing causality, yet 
they are important in science (Pawson 2006). In social science, strict regularities are not 
always viable, as they are in engineering or chemistry where total control of variables is 
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the objective. Therefore, evidence based policy would aim to choose an intervention 
that has a high chance of repeating the positive outcomes achieved elsewhere. To do 
this, outcome patterns must be sought rather than outcome regularities. Significant 
outcome patterns are embedded and dependent on the introduction of not only suitable 
ideas and interventions (mechanisms) but also the appropriate existing social and 
cultural conditions (contexts). In metaphoric terms, causality is thus attributed to the 
right substance being activated in the right conditions (Pawson and Tilley 1997).  
 
How is a social programme evaluated?  
Social programmes provide resources (such as ACP, the traffic light system of wellness, 
the new palliative care unit), which activate people’s reasoning (M). However, the 
activation of the mechanism is dependent on the characteristics and circumstances of 
subjects, situations and societies (C), resulting in a varied pattern of impact (O) (Pawson 
2006), as detailed in Figure 1. These three concepts are the crucial sources of evidence 
in realist evaluation. Realist evaluation does not ask if a social programme works, 
instead it focuses on the fundamental question, “what works for whom, in what 
contexts, in what respects and how”? Thus, in order to evaluate social programmes, the 
theories within a programme must be made explicit, by developing clear hypotheses 
about how, and for whom, programmes might work. This is done by identifying context 
(C), mechanism (M) and outcome (O) configurations (CMOC) because causal outcomes 
following from mechanisms acting in contexts is the base upon which all realist 
explanation builds (Pawson and Tilley 1997). A CMOC, as depicted in Figure 1, is a 
suggestion that states what it is about a social programme which might work, for whom, 
in what circumstances. A programme theory or initial CMOC is the starting point for 
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evaluation, and refinement of this CMOC through data analysis leads to the concluding 
finding of an evaluation (Pawson and Tilley 1997). This is an iterative process. In order 
to construct and refine CMOCs, evaluators need to engage with policy makers, 
practitioners and participants (Pawson and Tilley 1997). This is especially important 
when refining CMOC. Since data collection needs to provide evidence for CMOCs and 
engage with several different forms of participants, it must be wide reaching and varied 
in content and pitch. It will not only concentrate on impacts but also on the process of 
implementation, context and underlying mechanisms that may lead to changes. This is 
why integration of the researcher into the locality was so important in this project. 
Knowledge of the locality and different GP practices involved with the ICP was 
essential in understanding and refining the initial programme theories.  
Although the findings from this study will be specific to the locality, they will have 
translational potential. They will offer explanatory potential to the broadest of palliative 
and end-of-life care scenarios, thus enhancing transferability. The study findings will 
enhance understanding of the crucial mechanisms within palliative and end-of-life care 
and how resources put into specific contexts lead to specific outcomes, both intended 
and unintended.  
 
 
 
 
 
  
87 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Traditional research formats aim to demonstrate a relationship of causality between 
resources inputted by a social programme and observed or measured outcomes. As 
exposed in ‘Mechanism’ above (pg.83) realist thinking posits that this causality is 
mediated by the context within which the resources are implemented and the reasoning 
this triggers in key stakeholders, which results in them acting in a different way and 
leads to observable outcomes. Causality is thus more complex, and reliant on often 
Figure 1: Context, Mechanism and Outcome Configurations in realist evaluation 
Often difficult to 
observe directly 
   Often directly observable and measurable 
MECHANISM Often assumed 
causal relationship 
        
     Reasoning 
OUTCOME 
Resources CONTEXT 
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unobservable and unmeasurable parameters, which the realist evaluator endeavours to 
shed light on.  
In order to make explicit the distinction between the intervention components (visible 
and known to practitioners) and the kind of reasoning this triggered in certain contexts 
(assumed or implicit), it was decided to disaggregate resources and reasoning 
throughout the thesis, as demonstrated in Figure 1. This is in order that readers from all 
backgrounds and prior knowledge of realist thinking can engage with the concept of 
‘causal mechanisms’. Figure 1 depicts how resources are introduced into pre-existing 
contexts which in collaboration result in reasoning of an individual which leads to an 
outcome. The reasoning border has softer lines to identify its psychological nature. The 
outcome box has a thick box surrounding it to depict its observable nature. 
In the description of CMOC throughout the results chapters they will be described in the 
following format: outcome, mechanism then context. This is because the inquiry usually 
started from an outcome. From here, relevant mechanisms and contexts that might have 
led to the outcome were identified. The only exception to this is Chapter 7 (p.231) 
where the presentation is context, mechanism, then outcome. This is because inquiry in 
this part of the thesis began with context.  
 
Research questions and programme theories  
 In terms of the ICP, what works, for whom, in what circumstances?  
The main research question stated above was very broad to allow the formulation of 
programme theories. Programme theories are the underlying assumptions about how an 
intervention is meant to work and what impacts it is expected to have (Pawson, 
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Greenhalgh et al. 2005). There is usually more than one programme theory per 
intervention and they differ from normal theory in that they include the two additional 
key components from realist methodology, context and mechanism. The programme 
theories in this study were prompted by outcomes of the ICP, the palliative care ICP 
literature, integration in the locality and consultation with practitioners implementing 
the ICP. Data available from the GP practice systems (MIQUEST and Death Audit) 
guided the formulation of the programme theories, as it provided crucial outcomes. The 
literature identified gaps in knowledge and highlighted why a realist evaluation was 
appropriate to address these, as exposed in Chapter 2 (p.40). It also contributed towards 
the initial programme theories. Furthermore, there was a lot of learning that occurred as 
a result of integration into the locality; in order to develop programme theories for the 
ICP immersion in the field was essential. This was achieved through observing 
consultations between GPs and palliative care patients, attending Palliative Care 
Partnership meetings, local research and education meetings, locality organised 
educational workshops, PCQVs, spending time at the locality palliative care unit and 
reading the ICP business cases and reports. Additionally, close contact with the ICP 
founder was established. This learning allowed my knowledge of the ICP and the 
locality to increase and formulate testable programme theories. Five programme 
theories were developed for the ICP. They are stated at the beginning of each Findings 
chapter and refined using the data collected; the refined programme theory is then stated 
at the end of each chapter. The five programme theories are stated below and 
accompanied by subsidiary questions: 
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Programme theory 1 
Integration into the locality has resulted in a basic knowledge of how the fourteen 
different GP practices work, the ethos they have in relation to the ICP and the outcomes 
they achieve. From this knowledge and literature surrounding communication, co-
ordination and team working in palliative care ICPs (Smith 2012), the following 
programme theory was developed.  
The number of people who die in their chosen location (outcome) will depend on the 
GP practice (context) they are registered with and how embedded the ICP is as indicated 
by the number of interventions used per patient (outcome). Thus, this is a programme 
theory about the process of implementation, considering implementation as an 
intermediary outcome.  
- Does the use of more interventions result in better outcomes?  
- Do CQI initiatives increase intervention use?  
- What characteristics do ‘high performing’ GP practices have?  
 
Programme theory 2 
The GSF states that palliative care patients should be identified early (The National 
Gold Standards Framework Centre 2009). Bower, Roderick et al. (2010) highlighted 
that using the GSF empowered health care professionals to identify patients with any 
illness early in their trajectory. From this knowledge and integration into the locality the 
following programme theory was created:  
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Palliative care registrations should increase (outcome) due to a focus on identifying 
patients early using the palliative care register (mechanism) in a health care domain that 
appreciates the palliative care needs of patients (context). 
- Are palliative care registrations increasing in the locality and if so why?  
- Are both cancer and non-cancer patients appropriately put onto the palliative 
care register? 
 
Programme theory 3 
The ICP promotes the use of preference discussions with patients and ACP. ACP is also 
explicitly advocated by UK policy in The End of Life Care Strategy (Department of 
Health 2008, Addicott and Ross 2010) and has been used in previous studies that have 
produced positive outcomes for patients (Hockley, Watson et al. 2010, Hall, Goddard et 
al. 2011, Reymond, Israel et al. 2011). Early integration into the field highlighted an 
increased awareness of the importance of documenting preferences. This prompted the 
following programme theory:  
There will be an increase in the use of preference discussions and ACP (outcome) as 
health care professionals become more confident with broaching the subject of death 
and dying with patients (mechanism) and aware of the importance of having and 
documenting preference discussions, which has been highlighted by recent policy 
(context). 
- Are preference discussions increasing and if so why?  
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- Are preference discussions occurring earlier in a patient’s illness trajectory 
(green traffic light phase)?  
- Is the number of locality advance care plans carried out with patients increasing 
and if so why?  
- Do preference discussions predict the use of advance care plans?  
 
Programme theory 4 
The literature highlighted that communication about death and dying can be difficult 
(Buckman 1984, Ptacek and Eberhardt 1996, Ptacek and Ptacek 2001, The National 
Council for Palliative Care 2009). Literature in psychology suggests that in health 
related risk situations individuals utilise distinctive attentional processing styles which 
allows them to be classified as a monitor or blunter (Miller 1995). It could be that 
matched coping styles could help examine why some palliative care consultations lead 
to more proactive discussions than others. Thus, the following programme theory was 
developed:  
The innate coping style of the GP and patient (context) facilitates a consultation if 
matched (mechanism), making a preference discussion and use of the locality advance 
care plan more likely to occur (outcome).  
- Are matched coping style consultations more successful (in terms of producing 
outcomes such as preference discussions and advance care plans)? 
- Can matched coping styles facilitate practice?  
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Programme theory 5 
Using a patient centred framework based on shared decision making is advocated in 
policy and in translational tools used in practice. In the literature chapter it was 
identified that Hockley, Watson et al. (2010) and Bower, Roderick et al. (2010) found 
using ACP (amongst other resources), which is based on shared decision making, 
resulted in a decrease in hospital deaths and an increase in home deaths, respectively. 
This knowledge and that gained from integration into the locality resulted in the 
following programme theory:  
The ICP can facilitate preferred place of death (outcome) and prevent emergency 
admissions (outcomes) through identifying patient preferences (context) and using ACP 
(mechanism). 
- Are home deaths increasing?  
- Are care home deaths increasing?  
 
 
Gaps in knowledge led to the formulation of the research question. Knowledge of the 
quantitative ICP outcomes available, reading the literature and access to contextual 
knowledge then enabled the formulation of programme theories and of questions to be 
asked of the data. The literature in Chapter 1 (p.6) highlighted gaps in knowledge which 
the programme theories address. For example Smith (2012) identified an increase in 
home deaths due to implementation of a palliative care heart failure service, however 
the findings do not highlight what contexts and mechanisms were necessary for this 
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outcome to occur; programme theory 5 aims to identify not only if home deaths are 
increasing in the locality but how and why, through investigation of patient preferences 
and ACP. The programme theories above recognise and illustrate key components of 
the programme (ICP) and include its strategies, functions or activities. Programme 
theories also map out the outcomes the ICP intends to generate and the specific 
components that contribute to particular outcomes.  
 
Data Collection and Analysis  
It is possible to use and integrate different combinations of data sources, methods and 
types of data as part of a study (Plowright 2011). Contributions of different data types 
and analyses were not confined to specific programme theories but some data analysis 
did feature more prominently in specific programme theories. Realist evaluation values 
mixed methods and states that data type should be selected on the basis of how 
informative it will be to the study. For more than a century, the supporters of 
quantitative and qualitative research paradigms have engaged in dispute (Johnson and 
Onwuegbuzie 2004). From these disputes, purists have emerged on both sides 
(Campbell and Stanley 1963, Lincoln and Guba 1985). Quantitative purists (Ayer 1959, 
Popper 1959, Schrag 1992, Maxwell and Delaney 2004) express assumptions consistent 
with a positivist philosophy and maintain that social science inquiry should be objective 
(Johnson and Onwuegbuzie 2004). Thus they pursue time and context free 
generalizations (Nagel 1986). Qualitative purists (Smith 1983, Smith 1984, Guba and 
Lincoln 1989, Schwandt 2000)  reject positivism and are also known as constructionists 
or interpretivists (Johnson and Onwuegbuzie 2004). They state that time and context 
free generalisations are neither possible nor desirable, and that research is value bound. 
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They also contend that it is impossible to differentiate causes and effects fully. Both 
quantitative and qualitative purists view their paradigm as the ideal for research 
meaning these paradigms and associated methods should not be mixed (Johnson and 
Onwuegbuzie 2004). However, to include only quantitative or qualitative methods falls 
short of the major approaches being used in the social and human sciences (Creswell 
2003). Currently, research practice is often not purely quantitative or qualitative but on 
a continuum between the two, using mixed methods (Creswell 2003). Mixed methods is 
a third research paradigm which recognises that both quantitative and qualitative 
research are important and useful and thus uses a combination of at least one 
quantitative and one qualitative component in a single research study (Bergman 2008). 
The goal of mixed methods research is to draw from the strengths of both quantitative 
and qualitative research whilst minimising the weaknesses in single research studies and 
across research studies.  It employs strategies of inquiry that involve collecting data 
either simultaneously or sequentially to best understand research problems (Creswell 
2003). Thus by using mixed methods numbers can be used to add precision to words, 
pictures, and narrative and a broader and more complete range of research questions can 
be answered (Johnson and Onwuegbuzie 2004). Furthermore, the use of mixed methods 
produces more complete knowledge that is necessary to inform theory and practice 
which is essential in this study (Johnson and Onwuegbuzie 2004). However, mixed 
methods can be more time consuming and expensive and some of the details of mixed 
methods research remain to be worked out fully (Johnson and Onwuegbuzie 2004).  
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Framework  
There are five types of data collection within this project. This is in order to 
understand and evaluate the ICP in a variety of ways, find evidence to support the 
programme theories and allow generation of multifaceted CMOCs. Each data 
collection form and analysis is explained further below and in Table 1.  
Fourteen of the fifteen practices implementing the ICP took part in the study. GP 
practices were lettered to maintain anonymity. All fourteen practices provided 
MIQUEST and GP practice data. Health care professionals from all fourteen practices 
were invited to take part in the focus groups, along with members from other key 
organisations such as the ambulance service, social services, and OOH services. Three 
of the GP practices were chosen as sites to collect data from patients and bereaved 
relatives. Practice H collected questionnaire data, practice D acted as gatekeepers and 
referred bereaved relatives and patients for interviews, and practice E acted as 
gatekeepers and recorded consultations with palliative care patients. Data collection 
was sited to avoid over burdening health care professionals, palliative care patients 
and bereaved family, friends and carers of palliative care patients. Practice D is in a 
large town (urban), practice E is in a smaller town (semi-rural) and practice H is in a 
village in a sparsely populated area (rural).  
All strands of data collection took place simultaneously. This allowed the generation 
of CMOCs across data sources, and allowed for further exploration of one factor 
through another data collection method. Furthermore, all different data collection 
forms were sited at different practices (Practices D, E and H) in order to only invite 
each potential participant to take part in the overall study once.
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Table 1: Data framework 
Major Research 
Question Answered  
Programme Theory Tested Participants Providing Data Data Source  Data Analysis 
Does the palliative care ICP 
work? 
Programme Theories 1, 2, 3 and 5 Palliative care patients from one of the 
practice sites 
MIQUEST data base/ 
Locality Death Audit  
Statistical analysis 
  Programme Theories 3 and 5.  Relatives of deceased palliative care 
patients and the health care professionals 
previously involved in the patients 
palliative care  
Quality of Dying and 
Death Questionnaire  
Descriptive comparisons 
What are the conditions of 
effectiveness of ICPs in 
palliative care? 
All programme theories  Health care professionals involved with 
the ICP 
Focus Groups  Soft systems 
methodology 
 Programme Theory 3 and 5 Palliative care patients and their families 
and bereaved families of palliative care 
patients  
Interviews  Thematic analysis 
Who does the ICP work for? Programme Theory 4 Palliative care patients and their GPs Coping Style 
Questionnaire 
Classified as monitor or 
blunter  
 Programme Theory 4   Voice Recording of 
Consultations 
Thematic analysis 
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1. MIQUEST and Locality Death Audit data (contributes to programme 
theories 1, 2, 3 and 5) 
Recruitment: No recruitment was needed for the GP practice data as it was already 
available from NHS North of Tyne PCT. Permission to use the data was sought 
from the GP practices using an invitation letter (Appendix 3), information sheet 
(Appendix 4), and consent form (Appendix 5). Permission for its use was also given 
by the Research and Development (R&D) manager at NHS North of Tyne PCT.  
Data Collection: Quantitative data available from the fourteen pilot sites is available 
in the form of the Death Audit and Morbidity Information Query and Export Syntax 
(MIQUEST). Both sets of data are routinely collected by practices: Death Audit 
data retrospectively since 2007 and MIQUEST searches have been run routinely 
since 2009. Whilst some of the data overlap, other data, such as that on locality 
advance care plans and sudden deaths, do not. This data is mostly about identifying 
outcomes of the ICP and the structure of the ICP implementation so that essential 
mechanisms that lead to these outcomes can be explored, identified and tested.  
Data Analysis: Statistical analysis was performed on MIQUEST and Death Audit 
data using IBM SPSS 17.0. The statistical tests used were: descriptive statistics, 
correlation, multiple regression, repeated measures t-test and cluster analysis. These 
tests investigated the tools the ICP uses, the good death outcomes the ICP generates 
and the embeddedness of the ICP. The embeddedness of the ICP refers to how 
many ICP interventions a GP practice uses; the more interventions that are used, the 
more it can be assumed the ICP is becoming routine in that GP practice. Practice 
comparisons were viable using statistics and contributed to essential contextual 
evidence.  All the analyses have been undertaken in the knowledge that intervention 
recording rates can vary. However, since realist approaches seek to develop 
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understanding of how, for whom and in what circumstances interventions work (as 
opposed to seeking absolute proof that they do), this was not considered an issue. 
 
2. The Quality of Dying and Death Measure (contributes to programme 
theories 3 and 5) 
Recruitment: Nurses from GP Practice H identified bereaved relatives 
systematically by looking at patients who died six months before data collection 
began (01/02/2012). Bereaved relatives were sent the invitation letter (Appendix 6), 
information sheet (Appendix 7) and consent form (Appendix 8) in the post by the 
GP practice (H) on headed paper. If they responded, the response was sent to me at 
Northumbria University. The bereaved relative was then sent the QDDM and an 
email was sent to the GP practice nurse, who asked the relevant GP (who had 
previously had a significant involvement with the bereaved relatives loved one) to 
also fill in the same questionnaire. The GP was also provided with an invitation 
letter (Appendix 9), information sheet (Appendix 10) and consent form (Appendix 
11). This was then emailed to me. Questionnaires were then matched and analysed. 
All bereaved relatives recruited to the study were between four and six months post 
bereavement; this was an inclusion criteria stated by the study and followed by the 
GP practices. All potential participants were discussed with the founder of the ICP 
who is a retired GP with an interest in palliative care, to ensure that they were 
suitable and deemed fit to participate in the study.  
Data Collection: There are several ‘good death’ measures available in the literature; 
however a recent systematic review found  the QDDM (Curtis, Patrick et al. 2002) 
to be the most widely studied and best validated (Hales, Zimmerman et al. 2010) 
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(Appendix 12 includes statistics about the psychometric properties of the measure). 
The QDDM was used to determine whether individuals who experience the ICP had 
a good death. This measure was distributed to bereaved families and key health care 
workers involved in a patient’s care. This section of data collection concerns the 
experiential and perceived outcomes of GPs and bereaved relatives. Experiential 
and perceived outcomes are extremely important, as the quantitative data lacks this 
rich quality.  
Data Analysis: The questions were used to identify areas within palliative care that 
GPs and bereaved relatives perceive similarly and differently to support CMOC.  
 
3. Focus groups with health care professionals and key organisation 
workers (contributes to all programme theories) 
Recruitment: Consent to contact staff who were eligible to take part in the three 
focus groups was obtained through R&D approval (Appendix 13) and letters to 
relevant organisations (Appendix 14). The date and time of the focus group was 
arranged and emailed to all the relevant potential participants (GPs, community 
matrons, social care workers, OOH staff, ambulance service, urgent care staff, 
voluntary organisations and relevant hospices including the locality palliative care 
unit) along with an invitation letter (Appendix 15), information sheet (Appendix 16) 
and consent form (Appendix 17). Participants were asked to read the study 
information provided, reply to the email to confirm their attendance and to bring 
their completed consent form with them to the focus group. Spare copies of the 
consent form were available at the focus group for those who forgot to bring it. 
Focus Group 1 (FG1) aimed to highlight how the ICP functioned in practice on a 
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regular basis. It took place in May 2012 and had twelve attendees (three GPs, two 
community matrons, two ward staff nurses, one social care team lead, one junior 
doctor, one palliative care unit project manager, one palliative care unit deputy 
manager, one team leader for the OOH nursing service). Focus Group 2 (FG2) took 
place in October 2012 and aimed to get constructive feedback on primitive CMOC; 
it had eight attendees (two GPs, one MacMillan nurse, one ward staff nurse, one 
community matron, one social care team lead, one district nurse, one palliative care 
unit deputy manager). Focus Group 3 (FG3) had six attendees and took place in 
October 2013 (four GPs, one care home manager, one social care team lead). This 
focus group aimed to refine final CMOCs. FG1 and FG3 did not require participants 
to do pre-focus group work (materials to review). FG2 required participants to study 
Soft Systems Methodology (SSM) maps that had been created based on the ICP 
(example provided, see appendix 37). This allowed participants to become familiar 
with the maps, generate ideas prior to the focus group and encouraged them to be 
confident in the discussion of them. FG2 participants were sent the SSM maps to 
review before they participated in the focus group.  
Data Collection: Focus groups were chosen in order to get input from all those 
involved with the ICP from different job roles. They have been identified as an 
effective technique for exploring the attitudes and needs of staff (Denning and 
Verschelden 1993) and allowed for collaborative discussion between health care 
professionals in order to refine ideas. They highlight the respondents’ attitudes, 
priorities, language and framework of understanding (Kitzinger 1995), all of which 
are of interest in this evaluation and can provide essential knowledge for CMOC. 
The interaction between participants also allows them to generate and answer their 
own questions and share common experiences, which generates deeper 
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understanding (Kitzinger 1995). Furthermore they allow essential interaction 
between the participants and the researcher allowing me to pose follow up questions 
or probe a particular topic of interest more deeply. Thus the focus group allowed for 
the role of the participants in producing interaction and the role of the researcher in 
guiding this interaction (Morgan 1996). FG1 provided essential knowledge to 
understand what exactly it is about the ICP that makes a difference to health care 
professionals and patients, in order to refine the initial programme theory. The 
information gained from the first focus group allowed the development of SSM 
maps which detail essential transformations within the pathway and can also be 
understood in terms of CMOC (discussed further in data analysis). FG3 was used to 
discuss and refine the studies final CMOC. 
The focus groups have contributed to CQI in the locality; informing decisions on 
documentation and data recording (for more information please see Chapter 6: 
Preference discussions and the locality advance care plan, p.199).  
Data Analysis: FG1 and FG3 were used to stimulate thoughts about how the ICP 
worked and refine final CMOCs, respectively. FG2 used knowledge from 
integration into the locality and findings from FG1 to create SSM maps - visual 
tools to collect and make sense of the data. It formulates carefully built models of 
systems which are used to represent and analyse a real world situation. The maps 
created were set against perceptions of the real world by a process of comparison 
which initiated debate between FG2 participants (Checkland and Scholes 1992). 
The epistemology of SSM is similar to that of realism in that the building of models 
accounts for the phenomenon being examined and these models are hypothetical 
descriptions which reveal underlying mechanisms of reality which can only be 
known by constructing ideas about them (Blaikie 2007). It was recognised that not 
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everyone understands mechanisms in a realist sense, however most people can 
relate to inputs, outputs, transformations and environmental factors. Therefore SSM 
maps were used as a form of CMOC as they allowed the health care professionals 
and key organisation workers in FG2 to talk in terms of CMOC, using terms such as 
‘transformations’ (to refer to underlying mechanisms) which occur through an 
‘input’ (mechanisms and resources), and produce an ‘output’ (reasoning and 
outcomes). The transformation is affected by ‘weltanschauung’ meaning worldwide 
view (context), ‘owners’ referring to those who can stop something from happening 
in practice (context) and environmental constraints (context). Furthermore, the 
visual presentation of SSM maps enabled FG2 discussions to be framed and 
generate further comments in a way that CMOC may not have; participants could 
see several factors in one domain, for example, several inputs, and discuss which 
was the most important for a particular transformation, such as ACP. This meant 
that FG2 participants evaluated several CMOC initially generated by the ICP 
founder and myself and generated their own CMOC through discussions initially 
triggered by the maps. This model helped highlight the contexts and mechanisms 
that are key to producing effective outcomes and allowed the research project to 
reflect practitioners’ combined organisational memory, experience and wisdom. 
SSM maps provided participants with an opportunity to think about their practice in 
a different way which enabled the surfacing of prior assumptions and implicit 
considerations, for example, a proactive GP is necessary to engage in early 
preference discussions.  
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4. Interviews with palliative care patients and bereaved relatives  
(contributes to programme theory 3 and 5)  
Recruitment: Patients and bereaved relatives were identified by GPs in Practice D. 
All bereaved relatives were four months post bereavement; this was an inclusion 
criterion of the study. Once a potential participant was identified by a GP, they were 
discussed with the founder of the ICP (retired GP with an interest in palliative care) 
to ensure that they were suitable and psychologically stable to participate in the 
study. Once it was agreed that the patient or bereaved relative was suitable they 
were sent an invitation letter (Appendix 18 for patients and appendix 19 for 
bereaved relatives), information sheet (Appendix 20 for patients and 21 for 
bereaved relatives) and consent form (Appendix 22 for patients and 23 for bereaved 
relatives) with a stamped addressed envelope, addressed to me at Northumbria 
University. Family members of palliative care patients were also provided with an 
information sheet (Appendix 20) and consent form (Appendix 24) if they wished to 
participate. The consent form for patients and bereaved relatives asked for the 
provision of a contact telephone number, so once the consent form was received I 
could telephone the participant and organise a convenient time for interview. All 
interviews were recorded in the participants’ homes. Researcher safety measures 
were put in place - I would inform my supervisors when I was scheduled to visit a 
participant’s house and then I would telephone my supervisors once the interview 
had finished and I had left the participant’s home. Four bereaved relatives and three 
palliative care patients were interviewed; all participants were given pseudonyms. 
Data Collection: Semi-structured interviews were conducted with palliative care 
patients, their families and friends and bereaved families. Interviews can overcome 
the poor response rates of a questionnaire survey (Austin 1981) and are appropriate 
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for exploration of participants’ attitudes, values, beliefs and motives (Richardson, 
Dohrenwend et al. 1965, Smith 1975), which are essential in the formulation of 
CMOC. Interviews provide the opportunity to evaluate the validity of the 
participant’s answers through observation of non-verbal cues (Gordon 1975); this is 
particularly useful when discussing sensitive issues such as palliative and end-of-
life care. Semi-structured interviews were used because they provide comparative 
data whilst allowing for follow up questioning that is specific to the individual 
(Barriball and While 1994). Furthermore, they are appropriate for the exploration of 
the perceptions and opinions of participants regarding complex and sensitive issues 
(Barriball and While 1994). They also enable the researcher to probe for more 
information and clarification of answers (Barriball and While 1994). This provided 
rich, in depth, qualitative data about the ICP and bereaved relatives’ and patients’ 
experiences of it, whether it was working for patients and their families, and if it 
contributes/contributed to a good death. Thus the interviews allowed for initial 
programme theory testing by asking about personal experiences of the ICP.  
Data Analysis: Interview transcripts were analysed thematically (Braun and Clarke 
2006). Thematic analysis is an accessible and theoretically-flexible approach used 
in the analysis of qualitative data. The method allows the researcher to identify, 
analyse, and report patterns (themes) within the data. It organises and describes the 
data set in (rich) detail. Additionally, thematic analysis can be used to interpret 
aspects of the research topic (Boyatzis 1998).  
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5. GP consultation recordings with palliative care patients  (contributes 
to programme theory 4) 
Recruitment: Patients were recruited by GPs at GP practice E. Patients were 
approached verbally by GPs and if they showed an interest were given the invitation 
letter (Appendix 25), information sheet (Appendix 26) and consent form (Appendix 
27). They then filled this in and returned it to the GP who provided them with the 
MBSS. The participant filled this in and returned it to the GP. The GPs were also 
provided with invitation letters (Appendix 28), information sheets (Appendix 29) 
and consent forms (Appendix 30) about the study as they too were participating by 
being audio recorded and completing the questionnaire. The GP completed their 
consent form and the MBSS and all forms were posted to me at Northumbria 
University. It is acknowledged that palliative care conversations take place over 
time, therefore GPs had the opportunity to record up to 3 consultations with one 
patient.  
Data Collection: Both a palliative diagnosis or information about palliative care can 
be classed as distressing, health threatening information which is difficult for the 
doctor to deliver, and for the patient to receive (Buckman 1984, Ptacek and 
Eberhardt 1996, Ptacek and Ptacek 2001). The literature suggests conversations 
about death occur infrequently and that this may be due to professionals not feeling 
at ease with broaching the subject (The SUPPORT Principal Investigators 1995, 
Hoffman, Wenger et al. 1997, National End of Life Programme 2011). It is 
proposed that in such health related risk situations individuals utilise distinctive 
attentional processing styles which allows them to be classified as a monitor or 
blunter (Miller 1995). When faced with a health related risk, monitors generally 
seek information, magnify disease related cues and display greater dissatisfaction 
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about the amount of information provided. Alternatively, blunters psychologically 
distract themselves from health related risk information and desire less knowledge. 
People can be classified as (high or low) monitors and (high or low) blunters using 
the MBSS (Appendix 31). The proposed use of coping style classification in this 
project was to investigate whether matched coping styles between patients and 
health care professionals offer any explanatory potential for outcomes achieved. For 
example, if a monitor health care professional and a monitor patient (classified 
through use of the MBSS) (Miller 1995) have a consultation, it is hypothesised their 
conversation about palliative care and death will be facilitated by their inherent 
coping strategy. In this study GPs and patients are classified as high or low monitors 
and blunters using the MBSS; following this, recordings of consultations about 
palliative care were made. This section of data collection sought to find if matched 
coping style resulted in a better outcome (testing programme theory 5).  
Data Analysis: The MBSS data was analysed by classifying individuals as high or 
low monitors or blunters. The audio recording of the consultation was transcribed 
and examples of high and low monitoring between GP and patient were sought. Due 
to a growing interest in medical stressors and coping style, an instrument was 
developed specifically to assess coping style when faced with medical threat, the 
Threatening Medical Situations Inventory (TMSI) (van Zuuren and Wolfs 1991, van 
Zurren and Hanewald 1993, van Zurren 1994). The TMSI describes four health 
threatening situations and has satisfactory reliability and validity (van Zurren and 
Hanewald 1993, van Zuuren, De Groot et al. 1996). However, the use of this scale 
was not employed in this study. The reasons for not using this scale are due to its 
relation to health care, and the hypothetical situations that are posed. One question 
asks the participant to “Imagine you suffer from headaches and dizziness for some 
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period of time already. You visit your doctor. He or she tells you things don’t look 
too well and refers you to a specialist for a rather trying medical examination”. This 
type of hypothetical situation may be very close to a palliative care patient’s actual 
experience and may cause distress. 
There is substantial academic as well as clinical debate about whether trait 
measurement is an adequate way of understanding peoples’ behaviours and 
attitudes. This focuses on states versus traits. Traits are stable, enduring 
characteristics that are consistent across situations, for example conscientiousness. 
States are transient experiences that are subject to change, such as emotional states 
or generosity. Difficulties in the differences between traits and states become 
apparent when focusing on anxiety. Cattell (1966) emphasised the importance of 
distinguishing between anxiety as an emotional state and individual differences in 
anxiety as a personality trait. Correspondence with the MBSS creator Dr. Suzanne 
Miller confirmed that Monitoring and Blunting are traits (Appendix 32). Dr. Miller 
stated:  
“Yes it is a trait. They (monitors and blunters) don’t change how they 
respond to the items on the questionnaire, but their (coping) 
strategies may change over time as the situation changes. Also some 
people are in the middle (a subset, perhaps a quarter) so that they are 
more influenced by changes in the situation” 
 
Thus if a person is classified as a monitor they are likely to remain a monitor despite 
changing situations. Therefore a person would be a monitor three weeks after 
receiving their terminal diagnosis and three months after receiving it; the trait is 
stable over time. However, coping strategies can change over time, meaning that 
denial could be primarily used before acceptance. Yet some people are influenced 
more readily by situational factors than others.  
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The operationalisation of the data collection into realist evaluation   
The five programme theories stated earlier were refined using the five data 
collection strands, although there was not one specific data strand for one specific 
programme theory. Outcomes were often investigated using GP practice data. These 
were retrieved and analysed early in the project time line in order to provide an 
engaging anchor for focus group discussions and to then help refine each 
programme theory as the project progressed. For example, information from FG1 
refined the programme theories stated above (pg.88), which were tested in FG2 
(using SSM maps to help health care professionals make sense of the ideas 
presented). The interviews with bereaved relatives and patients were conducted 
using an interview schedule which was approved by the NHS REC and could thus 
not be amended in response to theory development. Thus, programme theories 
could not be refined in between data collection from individual patients/bereaved 
relatives, as this would mean asking very different questions. Similarly, the 
questionnaire was a standardized questionnaire which was approved by the NHS 
REC and could not be changed, and the consultation recordings were conducted by 
GPs thus giving me no opportunities for input. Furthermore, these consultation 
recordings were meant to be a representation of a true palliative care consultation 
and therefore asking the GP to ask specific questions would not have been 
appropriate.  
The multiplicity of data collection strands that could work in conjunction with one 
another was designed to allow for an in-depth investigation of all possible 
mechanisms. Thus if a question was raised by one data collection strand, the answer 
would either be found in other strands, in informal discussions with practitioners 
during field visits, in focus groups, in PCQV or in discussion with the ICP founder. 
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In conjunction, all these (formal and informal) interactions with the data were used 
to refine and/or confirm programme theories as data was analysed. The complex 
data collection strategy also mitigated against the constraints of the requirement for 
ethics (including questionnaires and fixed interview schedules), so that theories 
could be developed and tested across datasets.  
The inclusion of the ICP founder as a supervisor in the team and attendance at 
locality PCQV acted as a further safeguard against the limitations of fixed data 
collection strategies. They meant that candidate explanatory theories were made 
explicit from early on, and refined on an informal basis as I familiarised myself with 
the field and discussed any confirming or disconfirming data finding with the 
founder. This process was not considered part of the formal data collection (as it 
might have been in other realist projects), but rather used for its theory refinement 
potential. This was because the ongoing involvement of the ICP founder enabled 
co-production of sense making that was grounded in practice experience and 
instrumental to the theory refinement process. Working in partnership, the founder 
was not a research participant but an invaluable source of knowledge that ensured 
greater practice validity of the findings. The focus groups, for which the schedule 
had been left open from the outset, came in addition to that. This was an iterative 
relationship between theory development and refinement and data analysis which is 
core to realist sense making processes.  
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Figure 2: The operationalisation of the method  
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The data collection design allowed for confirming and disconfirming evidence to 
refine programme theories (see Figure 2). If the findings from one data collection 
strand contradicted an initial programme theory, this theory was refined to further 
understand this. There was never an instance where two data sets completely 
contradicted one another, as there was always explanatory potential in all data 
strands. Thus, where it initially seemed that data strands showed different results, 
when combined they created a stronger, refined programme theory.  
This concludes the description of the data collection framework. Table 2 highlights 
the type and number of participants in each data collection activity.  
 
Table 2: The type and number of participants in each data strand 
 
  Type of participant  
Number of 
participants  
MIQUEST and Death Audit 
data analysis  Patients  
 4, 182 patients (who 
died between 2007 and 
2012) 
QDDM 
Bereaved relatives and 
health care professionals  
4 bereaved relatives 
and 4 health care 
professionals 
Focus groups (1, 2 and 3) 
Health care 
professionals  
FG1 = 12 attendees    
FG2 = 8 attendees       
FG3 = 6 attendees  
Semi-structured interviews  
Patients and bereaved 
relatives 
3 patients and 4 
bereaved relatives 
Consultation recordings  
Patients and health care 
professionals  
3 patients and 3 health 
care professionals 
 113 
 
The data collection activities include interviews and consultation recordings with 
palliative care patients and bereaved relatives. The analysis from the interviews and 
consultation recordings are used throughout the findings chapters (Chapters 4, 5, 6, 
7, and 8) intermittently, as all data is presented cohesively in order to refine the 
programme theories. Hence, a table is now provided in order to introduce the 
palliative care patients and bereaved relatives (Table 3).  
Table 3: A table to introduce the palliative care patients and bereaved relatives 
who participated in the study 
 
Pseudonyms Participant  Data collection tool  
Ned and Caroline  Bereaved relative  Interview 
Mark  Bereaved relative  Interview 
Linda Bereaved relative Interview 
Rachel  Bereaved relative Interview 
Doris (and her son Richard) Palliative care patient Interview 
Janet (and her daughter Jill) Palliative care patient Interview 
Michael (and his wife Barbara) Palliative care patient Interview 
Mary Palliative care patient Consultation recording  
John (and his wife Janice) Palliative care patient Consultation recording  
Susan  Palliative care patient Consultation recording  
 
Ethical approval  
Ethical approval was granted from the School of Health, Education and Community 
studies on 28/09/2011 (Appendix 33). Following this the NHS local ethics 
committee approved the study (REC reference number: 11/NE/0318) on 13/12/2011 
(Appendix 34). Research & Development approval was gained from four different 
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trusts, and relevant voluntary organisations and the local council were informed 
about the research. 
 
Chapter Summary  
This chapter has situated the research in a philosophical and methodological context 
that will allow the complexities of the ICP to be acknowledged throughout the 
evaluation. Realism does not aim to eradicate confounding variables but embraces 
them in the complex social nature of reality. The research question has been 
specified which has generated specific, testable programme theories. Finally, a data 
collection framework has been created in order to generate data that can test the 
programme theories and that will produce the most informative findings.  
 
Findings chapters 
The findings are presented in five distinct chapters matching the programme 
theories:   
 Embeddedness of the Integrated Care Pathway as a new initiative. 
 Identifying palliative care patients and registering them appropriately. 
 Preference discussions and the locality advance care plan. 
 Facilitating difficult conversations in palliative care. 
 Facilitating a home death.  
Although the chapters are presented separately, they do relate to one another. Many 
discuss the same tools or concepts but in different aspects. For example, the 
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chapters ‘Facilitating difficult conversations in palliative care’ and ‘Facilitating a 
home death’ both include comments around ACP. However, in each I refer to and 
use ACP in a different way to provide explanations about crucial aspects of the ICP. 
Understanding how the chapters relate to one another and why this is significant 
will be discussed in depth in the discussion.  
The chapters are ordered chronologically in terms of the patient’s palliative care 
journey. The first findings chapter (Chapter 4, p.117) concentrates on the 
embeddedness of the ICP, as for the patient to receive the ICP it must first be 
embedded into the GP practice. The chapter explores if and how the service has 
been adopted and used within the locality and to what extent. This includes 
consideration of variations in use of the ICP between practices. Chapter 5 (p. 163) 
moves on to discover CMOCs related to the palliative care register. Issues with non-
cancer patients and the palliative care register are explored and understood over 
time in relation to practitioners’ self-efficacy. Chapter 6 (p.199) concerns preference 
discussions and the locality advance care plan, specifically it highlights the 
importance of markers for initiating preference discussions; the role of false hope; 
time constraints; and the MCA. The final CMOC in this chapter explores the CQI 
element of this study, demonstrating how a change from the locality advance care 
plan to the advance statement from Deciding Right (NHS North East 2012) 
occurred. Chapter 7 (p.231) focuses on how ACP takes place in practice and 
explores the role of behavioural traits in the consultation. Finally, Chapter 8 (p.262) 
explores how a home death is facilitated in the locality with a focus on open 
communication strategies both at home and in the care home.  
 116 
 
The key domains (chapters) emerged from the data analysis and were used as a 
framework to refine the programme theories and to answer the subsidiary questions. 
This is explicitly explored at the end of each chapter.  
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Chapter 4: Embeddedness of the 
Integrated Care Pathway as a new 
initiative 
 
This chapter will explore a CMOC related to innovation diffusion, or 
‘embeddedness’. The more the ICP is used by the locality GP practices, the more 
confidence they build in using the ICP interventions, the higher the probability that 
it will not be considered as ‘new’ by the staff anymore and thus transform into 
routine practice; it will become embedded. Embeddedness is therefore considered as 
an intermediate outcome. Alternatively, the enthusiasm about the ICP could 
diminish, resulting in less use of the ICPs interventions (Pawson 2013). This chapter 
considers how the locality GP practices have used interventions over time, and 
compares GP practices to identify and understand if and why the ICP has embedded 
to different levels in the fourteen GP practices from the locality.  
 
Initial questions asked of the data 
The programme theory and subsidiary questions that this chapter focuses on were 
first stated in the methodology chapter and are stated below.   
Programme theory 1: The number of people who die in their chosen location 
(outcome) will depend on the GP practice (context) they are registered with and 
how embedded the ICP is, as indicated by the number of interventions used per 
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patient (outcome). Thus, this is a programme theory about the process of 
implementation, considering implementation as an intermediary outcome. 
- Does the use of more interventions result in better outcomes?  
- Do CQI initiatives increase intervention use?  
- What characteristics do ‘high performing’ GP practices have?  
Four CMOCs are presented below that relate to embeddedness. CMOC1 explains 
how the introduction of the ICP changed the capacity and capability to provide 
palliative care in the locality and what outcomes this resulted in. CMOC2 describes 
how the ICP interventions have been used within the locality, whilst CMOC3 
indicates which practices have adopted the ICP more proficiently and provides an 
explanation of why some practices are ‘high performers’.  
 
CMOC1 – Integrated Care Pathway intervention use and preferred 
place of death  
Outcomes: Intervention use predicts presumed preferred place of death 
The relationship between the number of ICP interventions administered per patient 
and the number of patients who achieved their presumed preferred place of death 
was investigated using a Pearson product moment correlation co-efficient, executed 
on MIQUEST data. The presumed preferred place of death refers to the patient’s 
own home, care home or a palliative care unit; deaths in these locations require 
planning and therefore are likely to be the patient’s preferred place. This 
relationship was investigated to test the informal hypothesis that the more 
interventions that are used per patient, the more likely they are to die in their 
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presumed preferred place of death, which is at home, in their care home or in a 
palliative care unit. This correlation showed that the number of ICP interventions 
administered per patient and the number of patients who achieved their presumed 
preferred place of death had a strong positive correlation (r = 0.54, n = 14, p < .05). 
The least squares regression line (line of best fit) in Figure 3 also displays this 
relationship.  
 
 
Figure 3: A correlation between the number of ICP interventions administered 
per patient and the number of patients who achieved their presumed preferred 
place of death  
 
A multiple regression was used to assess the ability of the ratio of interventions 
administered to patients who died to predict presumed preferred place of death. 
Preliminary analyses were conducted to ensure no violation of the assumptions of 
normality, linearity, multicollinearity and homoscedasticity. The model was 
significant (F(1,12) = 4.87, p < .05). The total variance explained by the model as a 
 120 
 
whole was 22.9% (Adjusted R2 = 0.229). Adjusted R2 was used due to the small 
sample size (fourteen practices). This means that the ratio of interventions used per 
patient who died accounts for 22.9% of the variance in achieving a death in the 
presumed preferred place. This means that the ratio of interventions used per patient 
is a good predictor of presumed preferred place of death. Thus this suggests that the 
ICP (and the interventions it advocates) are leading to good deaths for patients, 
when used appropriately, at least in terms of place of death. Thus the ICP ‘works’. 
 
Mechanism - The ICP and increasing perceived capability and capacity 
The ICP, in providing newly commissioned services, interventions and a planned 
pathway for palliative care patients (resources) provided the health care 
professionals in the locality with greater capacity and better capability to provide 
palliative care. Education and information about palliative and end-of life care for 
health care professionals (through Quality Improvement Skills for Primary Care 
days, Practice Based Commissioning Group, PCQV and PCP) and financial 
incentives through the formulation of Locally Enhanced Schemes (LES) for the ICP 
(palliative care registration and advance care plans) also supported the provision of 
this care (resources). The introduction of these new resources altered the reasoning 
of health care professionals as they now had a perceived improved ability and 
capacity to provide palliative care in the community (reasoning). Thus health care 
professionals working within the locality by using the ICP were able to provide high 
quality palliative and end-of-life care that could be patient centred and preference 
based. 
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Context: Palliative care at the top of the political agenda 
Prior to the introduction of the ICP, there were gaps in care which resulted in 
hospital admissions, OOH services were not routinely informed about palliative 
care patients unless they were nearing end-of-life, and there were few alternative 
options to a home or hospital death apart from a hospice outside the locality. In 
2008 the policy context for palliative and end-of-life care changed significantly, 
with the publication of the End-of-Life Care Strategy by the Department of Health 
(2008). This was the year the ICP was introduced to the locality. A policy push of 
this type, which occurs at the early implementation stage can facilitate an 
innovation’s chance of success (Greenhalgh, Robert et al. 2004). This change 
(context) resulted in a focus on equality of resource provision for all palliative care 
patients. Early identification of palliative and end-of-life care patients in the End-of-
Life Care Strategy (Department of Health 2008) may have contributed to the 
commissioners’ decision to fund the ICP, and instigated a desire for change in 
health care professionals in the locality. Thus, the publication of policies in 
palliative and end-of-life care may have increased motivation to adopt the ICP in 
the locality (Greenhalgh, Robert et al. 2004), as prior to its introduction capacity to 
facilitate home death was limited in the locality in terms of commissioned services, 
interventions and health care professional education.  
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Figure 4: CMOC1, ICP intervention use and preferred place of death 
 
Summary 
The publication of the End-of-Life Care Strategy (Department of Health 2008) 
identified a need for enhanced palliative care services and put palliative and end-of-
life care at the top of the political agenda in health care (context). At the time of this 
policy publication the locality introduced the ICP to provide enhanced services for 
those with palliative care needs approaching the end of their life (resources). This 
improved perceived ability and capacity to provide palliative care in the community 
(reasoning), with incentive from political directives. The ICP provided 
commissioned services, interventions and a planned pathway (resources) for 
patients that health care professionals could readily use. This instigated a change in 
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reasoning in health care professionals, enhancing their capacity to provide palliative 
and end-of-life care in the community. Increased intervention use has a strong 
positive correlation with increased presumed preferred place of death; a regression 
analysis identified that intervention use predicts presumed preferred place of death 
(outcome). This indicates that the ICP ‘works’ in terms of outcomes for patients, as 
most people would least prefer to die in hospital (Gomes, Calanzani et al. 2011). 
CMOC1 (Figure 4) shows this in diagrammatic format.  
 
 
CMOC2 – Commissioned services in the ICP  
Outcome: Variable commissioned service use  
Interviews with palliative care patients and bereaved relatives highlighted that use 
of the palliative care unit and the Hospice at Home service (commissioned services) 
was variable. However, variable uptake does not reflect lack of value, but rather 
highlights the breadth of what was on offer to supplement people’s natural support 
networks. Quantitative data was not available to support the qualitative findings 
from the interviews in relation to commissioned service use.  
 
Mechanism: Increased support for palliative care patients who need it 
The commissioned services provided more support for palliative care patients and 
their family members (resource) and were highlighted in interviews with some 
palliative care patients and bereaved relatives. It is beyond the remit of this study to 
explain how commissioned services have been made use of and whether they have 
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been effective. However, interviews with palliative care patients and bereaved 
relatives highlighted that use of the services was variable. This was often due to 
individual patients’ or family members’ reasoning.  
Interviewees explained why they did not accept offers from health care 
professionals to arrange their end-of-life care in the palliative care unit. Linda 
(bereaved relative) described how the district nurse offered this service very early in 
Linda’s husband’s palliative care journey. However, Linda’s husband was very 
clear that he wanted a home death, therefore when the palliative care unit was 
offered, he refused it.  
Linda (bereaved relative): “No, he made it very clear from the first 
visit of the, of the nurse, because she, the district nurse pointed out 
that there was erm, very nice 24 hour doctors’ beds in (name of 
palliative care unit)?” 
 
The health care professionals involved in Mark’s (bereaved relative) mother’s care 
mentioned the palliative care unit to Mark. However, he never took this offer further 
as his mother was content at her care home.  
Mark (bereaved relative): “Yeah I’d heard of it and I was aware 
what they did and I have friends who, a very good friend who’s 
mother is there at the moment, erm, so, it was mentioned, erm, but 
I don’t think she’d have wanted to go there, I don’t think, she was 
very happy where she was.” 
 
The aforementioned participants’ loved ones were informed of the palliative care 
unit’s services early in their palliative and end-of-life care journey. Rachel 
(bereaved relative) was offered this service much later and it may be that the timing 
of this offer was inappropriate, as she felt that she and her husband had overcome 
the most challenging parts of her husband’s end-of-life journey.  
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Rachel (bereaved relative): “So that was, er there was twice Dr. 
(name), she was lovely, she said, erm, it was the Saturday night 
she said would you like us to get him into (palliative care unit) for 
a couple of nights and I said no not now I've done the worst, you 
know.” 
 
However it must also be noted that similar to Linda’s husband, Rachel’s husband 
also had a strong wish to be at home and this may have contributed to her decision 
to refuse admission to the palliative care unit. A palliative care patient’s wife, 
Barbara, described how the palliative care unit had not been offered by primary 
care, but by secondary care.  
Barbara (Michael’s wife): “Yeah, they mentioned that at the 
hospital to you, you know, they said do you want to go to the 
(palliative care unit) we said no. Yes we prefer to be at home. They 
did mention that at the (hospital in town), but we did say he 
wanted to be at home.” 
 
Again, a desire to stay at home prompted the refusal of the palliative care unit. 
Another palliative care patient who was decreasing in physical wellness and starting 
to require social care help was asked about the palliative care unit.  
Interviewer: “Yes and have you ever stayed there?” 
Doris (palliative care patient): “No.”  
Interviewer: “No. And has that ever been mentioned to you?”  
Doris (palliative care patient): “No.” 
 
Doris (palliative care patient) had not been informed about the palliative care unit. 
However she too had a great desire to remain in her own home for as long as 
possible, which she stated, but which was also evident due to her decreasing health 
and wish for social care help as opposed to consideration of a care home.  
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Doris (palliative care patient): “Oh I’d stay at home as long as 
possible, definitely.” 
 
Similar to Doris, Janet (palliative care patient) and her daughter Jill had also not 
been informed about the palliative care unit. However, unlike Doris they felt the 
palliative care unit was something they would definitely consider for Janet’s end-of-
life care.  
Janet (palliative care patient): “That sounds interesting actually I 
might…” 
Jill (Janet’s daughter): “I’ll ask about that.” 
 
Jill explained that she hadn’t known about the palliative care unit, but then blamed 
herself for not investigating available palliative care and just presuming there was 
only the one well-known hospice in the city centre 20 miles away.   
“Jill (Janet’s daughter): Yeah, I mean, I, I, you know you 
mentioned a few, a few things about the (palliative care unit), I 
didn’t realise that, I didn’t realise” 
Janet (palliative care patient): “No, no, that is interesting” 
Jill (Janet’s daughter): “But you probably should go and find out 
about it anyway.”  
 
The interviews highlighted that the palliative care unit (resource) commissioned by 
the ICP was being offered to patients from both primary and secondary care, which 
is extremely important as it shows cohesion between services. Refusal of the 
palliative care unit was often due to the desire to remain at home (reasoning). 
However, the inappropriate timing of offering the palliative care unit could also be a 
factor, with relatives feeling they have experienced ‘the worst’ of their loved one’s 
end-of-life care journey and not wishing to give up on their aim to enable a home 
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death. Furthermore, it is very difficult for a relative to deny a dying person their 
preferred place of death (home) and resort to a palliative care unit, particularly when 
it is unplanned. This is even in the case of respite as often this can result in full end-
of-life care due to an unexpected decline in symptoms making it unfeasible for the 
patient to be transported back home, in case of death during the journey. However, 
two current palliative care patients had not been informed about the palliative care 
unit, one of whom was very interested in their services and planned to investigate it 
after the interview. It must be noted that despite people’s strong preferences to die 
at home it is to their advantage to be aware of other options excluding hospital. 
However, it must also be noted that all of the patients who participated in the 
interviews or were discussed in the interviews (by bereaved relatives) were living or 
had lived at home or in a care home with strong support networks around them; 
therefore they may have had less need to plan for a death elsewhere. The data 
indicates that the offer of care from the palliative care unit (resource) is often not 
taken due to personal circumstances including a strong will to die at home 
(reasoning).  
 
Hospice at Home Service  
A Hospice at Home service was commissioned by the ICP and available for those 
patients living in their own home.  Two of the bereaved relatives who cared for their 
husbands at home had very different experiences with the Hospice at Home service, 
one having contact from the start of her husband’s palliative care journey and the 
other not being aware of the service.  
Linda (bereaved relative): “Erm, I could have done, they were very 
good, they did ring me up.” 
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Rachel (bereaved relative): “I’ve never been in contact with 
(Hospice at Home), they’ve never been in contact with me.” 
 
Linda used the Hospice at Home’s night sitters in her husband’s end-of-life period, 
as did Caroline. However, Caroline had night sitters for around two weeks prior to 
her mother’s death, whereas Linda only had them on the evening of her husband’s 
death. Both bereaved relatives had a positive experience with the Hospice at Home 
night sitters and appreciated their efforts to prognosticate the dying process so that 
they could be with their loved ones when they passed away.  
Linda (bereaved relative): “I did have them at the last day, the last 
night, they sent a, because I’d been up the night before, and 
friends and myself had, erm, kind of, did a shift during the night 
because (husband) was unconscious so we kind of err had no sleep 
that night, and as Dr. (name) said, he thought it was a good idea 
that, somebody from the hospice came out, and I had a nurse on 
the night (husband) died. There was, there was a nurse sitting with 
him while I was in another room but getting up at a you know, sort 
of at an interval, and she got me in time to be with him. So yes the 
(Hospice at Home).” 
 
Caroline (bereaved relative): “Um and it was a lady from the 
(Hospice at Home) who was there when mummy died who woke 
me so I was there for her last minutes and that was very, 
wonderful. Absolutely wonderful.” 
 
Doris, a palliative care patient explained how she had used the Hospice at Home’s 
transport service to get to her hospital appointments. Doris really valued the one to 
one nature of the transport service and the way it allowed her to attend appointments 
without using an ambulance. Doris evaluated the Hospice at Home transport service 
positively, describing how she has never felt the need to use another transport 
service.  
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Doris (palliative care patient): “I tell you they’ve (Hospice at 
Home) been very very good that way. Very good… I have always, 
always used them I haven’t ever used anybody else actually.” 
 
One of the palliative care patients interviewed had not been informed about the 
Hospice at Home service, but the other two palliative care patients interviewed were 
aware of it. Three out of four of the bereaved relatives were aware of the Hospice at 
Home service. Reasons for not using the service included personal circumstances, 
as Rachel, Linda and Barbara (palliative care patient’s wife) explained.  
Rachel (bereaved relative): “Right, right then, well to be fair I 
used to, well I was still sleeping with (husband) I slept in the bed 
with him every night because that was the way he wanted it. Erm, 
even the night before he died I was still in the bed with him so that 
would never have worked really because he wouldn’t have let us 
go into another room you know, because he was frightened. So 
that (night sitters), that wouldn’t have worked I don’t think.” 
 
Linda (bereaved relative): “So yes the (Hospice at Home). I could 
have used them more, but, I didn’t have the need to. I had friends, 
and family around me. I didn’t, you know, if I needed them to sit in 
with (husband), because he was never left, I would have used them 
more, my only reason for not using them was because I had other 
support.” 
 
Barbara (palliative care patient’s wife): “Ah the neighbours, you 
know, they come in and, yesterday, last week, and there’s a one 
coming tomorrow afternoon, just, erm as I say we’ve got good 
neighbours, there’s a gentleman along the street and there’s a lady 
along the other side. They’re all, they’re all good.” 
 
A perceived strong home support system was pivotal in not requiring Hospice at 
Home services, as highlighted by Linda and Barbara above. Personal circumstances 
and preferences (reasoning), as Rachel explains, are also very important in reference 
to uptake of the service.  
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To summarise, the Hospice at Home service was relatively well known, although 
there was one palliative care patient and one bereaved relative who hadn’t been 
informed about the service. Experiences of the service were all positive, including 
night sitters and transport services. Reasons for not using the service were mainly 
due to a lack of need which was often related to a strong support system and 
personal preferences (reasoning), but also may have included a lack of information 
about it in the cases of those who were not informed about it.  
Commissioned services are being used variably by patients. The palliative care unit 
should be offered as early as possible in a patient’s palliative care journey and not 
used solely as a respite or unplanned option near to the end-of-life. Patients need to 
be aware of their options in order to have extended choices. However, it must be 
acknowledged that home deaths are preferred to hospice deaths (Gomes, Calanzani 
et al. 2011) which is why uptake may be limited in this rural locality. The Hospice 
at Home service was evaluated positively by those who had used it and those who 
did not expressed that they had not had a need to, due to strong support networks. 
ICP commissioned services should be offered to all patients yet may be of most use 
to those with weak support networks who will not have the capacity to stay at home, 
thus it is essential health care professionals identify this vulnerable population early 
to avoid a hospital death. However, in order for services to be utilised, patients, 
relatives and carers must have knowledge of them, which in some cases they did 
not. To conclude, in the context of increased palliative care services, the palliative 
care unit and Hospice at Home service provided increased support for palliative care 
patients and their families (resource), however uptake of this support was based on 
patients’ and family member’s preferences and needs (reasoning).  
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Context: Increased need for palliative care services  
Additional palliative care services were required in order for patients’ preferences to 
be met. An alternative outlet for hospice care (palliative care unit) and increased 
palliative care services in the community (Hospice at Home service, complementary 
therapy charity) were required. The provision of the palliative care unit and Hospice 
at Home service (resources) met this need and allowed the mechanism to ‘fire’ for 
those who required additional support.  
Summary  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: CMOC2, commissioned services in the ICP 
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The locality was in need of enhanced services for palliative care (context). The 
provision of commissioned services such as the palliative care unit and the Hospice 
at Home Service have resulted in increased available support (resource) for 
palliative care patients and their family members. Whether patients and family 
members use the services is dependent on personal circumstances (reasoning), with 
a perceived strong support network often stated as a reason to decline the use of 
services (reasoning). This has resulted in variable uptake of the palliative care unit 
and the Hospice at Home service in the locality. CMOC2 is displayed 
diagrammatically in Figure 5. 
 
CMOC3 – Continuous quality improvement and intervention use  
Outcome: Increased use of Integrated Care Pathway interventions  
Comparisons of intervention use over time indicate whether the ICP’s components 
are being delivered more regularly and thus whether they are becoming standard 
practice. Clinical audits undertaken before and after the inception of quality 
improvements are an effective way of assessing whether the attempts are working 
(Sullivan and Garland 2010). Increased use of the ICP interventions over time 
means that they are being used for more palliative care patients, thus more 
appropriately. It must be noted that from 2009 to 2010 the population who received 
the ICP increased by 60,000 to 78,000 due to two additional practices joining the 
locality group and implementing the ICP. This means that these practices would not 
have had the same level of input in 2010 as the practices which joined in 2009; 
therefore they were not as experienced in the ICP interventions and may not have 
achieved the outcomes they could have if they had joined in 2009. Additionally, 
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values for 2007, 2008 and 2009 do not include the two additional practices. 
However, the calculations controls for these missing values. The interventions that 
have been focused on are: palliative care registration, preference discussions, the 
locality advance care plan, anticipatory medication and LCP use.  
 
Palliative Care Registration 
A one-way repeated measures ANOVA was conducted to compare numbers of 
palliative care registrations from 2008 to 2012, using Death Audit data. Death Audit 
and MIQUEST data both provide values for palliative care registrations; Death 
Audit data was used as it provided an additional 2 years of data. Mauchly’s Test of 
Sphericity was significant (p < .05), meaning that sphericity was not assumed and 
Greenhouse-Geisser values are reported. There was a significant effect of time on 
palliative care registrations (F(2.74, 30.17) = 9.93, p < .001, 2p = 0.47). Using the 
guidelines proposed by Cohen (1988) for the 2p  (0.01 = small, 0.06 = moderate, 
0.14 = large effect), this result suggests a large effect size. The means and standard 
deviations for palliative care registrations from 2007 to 2012 are presented in Table 
4, the means show an overall increase in palliative care registrations from 2008 to 
2012. However there is a small decrease in the mean from 2010 to 2011. This is 
depicted in Figure 6.  
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Table 4: Descriptive statistics for palliative care registrations conducted in the 
GP practices signed up to the ICP over time, using Death Audit data. 
 
Time 
Period  
Number 
of 
practices Mean 
Standard 
Deviation  
2007 12  9.33 10.77 
2008 12   10.33 9.23 
2009 12   14.33 11.4 
2010 12  19.83 16.24 
2011 12  18.42 11.11 
2012 12  26 16.85 
 
Figure 6: Mean number of palliative care registrations between 2007 and 2012, 
using Death Audit data. 
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Preference Discussions  
A one-way repeated measures ANOVA was conducted to compare numbers of 
preference discussions that were documented on the data system in 2009/10, 
2010/11 and 2011/12. The means and standard deviations are presented in Table 5; 
the means show an increase in preference discussions recorded on the data system 
over time. Mauchly’s Test of Sphericity was not significant so sphericity was 
assumed. There was a significant effect of time on preference discussions recorded 
on the data system (F(2, 22) = 15.95, p < .001, 2p = 0.59). Using the guidelines 
proposed by Cohen (1988) for the 2p  (0.01 = small, 0.06 = moderate, 0.14 = large 
effect), this result suggests a large effect size. The increases over time in preference 
discussions recorded on the data system are identified in Figure 7. 
 
Table 5: Descriptive statistics for preference discussions recorded on the data 
system conducted in the GP practices signed up to the ICP over time, using 
MIQUEST data. 
 
Time 
Period  N Mean 
Standard 
Deviation  
2009/10 12 2.58 4.06 
2010/11 12 5.58 8.2 
2011/12 12 10.75 7.61 
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Figure 7: Mean number of preference discussions between 2009/10 and 
2011/12, using MIQUEST data.  
 
The number of practices involved in the analysis (N) is twelve instead of fourteen as 
SPSS accounts for there being no data for two of the practices in 2009/10 as they 
joined the ICP at a later date. These missing values are not regarded as an issue as 
the reason they are missing is not related to the data or intervention.  
 
Locality advance care plan  
A one-way repeated measures ANOVA was conducted to compare numbers of 
locality advance care plans completed in 2009/10, 2010/11 and 2011/12. There was 
no significant effect of time on locality advance care plans completed (F(2, 22) = 
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0.21, p > .05, 2p = 0.2). This means that the number of locality advance care plans 
being carried out since the introduction of the ICP has not significantly increased. 
 
Anticipatory medication  
In order to assess whether the use of anticipatory medication has increased over 
time a one-way repeated measures ANOVA was conducted. There was no 
significant effect for time on anticipatory medication used (F(2, 22) = 2.67, p > .05, 
2
p = 0.2). Therefore, despite Figure 8 displaying that anticipatory medication is 
increasing, this increase is not statistically significant.  
 
 
 
Figure 8: Anticipatory medication prescriptions from 2009/10 to 2011/12. 
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Liverpool Care Pathway for the Dying Patient  
A one-way repeated measures ANOVA was conducted to compare numbers of 
patients who died with the LCP. The means and standard deviations are presented in 
Table 6; the means show an increase in LCP use over time. Mauchly’s Test of 
Sphericity was not significant so sphericity was assumed. There was a significant 
effect for time on LCP use (F(2, 22) = 3.67, p < .05, 2p = 0.25). Using the 
guidelines proposed by Cohen (1988) for the 2p   (0.01 = small, 0.06 = moderate, 
0.14 = large effect), this result suggests a large effect size. Therefore it can be 
concluded that the GP practices are significantly increasing their use of the LCP 
since the introduction of the ICP, this increase is shown in Figure 9. The means and 
standard deviations indicate a large increase from 2009/10 to 2010/11.  
Table 6: Descriptive statistics for LCP use in the GP practices signed up to the 
ICP over time, using MIQUEST data. 
 
Time 
Period  N Mean 
Standard 
Deviation  
2009/10 12 5.83 5.70 
2010/11 12 9.58 10.1 
2011/12 12 10.17 9.95 
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Figure 9: Mean number of LCP use between 2009/10 and 2011/12, using 
MIQUEST data. 
 
Summary of ICP intervention analysis  
The statistical analysis of GP practice data suggests that the use of some of the ICP 
interventions is increasing over time: palliative care registrations, preference 
discussions and LCP. All of these interventions indicated a significant increase in 
use from implementation of the ICP to 2012. Furthermore, Cohen’s (1988) effect 
sizes indicated that all of the significant increases in intervention use were large. 
However, neither anticipatory medication nor locality advance care plans showed 
significant increases over time. In terms of locality advance care plans, this non-
significant increase might be due to health care professionals’ difficulties with the 
documentation (discussed later in chapter 6, p.199). 
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Mechanism: Continuous Quality Improvement 
In the ICP CQI takes the form of PCQVs which utilise GP practice data (Death 
Audit and MIQUEST) to feedback information on performance to practices. It is a 
resource that the ICP provides, as CQI requires leadership (from the ICP’s founder) 
and financial resources (through ICP commissioning streams) to educate and enable 
health care professionals to evaluate themselves. It involves not only identifying 
issues with the ICP and problems in practice but also gives recognition of effort 
(reward systems) in both verbal and written forms (McLaughlin 1994). These 
clinical governance visits consist of the founder of the ICP visiting the GP practices 
MDT meeting to:  feedback data, reflect on the practice’s performance, discuss how 
the practice staff would manage a fictional palliative care patient from diagnosis to 
death, talk about difficult issues experienced when using the ICP, and identify and 
provide potential solutions for problems specific to that individual practice. Thirteen 
of the fourteen GP practices involved in the ICP and this study have received one 
PCQV. The PCQV were evaluated positively by both a community matron and a 
GP, who felt that they received constructive feedback tailored to the individual 
practice (resource) which helped them to improve as a team.  
Community Matron 2 (FG1): “(I’ve) been involved with two 
because we cover two practices, and they’ve both been very 
different and they’ve been constructive, very honest, but 
constructive and actions have happened as a consequence.”  
 
GP3 (FG1): “Yeah, (inaudible) brought the team together to 
discuss it with (ICP founder) and we did get very helpful feedback 
which we took on board”  
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GP2 suggested that the PCQV resulted in practices engaging with the ICP more 
(reasoning), due to the information that they were provided with about their 
performance.  
GP2 (FG2): “And I wondered if under input, and again it’s a more 
general comment, whether we should be putting something about 
audit, feedback, education process into this, and I was thinking 
specifically about (ICP founder’s) visits to practice, because I 
know that a lot of the practices, you know, have engaged a lot 
more, further, after one of (founder’s) visits because of the 
information that was fed back to them.”  
 
Community Matron 2 and GP2 then built on the above quotes by explaining how 
even just the prospect of the PCQV resulted in them improving their performance 
(reasoning).  
GP2 (FG2): “Yes I think there’s, there’s, before you’re about to 
have it there’s a stimulus, after you’ve had it because of the 
feedback there’s a stimulus and I know I’ve, in the past our 
statistics improved because it stimulated us.”  
 
 
Community Matron 2 (FG1):  “There’s something about, which 
I’ve thought about since the beginning of this meeting, is that 
there’s been a great leadership with this, these visits, it was the 
same with others, like diabetes and heart quality visits that there 
was, exactly what you said, before we’ve got to get it ready, we’ve 
got to get it right and then you do sort of pick up on the points and 
then it’s just human nature everything drops off again and I think 
if the leadership doesn’t keep going it’s sort of keeping that, gotta 
keep it going, so there is something about that (inaudible) tha t’s 
lost.”  
 
This highlights how CQI is itself modifying the delivery of the programme. The 
knowledge of an upcoming PCQV visit (resource) is enough to make staff feel they 
need to adhere to the programme (ICP) specification more rigidly. However, the 
negative facet to this is that post PCQV, after initial motivation and enthusiasm 
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from the visit has peaked and then diminished, health care professionals may begin 
to lose sight of the ICP goals and ethos and make less use of the associated 
interventions. Pawson (2013) highlights that enthusiasm is time bound and can dip 
as the ICP (social programme) is used more by those who implement it. The social 
programme then becomes less capable of inspiring change through enthusiasm for a 
new innovation. This could be the case in the ICP, as palliative care registered 
patients are increasing (see the quantitative analysis above, p.128) and thus it could 
be assumed that the ICP is less capable of producing change, due to the enthusiasm 
about the initiative depleting. However, as will be discussed in chapters to come, 
palliative care registrations are increasing for some palliative care patients, but not 
all (See Chapter 5: Identifying and registering palliative care patients, p.163). This 
means that the PCQV are still capable of inspiring change, educating, increasing 
motivation and enthusiasm, which is demonstrated in the quotes from the focus 
groups, from the health care professionals who deliver the ICP. The participants 
describe benefitting from several outcomes of the PCQV (resource): education, 
feedback, evaluation, motivation and renewed enthusiasm. In a large scale 
systematic review by Greenhalgh, Robert et al. (2004) it was highlighted that the 
capacity to evaluate an innovation was crucial to its successful diffusion into routine 
practice. If suitable systems and skills are present to monitor and evaluate the 
innovation (ICP) this leads to a higher probability of it becoming embedded, 
assimilated and sustained (Greenhalgh, Robert et al. 2004). Thus, PCQVs should 
help the ICP to become embedded.  
In summary, the health care professionals’ reasoning is changed, as they improve 
their performance and use of ICP interventions, due to the knowledge of an 
upcoming PCQV or in reaction to feedback from a PCQV (resource). This then 
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leads to the more frequent use of interventions advocated by the ICP, as described 
in the outcome section to follow.  
 
Context: Proactive and patient centred care  
Many of the ICP interventions are focused on proactive care (palliative care 
registration, preference discussion, ACP, anticipatory medication), meaning that in 
the use of the interventions GPs are implicitly being proactive. Thus the medical 
and political drive for proactive care is a factor that will affect the use of ICP 
interventions. Patient centred care is another philosophy that is widely advocated in 
health care (Little, Everitt et al. 2001, McCormack, Treiman et al. 2011, Mulley, 
Trimble et al. 2012) and can also be considered as a context that affects the use of 
the ICP interventions and consideration of place of death. Patient centred care is the 
process of providing care that is responsive to individual personal preferences, 
values and needs and ensures that patient values are central to all clinical decisions. 
Some of the ICP interventions, such as preference discussions and ACP, explicitly 
present operationalisations of patient centeredness. All health care professionals in 
the focus groups were very aware of the notion of patient centred care and 
highlighted it in FG2 as the most important context in regard to several 
interventions that the ICP uses: the ICP overall, palliative care registration, ACP, 
MDT meetings and the traffic light system. CQI also aims to improve services with 
a view to providing patients with a good death (being patient centred).  
FG3 highlighted that proactive and patient centred care were the crucial context in 
this CMOC, with the NHS drive for CQI acknowledged but not pivotal. The NHS 
drive for improvement is actually incorporated in the social programme and forms 
part of the mechanism resource.  
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GP3 (FG3): “I would suggest that proactive and patient centred care 
is the most important context… Well of the two, whilst the NHS drive 
for CQI is there in the background I don’t see it as something that 
drove us.” 
 
GP4 (FG3): “No I mean I, I agree, the NHS drive for the CQI is there 
in a lot of domains but I would say that locally, the end-of-life care is 
one of the things that we did really progress, and I think that’s 
probably come from the feedback from (palliative) care quality visits. 
Erm that was one of the reasons I think that we were more enticed 
into that role than all the other stuff that was sent to us really” 
 
Despite the important role of CQI as a mechanism, it was not considered to be a 
contextual factor that drove the use of ICP interventions.  
Summary  
 
 
 
 
 
 
 
 
 
 
 
Figure 10: CMOC3, CQI and intervention use 
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The drive to provide patient centred and proactive care in the locality (context) 
means that the education and feedback PCQVs provide (resources) result in 
motivation and enthusiasm from the health care professionals, both prior to and post 
PCQV. This makes them engage with the ICP more (reasoning). This mechanism 
results in increased use of interventions (outcome): palliative care registration, 
preference discussions, LCP. However, locality advance care plans and anticipatory 
medication use have not significantly increased. Explanation of the non-significant 
increase in locality advance care plans will be discussed elsewhere in the thesis 
(Chapter 6: Preference discussions and locality advance care plans, p.199). 
Anticipatory medication may not have significantly increased because GP practices 
can be very variable in their recording of anticipatory medication. This CMOC 
demonstrates the importance of the PCQV in continually improving the ICP and 
increasing intervention use and recording through motivating and educating the 
health care professionals who deliver it. CMOC2 (Figure 10) illustrates the 
relationship between the contexts, mechanisms and outcomes in this configuration. 
 
 
CMOC4 (I) – Peer support, leadership and embeddedness of the 
ICP  
Outcome: Embeddedness - three high performing practices 
Cluster analysis can be used to discover structures in data but does not explain why 
they exist. Thus in this analysis it will be used to identify relatively homogeneous 
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groups of GP practices based on selected characteristics (such as ICP interventions 
or place of death outcomes), input by the analyst, which will be stated below in each 
cluster analysis. Two separate cluster analyses were conducted - one focused on 
outcomes (place of death, number of interventions administered and number of 
palliative care registered deaths), the other focused on a number of intermediate 
outcomes from ICP interventions (palliative care registration, the locality advanced 
care plan, OOH notification, DS1500 forms for monetary benefits, anticipatory 
medication and LCP). Two clusters were selected from the data collected from 
fourteen GP practices. Hierarchical clustering was used, which involves factors 
being organised into a hierarchical structure as part of the procedure. This was done 
with a between groups linkage that clusters objects based on the distance between 
them.  
 
Cluster Analyses I 
The first cluster analysis completed showed two clusters when using four factors 
from 2011/12 data: patient death in their own home (MIQUEST), patient presumed 
preferred place of death including home, care home and palliative care unit/hospice 
(MIQUEST), ratio of interventions administered to total deaths (MIQUEST) and 
ratio of palliative care registered deaths to total deaths (MIQUEST). These four 
factors were selected as they are outcomes of the ICP and offer explanatory 
potential however they are not outcomes of intervention use in their primary form 
(as in Cluster Analyses II). The analysis identified two clusters, cluster 1: GP 
Practices A, B, C, F, G, H, J, K, L, M and N, and cluster 2: GP Practices D, E and I.  
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T-tests were performed to find out which factors significantly contributed to the 
clusters. Normality of data was checked for all outcomes the t-tests were performed 
on; normality pertained in all instances. There was a significant difference between 
clusters for the numbers of home deaths patients achieved (t(12) = -3.07, p < .05). 
Cluster 2 (practices D, E and I) had significantly more patients who died in their 
own homes (M = 10.33, SD = 4.51) than cluster 1 (M = 4.36, SD = 2.58). There was 
also a significant difference between clusters for presumed preferred place of death 
(MIQUEST) (t(12) = -6.29, p < .001). The presumed preferred place of death is a 
combination of home, care home and palliative care unit/hospice deaths. It is 
assumed that these are preferred places of death for patients as a considerable effort 
would be needed in order for a patient to die in this location, and hospital is reported 
as the least preferred place to die in both locality and regional data (Gomes, 
Calanzani et al. 2011).  Significantly more patients died in the presumed preferred 
place of death in cluster 2 (M = 29.33, SD = 6.81) than in cluster 1 (M = 8.45, SD = 
4.68). The ratio of interventions administered (t (12) = -1.7, p > .05) and the ratio of 
palliative care registrations to total deaths (t(12) = -1.29, p > .05) were both not 
significantly different between cluster 1 and cluster 2. 
To summarise, cluster 2, which consisted of practices D, E and I helped patients to 
achieve a home or presumed preferred place of death significantly more than cluster 
1 (all other practices from the locality).  
 
Cluster Analyses II  
The second cluster analyses focused on interventions and formal outcomes of the 
ICP. This cluster organised the GP practices in the same way as cluster I; cluster I 
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consisted of GP practices A, B, C, F, G, H, J, K, L, M and N, and cluster 2 consisted 
of GP Practices D, E and I. The factors entered into the cluster analysis were 
palliative care registration, locality advance care plan, OOH notification, DS1500 
forms, anticipatory medication and LCP. All data was from 2011/12.  
T-tests were performed to find out what significant differences contributed to the 
clusters. Normality of data was checked for all interventions t-tests were performed 
on; normality pertained in all instances. There was a significant difference between 
clusters for the number of palliative care registrations made (t(12) = -4.63, p < 
.001). Cluster 2 (practices D, E and I) registered significantly more patients on the 
palliative care register (M = 36, SD = 12.12) than cluster 1 (M = 13.27 SD = 6.23).  
There was not a significant difference for use of the locality advance care plan 
between the two clusters, although the p value was near significance (t(12) = -1.94, 
p = 0.76) and the means indicated that cluster 2 (M = 9.33, SD = 3.22) completed 
more advance care plans than cluster 1 (M = 4 .64, SD = 3.8).  
OOH notifications were significantly different between the two clusters (t(12) = -
3.3, p < .01), with cluster 2 completing significantly more OOH notifications (M = 
15.33, SD = 5.77) than cluster 1 (M = 6.27, SD = 1.153).  
A t-test showed that cluster 1 and 2 had a significant difference for DS1500 forms 
completed (t(12) = -2.45, p < .05), with cluster 2 administering more DS1500 forms 
(M = 8.33, SD = 6.66) than cluster 1 (M = 3.09, SD = 2.02).  
Clusters 1 and 2 showed a significant difference on the amount of anticipatory 
medication prescribed to patients (t(12) = -4.76, p < .001). Cluster 2 prescribed 
significantly more anticipatory medication (M = 14.67, SD = 3.22) than cluster 1 
(M = 5.18, SD = 3.03).  
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There was a significant difference in the amount the LCP was used between cluster 
1 and cluster 2 (t(12) = -7.26, p <  .001). Cluster 2 used the LCP significantly more 
(M = 26.67, SD = 6.51) than cluster 1 (M = 6.45, SD = 3.67).   
To summarise, cluster 2, consisting of practices D, E and I, administered or 
completed significantly more formal interventions from the ICP than cluster 1 on all 
formal interventions apart from use of the locality advance care plan, where the 
outcome was not significant, but it was extremely close to significance. They also 
had significantly more home or presumed preferred place of death (home, care 
home or palliative care unit). Since it has now been highlighted by this quantitative 
analysis that practices D, E and I can be considered as ‘high performers’ a 
comparison can be made; between the high performing practices and the other 
practices in the locality.   
 
Mechanism: Opinion leaders and a champion  
Peer support and leadership are both very important when implementing new 
initiatives (Greenhalgh, Robert et al. 2004) and contribute to embeddedness. 
Practice D, E and I all have peer support and leadership in the form of opinion leads 
or a champion. Practice I hosts the GP Locality Lead for Research who is very 
research active and a data active GP who ensures the recording, analysis and 
feedback of data to the practice is of a high standard. This GP and the GP Locality 
Lead for Research could be considered as peer opinion leaders (Greenhalgh, Robert 
et al. 2004). These two peer opinion leaders at practice I had a positive effect on 
ICP diffusion in their practice, they adopted the ICP promptly after sign up due to 
their active roles and their desire for constant progress through research, feedback, 
and innovation and this had an effect on others in the practice (I).  
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Practice D also has an opinion leader present (resource), but this opinion leader is 
an expert opinion leader, as opposed to a peer. An expert opinion leader exerts 
influence through their authority and status (Greenhalgh, Robert et al. 2004). The 
expert opinion leader is a GP at practice D and the Director of the Clinical 
Commissioning Group. He was a great supporter of the ICP, involved in its design 
and implementation; his support of the ICP influenced others in his practice 
(practice D) to also support it.  
The literature on innovation diffusion highlights that the ICP’s founder is a 
‘champion’. A champion (resource) can aid innovation diffusion as they exert 
influence on others. Before retiring in 2011, the founder was a GP at practice E. 
Thus, the presence of a champion may have resulted in the ICP becoming more 
embedded at practice E, hence their better outcomes in comparison to other 
practices. The founder of the ICP meets the criteria to be a champion, described in 
Chapter 2 (p.40) He hosts PCQV to provide a forum for the health care 
professionals who deliver the ICP to discuss their unique practice problems 
(organisational maverick). The founder then works collaboratively with them to 
formulate autonomous solutions. The PCQVs also allow the founder to feedback to 
the practices on their performance, thus providing a flexible monitoring system that 
gives information on resource use such as the commissioned palliative care unit or 
ACP (organisational buffer). This flexible monitoring system also ensures that 
innovators properly use the organisation’s resources while still allowing them to act 
creatively (organisational buffer). He is also a well-respected, long standing GP 
from the locality (now retired), thus he inherently has organisational, clinical and 
local knowledge that is valued by others (transformational leader). Finally, he acts 
as a network facilitator, as he develops cross-functional coalitions within the 
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organisation by regularly hosting multidisciplinary workshops for the full locality 
including all fourteen practices (network facilitator). Specifically, coalitions have 
been made between social care and nursing care staff via workshops which 
addressed issues that affected practice (Greenhalgh, Robert et al. 2004). 
Furthermore, the ICP founder worked closely with the management support that 
was contracted to aid implementation of the ICP.  
New systems that have a clear, explicit advantage in either effectiveness or cost-
effectiveness are more easily accepted and implemented (Greenhalgh, Robert et al. 
2004). Thus if health care professionals see no relative advantage (reasoning) in the 
ICP, they usually will not consider it any further and therefore will not use it 
(Greenhalgh, Robert et al. 2004). Therefore, seeing the relative advantage is an 
essential reasoning for ICP adoption. Opinion leaders and champions who provide 
peer support and advocate the ICP by pushing the palliative care agenda will help 
other members of their team to see its relative advantage. When asked about the 
relative advantage of the ICP, representatives from Practices D and E stated:  
Practice D representative: “The ICP ensures good communication 
around patient care and thus improves patient care. The palliative 
care pathway helps us provide high quality palliative care. It 
ensures all aspects of palliative care are addressed and also 
communicated to Out of Hours care providers.” 
 
Practice E representative: “It is a good framework for us, based on 
sound clinical evidence.” 
 
Opinion leaders and champions were identified in high performing practices 
through field work prior to FG3. However, in this focus group, one of the GPs who 
works at a high performing practice (practice D) identified correctly that they had 
an expert opinion leader, confirming the field work theory.  
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GP4 (FG3): “I think from my point of view (founder) visits were very 
supportive and helpful but in addition to that, (expert opinion leader) 
here (at practice D), he was sort of pushing the (advance) care 
planning agenda as well and motivated us as a practice as well.” 
 
The comments from GP4 confirmed that opinion leads played an important role in 
the embeddedness of the ICP.  
 
Context: Shared nursing team on site which facilitates MDT meetings 
Nursing care can be shared between practices in the locality. All of the high 
performing practices share a nursing team with a neighbouring practice. However, 
despite being shared with another practice, all of the high performing practices have 
their nursing team on site. This has an impact on the mechanism, as having the 
nursing team on site will make weekly MDT meetings more achievable. 
Furthermore, it increases the likelihood of informal contact and enhances 
professional relationships within the MDT. MDT meetings are important as they 
allow for discussions of palliative care and implementation of the ICP. Intra-
organisational communication across departmental boundaries within a practice 
enhances the success of innovation diffusion and therefore enhances embeddedness 
(Greenhalgh, Robert et al. 2004). The presence of opinion leads will facilitate this 
by pushing the palliative care agenda at these meetings and helping other health 
care professionals see the relative advantage of the ICP. Although some of the 
practices that were not classified as high performing also have their nursing team on 
site, they do not have other facets of the CMOC such as opinion leaders or 
champions. Other practices in the locality also have fewer MDT meetings, either 
monthly or bimonthly.  
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Both the social care team lead and GP4 highlighted the importance of regular MDT 
meetings in FG3, confirming the important context of having a shared nursing team 
on site. GP4 was from one of the previously identified ‘high performing’ practices. 
Social care team lead (FG3): “So you’re talking about physical face 
to face, peer support, sharing information and sort of good practice 
and having a bit of reflection going on and that sort of pushes it 
forward and keeps up that enthusiasm around it really. You can see 
good outcomes for people.”  
 
GP4 (FG3): “And I think also the regular MDT meetings, we talk 
about out palliative care meetings each week and possibly stuff gets 
highlighted then that wouldn’t necessarily in the course of everyday 
surgery because it actually is a space to talk about these patients 
regularly and also I would say that the district nurses are our eyes on 
the ground really, they see a lot more of the patients on a daily basis 
than we do as GPs and its good for them to remind us exactly what’s 
going on regularly regarding these patients.” 
 
Discussions in FG3 also highlighted that having the nursing team on site is not only 
useful due to its facilitation of regular MDT meetings, but also because nurses often 
prompt GPs to carry out important tasks. This may be due to their more regular 
contact with patients in the community, as referred to in the quote above from GP4.  
GP3 (FG3): “The thing with nurses being on site… (district nurse) 
was always prodding us (as GPs) to do things.” 
 
In summary, health care professionals value regular MDT meetings highly and find 
these useful in addressing the needs of palliative care patients. Having the nursing 
team on site can aid regular MDT meetings and nurses can also prompt GPs 
regularly to carry out important actions. Effective communication across structural 
boundaries within the organisation enhances the success of implementation and the 
chances of ICP sustainability (Greenhalgh, Robert et al. 2004). Thus having the 
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nursing team on site is crucial as it facilitates MDT meetings and informal 
discussions in practice (meeting in the corridor). 
 
Summary 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: CMOC3 (I), peer support and embeddedness of the ICP. 
 
The mechanism of leadership and peer support in a fertile context (nursing tem on 
site facilitating regular MDT meetings) has resulted in three practices becoming 
high performers in terms of intervention use and outcome (preferred place of death). 
This CMOC (Figure 11) explains how the ICP is working for the high performing 
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practices. The next CMOC will be its associate, describing how the ICP has not 
worked as well for one of the other practices in the locality.  
 
 
CMOC4 (II) – Low peer support and perceived detachment   
This CMOC is based on evidence from the PCQV with Practice C, a practice that 
was not performing as well as could be expected. The evaluation of the ICP began 
in 2011 whilst the ICP began in 2008. This meant that most PCQVs had already 
been undertaken by the time the evaluation began. However, the PCQVs attended 
provided crucial insight into some of the practices in the locality.   
 
Outcome: Less use of the palliative care register and other interventions 
Figure 12 shows that Practice C is increasing its use of the palliative care register. 
However, table 7, which displays the number of interventions given to patients, 
indicates that palliative care registration is still not meaningful to this practice; little 
further action comes from it.  
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Figure 12: The number of palliative care registrations in Practice C from 2007 
to 2012, using Death Audit data. 
 
Table 7: The number of patients who had interventions in Practice C, using 
MIQUEST data. 
 
  2009/10 2010/11 2011/12 
Preference Discussions 3 3 10 
ACP 2 2 5 
Anticipatory medication 3 3 8 
LCP 2 4 8 
 
 
 
Despite recent (2011/12) increases in intervention use in practice C, intervention use 
is still low in comparison to the numbers of palliative care patients registered (see 
Table 7). This practice’s data is reminiscent of the old palliative care registers that 
were used in the locality where patients were registered but few interventions were 
provided. 
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Mechanism: Lack of communication  
The PCQVs revealed that Practice C did not have a cohesive team (lack of 
resource), with the lead palliative care GP having several issues with implementing 
the ICP. Other staff would not administer or record interventions using the system 
templates. CQI is based on the premise of a cohesive team who work well together 
under high quality leadership (Robbins and Finley 1995). Thus the CQI mechanism 
is unlikely to enhance engagement with the ICP in this circumstance. Practice C 
also has fewer MDT meetings (monthly) in comparison to the high performing 
practices (weekly). This gives them less time to provide peer support to one another, 
an aspect of the MDT meeting that was valued as very important to health care 
professionals in FG3.  
MacMillan Nurse (FG2): “And experience as well you know, 
you’ve got so many different people with levels of experience and 
things like that, that you can feed off each other and learn so much 
from each other, and I think that gets lost doesn’t it when you…  
(Trails off). Especially in the community because you spend a lot 
of time on your own, so it’s nice to get together and have those 
times when you can discuss.”  
 
GP1 (FG3): “A very big function of it (MDT meeting) is, is support 
of members (inaudible) of that (working) family, because every 
palliative care is different, everyone, everyone is, is different in its 
own way, it’s unique and challenging. I think that’s a really 
important output.” 
 
GP3 (FG2): “I think support is vitally important to be giving each 
other and I (inaudible), I can see that going in many different 
directions. And er, one of the last locums I did here (GP practice), 
there was a discussion, must have been just before (specialist) left, 
of a very difficult case which the nurses and the doctors, and most 
of the support went actually from the district nurses to the two GPs 
who felt incredibly exposed in the situation, but left the meeting 
feeling so much more supported, when everybody else had realised 
the difficult situation they had been in. So I think that the support, 
seeing it as a whole team was so important.”  
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It was also apparent from the PCQV that practice C did not see the relative 
advantage of the ICP (reasoning) due to their lack of teamwork. Despite being asked 
to, they refused to display their palliative care register on a board where all 
members of the health care team could see it. This would mean that if one GP 
places a patient on the palliative care register, no other team members would be 
aware of this registration until the monthly MDT meeting, unless through informal 
communication. Furthermore, since the MDT meeting is only monthly and will 
have a large agenda, palliative care may not be discussed in depth due to time 
restrictions. This contributes to the low numbers of interventions patients receive 
once put on to the palliative care register. Nurses are often those who carry out 
preference discussions and ACP and suggest the need for anticipatory medication, 
whereas GPs are more likely to register patients. This lack of communication 
(resource) via a palliative care register that all health care professionals can see is 
having an effect on the interventions provided. To summarise, health care 
professionals’ reasoning is not being changed to see the relative advantage of the 
ICP through weak team support and leadership, which leads to less intervention use 
due to crucial breaks in communication between team members.  
 
Context: Detachment from the ICP and locality  
At the PCQV the lead GP described feeling detached from the locality in general. 
This led to late adoption and slow implementation of templates and backup for 
administrative purposes. Furthermore, the nursing team are shared but are not on 
site at Practice C, a crucial context identified previously in CMOC4 (I). The nursing 
team are actually shared with Practice E (a high performing practice). Thus despite 
having the same nursing staff, one practice (E) is performing extremely well, 
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administering significantly more interventions and achieving better outcomes (place 
of death), and one GP practice is not (C).  
Summary  
 
 
 
 
 
 
 
 
 
 
 
Figure 13: CMOC3 (II), low peer support and perceived detachment 
 
Practice C is detached from the locality and the ICP (context). They share a nursing 
team with one of the high performing practices previously identified, but crucially 
this nursing team is not on site (context). Health care professionals’ reasoning has 
not been changed to see the relative advantage of the ICP through peer support 
(resource) from those with significant involvement in palliative care or the ICP (less 
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frequent MDT meetings, no opinion leader or champion present). This has resulted 
in limited increase in use of ICP interventions such as palliative care registration, 
preference discussions and LCP use (outcome). Thus, the ICP is less embedded in 
this practice (outcome), as depicted in Figure 13.  
 
 
Chapter Summary 
The ICP has embedded into GP practices to varying degrees. Peer support and CQI 
are essential to ICP embeddedness, with those who have a strong peer support using 
more ICP interventions and getting better outcomes for patients in terms of place of 
death. CQI has contributed to practices significantly increasing their palliative care 
registrations, preference discussions and LCP use across the locality. Thus the ICP 
works as it is increasing intervention use (apart from ACP and anticipatory 
medication which will be discussed elsewhere in the thesis) and it works 
particularly well for those practices that have strong peer support mechanisms and 
CQI sessions. Furthermore, the ICP itself is a mechanism which provides 
interventions; intervention use predicts some of the variance in place of death, thus 
showing that the ICP works as a palliative care pathway. Finally, interviews 
highlighted that uptake of commissioned services was variable. This was attributed 
to personal circumstances and needs yet does not necessarily reflect lack of service 
value.  
Programme theory 1 stated that some GP practices will have better outcomes in 
terms of place of death than others (context) due to use of interventions 
(mechanism). This programme theory has been expanded and refined. Some GP 
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practices (Practices D, E and I) do have better outcomes than others in terms of 
place of death, which is predicted by intervention use. However, there are also other 
essential mechanisms such as peer support and CQI.  
The next chapter focuses on the first intervention in the ICP, palliative care 
registration. This intervention is crucial, as it allows health care professionals to 
identify appropriate patients and work within a palliative care framework and to 
administer further interventions from the ICP such as preference discussions, ACP 
and LCP.  
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Chapter 5: Identifying and registering 
palliative care patients  
 
Palliative care registration is the first step in engaging with the ICP and allows 
access to further appropriate interventions; palliative care registrations can thus be 
considered as a measurable proxy for early identification and ICP use. In line with 
national policy (Department of Health 2008) one of the key aims of the ICP was to 
identify palliative care patients within 6 months of the end-of-life and place them on 
the practice palliative care register. This leads to the use of ICP interventions such 
as OOH notifications and ACP. It also allows health care professionals to use the 
traffic light system to identify when patients are declining and allows for more 
responsive, comprehensive and individualised care in the patient’s preferred setting, 
where possible. In turn, this early identification can lead to a good death 
(Department of Health 2008). A second aim of the ICP was to identify and register 
all palliative care patients, regardless of diagnosis, with a specific focus on 
increasing the registration of non-cancer patients. This was due to the 
acknowledgement within the locality that non-cancer palliative care patients were 
rarely identified early. This is also particularly important as population based 
studies using random samples of deaths and bereaved carer reports indicate that 
there are more symptom issues in the last year of life in those suffering from 
progressive non-cancer diseases than those suffering from cancer (Higginson 1997). 
This is due to the more extended trajectory of decline in non-cancer illnesses 
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(Murray, Boyd et al. 2005). This suggests that non-cancer patients will rely heavily 
on palliative care symptom control; the palliative care register identifies these 
patients and highlights them to health care professionals who can meet their needs. 
This chapter will describe CMOCs focused on the registration of palliative care 
patients in order to address the research questions and programme theory below.  
 
Initial questions asked of the data  
The programme theory and subsidiary questions that this chapter focuses on were 
first stated in the methodology chapter and are reiterated below.   
 Programme theory 2: Palliative care registrations should increase 
(outcome) due to a focus on identifying patients early using the palliative 
care register (mechanism) in a health care domain that appreciates the 
palliative care needs of patients (context). 
- Are palliative care registrations increasing in the locality and if so 
why?  
- Are both cancer and non-cancer patients appropriately put onto the 
palliative care register? 
 
CMOC1 focuses on palliative care registrations for all palliative care patients 
regardless of disease type and explains how this is affected by the consensus of a 
palliative care definition in the locality. CMOC2 investigates the differences 
between cancer and non-cancer deaths on the palliative care register and the stress 
associated with non-cancer registrations. Supporting CMOC2, CMOC3 elucidates 
 164 
 
the anxieties health care professionals have about over populating the palliative care 
register with elderly and frail care home residents who have non-cancer illnesses. 
CMOC4 explains the recent increase in non-cancer registrations from 2011 to 2012.  
 
 
CMOC1 – Palliative care registrations  
Outcome: Increase in all palliative care registrations from 2008 to 2012 
As discussed in relation to the embeddedness of the ICP, palliative care registrations 
are significantly increasing over time; a one-way repeated measures ANOVA was 
conducted to compare numbers of palliative care registrations from 2008 to 2012, 
using Death Audit data. Mauchly’s Test of Sphericity was significant (p < .05), 
meaning that sphericity was not assumed and Greenhouse-Geisser values are 
reported. There was a significant effect of time on palliative care registrations 
(F(2.74, 30.17) = 9.93, p < .001, 2p = 0.47), indicating a large effect (Cohen 1988). 
The means showed an overall increase in palliative care registrations from 2008 to 
2012, therefore it can be concluded that palliative care registrations have increased.  
 
Mechanisms: The decision to register patients  
Presented below are two mechanisms which work at different levels – the individual 
level, which contributes to the second mechanism which is at the team level.  
Individual level  
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‘Would you be surprised if this patient was to die in the next 6 months?’ (The 
National Gold Standards Framework Centre 2009) (resource) is used by health care 
professionals in the locality to assess suitability of a patient for the palliative care 
register. This resource increases individual health care professionals’ confidence to 
suggest palliative care patients for registration at the MDT meeting (reasoning).  
GP2 (FG2): “I think it’s one of the things that the palliative care 
pathway helped us with, in creating our palliative care registers 
we had to question, we had to ask ourselves, would you be 
surprised if this person died within six months? And that most 
certainly helped me define who I had previously would not have 
defined as palliative care… so I think that the pathway has helped 
that definition but that’s a local phenomenon I think.” 
 
The surprise question is a resource that health care professionals can use in isolation 
to make decisions about individual patients. If a health care professional believes 
that the patient may die in the next 6 months then they should suggest them for 
registration at the next MDT meeting.   
Team level  
The surprise questions prompts individuals to make a decision about whether to 
suggest a patient for palliative care registration at the MDT meeting. The support 
that these meetings provide for health care professionals was evident in FG2. The 
social care lead in FG2 described how she felt that MDT meetings provided support 
by providing safety.  
Social care team lead (FG2): “I think it’s strength in numbers isn’t 
it, with support for each other as well as safety. It, it’s safer, it’s a 
safer way to practice all round if you’re making multidisciplinary 
decisions.”  
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In FG3 support in the palliative care MDT meetings was also described as non-
hierarchical; with nurses sometimes providing support for GPs. Palliative care MDT 
meetings (resource) provide non-hierarchical support for health care professionals 
which they value highly. Decisions about palliative care registrations take place in 
these supportive MDT meetings, thus enhancing the confidence of health care 
professionals in deciding that the patient is appropriate for palliative care 
registration and removal from unhelpful life prolonging treatment (reasoning). 
GP1 (FG1):  “And what I think is you grow in confidence as a GP 
with your team and if the whole teams saying the same thing you 
feel more empowered to take control and confidently disconnect 
them from unhelpful (life prolonging) hospital appointments”  
 
 
Community matron (FG1): “I think it (MDT meeting) gives you 
that permission to say, right where do we stop, you know? And it’s 
about quality of life, not length of life and it’s about having that 
conversation with the patient to say, you know what do you want 
out of this? You know, the chemotherapy isn’t going to make you 
better? You know? It, it’s going to make them feel rotten anyway, 
so what do they want out of it? …But I think it allows you to, like 
GP1 says, (MDT working and meetings) gives you that confidence 
to have those conversations.”  
 
 
Community matron 2 (FG1): “I think as a primary health care 
team member, when we meet and discuss our patients who are on 
that register, it makes, makes you talk about them a bit more than 
you would have done without it. You know you, it allows you to, 
erm, you know, once a week or once a fortnight, depending on 
how often you hold your meetings, it allows you to bring those 
patients and to, you know, and they’re not forgot about, and both 
the GPs and the nurses and everybody that’s involved with it can 
share their views and concerns in a structured way, so I think in 
that way its good.”  
 
 
The GP and community matron felt that MDT meetings gave them confidence to 
operate within a palliative care framework where appropriate (reasoning). Thus, 
health care professionals’ reasoning is being changed in response to the MDT 
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meetings that the ICP provides (resource), to have increased confidence that a 
patient is appropriate for palliative care (reasoning) and registration.  
To summarise the mechanisms, at the individual level the surprise question 
(resource) increases health care professionals’ confidence to suggest a palliative 
care patient for registration at the MDT meeting (reasoning). This mechanism 
triggers the next, which operates at the team level; MDT meetings (resource) then 
provide additional support and further enhanced confidence that a patient is 
appropriate for palliative care (reasoning). Health care professionals’ reasoning is 
being changed to be confident that the patient is appropriate for palliative care in 
response to resources that the ICP provides, both for the health care professional 
working in isolation (surprise question) and then as part of a MDT (MDT meeting). 
Confidence can be related to self-efficacy, which is the perceived ability to perform 
a  task (Bandura 1977). It has been shown to be an underlying mechanism in a wide 
range of behaviours (O'Leary 1985, Strecher, DeVellis et al. 1986, Yalow and 
Collins 1987, Bandura 1991) and can reasonably be linked to the increase in 
confidence seen in health care professionals in this CMOC.  
 
The ICP offers many resources which can be used in different ways – for example 
in isolation (the surprise question) or collaboratively (the MDT). Thus it is 
sometimes impossible to disentangle the different elements of the ICP because they 
have a synergistic effect on one another. For example, in isolation, the surprise 
question or MDT meetings may not result in a sufficient increase in confidence to 
register a patient. Therefore either the surprise question or MDT meetings in 
isolation provide limited explanatory potential for the increase in all palliative care 
registrations.  
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Context: Consensual definitions 
In 2008, the End of Life Care Strategy (Department of Health 2008) was published 
which made palliative and end-of-life care a priority. The locality absorbed this 
information and made it applicable through the design and use of the palliative care 
registers.  The publication of this policy and implementation of the ICP prompted 
the need for enhanced understanding of the definitions of palliative and end-of-life 
care. Individuals living with progressive and complex illnesses eventually 
experience the transition from treatment focused on stabilisation, even remission of 
their disease, to treatment focused on palliation (Thompson, McClement et al. 
2006). FG2 highlighted that some health care professionals are still not confident in 
identifying when curative care should become palliative care, resulting in less 
palliative care registrations.  
GP2 (FG2): “Definition of what is palliative care, I think that lots 
of us, (laughs) are not sure when people enter palliative care, 
some people think it’s the last 3 days of life and some people think 
it’s the last 3 years of life. I think what we mean by it is a 
constraint to some practices.”  
 
Community Matron (FG1): “It is a new term, it’s a new term and 
we’re all used to, you know, the palliative being end-of-life and 
now it’s separated and it is confusing.” 
 
Palliative care is described by the community matron as a new term that causes 
confusion, this is unexpected given that the recent political agendas focus on 
improving palliative care services (Department of Health 2008, The National Gold 
Standards Framework Centre 2009, NHS North East 2012). In order to 
appropriately register patients, health care professionals need to understand the 
definitions of curative care, palliative care and end-of-life care. However, as the 
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community matron highlights, this is difficult. In the locality, generally health care 
professionals refer to palliative care patients as those with palliative care needs 
(holistic, supportive care for those with a terminal diagnosis), and end-of-life care is 
referred to as the last 3 days of life when the LCP is implemented. The differences 
between these types of care (curative, palliative and end-of-life) can seem very 
distinct and therefore the cessation of curative treatment is often viewed as a 
discrete event. However, current guidelines suggest a palliative approach should be 
adopted gradually alongside disease progression (Schofield, Carey et al. 2006). Yet 
this is not an easy process, with modern advances in treatment illnesses which can 
last for many months, even several years and therefore this makes the sharp 
transition from curative to palliative care blurred and difficult to operationalise 
(Schofield, Carey et al. 2006), as described by GP1.  
GP1 (FG1): “I think it’s very difficult (definitions of palliative 
care) and it’s something we’ve endlessly discussed in our practice, 
and the nomenclature is very confusing, and I think cancer 
treatment makes it even more confusing, for example breast 
cancer, is often palliative but it doesn’t mean that, they may live a 
long life, it’s like a chronic illness isn’t it, the definition of 
palliative has to start to change, it’s very difficult, you know, what 
do you call people? I use the palliative care register and then 
people get confused that I mean the very end of life, the Liverpool 
pathway, it is very confusing.”  
 
Despite health care professionals’ discussions about the difficulties they had 
encountered with nomenclature, consensus in FG2 was that curative care precedes 
palliative care which precedes end-of-life care, as demonstrated by the quotes 
below.  
GP1 (FG1): “you may be able to surmise that you should turn this 
palliative because they’ve got dementia etc, but they might not be 
the right person for full end-of-life care and all that, who needs 
hospital avoidance and all of that.” 
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GP3 (FG1): “Once you have that label of palliative care, we’re 
meaning would you be surprised if this patient was to die in the 
next 6 to 12 months, yes and therefore let’s put them on the 
palliative care register, to hospital teams that might be like right 
ok, very different meaning.”  
 
 
GP1 (FG2):  “Because yes they’re palliative, but they might still 
want specific active treatment, and to understand and give active 
treatment and then discharge.”  
 
GP1: “Just to tell you the, mix, the kind of, erm, confusion out 
there about what a palliative care register is, I put him on the 
palliative care register and there was merry hell on with the 
learning disability team. Merry hell. It was hilarious actually. It 
was a very good learning experience actually. They all thought I 
had said he was about to die and that’s the degree of confusion 
about what a palliative care register is.”  
 
The traffic light system can be used to facilitate health care professionals’ 
understanding of curative, palliative and end-of-life care. Green can relate to when a 
curative framework is in operation, but palliative care should begin to be 
considered. Amber relates to a decrease in functioning, suggesting illness 
progression; a palliative care framework should have been adopted by this point. 
Red refers to end-of-life, where the LCP would have been implemented (pre-phase 
out).  
Community matron (FG1): “Are they green amber or red? Where 
do they sit?” 
 
GP1 (FG1): “Yeah that’s (traffic light system) quite well defined 
now and I think it’s nice that it is so well defined. And I think that 
will encourage people to use the palliative care register better 
because I do think palliative gets connected with death and dying 
and it’s not and we need the palliative care register to be bigger 
so we can then hone down and pick out the end-of-life care 
pathway patients.” 
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Once health care professionals in the locality had formed an informal consensus 
about these definitions and had experienced using the traffic light system they could 
then use these concepts in practice to place patients on the palliative care register. 
The palliative care register can be considered as a tool to keep a track of patients 
with palliative care needs. FG3 discussions highlighted that health care 
professionals had become sensitised to the appropriate definitions over time, from 
2008 to 2012.  
GP4 (FG3): “I presume something’s changed between 2008 and 
2012 and I think presumably the health care professional 
knowledge of the patients and family hasn’t changed very much in 
relative terms, so I guess obviously the end of life strategy and the 
agreed consensus of palliative care terms are where awareness 
has been heightened over the past few years. And I guess that’s 
facilitated the registration of palliative care patients on to the list 
and erm, you know use of the pathway I suppose.”  
 
The GP in FG3 explains how health care professionals’ understanding and 
awareness of palliative care has increased since the implementation of the ICP.  
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Summary 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: CMOC1, palliative care registrations  
 
In summary, publication of essential policy in the form of the End of Life Care 
Strategy (Department of Health 2008) sensitised practices to the need to improve 
palliative and end-of-life care which the locality did through the development and 
use of palliative care registers. In order to do this they needed to become familiar 
with and form consensual definitions of active, palliative and end-of-life care 
(context). Despite on-going difficulties, discussions identified that this had been 
mostly achieved. The surprise question (individual resource) has increased health 
care professionals confidence (individual reasoning) to suggest the patient for 
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palliative care registration at MDT meetings (team resource) which further increases 
confidence of the health care professionals to operate within a palliative care 
framework where appropriate (reasoning). These two mechanisms (individual and 
team) have resulted in an increase in palliative care registrations from 2008 (ICP 
implementation) to 2012. This CMOC is displayed diagrammatically in Figure 14. 
It is also important to note here the importance of MDT meetings. High performing 
practices identified in Chapter 4 (Embeddedness of the ICP as a new initiative, 
p.117) had more frequent MDT meetings, which were facilitated by having the 
shared nursing team on site. MDT meetings also have a key role in this CMOC, 
resulting in more palliative care registrations.  
 
 
CMOC2 – Registering non-cancer patients 
Outcome: Less non-cancer patients than cancer patients registered 
Analyses were conducted to investigate whether there were fewer non-cancer 
registrations than cancer registrations using the most recent data available at the 
time, from 2011. The 2012 data was made available at a later date allowing extra 
comparative analyses to be conducted. All data includes sudden deaths, as removing 
these cases would result in biases; the definition of a sudden death is variably 
interpreted in some practices in the locality, one practice had recorded all non-
cancer deaths as sudden. Removing these people would result in a greater bias than 
leaving them in the analyses.  
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Histograms were created in order to visualise the number of cancer and non-cancer 
patients registered in each practice (Figures, 15, 16 and 17).  
 
 
Figure 15: The number of cancer deaths in total compared to the number of 
cancer deaths that were on the palliative care register, for 2011, using Death 
Audit data. 
 
Figure 15 indicates that a majority of cancer deaths in each practice are on the 
palliative care register, although there are wide variations. For example, four of the 
practices managed to register all of the cancer deaths in 2011, whereas practice N 
registered very few (the differences between practices was focused upon in more 
detail in the previous chapter on embeddedness, p.117).  
 175 
 
 
 
Figure 16: The number of non-cancer deaths in total compared to the number 
of non-cancer deaths that were on the palliative care register, for 2011, using 
Death Audit data. 
 
Figure 16 shows that in every practice there are a substantial number of non-cancer 
deaths that occur that are not on the palliative care register. In comparison to Figure 
15 a visual discrepancy becomes apparent; there are more cancer deaths registered 
than non-cancer deaths registered, even in practices that clearly use the palliative 
care register extensively for cancer patients.   
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Figure 17: Ratios of palliative care registered to not palliative care registered 
deaths for those with cancer and non-cancer for each practice in 2011, using 
Death Audit data. 
 
The use of ratios in Figure 17 allows for comparisons of cancer and non-cancer 
palliative care registrations irrespective of practice population size. Using ratios, a 
score of 1 would mean that all of the cancer or non-cancer patients who died in 
2011 were on the register. A score of 0.5 would mean half of the patients were 
registered. Figure 16 shows that a lot more cancer patients are put on to the 
palliative care register than non-cancer patients, in all practices. However, there is 
significant variability, some practices do have better outcomes than others, for 
example, Practice A registered no non-cancer patients, whereas practice D 
registered around half of all non-cancer deaths.  
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A Pearson product moment correlation co-efficient showed that there was a weak 
non-significant correlation between cancer and non-cancer palliative care 
registrations (r = 0.26, n = 14, p > .05), suggesting that in each practice the number 
of non-cancer registrations does not increase as the number of cancer registrations 
does. This finding is unexpected as cancer deaths only account for around 30% of 
overall deaths (Office for National Statistics 2013). 
A paired samples t-test was conducted to investigate this further and evaluate the 
impact of the ICP on cancer and non-cancer registrations in 2011, using the ratio of 
cancer deaths on the palliative care register to total cancer deaths and the ratio of 
non-cancer deaths on the palliative care register to total non-cancer deaths. A 
significant difference between cancer and non-cancer registrations was identified 
(t(13) = 8.78, p < .001). There were significantly more cancer palliative care 
registrations (M = 0.78, SD = 0.06) than non-cancer palliative care registrations (M 
= 0.25, SD = 0.16) in 2011 across all fourteen practices. This highlights that there 
are significantly more cancer patients than non-cancer patients being put onto the 
palliative care register. 
 
Mechanism: Stress when registering a non-cancer patient 
FG3 highlighted that health care professionals find registering non-cancer patients 
difficult. This is due to the non-predictable trajectory of non-cancer illnesses, the 
difficulty in considering non-cancer patients as appropriate for palliative care and 
the lack of health care professionals’ involvement in treating progressive symptoms.  
GP4 (FG3): I think, erm the other things as well, historically with 
cancer patients rather than with non-cancer patient’s we’ve been 
more actively involved in proactively managing symptoms as 
they’re reaching end-of-life. Whereas in a lot of the non-cancer 
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deaths we might have been possibly, for example, more frequently 
treating infections but often it’s a gradual slide with a lot more 
intervention on our part necessarily, and I think the same goes for 
the nurses as well.” 
 
GP5 (FG3): “You’re acknowledging that they’re declining but 
you’re not necessarily actively doing a lot more for the 
symptomology… You don’t necessarily understand the pain that 
they’re feeling like you would with bone mets in the spine (in 
cancer).” 
 
GPs 4 and 5 explained how they felt that this lack of experience in treating the 
symptoms of non-cancer patients as they approach end-of-life, and the context of 
non-cancer patients’ unpredictable illness trajectory led to stress when deciding 
whether to put non-cancer patients on the palliative care register.  
GP5 (FG3): Err, so how do you make choices? So I make choices 
and then they come off the board.” 
 
GP4 (FG3): “There is stress with non-cancer registrations. With a 
cancer diagnosis you have a fixed underlying illness I think 
haven’t you? That the family are aware of and recognise that their 
relatives generally going downhill. But with a non-cancer 
diagnosis you know they might have had heart failure for years 
and years and years and yes they’re getting a bit worse but they’ve 
had this diagnosis for years whereas with cancer, quite often, 
there’s the downhill trend. 
 
A stressful decision like this would mean that health care professionals’ confidence 
about the decision is low. Low confidence in a decision would mean that they are 
less likely to register a non-cancer patient.  
GP5 (FG3): “But I still find it difficult in my head because there’s 
a blip, you’re just not as confident in putting someone on the 
board when they’re non cancer than you are if they’re cancer. 
You’re just not confident about where the end point is going to 
happen, how it’s going to happen, what it’s going to be like, so 
there is kind of a confidence thing about it.” 
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Self-efficacy is the perceived confidence to carry out desired tasks (Bandura 1977) 
and can be influenced by experience, persuasion, or physiological and psychological 
states such as distress. High self-efficacy correlates with low perceived stress in 
professional caregivers (Hulbert and Morrison 2006), thus suggesting that when 
health care professionals have more confidence (self-efficacy) then they have less 
stress about the decision they have to make. The results indicated that health care 
professionals were confident in registering cancer patients but less confident in 
registering non-cancer patients. This suggests they have a lower self-efficacy 
(reasoning) when registering non-cancer patients with unpredictable prognoses 
(context), giving them more perceived stress about the decision (reasoning) which 
results in less non-cancer registrations. Furthermore, effective co-worker 
communication and work place peer support have been identified as important 
variables for occupational stress management (Alexander and Ritchie 1990, Searle, 
Bright et al. 2001, Bradley and Cartwright 2002). The three practices which were 
identified as high performers (in Chapter 4: Embeddedness of the ICP as a new 
initiative, p.117) demonstrated strong peer support for palliative care. Therefore, 
peer support may have reduced occupational stress in these practices which may 
have subsequently facilitated their use of the ICP.  Previous research which found 
high levels of occupational stress to be related to low levels of self-efficacy 
provides support for this relationship (Grau, Salanova et al. 2001). Self-efficacy is 
crucial in registering patients on the palliative care register, especially non-cancer 
palliative care patients. Thus the strong peer support in the three high performing 
practices may have some explanatory potential, as these three practices registered 
significantly more patients on the palliative care register than the others, in Cluster 
Analysis I. 
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In addition to low self-efficacy in dealing with non-cancer patients, the traffic light 
system (resource) is not as useful when dealing with non-cancer trajectories. Non-
cancer patients often move between traffic light stages non-linearly meaning that if 
a patient is in ‘green’ they could very quickly deteriorate to ‘red’ and potentially be 
put on to the LCP, but their condition could improve and they can become ‘green’ 
again. This is unlikely to happen in cancer diagnoses. Thus, the traffic light system 
(resource) and the increased self-efficacy it gives health care professionals 
(reasoning) to register palliative care patients cannot be used as efficiently in the 
context of the unpredictable trajectory of non-cancer diagnoses.  
To summarise this mechanism, health care professionals have little experience of 
treating the symptoms of non-cancer palliative illnesses and thus have low self-
efficacy (reasoning) in registering this patient group.  The traffic light system, that 
is one of the resources used to help register cancer patients, is not as useful in the 
context of unpredictable trajectories of those patients with non-cancer illnesses.  
 
Context: Unpredictable illness trajectories  
As discussed in the opening of this chapter, non-cancer diagnoses typically have an 
unpredictable trajectory. This makes decisions about when palliative care is 
appropriate particularly difficult and may help to explain why health care 
professionals’ self-efficacy in treating this patient group is low. Therefore 
registering a non-cancer patient is challenging for health care professionals, as a 
period of significant decline can be followed by substantial improvement, despite a 
downward trend in wellness (Murtagh, Preston et al. 2004, Murray, Boyd et al. 
2005). A GP in FG3 explained this.   
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GP5 (FG3): “I think the, the definition of palliative care is still 
difficult, not so much with cancer deaths, but still with non-cancer. 
I still put people on the board and then take them off it, they’ve 
rallied. I’m like “err, he was dying last week?” and now he’s 
rallied, you know (inaudible).” 
 
The same GP went on to elaborate on the difficulty of the unpredictable prognosis 
in older people with non-cancer. He felt that all older people are at risk of entering 
end-of-life care rapidly and this is an unpredictable transition from palliative care.  
The care home population frequently have non-cancer illnesses which can 
exacerbate quickly and unpredictably. Health care professionals cannot predict this 
but also do not wish to over populate their palliative care registers by registering all 
non-cancer elderly patients. Once a decline in health begins in elderly people with 
non-cancer illnesses, it can be very rapid and thus end-of-life care is implemented. 
The GP felt that this left no time for putting people on to the palliative care register. 
Comparatively, this is not the case with cancer diagnoses as often there is a specific 
diagnosis and steady illness trajectory.  
GP5 (FG3): “I think the confidence comes from the potential for 
flood gates, really, if you say well basically everyone in a care 
home, I wouldn’t be surprised if they all had an acute illness and 
died from whatever frailty the suffer, COPD, dementia, whatever, 
you feel that you could then just open the flood gates to say that 
everyone could be on the palliative care register. You know, 
they’re all in their 80s and 90s, they’re all getting to the end of 
their life, and so it’s very difficult to kind of be selective about 
them, and the illness that they get that ends their life is only a 
matter of weeks which isn’t a lot of time to engage palliative care 
in your brain and go to the board and write it down, you’re 
chasing your tail really. At least in cancer you’ve got this 
progression and diagnosis and it’ll end in one way, but with this 
you’re chasing your tail, it’s just the timing and the... I could put 
basically everyone in care homes on that list.  
 
The inequity between cancer and non-cancer palliative care registrations may also 
be exacerbated due to the emergence of the palliative care register from the cancer 
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register. In the past, practices were required to identify and register people with 
cancer and then undertake an annual review. Following this, a requirement to have a 
palliative care register emerged. However, these registers were under populated and 
those on the list were often cancer patients (identified from the aforementioned 
cancer register). Furthermore, typically no action was taken following registration. 
This history of palliative care registers being populated almost solely by cancer 
patients exacerbates the notion that palliative care only relates to terminal cancer 
illnesses and thus may cause health care professionals to refrain from registering 
non-cancer patients.  The evidence highlights that a health care professional who 
has a palliative care definition inclusive of non-cancer will be more likely to register 
such a palliative care patient. 
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Figure 18: CMOC2, registering non-cancer patients 
 
The unpredictable trajectory of non-cancer illnesses and difficulties in considering 
non-cancer patients as appropriate for palliative care (context), mean that health 
care professionals have less experience of treating palliative and end-of-life care 
symptoms in those with non-cancer (in comparison to cancer), meaning that health 
care professionals are less confident in registering non cancer patients (reasoning). 
This results in significantly less non-cancer patients than cancer patients being 
registered in 2011. This CMOC is displayed in Figure 18.  
 
 
MECHANISM 
 
Reasoning: Low self-efficacy   
when treating palliative and end-
of-life care symptoms in non-
cancer patients and the traffic 
light system is not as useful with 
this population 
 
 
OUTCOME: More 
patients with cancer 
diagnoses are registered 
than patients with non-
cancer diagnoses.   
Resources: The 
traffic light system 
 
 
 
CONTEXT: 
Non-cancer’s 
unpredictable 
illness trajectory 
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CMOC3 – Care home residents  
Outcome: Less non-cancer patients than cancer patients registered 
As described in CMOC2, in 2011 there were significantly more cancer palliative 
care registrations (M = 0.78, SD = 0.06) than non-cancer palliative care registrations 
(M = 0.25, SD = 0.16) across all fourteen practices.  
 
Mechanism: Anxiety about registering care home residents 
In FG3 health care professionals discussed the difficulties in the decision 
(reasoning) to put elderly patients who are in care homes and have a non-cancer 
diagnosis on the palliative care register (resource), due to their rapid declines and 
unexpected recoveries (context). This led to concerns regarding the over population 
of the palliative care register, as described by GP5.  
GP5 (FG3): “There is the potential for flood gates, really, if you 
say well basically everyone in a care home, I wouldn’t be 
surprised if they all had an acute illness and died from whatever 
frailty they suffer, COPD, dementia, whatever, you feel that you 
could then just open the flood gates to say that everyone could be 
on the palliative care register. You know, they’re all in their 80s 
and 90s, they’re all getting to the end of their life, and so it’s very 
difficult to kind of be selective about them, and the illness that they 
get that ends their life is only a matter of weeks which isn’t a lot of 
time to engage palliative care in your brain and go to the board 
and write it down, you’re chasing your tail really. At least in 
cancer you’ve got this progression and diagnosis and it’ll end in 
one way, but with this you’re chasing your tail, it’s just the timing 
and the... I could put basically everyone in care homes on that list. 
Err, so how do you make choices? So I make choices and then they 
come off the board.” 
 
Although the ICP and surprise question (The National Gold Standards Framework 
Centre 2009) premise would suggest that all patients who are likely to die in the 
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next 6 months should be registered, this can result in over population of the 
palliative care register. This can lead to a greater workload for health care 
professionals who already have stringent time constraints and laboured discussions 
about palliative care patients at MDT meetings. The social care team lead and a GP 
in FG3 described how it is unhelpful to over populate the register, especially with 
frail elderly people in care homes, as this results in those who need high care input 
not receiving it.  
Social care team lead (FG3): “You want to be giving care to those 
who most need it” 
GP6 (FG3): “And that’s a burden administratively, the dangers 
are that we take our eye of the ball because we have so little time 
and focus on people who really need the medical input.” 
 
GP5 suggested that the palliative care register is inappropriate for those with non-
cancer palliative care needs and that another tool that is more flexible may be more 
useful. However, it seems that this would still result in the same issue of register 
over population.  
GP5 (FG3): I think defining it, fear of flooding the board, and erm, 
perhaps, perhaps we should be using the palliative care register 
less as a black and white thing in our mind and more of a kind of 
flexible, ah here’s someone getting a bit worse, put them on the 
board. A palliative care, sort of declining, register (laughs). A bit 
softer, it kind of helps you to see it as some kind of, ‘going through 
a blip register’. You know, may not recover register, I dunno. 
Something that’s a bit more flexible but palliative for non-cancer 
is really the wrong word because they go through this dip and 
you’re not quite sure if they’re going to recover. The definition 
doesn’t quite fit; it’s difficult to put them in that box. It’s difficult. 
 
The GP referred to ‘palliative care’ as inappropriate for those with non-cancer. 
Other health care professionals in the locality did not express the same belief but did 
agree that non-cancer patients are a difficult population to provide palliative care to.  
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Context: Elderly non-cancer patients’ prognosis is difficult to predict  
The literature highlighted that there is an ageing population in the UK (Forder and 
Fernandez 2011, Gomes, Calanzani et al. 2011) and the level of frailty, impairment 
and need of people admitted to care homes is now higher than it was 10-15 years 
ago (Forder and Fernandez 2011). Non-cancer elderly patients’ health can decline 
rapidly, which makes palliative care registration difficult for health care 
professionals.  
 
GP5 (FG3): They’re insidious aren’t they? The lethargy that 
comes with being ninety kind of, you just kind of accept the fact 
that someone starts using a Zimmer frame because of their 
arthritis” 
 
Accompanying this rapid decline can be an unexpected recovery. 
GP5 (FG3): “They become Lazarus and rise from the dead and 
start having breakfast the next day.” 
 
The unpredictable prognosis of elderly patients in care homes with non-cancer 
diagnoses poses particular issues for effective health care management. Elderly 
people in care homes form a key context within which the decision to register is 
difficult to trigger (reasoning) even with ICP resources (surprise question, traffic 
light system, MDT team meetings). 
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Figure 19: CMOC3, care home residents.  
 
The literature has indicated for some time that failure of health care professionals to 
consider patients as palliative may contribute to the inappropriate care of patients 
(Graham and Livesley 1983), thus it is essential that appropriate patients are put on 
to the palliative care register, regardless of diagnosis. However, elderly people in 
care homes constitute a key context, in which the decision to register is difficult. In 
2011, fewer non-cancer patients who died were on the palliative care register 
(outcome). This could be due to health care professionals’ decisions not to register 
elderly care home residents with non-cancer diagnoses (reasoning) due to anxiety 
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about flooding the register and not providing needs based care to patients requiring 
palliative or end-of-life care (Figure 19). Contributing to this is CMOC2, in that 
most care home patients have non-cancer illnesses which can be very difficult to 
prognosticate.  
 
 
CMOC4 – Recent increase in non-cancer registrations  
Outcome: Significant increase in non-cancer registrations from 2011 to 2012 
Although significantly less non-cancer patients than cancer patients were put on to 
the palliative care register in 2011, this does not indicate whether non-cancer 
palliative care registered deaths are increasing. To identify if practices using the ICP 
were increasing their registration of non-cancer patients 2011 data was compared to 
2012 data.  
Data from the 2011 and 2012 Death Audit allowed more refined questions to be 
answered by the data sets; allowing the number of people who died of cancer and 
non-cancer that were on the palliative care register to be identified. Two ratios were 
made for each year (2011 and 2012) and for each GP practice using their cancer 
deaths on the palliative care register divided by the total cancer deaths that year and 
the non-cancer deaths on the palliative care register divided by all non-cancer deaths 
that year. The mean and standard deviations for these ratios are presented in Table 
8. The cancer ratios for 2011 and 2012 were then compared, and the non-cancer 
ratios were then compared with each other. Ratios were created in order to account 
for differences in practice population sizes.  
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A paired samples t-test was conducted to compare the ratios of cancer deaths on the 
palliative care register between 2011 and 2012. There was no significant effect of 
time on cancer death palliative care registrations (t(13)= -1.06, p > .05, two tailed). 
The means and standard deviations of the palliative care registered cancer deaths to 
all cancer deaths ratio are displayed in Table 8 and indicate an increase from 2011 
to 2012.  
Table 8: Ratio of registered cancer deaths to total cancer deaths in 2011 and 
2012  
 
Time  N Mean  Standard Deviation 
2011 14 0.78    0.21 
2012 14 0.84 0.12 
 
A paired samples t-test was conducted to allow a comparison of the ratios of non-
cancer deaths on the palliative care register between 2011 and 2012. There was a 
significant effect of time on non-cancer death palliative care registrations (t(13) = -
2.56, p < .05, two tailed). The means and standard deviations are presented in Table 
9 and show an increase from 2011 to 2012, meaning that GP practices are 
significantly increasing the number of non-cancer palliative care registrations they 
make. Increases appear small due to the data being in ratio form, where 1 would 
mean that all patients who died of cancer were on the palliative care register. The 
eta2 statistic (0.34) indicated a small effect size, according to Cohen (1988).  
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Table 9: The ratio of non-cancer deaths to total non-cancer deaths in 2011 and 
2012. 
 
Time  N Mean  
Standard 
Deviation 
2011 14 0.25 0.16 
2012 14 0.34 0.19 
 
These two statistical tests indicate very important outcomes; between 2011 and 
2012 practices did not significantly increase the number of cancer patients they 
registered but did increase the number of non-cancer patients they registered. The 
lack of increase in the number of cancer patients registered who died could be 
attributed to most practices being quite competent in registering them. 
However, it is not possible to know whether non-cancer registrations have been 
increasing since ICP implementation (2008) or whether they have just started to 
increase from 2011 to 2012. This is due to data restrictions explained earlier; the 
tools that collect data only asked more refined questions about disease type from 
2011.  
 
Mechanism: Legitimation through education 
Discussions in FG3 highlighted that health care professionals now had more 
informal education about non-cancer diagnoses and their relevance and need for 
appropriate palliative care. This was following the publication of national policy 
such as the End of Life Care Strategy (Department of Health 2008), educational 
events, PCQV and informal learning from the ICPs founder.  
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GP4 (FG3): “I think it’s more that we’ve been legitimised to put 
palliative care patients on the register, you know, through 
educational events and people like (founder), the End-of-Life Care 
Strategy and things such as that.” 
 
GP3 (FG3): “I think its education, really. We’ve been educated 
that we can now think that non-cancer patients require palliative 
care. And the permission, it’s the permission that you can consider 
non-cancer patients as palliative.” 
 
Health care professionals felt that these forms of education (resource) had 
legitimised their decision to put palliative care patients on the register (reasoning) 
which increased their self-efficacy to provide high quality palliative care to all. 
Health care professionals also felt that as their experience built in providing 
palliative care for cancer patients, so did their self-efficacy in providing palliative 
care for non-cancer patients.  
GP6 (FG3): “Experience wise, you start feeling, maybe there’s a 
confidence thing there as well. We’re starting to build more 
confidence in cancer deaths and as a result of that we’re thinking 
this is quality (care), and actually why shouldn’t that person there 
have the same bit of me or the same pathway. I mean that is a 
significant challenge due to prognostics, that’s really difficult isn’t 
it. So maybe our reasoning is, why not? Why not this group of 
people, if cancer patients get it, but also as a confidence thing as 
well maybe. I feel happy I could manage these kind of dying 
patients so why can’t I manage all my dying patients rather than 
just a select few?” 
 
GP6 highlights how health care professionals in the locality have increased their 
self-efficacy to provide palliative care to non-cancer patients.  
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Context: Changes in cause of death and palliative care for all 
The literature highlighted that non-cancer illnesses such as dementia are expected to 
increase, from 800,000 in 2012 to 1,000,000 in 2021 (Alzheimer's Society 2013). 
This evidence, alongside the knowledge that the population is aging (Caley and 
Sidhu 2011) and cancer treatment is advancing (Costanzo, Ryff et al. 2009), 
suggests that cancer deaths will continue to decrease and non-cancer deaths will 
increase in the future. The participants in FG3 commented upon the changes in 
cause of death in the UK.  
GP5 (FG3): “Also, I think there’s less, less, some cancers that 
people aren’t dying from that much now. Breast cancer for 
example, we’re just better at treating it. They’re just not coming 
through the door quite so regularly.” 
 
GP4 (FG3): “I think the other thing as well is that people, not just 
cancer patients but patients with other terminal illnesses such as 
heart failure due to modern medicine are living longer than they 
ever did and this has kind of filtered down, as in days gone by 
hospices would only take cancer patients whereas now hospices 
will take people with end stage heart failure or end stage COPD 
and things and that’s because they’ve lived longer than they would 
have done historically.” 
 
The increasing numbers of non-cancer deaths mean that the identification of non-
cancer palliative care patients needs to be of the same standard as the identification 
of cancer patients (via palliative care registration) and non-cancer patients need to 
be considered as appropriate for palliative care. However, FG2 highlighted that 
some health care professionals still have uncertainties about palliative care and its 
applicability to all terminal illnesses.  
Community Matron (FG2): “And I think that erm, maybe 
sometimes we do tend to, when you say palliative care, you do 
think of cancer diagnoses whereas your COPD and heart failures 
and things like that, and I think they’re quite difficult from our 
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perspective to know when, you know if they have an exacerbation 
then yes they’re really struggling but the next week they could be 
fine so at what point do you think well, they might be ready for the 
pathway (ICP)?”  
 
This nurse refers to an important context when registering a non-cancer palliative 
care patient, the inequality between cancer and non-cancer diagnoses due to the 
association cancer has with palliative care. The nurse explicitly states that palliative 
care still has strong associations with cancer. However, health care professionals are 
increasingly viewing non-cancer patients as appropriate for palliative care. In FG2 
most health care professionals selected palliative care for those with non-cancer 
diagnoses as an important context for palliative care registrations. This suggests that 
they are aware of the difficulties associated with non-cancer diagnoses and the need 
for and importance of palliative care for non-cancer patients. In FG3 a GP referred 
to the increasing recognition of non-cancer patients requiring palliative care.  
GP4 (FG3): “That’s why more non-cancer patients are being 
registered. And because historically we wouldn’t have thought of 
it, palliative meant cancer patients. I think that’s the biggest 
factor.”  
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Figure 20: Recent increases in non-cancer registrations 
 
Health care professionals have an increased recognition that causes of death are 
changing and that palliative care should be inclusive of non-cancer patients 
(context). The education the ICP has provided (resource) through several mediums 
has legitimised registering non-cancer patients and the experience with cancer 
patients has built self-efficacy in registering non-cancer patients (reasoning) and 
providing them with the same high quality palliative care. The outcome of this is 
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that more non-cancer registrations are increasing from 2011 to 2012, as displayed in 
Figure 20.  
It is important to note the impact of CQI efforts in the ICP, in the form of PCQV. 
They not only impacted on the embeddedness of the ICP (Chapter 4, CMOC3, 
p.133) but have also aided in increasing the registrations of a difficult population 
(non-cancer patients).  
 
 
Chapter Summary  
Putting patients on to the register is an essential step when health care professionals 
assess a patient as requiring palliative care. It prompts the use of other ICP 
interventions and helps health care professionals to work within a palliative 
framework. Although all palliative care registrations are increasing (from 2008 to 
2012) due to resources the ICP provides (the surprise question and MDT meetings – 
CMOC1) there are still significantly more people with cancer diagnoses registered 
than non-cancer diagnoses. This is because health care professionals feel the 
unpredictable prognosis of non-cancer illnesses makes registering patients a 
stressful process; they are unconfident with it (CMOC2). Providing palliative care 
in care homes to frail elderly people with non-cancer illnesses can also be 
particularly difficult (CMOC3). However, from 2011 to 2012 registrations of non-
cancer patients have increased. This is due to the increased recognition of change in 
cause of death and of non-cancer patients requiring palliative care (context) formal 
and informal education provided by the ICP and experience from providing high 
quality palliative care to cancer patients (resource) (CMOC4). These factors are 
slowly building confidence in health care professionals to place more non-cancer 
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patients on the register. Throughout all of the CMOCs reasoning is related to 
confidence or self-efficacy (the perceived ability to carry out a task) which is related 
to confidence. Health care professionals need to have confidence to provide 
palliative care for non-cancer patients. This can come from a variety of sources: 
MDT meetings (peer support), ICP tools (the surprise question, the traffic light 
system), education (formal and informal), experience from providing palliative care 
to cancer patients.  
Programme theory 2 stated that palliative care registrations should increase 
(outcome) due to a focus on identifying patients early using the palliative care 
register (mechanism) in a health care domain that appreciates the palliative care 
needs of patients (context). The registration of all palliative care patients is 
increasing (outcome) due to the use of ICP tools such as the surprise question, the 
traffic light system and MDT meeting (resources) and a consensus of the definition 
of palliative care. However, data has shown that there are difficulties in providing 
palliative care for all patients who need it, due to the difficulties of prognostication 
with non-cancer illnesses (context), which causes stress in decisions about 
registering patients; this results in less people with non-cancer illnesses being 
registered (outcome). Elderly people who live in care homes with non-cancer 
illnesses (context) also posed a difficulty for health care professionals in terms of 
palliative care registrations. However, the health care professionals in the locality 
are increasing their use of palliative care registrations for non-cancer patients 
(outcome). They felt that this was because they were building confidence in 
registering non-cancer patients (reasoning) from education and experience of 
registering cancer patients (resources) and a legitimisation of non-cancer patients as 
appropriate for palliative care. Thus the programme theory (2) described is 
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generally supported, as all palliative care registrations are increasing from 2008 to 
2012. However, there are underlying facets to this general CMOC that are 
extremely important to equality of care.  
Once patients have been identified as requiring palliative care and registered as 
such, health care professionals may wish to broach preference discussions and offer 
the use of the locality advance care plan to the patient. The next chapter focuses on 
these difficult conversations and their documentation.  
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Chapter 6: Preference discussions and 
the locality advance care plan  
 
One of the crucial roles health care professionals have throughout a patient’s 
palliative care is to try to assess preferences for end-of-life care, specifically 
regarding the type of care they would wish to receive and where they wished to be 
cared for (Department of Health 2008). These preferences are important for patient 
centred care and planning, but also in case a patient loses capacity and therefore is 
unable to express a preference in the future. Even though preference discussions are 
of high importance they need to be entered into mutually by health care professional 
and patient. Thus they require skill and sensitivity, and the health care professional 
may have to approach the subject several times before the patient is willing to 
engage; but providing the opportunity to engage as early as possible is crucial, to 
avoid loss of capacity issues. The outcomes of preference discussions should be 
documented, regularly reviewed and communicated to other relevant people 
involved in the patient’s care: family members, carers and other health care 
professionals (Department of Health 2008). This process is referred to as ACP. 
Until April 2012, a locality advance care plan was in use to document patient 
preferences. This was then replaced with the introduction of Deciding Right (NHS 
North East 2012), which explained ACP as an umbrella term, with several potential 
formal outcomes: the advance statement, the DNACPR form, the ADRT, EHCP or 
PW-LPA including health (all of which were described fully in the introduction 
chapter).  
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Initial questions asked of the data  
The programme theory and subsidiary questions that this chapter focuses on were 
first stated in the methodology chapter and are restated below.   
 Programme theory 3: There will be an increase in the use of preference 
discussions and use of the locality advance care plan (outcome), as health 
care professionals become more confident with broaching the subject of 
death and dying with patients (mechanism) and aware of the importance of 
having and documenting preference discussions, which has been highlighted 
by recent policy (context).  
- Are preference discussions increasing and if so why?  
- Are preference discussions occurring earlier in a patient’s illness 
trajectory (green traffic light phase)?  
- Are the number of locality advance care plans carried out with 
patients increasing and if so why?  
- Do preference discussions predict the use of advance care plans?  
 
CMOC1 explains the increases in informal preference discussions between health 
care professionals and patients, prompted by changes in condition or need. CMOC2 
identifies why these preference discussions may sometimes occur late in a patient’s 
illness, even when their illness trajectory is predictable. The time constraints in 
primary care are discussed in relation to the use of the locality advance care plan in 
CMOC4 and the change to the advance statement from the locality advance care 
plan is detailed in CMOC5.  
 200 
 
CMOC1 – Markers for initiating preference discussions  
Outcome: Increase in preference discussions  
A one-way repeated measures ANOVA was conducted to compare numbers of 
preference discussions that occurred and were recorded on MIQUEST in 2009/10, 
2010/11 and 2011/12. The means and standard deviations are presented in Table 10; 
the means show an increase in preference discussions over time. Mauchly’s Test of 
Sphericity was not significant so sphericity was assumed. There was a significant 
effect for time on preference discussions (F(2, 22) = 15.95, p < .001, 2p =0.59). 
Using the guidelines proposed by Cohen (1988) for the 2p  (0.01 = small, 0.06 = 
moderate, 0.14 = large effect), this result suggests a large effect size. Post hoc tests 
revealed a significant difference between 2009/10 and 2011/12 (p < .001) and a 
significant difference between 2010/11 and 2011/12 (p < .005) in preference 
discussions. There was no significant difference between 2009/10 and 2010/11 (p > 
.05), although it was close to significance (p = .08). Therefore it can be concluded 
that the GP practices are significantly increasing their use of preference discussions 
since the introduction of the ICP, with these increases being significant from 
2009/10 to 2011/12 and 2010/11 to 2011/12. It may have been that in the first year 
(2009/10 – 2010/11) the ICP had not become embedded enough yet to yield a 
significant increase. The increases over time in preference discussions are 
represented in Figure 21. 
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Table 10: Preference discussions over time, using MIQUEST data. 
 
Time 
Period  N Mean 
Standard 
Deviation  
2009/10 12 2.58 4.06 
2010/11 12 5.58 8.2 
2011/12 12 10.75 7.61 
 
The number of practices involved in the analysis (N) is twelve instead of fourteen as 
SPSS accounts for there being no data for two of the practices in 2009/10 as they 
joined the ICP at a later date. These missing values are not regarded as an issue as 
the reason they are missing is not related to the data or intervention.  
 
 
Figure 21: Mean number of preference discussions between 2009/10 and 
2011/12, using MIQUEST data. 
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In addition to the statistical outcomes, the QDDM identified that preference 
discussions that are taking place are holistic. Planning for a funeral can be a very 
important aspect of preference discussions, and all GPs and bereaved relatives who 
answered the question relating to funeral planning scored it very highly, suggesting 
that the GP did broach funeral plans within preference discussions with the patient 
and their family.  
 
Mechanism: Health care professionals’ desire to be patient centred  
Through using the ICP framework, health care professionals know that they have a 
responsibility to document patients’ preferences (resource). Following from this 
they need to ensure that these preferences will be adhered to, to ensure a preference 
based, patient centred, death. The ICP framework (resource) has always promoted 
the use of preference discussions through educational events, PCP meetings, PCQV 
and its underlying principle of proactive care and early intervention. Preference 
discussions provide patients with the opportunity to discuss concerns that may not 
otherwise be addressed. These discussions help patients to express where they 
would wish to be cared for and die if their condition worsens. Although preference 
discussions can sometimes be difficult to broach, they help patients to plan 
holistically for a good death, assessing spiritual, emotional and physical needs, and 
they are therefore a necessity. The increase in preference discussions is a 
combination of factors: the ICP’s framework (resource) which is enhancing health 
care professionals patient centred practice (reasoning). 
Social care team lead: “I think it’s about empathy as well, I think 
gosh if that was me, what would I want? You can, you know, if 
you’ve got lots of management and skills around that area you 
want that person to have the best because that’s what you would 
want. Erm, and I think that we can’t underestimate the value of 
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planning and if you can plan that pathway for that person and so 
they have a you know smooth and… that’s being kind and 
empathetic and person centred isn’t it.” 
 
Health care professionals have increased their use of preference discussions due to 
the ICP framework (resource), which focuses on proactivity and patient centred 
care, thus resulting in health care professionals’ drive to be patient centred and 
proactive (reasoning). Supporting this, all participants who answered the QDDM 
question referring to the opportunity to discuss funeral plans scored this as a 9 or 10 
meaning that they felt this experience was almost perfect. This suggests that 
preference discussions are holistic, proactive and patient centred, including 
conversations about the patient’s funeral and not just assessing physical aspects of 
palliative care.  
 
Context: A change in condition or increased needs  
Some patients have very clear end-of-life care preferences but they often rely on 
health care professionals to initiate discussions about this (Hanson, Danis et al. 
1997). However, few health care professionals agree on a clinical marker as to when 
preference discussions should be initiated (Quill 2000, Thoonsen, Groot et al. 
2011). A national questionnaire answered by multiple health care professionals 
identified the lack of prognostic indicators and clinical triggers for initiating 
palliative care, which appeared to be the main missing link in applying palliative 
care in primary care (Shipman, Gysels et al. 2008). Thus, if a palliative care 
framework is adopted at a late stage then preference discussions can often occur late 
or in crises (Quill 2000). However, in FG3 health care professionals stated that a 
change in a patient’s condition often resulted in them broaching preference 
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discussions. This included a deterioration of condition, a formal terminal diagnosis 
or inappropriate hospital admission.  
GP4 (FG3): “A deterioration in their condition (would prompt 
preference discussions), no possibility of further treatment, so end 
of the line… It’s sometimes a hospital admission that you consider 
to be inappropriate as well. You think, they probably shouldn’t 
have gone in, can we prevent this happening again, should we 
have a chat with the patient” 
 
Consensus has evolved among health care professionals that meaningful end-of-life 
discussions often occur too late. Quill (2000) suggests that if a patient has recently 
had an admission to hospital then a preference discussion can be prompted, but that 
this is too late. This is especially the case if the patient has had repeated admissions 
to hospital for severe progressive illness. This may be why most preference 
discussions in the locality are occurring at the amber stage of the traffic light 
system, as opposed to the green stage (verified by health care professionals in the 
locality and the founder of the ICP). However, this is an improvement from 
preference discussions occurring only in the red stage (end-of-life care being 
implemented and use of the LCP).  
Another GP went on to elaborate that not only deterioration in condition but also an 
increase in needs could prompt him to broach preference discussions with a patient. 
This included increased use of service such as social care and district nurses.  
GP6 (FG3): “I think also, when someone’s needs are, what can 
we, what can we provide for someone’s needs and (inaudible) from 
the community, so carers are going in, the DNs are going in, their 
nursing needs are escalating… they’d been in hospital several 
times and you think, hang on here, do we need to wrap this up and 
start to put a pathway in?” 
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GP6 highlights how an increase in a patient’s needs can trigger a change to 
palliative care from a previously curative framework.  
 
Summary  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: CMOC1, markers for initiating preference discussions 
 
Deterioration of a condition, increase in need (due to deterioration), or inappropriate 
hospital admission(s) are hospitable contexts for the ICP framework (resource) to be 
used which results in an enhancement in health care professionals’ proactive and 
patient centred care (reasoning) through preference discussions (outcome). CMOC1 
is displayed diagrammatically in Figure 22. This CMOC does not infer that health 
care professionals were previously not operating within a patient centred 
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framework; it explains that the ICP’s framework enhanced their patient 
centeredness.  
CMOC2 – False hope can prevent preference discussions  
Outcome: Preference discussions can occur late  
Interviews identified that preference discussions often occurred late, even with 
patients who had cancer and a predictable disease trajectory. All of the palliative 
care patients interviewed had engaged in preference discussions with their GP but 
this was at a very late stage, when they were very unwell and bed bound.  
Richard (Doris’s son): “Dr. (name) did ask when you were really 
poorly.” 
Doris (palliative care patient): “Yeah, yes he did, yeah.” 
Richard (Doris’s son): “And, and you said home. Yeah” 
 
Janet (palliative care patient): “It was a particular, that doctor, 
because I remember her standing at my bedside looking directly at 
me and she didn’t exactly say you know, what would you like to 
end, happen at the end. But I think that the way she used her 
words, I think I realised what she was getting at.”  
 
Michael (palliative care patient): “Yes, Dr. (Name) asked (where 
he’d like to be cared for), erm, it’d be last week, last Tuesday. We 
had Dr. (name) and 2 student doctors here… And he did ask, and 
we said at home.” 
 
All of these patients were cancer patients, which suggest that the prognosis of their 
condition would have been quite clear. Despite this, these quotes suggest that GPs 
have initiated preference discussions when patients become very unwell and bed 
bound, as opposed to in advance of a significant deterioration in health due to their 
terminal illness.  
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None of the palliative care participants interviewed had a locality advance care plan 
(the predominant form at the time, before it was replaced with the advanced 
statement from Deciding Right (NHS North East 2012) or any other associated care 
planning forms (DNACPR form, EHCP) and only one of the bereaved relatives 
recalled their loved one having a formal document (Caroline). The others just had 
informal preference discussions with their GPs.  
Richard (Doris’s son): “No it was just general conversation I 
wasn’t there at the time, he did come and mention it to me.” 
Doris (palliative are patient): “Yes he did, he came and had a word 
with you.”  
 
Barbara (Michael’s wife): “We’ve had it (preference discussion) 
yeah.” 
Interviewer: “But you just haven’t got it written down?” 
Barbara (Michael’s wife): “No, that’s right.” 
 
The quotes above indicate that these palliative care patients and their relatives had 
not been asked to engage in the formal ACP process, thus meaning that late 
preferences discussions (discussed above) were the only form of eliciting 
preferences for these patients. This was despite one of the patients, Janet, 
specifically stating to a health care professional that she did not want to be 
resuscitated, which should have prompted the use of a DNACPR form but did not.  
Janet (palliative care patient): “I do remember people asking me, 
erm, I don’t know the way she put it, she didn’t put it to me directly 
you know, do you want to carry on, but you know I made it quite 
sure and quite certain, hoped I had, have, but you know I don’t 
want resuscitation, I don’t want anything, I just want to go.”  
 
Jill (Janet’s daughter): “You haven’t filled one (DNACPR) in. It’s 
just been, it’s, it’s been said but you haven’t put anything into 
writing or filled… no.”  
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Janet (palliative care patient): “No I haven’t signed anything or… I 
don’t want, I don’t want to be resuscitated.”  
 
The QDDM (Curtis, Patrick et al. 2002) results support this outcome in that some 
GPs and bereaved relatives had markedly different perceptions on preference 
discussions. Three out of four of the matched GP and bereaved relatives had very 
different scores; GPs scored 8-10 indicating an ‘almost perfect experience’ of 
preference discussions and bereaved relatives scored zero to three, indicating a 
‘terrible experience’. This could be due to preference discussions occurring late. 
However, this questionnaire asks bereaved relatives to answer on behalf of their 
loved ones, thus it may be that preference discussions occurred when relatives were 
not present, or relatives could feel that their own needs in terms of end-of-life 
preference discussions were not met. Again, this could be because they were not 
involved in preference discussions or because their loved one did not wish to 
engage in them, potentially due to their false hope for recovery.  
To conclude, preference discussions with palliative care patients can still occur very 
late in the palliative care process, often when a GP believes that the patient is 
nearing end-of-life. This is evident by the participants’ statements about when they 
were asked about their preferences; all of the patients were bed bound at the time. 
DNACPR forms had not been filled in despite one patient specifically telling a GP 
that she did not wish to be resuscitated. The qualitative data analysis supports the 
quantitative GP practice data; preference discussions are increasing; however the 
quantitative data alone did not highlight that preference discussions are still 
occurring very late in the illness trajectory.  
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Mechanism: Preference discussions can dash patients’ hopes for recovery 
GPs 4 and 5 stated that they felt patients often had false hope from secondary care 
treatment options.  
GP4 (FG3): “I think sometimes with cancer patients there is an 
element of possibly being given false hope by the cancer specialists 
in terms of what treatment is available and continuing treatment 
till quite late in an illness. And I think it’s quite hard as a GP to 
come in and dash those hopes.” 
 
GP3 (FG3): “I think (GP4’s) point about conflicting advice is one 
of the difficulties, be it oncologists or surgeons or haematologists. 
Then how can you have a conversation with somebody when 
somebody else is saying we’re going to add in drug y to drug x and 
Z that you’ve already got. It makes it a very difficult conversation 
to have.” 
 
GPs 4 and 5 stated in FG3 that they found it difficult to broach preference 
discussions when patients were being given false hope from secondary care and 
pursuing aggressive treatment. They felt that if they broached preference 
discussions (resource) it might affect patients’ hopes that had been raised in 
secondary care consultations (reasoning).  
 
Context: False hope from secondary care  
Receiving realistic information about the different treatment options and the 
likelihood of successful treatment or adverse effects and symptoms is difficult for 
palliative care patients (Matsuyama, Reddy et al. 2006). The literature indicates that 
patients would have chemotherapy for much smaller improvements in outcome than 
would health care professionals (Matsuyama, Reddy et al. 2006). However, patient 
autonomy and choice should always be valued and thus patients’ options should 
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always be presented in a balanced manner (Earle 2006). However, there is a 
subjective discrepancy in how aggressive palliative treatment is viewed by patients, 
bereaved relatives and health care professionals. Both bereaved relatives and health 
care professionals who have experienced aggressive treatment for palliative care 
patients would avoid it, giving more time to plan hospice and end-of-life care (Earle 
2006). However, in focus groups, terminally ill cancer patients who by virtue of still 
being alive had not experienced the whole course of their illness were more inclined 
to consider aggressive palliative treatment (Earle 2006). This discrepancy suggests 
that there is a gap between the informed opinions of bereaved relatives and health 
care professionals, and the decisions of patients. Slevin, Stubbs et al. (1990) make 
this more explicit, stating that 53% of cancer patients are willing to contemplate 
aggressive chemotherapy if chances of a cure were increased by as little as 1%. 
Furthermore, patients have stated that they would accept chemotherapy or 
radiotherapy despite being aware that it would have no clinical benefit and no gain 
in survival chances (Palda, Llewellyn et al. 1997, Jansen, Kievit et al. 2001). This 
could be due to explanations from those providing the treatment being unclear. A 
quote from de Haes and Koedoot (2003) suggests that oncologists prefer to give 
treatment as opposed to deny it, despite doubtful expectations about a positive 
result. 
“Giving chemotherapy, rather than watchful waiting, is what I 
have been educated to do; that’s what I have to sell in my shop.” 
(de Haes and Koedoot 2003, p. 45). 
 
Another explanation of preference discussions not being broached with those who 
are receiving aggressive palliative treatment is that primary care professionals do 
not feel comfortable in communicating this information. This could be attributed to: 
a lack of tools in conveying pros and cons; the subject being too emotionally 
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distressing to discuss; patients being unable to comprehend the realistic outcomes; 
an attempt to not be totally honest in order to preserve hope (Earle 2006). 
Although aggressive treatment can sometimes be inappropriately offered to non-
cancer patients experiencing exacerbations, it is more often offered to those with 
cancer in the form of chemotherapy, especially those in the later stages where it 
could be considered to be inappropriate (Mayor 2008). Furthermore, when health 
care professionals were discussing false hope it was in reference to those patients 
who have cancer. The CMOC is therefore more relevant to cancer patients, as is the 
literature discussed surrounding the pursuit of aggressive treatment. 
 
Summary  
 
 
 
 
 
 
 
 
 
 
 
Figure 23: CMOC2, false hope can prevent preference discussions 
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As displayed in Figure 23, patients are often given false hope from secondary care 
and offered aggressive treatment when they are approaching end-of-life (context). 
This makes it difficult for health care professionals to broach preference discussions 
(resource) due to a fear of affecting their hope about prognosis (reasoning). This has 
resulted in preference discussions sometimes occurring late in the locality. CMOC2 
can be construed in a positive way. If patients remove themselves from aggressive 
treatment from secondary care or if it is not offered (change in context), then health 
care professionals might be able to be open about illness progression and broach 
preference discussions (resource) without the fear of destroying patients’ hope 
(reasoning). This would result in preference discussions being viable earlier in the 
patient’s palliative care journey.  
 
 
CMOC3 – Time constraints in primary care  
Outcome: Preference discussions do not predict use of the locality advance care 
plan 
Preference discussions and the locality advance care plan are both part of the ACP 
process. It is assumed that if a locality advance care plan has been completed with a 
patient then they have engaged in the ACP process. This is more of a robust process 
than preference discussions alone. A Spearman’s rank correlation co-efficient was 
used to see whether there was a relationship between preference discussions and the 
locality advance care plan (documentation) as the data was not linear. The 
correlation showed that preference discussions and the locality advance care plan 
(documentation) have a significant positive relationship (r = 0.55, n = 14, p < .05), 
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the least squares regression line (line of best fit) in Figure 24 displays a large 
strength positive trend (Cohen 1988). This suggests that practices that do more 
preference discussions also use the locality advance care plan documentation more 
often.   
 
 
Figure 24: A correlation between preference discussions and locality advance 
care plans. 
 
The correlation prompted a multiple regression, a stronger statistical test that 
identifies not only a relationship, as a correlation does, but whether one factor 
predicts another. Thus it was used to assess the ability of preference discussions to 
predict the use of the locality advance care plan (document). Preliminary analyses 
were conducted to ensure no violation of the assumptions of normality, linearity, 
multicollinearity and homoscedasticity. The model was not significant (F(1,12) = 
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3.35, p > .05) thus meaning that preference discussions do not predict the use of the 
locality advance care plan. 
In summary, the statistical tests indicated that there was a significant strong positive 
correlation between preference discussions and the use of the locality advance care 
plan, using 2011 data; however preference discussions do not predict the use of the 
locality advance care plan.  
 
Mechanism: Additional paper work generated from the locality advance care 
plan  
In FG1 the community matron stated that she felt the locality advance care plan was 
difficult to use.  
Community Matron (FG1): “The prin, the principle of the 
document is great and very, very sound. But it really needs to be 
made more, erm, more user friendly.” 
 
If a document is difficult to use then it is likely to be time consuming, which in the 
time constrained environment of primary care (context) makes the document less 
likely to be completed. Three of the GPs in FG3 commented on how much paper 
work the advance care plan generates.  
GP4 (FG3): “It comes down to communication skills and time. 
That’s one of the biggest constraints, not having the time to do 
advance care planning. You know, the days are just getting more 
and more hectic so there’s less and less time to effectively do 
things like this.” 
 
GP6 (FG3): “I mean undoubtedly there a huge work load there, in 
paper work… So it’s an issue over, as a format it’s a good thing, 
but it has to be built on communication and that’s a timely thing. 
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And maybe that’s the issue. With care planning and with end-of-
life advance care planning. Maybe that’s the issue… It’s resource, 
and the biggest resource we don’t have is time.” 
 
GP3 (FG3): “Certainly when I was in practice it was the time 
consuming paper work that was the problem”.  
 
The GPs may have opted to not use the locality advance care plan due to the 
extensive amount of paper work it generated (reasoning), especially due to the time 
constraints in primary care (context). The social care team lead described how time 
constraints became stressful for health care professionals in primary care. 
Social care team lead (FG3): “And that’s stressful, because you 
know what you should be doing but it’s, and how you should be 
doing it, but it’s just so difficult when you’re stretching yourself 
ever so thinly.” 
 
Context: Time constraints in primary care 
The literature in the introduction highlighted that health care professionals in the 
UK have time constraints with patients (Elwyn, Edwards et al. 1999). Both the 
social care team lead and a GP commented on how time pressured they felt in 
practice.  
Social care team lead: “We need more hours in the day” 
 
GP6 (FG3): “An 8 day week would just about cover it (tasks to be 
completed)” 
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The quotes above highlight that health care professionals using the ICP feel 
pressured to complete all the necessary tasks they have to do in the short time they 
are given.  
Summary  
 
 
 
 
 
 
 
 
 
 
Figure 25: CMOC3, time constraints in primary care 
 
The decision not to use the locality advance care plan (resource) may be due to the 
time consuming paper work it generates (reasoning), which is not feasible in a time 
constrained primary care setting (context), as shown in Figure 25. This has resulted 
in preference discussions not predicting the use of the locality advance care plan. 
However, engaging in preference discussions can make the use of a locality advance 
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care plan more likely, as demonstrated by the correlation showing a positive 
relationship between the two tools.  
 
CMOC4 – The Mental Capacity Act and the locality advance care 
plan 
Outcome: No significant increase in locality advance care plans from 2009 to 
2012 
A one-way repeated measures ANOVA was conducted to compare numbers of 
advance care plans completed in 2009/10, 2010/11 and 2011/12. There was no 
significant effect for time on locality advance care plans completed (F(2, 22) = 0.21, 
p > .05, 2p = 0.2). This means that the number of locality advance care plans being 
carried out since the introduction of the ICP has not significantly increased. Figure 
26 depicts this.  
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Figure 26: The mean number of patients who had locality advance care plans 
from 2009 to 2012, using Death Audit data. 
 
Mechanism: The mental capacity act and instability of capacity 
The impairment that causes a lack of capacity can be temporary or permanent. A 
person must be assumed to have capacity unless it is established that they do not 
have capacity to make a certain decision about a certain matter (NHS North East 
2012). This means that a lack of capacity does not apply to all decisions but only the 
one in question at that current time. Thus, capacity is unstable, as it relates to the 
decision that is being made and the functionality of the person at the time of the 
decision. This instability of capacity (resource) was commented upon in FG3.  
GP4 (FG3): “It’s (capacity) is individual and it’s time specific.” 
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GP3 elaborated on GP4’s comments, stating that capacity is very difficult to 
decipher and with is comes a fear of litigation from families (reasoning), suggesting 
that health care professionals have low confidence in their capability to efficiently 
assess capacity.  
GP3 (FG3): “It’s the variability of capacity, erm, and in certain 
ways that can point to litigation. You see somebody you thought on 
this day seemed to understand and have capacity but then in three 
days time they may not even remember that they had the 
conversation and then if you’re certain you’ve got their 
preferences for do not resuscitate etc. and then the family say well 
they clearly couldn’t make that decision… Society believes that 
you never die. And that if you do then it’s someone’s fault.” 
 
GP3 also felt that the lengthy locality advance care plan made completing it with 
someone who’s capacity was questionable even more difficult.  
GP3 (FG1):  “I would welcome it (a shorter advance care plan). I 
am put off by the amount of detail present (in the locality advance 
care plan). The locality advance care planning document makes a 
difficulty of assessing mental capacity. For example, does this 
person have mental capacity for all of this document or just bits of 
it? I think a shorter document would be more defined.” 
Health care professionals have a fear of repercussions (reasoning) from assessing 
patients’ capacity which can be unstable (resource). This results in less use of the 
locality advance care plan.  
 
Context: The locality advance care plan is to be used with those who have 
capacity to engage 
Most patients on the palliative care register have cancer diagnoses. However, some 
have non-cancer diagnoses which can result in cognitive impairment. A large 
proportion of patients with non-cancer diagnoses in the locality are in care homes 
and some do not have capacity to make decisions about their health care. However, 
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in an increasingly patient-centred health service, individuals wish to make 
independent judgements about their care (Kon 2012), which can cause issues. The 
MCA (Justice 2007) provides a legal and clinical framework that health care 
professionals should adhere to when assisting patients in making treatment decision. 
GP3 highlighted the MCA as an important context (using SSM) in FG2.  
GP3: “A factor in the worldwide view is the mental capacity act, 
because I think that that is agonised over most and trying to do 
them (advance care plans), does this patient have the mental 
capacity to make these, these questions I was trying to ask them, 
so, but I mean, I would agree patient’s and carers, but the mental 
capacity act most certainly has an impact.”  
 
The quote above identifies that health care professionals are aware that the locality 
advance care plan (and all ACP) must be carried out with those who have capacity, 
and the MCA therefore has an impact on how they manage their use of locality 
advance care plans in practice. GP1 explains how this affects her use of ACP.  
GP1 (FG1): “I go to the same care home every week and see little 
old ladies and not one of them recognises me, because they have 
dementia and therefore advance care planning is not feasible”  
 
The quote above highlights how GP1 feels that ACP is not appropriate for a 
proportion of the palliative care population.  
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Figure 27: CMOC4, the MCA and the locality advance care plan 
 
A diagrammatic explanation of CMOC3 is provided (Figure 27). The underlying 
principles of MCA (Justice 2007) mean that individuals must have capacity for the 
decisions they make (context). This makes it difficult for health care professionals 
to carry out locality advance care plans or ACP in general (resource), as capacity 
can be unstable. This gives health care professionals a fear of repercussions 
(reasoning) suggesting that they have low confidence in assessing mental capacity. 
This has resulted in no significant increase in the use of locality advance care plans 
from 2009 to 2012 (outcome).  
 
 
MECHANISM 
 
  Reasoning: Health care 
professionals have a fear of 
repercussions from incorrectly 
assessing capacity due to low 
confidence 
OUTCOME: No 
significant increase in 
locality advance care plans 
from 2009 to 2012. 
Resources: The 
mental capacity act 
and the locality 
advance care plan 
 
 
CONTEXT: The 
locality advance care 
plan is to be used with 
those who have 
capacity to engage (as 
per the Mental 
Capacity Act) 
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CMOC5 – A change to the advance statement from Deciding Right  
CMOC 5 describes a change that occurred within the locality, partly as a result of 
the focus group discussions that took place as part of this PhD, and provided 
information on health care professionals’ perceptions of the locality advance care 
plan.  
 
Outcome: The locality changed to the use of the advance statement  
The discussions with the Palliative Care Partnership and the focus groups prompted 
the change to the advance statement and the use of other tools from Deciding Right 
(NHS North East 2012). The use of the advance statement may potentially result in 
an increase in advance statements (previously the locality advance care plan) in the 
future.  
 
Mechanism: The advance statement 
The focus groups identified that health care professionals were not comfortable 
using the locality advance care plan. Participants felt that it was time consuming; 
they were confused about where to write and thought that a lot of the questions were 
unnecessary.  
GP3 (FG1): “I would definitely vote for that because I was 
definitely put off by the amount of detail in the present (locality) 
advance care plan. I look at it and think where should I write? I 
mean the difficulty of mental capacity, the present document makes 
it even more difficult. Does this person have mental capacity for 
all of this document or for bits of it?” 
GP3 (FG2): “Our staff didn’t know where to write, and as a GP I 
would include myself in that, I used to write on any page I could 
find to write on.”  
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A tailored, shorter version was required. This resource was offered in the form of 
the advance statement, one of the tools provided in the Deciding Right 
documentation (NHS North East 2012). Both myself and the PCP thought that the 
advance statement would be more user friendly and may encourage health care 
professionals to complete advance statements (reasoning).  
 
Context: The locality advance care plan is not user friendly  
The locality advance care plan was not being used by focus group participants 
(health care professionals) as it was time consuming and not user friendly.  
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Figure 28: CMOC5, a change to the advance statement from deciding right 
 
The advance statement is a shorter document which may mean that less paper work 
is generated for health care professionals. They may therefore be more likely to 
engage with it and use it as a tool to help patient plan their care, as opposed to 
relying on preference discussions. However, the change does not affect health care 
professionals’ fear of repercussions from assessing unstable capacity. Although, 
Deciding Right, the documentation that provides the advance statement, does offer 
clear instructions on assessing mental capacity and the health care professionals in 
the locality have now (post data collection) had workshops on using Deciding 
Right, including assessing mental capacity. Thus, CMOC5 (displayed 
 
 
MECHANISM 
 
 
   Reasoning: The advance statement 
is shorter and more user friendly 
  
OUTCOME: Potential 
increase in advance 
statements in the future.  
 
Resources: The 
advance statement 
from Deciding Right.  
 
 
CONTEXT: The 
locality advance 
care plan is not 
user friendly  
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diagrammatically in Figure 28) indicates that the locality advance care plan was not 
user friendly (context). The advance statement (resource) was a more concise 
document that may encourage health care professionals to engage with it 
(reasoning). This resulted in a change to the advance statement (outcome). This 
CMOC is also presented to demonstrate how the ICP is not a static intervention, but 
in itself responds to evolving contexts and new mechanisms. Therefore, whilst this 
PhD is an evaluation of the ICP, it also contributed to its development over time.  
 
Chapter Summary  
It has been highlighted that preference discussions are increasing (outcome) and 
often happen when patients’ condition or needs change (context). The increase in 
preference discussions may be due to the ICP framework (resource) which 
encourages health care professionals to engage in preference discussions, to be 
proactive and patient centred. Health care professionals have a desire to be patient 
centred and provide high quality palliative care to facilitate the patient’s good death 
(reasoning). However, preference discussions can happen late in the patient’s illness 
trajectory (outcome), as they approach end-of-life; this can happen when health care 
professionals feel that patients have false hope about their prognosis (context), 
which will often come from secondary care treatment providers. Preference 
discussions do not predict the use of the locality advance care plan (outcome). The 
decision by health care professionals not to use the locality advance care plan 
(resource) may be due to the amount of paper work it generates, which is not 
feasible to complete (reasoning) in a time constrained environment such as primary 
care (context). This is supported by no significant increase in use of the locality 
advance care plan from 2009 to 2012 (outcome). This could be partly explained by 
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the need to complete the locality advance care plan with those who have capacity 
(context), when capacity can be unstable, as assessed by the MCA (Justice 2007) 
(resource). This results in health care professionals having fear of repercussions 
from inaccurately assessing the patient as having capacity and engaging in 
(documented) care planning with them. However, now the study and Palliative Care 
Partnership have prompted the change to the advance statement, and the locality has 
had workshops focusing on mental capacity and the use of Deciding Right (NHS 
North East 2012), there may be an increase in the advance statements (that replaced 
the locality advance care plan) completed.  
From the analysis it appears that health care professionals engage in preference 
discussions more readily than they use the locality advance care plan. This may be 
due to issues surrounding the implementation of the locality advance care plan. 
Health care professionals felt that using the locality advance care plan was difficult, 
due to capacity issues and time constraints. Time to complete advance care plans 
has previously been highlighted as an issue in the literature (Seymour, Almack et al. 
2010). In a study on advance directives it was found that nursing staff had very low 
rates of advance directive completion despite most nurses feeling that advance 
directives were valuable to the patient (Duke and Thompson 2007). This was 
attributed to the need for more resources including administrative support and time 
to engage in the process. Similar results were found in this study, with health care 
professionals seeing the need and value of the locality advance care plan, but not 
having the time or administrative support to carry it out. Without the resources to 
implement documented care plans, despite the potential of the tool to empower 
patients, health care professionals will not feel able to use it and therefore will have 
no ownership of it.  
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Programme theory 3 stated that there would be an increase in the use of preference 
discussions and the locality advance care plan (outcome), as health care 
professionals become more confident with broaching the subject of death and dying 
with patients (mechanism), and aware of the importance of having and documenting 
preference discussions, which has been highlighted by recent policy (context). This 
programme theory is not wholly supported by the findings. Preference discussions 
are increasing (outcome) but can sometimes occur late in a patient’s illness 
(outcome), when they are approaching end-of-life. A change in the patient’s 
condition or need (context) would prompt health care professionals to broach 
preference discussions with the desire to be patient centred (mechanism).  When 
preference discussions occurred late it was due to patients having false hope 
(context). Thus, in order for preference discussions to occur (outcome), health care 
professionals seem to need some reassurance that they initiate this delicate 
conversation at the appropriate time: a change in condition or need, or the patient’s 
acceptance that they are in their final illness (refusing aggressive palliative 
treatment from secondary care). This allows the health care professional to then 
work within a palliative care framework, being patient centred and broaching 
preference discussions. Thus, a refined programme theory can be created for 
preference discussions. A change in the patient’s illness progression, in terms of 
condition deterioration, increased need or psychological acceptance (context), 
allows health care professionals to be patient centred and address sensitive issues at 
an appropriate time for the patient (reasoning), using preference discussions 
(resource). This has resulted in an increase in preference discussions from 2008 to 
2012. Health care professionals also noted that often patients themselves would 
broach conversations about their preferences and wishes for end-of-life , but data 
was insufficient to support a CMOC for this. However, the programme theory (3) 
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does not support the findings for use of the locality advance care plan. Use of the 
locality advance care plan has not increased from 2008 to 2012 (outcome), and 
preference discussions do not predict the use of the locality advance care plan 
(outcome). The explanation for this is related to the pragmatic issue of the time 
consuming paper work the locality advance care plan generates (mechanism), and 
difficulties in assessing capacity (which can be unstable) using the MCA 
(mechanism).  
This chapter has identified that documenting patients’ preferences can be difficult. 
The next chapter will explore the potential of an information seeking and avoiding 
explanatory framework (monitoring and blunting) in facilitating consultations about 
palliative and end-of-life care, which often include preference discussions and ACP. 
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Chapter 7: Facilitating difficult 
conversations in palliative care 
 
Clinicians need to create several opportunities for patients to engage in discussions 
about their future and end-of-life care (Barclay 2010). These discussions need to be 
guided by the patient as to timing, pace, and content. However, GPs must also be 
respectful of the wishes of those who do not want to discuss such matters but 
continue to give opportunities at different consultations to engage in discussions 
about end-of-life care (Barclay 2010). Thus, health care professionals must be 
respectful of those who both seek and avoid chances to engage in information 
sharing about end-of-life care.  
 
Initial questions asked of the data  
The programme theory and subsidiary questions that this chapter focuses on were 
first stated in the methodology chapter as:   
 Programme theory 4: Innate coping style of the GP and patient (context) 
will facilitate a consultation if matched (mechanism), making a preference 
discussion and use of the locality advance care plan more likely to occur 
(outcome).  
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- Are matched coping style consultations more successful (in terms of 
producing outcomes such as preference discussions and advance care plans).  
- Can matched coping styles facilitate practice?  
This chapter focuses on the micro, concentrating on interactions between one 
patient and one GP in each CMOC to unpack the effects of coping style. From the 
programme theory and knowledge about monitoring and blunting styles a CMOC 
matrix was devised (Table 11).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 231 
 
Table 11: CMOC matrix, matched monitoring and blunting health care 
professional-patient interactions and the outcomes they can result in. 
 
Consultations were recorded between three patients and their GPS. MBSS scores 
are out of 16 for both monitoring and blunting and are displayed in the table below 
(Table 12). A score of 10 or above for monitoring is considered a high monitor, thus 
two of the GP and patient pairs were high monitors (GP-A and Mary, GP-B and 
Context    Mechanism    Outcome  
          
Patient  Health care professional  Resource  Reasoning    
          
High 
Monitor  Low Monitor 
Health care 
professional’s 
knowledge of 
preference 
discussions 
and their 
benefit to 
patients 
Communication 
between patient 
and health care 
professional 
determined by 
monitor blunter 
combination, 
perseverance of 
health care 
professional 
and 
receptiveness 
of the patient.  
No preference 
discussion 
broached  
Low 
Monitor  High Monitor     
Health care 
professional 
makes repeated 
attempts at 
preference 
discussions 
until successful  
High 
Monitor  High Monitor      
Preference 
discussion 
broached  
Low 
Monitor  Low Monitor     
No preference 
discussion 
broached  
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John) and one of the pairs were low monitors (GP-B and Susan). However, the same 
low monitor pair also had low blunter scores, as did GP-A and Mary. GP-B and 
John who had high monitor scores also had high blunter scores.  The MBSS creators 
do not provide a score to define high and low blunters but in comparison to the 
other patients, GP-B and John have much higher blunting scores (8/16 and 9/16, 
respectively).  
 
Table 12: Monitoring and blunting scores out of 16 for GPs and patients. 
  GP-A 
Patient 1 
(Mary) GP-B 
Patient 
2 (John) 
GP-
C 
Patient 3 
(Susan) 
Monitor Score 10 11 10 10 7 6 
Blunter Score 2 5 8 9 3 2 
 
Table 12 indicates that the patients and health care professionals are quite well 
matched in terms of their monitoring and blunting scores. Thus if the programme 
theory is correct, it would be predicted that GP-A and Mary are most likely to have 
a consultation that includes ACP (preference discussions and use of the locality 
advance care plan), as they both have a high monitoring score and low blunting 
score. GP-B and John have high monitoring scores but also have high blunting 
scores. GP-C and Susan have slightly lower monitoring scores than the other two 
GP-patient partnerships but also have low blunting scores.  
 
This chapter will describe CMOC in a different order to the other chapters in the 
thesis. The CMOC will begin with an explanation of the context and end with 
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exploration of the outcome as this is how they were formulated. The chapter uses 
consultation recordings to test the impact of different combinations of contexts on 
the mechanism of ACP.  
 
CMOC1 - High monitor and low blunter 
Context: Information seekers: GP-A and patient 1 (Mary) 
GP-A and Mary were both classified as high monitors and low blunters. High 
monitors are information seekers, those individuals who are likely to cognitively 
scan for, attend to and magnify threatening cues (Miller 1987). They have increased 
risk-related perceptions and higher levels of distress, regardless of their objective 
risk (Muris, de Jong et al. 1995, Schwartz, Lerman et al. 1995). Additionally, high 
monitors have increased anxiety about health risks and ruminate about information 
they perceive as threatening (Miller, Roussi et al. 1994, Muris, de Jongh et al. 1994, 
Miller, Rodoletz et al. 1996). Thus, it is likely that high monitors will wish to 
engage in preference discussions (seek information) and the ACP process in 
general.  
 
Mechanism: Advance Care Planning  
Over a course of two consultation recordings GP-A and Mary review Mary’s 
locality advance care plan, which was completed prior to the recording. The GP 
begins by seeking information on general well-being and function:  
GP: “So are you having to get them (social care) to do any more 
for you?” 
Mary: “No. Empty the dishwasher and make the bed (laugh)” 
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The conversation develops with Mary talking about her locality advance care plan. 
The GP seeks information about who Mary feels is involved in her advance care 
plan. This is a way of ensuring that Mary understands the locality advance care plan 
and what has been stated on it. It also helps her to refine and develop it if and when 
her preferences change. Thus the GP is demonstrating their understanding that 
preferences and the locality advance care plan need to be reviewed regularly as 
patient’s preferences and needs are not static (resource). Mary explains that she 
prefers to stay at home and has all the support she needs.  
Mary: “I feel safe here, I feel I know who I can call upon. And not 
just one person, two or three people I feel I could call upon. It 
gives me a great sense of security knowing all of the people who 
are involved in the, in the (advance) care plan really.” 
 
GP: “Sure ok. So who would you say is involved at the moment? If 
you were sort of to make a list.” 
 
Mary: “Well obviously you probably. Erm, the nurses. The 
community nurses, erm, the, Macmillan nurses, err…” 
 
Mary was very open to the notion of ACP when she found out about her terminal 
illness. This may have been due to her information seeking disposition (high 
monitoring score) and low information avoidance (low blunting score). Mary 
wished to know her options, discuss them and then have them formalised 
(reasoning).  
GP: “So what difference do you think having that care plan or 
talking though the care plan actually makes, do you think it’s, do 
you think it’s a situation that you people knew about anyway, I 
think when we’d talked about it you’d already discussed it with 
your family.”  
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Mary: “Yes I did. I did, as soon as I knew what the diagnosis was. 
I felt, I don’t know how long I’ve got, I mean I might have a longer 
time or a shorter time but I just wanted something down in black 
and white.” 
 
Mary then states that she thinks the advance statement will need to be updated as 
time progresses and the GP reassures her that this can be completed as and when 
needed, indicating that the GP has a good knowledge of the ACP process (resource). 
In this instance Mary is seeking information without asking questions.  
Mary: “I mean obviously you don’t know what’s the future but you 
don’t know how much nursing care I might need (referring to 
hospice care), but I think I’ve got, yes. I’m very happy with 
(advance statement)…” 
 
GP: “And we can update it as things change, if things change.”  
 
Mary: “Yes, yes.”  
 
Discussions about the advance care plan between Mary and the GP then lead Mary 
to discuss other end-of-life issues, related to symptom management. She does this 
explicitly and implicitly, using questioning techniques and statements which seek 
confirming reassurance from the GP, respectively.  
Mary: “Yes, as long as I’ve got a reasonably comfortable end, I’m 
sure I won’t be allowed to suffer unnecessarily will I?”  
 
GP: “Not if any of us have anything to do with it.”  
 
Mary: “Yes”  
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GP: “Which we will.”  
 
*** 
 
Mary: “Well as you know I feel extremely calm about all that 
(death and dying).” 
 
GP: “Always been very calm.”  
 
Mary: “Because, erm, well I feel all the family, fortunately I’ve got 
a very loving family who know what my future’s going to be.”  
 
GP: “Sure.”  
 
Mary: “And what’s wrong with me. And also I have some good 
friends and neighbours and erm I don’t feel. I’m not afraid of 
dying. I’m just not afraid of it at all.”  
 
GP: “Mmm.”  
 
Mary: “As long as I’m not writhing in pain and they said oh well I 
don’t think I’ll be doing that.”  
 
GP: “No” 
 
*** 
Mary: “And as I say, I say I’m so lucky because I don’t have any 
pain and that’s the thing, I never have had and I still haven’t so. 
But you don’t know do you? When it’s? what that’s? (laughs 
nervously).” 
 
GP: “Nobody knows.” 
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Mary: “They don’t.”  
 
The GP then seeks information from Mary about how palliative and end-of-life care 
and her terminal illness affect her psychologically, in her thoughts and her decision 
making.  
GP: “Have you been doing much thinking about what’s going to 
happen or what might happen?”  
 
Mary: “Erm, not, not a lot. Erm, I mean not so, not every day, 
particularly, sometimes, well sometimes when I’m awake in the 
night but no I don’t really worry about it  if that’s, I’ve not got an 
anxiety about it.” 
 
 
In the quote above the GP seeks information to understand Mary’s psychological 
position in attending to her approaching end-of-life. This may help the GP to 
provide more sensitive or appropriate care (reasoning).  The GP also seeks 
information about Mary’s decision making in relation to palliative care and 
investigative treatment. This demonstrates that the GP wishes to support Mary in 
her palliative care journey by avoiding aggressive treatment (resource).  
GP: “So if he was to say to you at the clinic you know, we could do 
an endoscopy, we could… check this, what would you say?”  
 
Mary: “No thank you. I’ll be very grateful for what you’ve done, 
already to relieve the symptoms but no I don’t want any.” 
 
In summary, throughout the consultation recordings GP-A demonstrates that they 
have a good understanding of the ACP process (resource). Mary wished to know her 
options and have them formalised (reasoning) which was done through use of the 
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locality advance care plan. Mary and GP-A have a good relationship, both seeking 
information from one another to aid understanding and facilitate conversations. This 
may be due to their matched high monitor and low blunter disposition (context).  
 
Outcome: Locality advance care plan reviewed  
Mary demonstrates a strong ownership of her locality advance care plan throughout 
the consultation recording which may have resulted in her determined attitude 
towards palliative care, rejecting hypothetical investigative treatment. Mary and 
GP-A successfully review Mary’s locality ACP – a crucial step in the ACP process 
in order to ensure that preferences are current.  
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Figure 29: CMOC1, high monitor and low blunter. 
 
Mary’s locality advance care plan was reviewed throughout this consultation 
recording (outcome) leaving Mary feeling in control of her care (outcome). It is 
reasonable to assume that this was due to the matched coping style, resulting in an 
inherent desire for information (context), the GPs efficient ACP skills (resource), 
and Mary’s desire to have her preferences formalised (reasoning). CMOC1 is 
displayed diagrammatically in Figure 29.  
 
 
 
 
MECHANISM 
 
 
Reasoning: Patient’s desire to 
formally document their preferences 
  
OUTCOME: Locality 
advance care plan 
reviewed 
 
Resources: GP’s 
understanding of 
ACP and the 
inherent importance 
of reviewing 
preferences 
 
CONTEXT: 
Information 
seekers: GP-A and 
patient 1 (Mary) 
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CMOC2 – High monitors and high blunters 
Context: Information seeker or avoider? GP-B and patient 2 (John) 
GP-B and John scored quite highly on the monitor and blunter scale. Blunters (also 
known in the literature as low monitors) are information avoiders and cognitively 
distract themselves from threatening cues. They tend to have low adherence to 
health behaviour regimes and therefore may underestimate their personal 
vulnerability for disease (Steptoe and O'Sullivan 1986).  Individuals with a blunting 
coping style (low monitors) also use strategies such as distraction and denial when 
under stress (Miller 1980, Miller 1987, Bonk, France et al. 2001). Having a high 
score on the monitoring and blunting scales is unusual in that it means that GP-B 
and John both seek and avoid information. This makes it difficult to predict whether 
they will seek or avoid information. It could be that in different situations GP-B and 
John’s monitoring or blunting trait is prevalent.  
 
Mechanism: Advance Care Planning 
In the two consultation recordings the GP does not broach ACP or discuss end-of-
life issues (resource). Both John and the GP sought information from one another, 
but this was always related to generic care or social care rather than palliative or 
end-of-life care. For example, in the quote below John implicitly seeks information 
from the GP about a specific symptom he is experiencing when eating food.  
John: “Well it’s funny because this (inaudible) mentioned about 
erm not being able to control me temperature when, when I’m 
eating food.” 
 
GP: “Yeah” 
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John: “I’ll be sitting there, I’ll be eating a meal and, just little 
meals you know, by normal standards and me temperature goes 
through the roof. And I suddenly get this, you know this sort of, 
this dark area around me vision. Like I was getting when I had low 
blood pressure, we’ve checked the blood pressure once or twice 
and it aint, it aint that.” 
 
GP: “Mmm.”  
 
John: “And then, then just as soon as you get back on the air again 
its five minutes and you’re fixed. So it’s psychological ish but I’m 
not really convinced.” 
 
*** 
John: “No, exactly. There was something, I seem to just pass water 
(urine) or some kind of mucus-y stuff.” 
 
GP: “Mmm” 
 
John: “I dunno if that’s worthy of worrying about or if it’s just the 
fact that there’s just nothing to come out.”  
 
GP: “Clear or?”  
 
John: “Clear, yeah.”  
 
GP: “I suspect its ok, just one of those things”.  
 
The GP also seeks information from John in order to provide individualised care 
that is most appropriate. An example of this is in reference to contact with the 
Motor Neurones Disease (MND) team.  
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GP: “I mean, do you feel you want to be in contact with the (MND 
team) again or do you feel really, they’re not really going to add 
much more?” 
 
John: “It’s hard to say after, after this time. I mean I wouldn’t be 
(inaudible) because she was very good. But she’s come, she’s 
hiding very low isn’t she (asking wife to confirm)?”  
 
At one point in the first consultation John seems to attempt to discuss end-of-life 
issues, or certainly the deterioration of his condition. However, the GP gives him 
the opportunity to not discuss this any further (resource). Unfortunately a section of 
the transcript is inaudible and the GP cannot recall what John said. However, both 
John and his wife clearly do not wish to engage in discussions about end-of-life care 
(reasoning).  
John: “That’s what the, really, what you’ve really gotta ask. I 
mean has a, has there been a deterioration, yes there has 
obviously. That’s what it (MND) does. (Inaudible).”  
 
GP: “We don’t need to talk about that today if you don’t want to.”  
 
John: “No” 
 
John’s wife: “No” 
 
It may be that the MND team have addressed palliative and end-of-life care issues 
with John and thus the GP feels that this aspect of care has already been addressed. 
However, it would be presumed that end-of -life care would be provided by the GP 
and community nursing team, if a home death was desired. Thus, communication 
about end-of-life care with primary care is essential. GP-B does not attempt to 
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engage John in preference discussions (resource) and John and his wife do not wish 
to discuss death and dying (reasoning). This may be due to their blunting scores 
(despite their equally high monitoring scores) and the associated tendency to avoid 
stressful information. Therefore, in this case, combined high monitoring and high 
blunting styles did not provide a favourable context for ACP to be initiated or 
reviewed. 
 
Outcome: Advance care planning does not occur  
No preference discussions occurred and the locality advance care plan was not used. 
John and GP-B have a good relationship and discuss general health care, but neither 
approach end-of-life care discussions, and both avoid this topic when it comes up 
spontaneously in the consultation.  
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Figure 30: CMOC2, high monitor and high blunter.   
 
As displayed in Figure 30, neither preference discussions nor use of the locality 
advance care plan has occurred as the context was not as fertile for these important 
conversations to take place. Furthermore, the GP did not broach preference 
discussions when they occurred spontaneously in the consultation (resource) thus 
questioning his understanding of repeated attempts to engage patients in ACP. 
Finally, the GP and the patient did not wish to discuss end-of-life care issues 
(reasoning), actually preferring to avoid these conversations. 
 
 
 
MECHANISM 
 
 
    Reasoning: Patient does not wish 
to discuss end-of-life care 
 
OUTCOME: ACP does 
not occur 
 
Resources: GP does 
not attempt ACP 
 
 
CONTEXT: 
Information seeker 
or avoider? GP-B 
and patient 2 
(John) 
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CMOC3 - Low monitor and low blunter 
Context: Low monitoring and blunting scores: GP-C and patient 3 (Susan) 
Susan and GP-C were both classed as low monitor and low blunter. Therefore it is 
difficult to predict whether they will seek or avoid information about end-of-life 
care.  
 
Mechanism: Advance Care Planning (not firing) 
Throughout the consultation the GP broaches preference discussions and the locality 
advance care plan several times (resource), where he sees appropriate opportunities 
to do so. Susan distracts herself from this as she wishes to avoid information about 
palliative and end-of-life care (reasoning).  
Susan: “Listen, I’ve had friends ring me up or come and say 
“You’ve got your funeral arranged?”  
 
GP: (laughs) 
 
Susan: “Have you decided what you’re having? I says I’m not 
going anywhere (laughs). I thought they were friends?”  
 
GP: “Yeah but it’s interesting because people deal with things in 
different ways.”  
 
Susan: “Course they do.” 
 
GP: “Yeah. So have you, have you had any thoughts like that at 
all?”  
 
Susan: “Oh well we’ve got enough to cover a funeral.”  
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GP: “Yeah.” 
 
In the above quote Susan avoids focusing on preference discussions in relation to 
health care by turning the conversation to an unemotionally charged issue, finances. 
The GP recognises this and doesn’t persist with this line of inquiry (resource). This 
is important as preference discussions must be entered into mutually. In the quote 
below Susan refers to the locality advance care plan which the GP had given her to 
look at (uncompleted) in a previous consultation. Susan avoids approaching 
information about the plan by changing the focus of the conversation to generic 
physical symptoms (reasoning). The GP persists in pursuing Susan’s preferences on 
this occasion by asking how her husband would feel about the locality advance care 
plan (resource). It is highlighted that Susan’s husband may also have a low 
monitoring style or a high blunting style.  
Susan: “But never mind I’m still here.”  
 
GP: “You are still here.”  
 
Susan: “I’m still here and that’s the main thing.”  
 
GP: “And your positive thinking has been a real feature in how 
you’ve dealt with it you know, it’s the…” 
 
Susan: “You’ve got to be. As I say I was on a bit of a downer 
yesterday after I sat and read that and I’d been busy and err, but 
today I’m fine. I just put it away out of my mind.” 
 
GP: “Yeah.” 
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Susan: “So, but I’ve got no other problems apart from me tongue 
and my fingers, that’s all.” 
 
GP: “Yeah. What would, what would (husband) think about a 
conversation along those lines? Would he be the same as you, 
would he not want to get involved or?”  
 
Susan: “I don’t know. I know he gets anxious. And he gets angry, 
with me.”  
 
GP: “Yeah.”  
 
Susan: “Very impatient. But he doesn’t talk about it.” 
 
The consultation also reveals that Susan’s daughter may have a low monitoring or 
high blunting style, as she too does not wish to discuss palliative and end-of-life 
care with her mother.  
GP: “Right. And what, what, conversations you’ve had with your 
daughter, have you had conversations about what happens if?”  
 
Susan: “No.”  
 
GP: “No.”  
 
Susan: “No. She’ll just say I don’t want to know mam.”  
 
GP: “So you’re all doing the I don’t want to know bit? (laughs).”  
 
Susan: “Yes (laughs).” 
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The consultation indicates that Susan has had few opportunities to discuss her 
palliative and end-of-life care preferences with her family, but she also does not 
currently wish to engage in these discussions with the GP (reasoning). The GP 
attempts to explain the concept of ACP to Susan, as an attempt to allow her to 
engage with it and discuss her preferences (resource).  
GP: “So just thinking about that, one of the, one of the things that 
we don’t want to do is cause you any more distress in any way, in 
any point in the future. And, and sort of, one of the ways that we 
can help with that is sort of through this advance care planning 
idea, thinking about how we want things to go for  you and work if 
and when.” 
 
Susan: “If and when. Might get knocked over.”  
 
GP: “So, it’s more, it’s more about that and just ensuring things 
and I, I don’t necessarily want to talk about that in detail today…” 
 
Susan: “No, course not.”  
 
GP: “But if you, it’s just a few things to, to think about and so that 
we know what you want.” 
 
GP: “Erm, because I think it’s sort of, it’s awful if you get there 
too late and there’s a panic situation, something happens that 
somebody wouldn’t have wanted, and again, this isn’t going to 
happen to you, but they become demented and they can’t make a, 
make a decision…”  
 
Susan: “A decision.” 
 
GP: “…at that point. So we’re just trying to get in there and find 
out what people’s views are. What they feel. So that we can look 
after that and make sure that it’s written down. And the different 
aspects of that to think about are, sort of where you’d like to be at 
the end of your life, whether it’s at home...” 
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Susan: “Mmm.” 
 
GP: “…In a hospice, or in a hospital, or in a nursing home, where 
would you like to be? Err in the understanding that we can make 
any of those things happen quite easily.”   
 
Susan: “Mhm.”  
 
Susan seems to display characteristics of denial (reasoning) when the GP tries to 
explain ACP, stating that she may not die of cancer but in an accident. Throughout 
the interview Susan makes many statements that could suggest that she is 
experiencing denial about her terminal illness and approaching end-of-life.  
Susan: “And I’ve never shed a tear.”  
 
GP: “No I know you haven’t, and that’s quite unusual. Are you 
proud of that or is that sort of something you feel?”  
 
Susan: “No. I just don’t feel like it.”  
 
GP: “Just don’t feel like it.”  
 
Susan: “No.” 
 
GP: “Yeah. OK.” 
 
Susan: “She would have been in floods of tears this friend of 
mine.”  
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GP: “Do you feel like it’s (upset) there waiting or do you just not 
feel like it’s there?”  
 
Susan: “Once or twice I’ve thought, oh, you know, I could sit down 
and cry but I don’t.” 
 
GP: “Yeah” 
 
 
Susan states that she has never become upset about her condition or prognosis. It 
may be that Susan avoids information due to her denial or a fear that information 
may upset her (reasoning). Susan also shows denial when discussing the type of 
tumour she has, indicating that she still believes there is a chance that her cancer is 
not terminal (reasoning).  
Susan: “You just, as I say, you’ve just got to take what comes. And 
then send it back.”  
 
GP: “No, you can’t.”  
 
Susan: (Laughs) “Well they are doing experiments on me tumours 
so.”  
 
GP: “Yeah they keep them for a while. Especially, tumours like 
yours that are quite rare and quite unusual.”  
 
Susan: “I’m different.” 
 
GP: “And present in a different way and have them puzzled for a 
bit. Yeah, those, those, they’ll want to do a bit of that.” 
 
Susan: “Yeah she said, she says that I’m unique.”  
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GP: “Yeah. That’s good (laughs).”  
 
Susan: “Course it is, one off (laughs). I’ll surprise them all yet. I 
hope.” 
 
GP: “Well yeah. And there’s no reason why, why you, why you 
shouldn’t. And sort of talking about things doesn’t make things 
happen, you know.” 
 
Susan: “Course it doesn’t.”  
 
GP: “And I know you know that. But it’s all that kind of, 
sometimes there’s that kind of block.”  
 
(Susan changes the topic of conversation) 
 
This relates to CMOC2 in chapter 6 (Preference discussions and the locality 
advance care plan, p.199), which identified that health care professionals often find 
it difficult to broach preference discussions as this may destroy patients hopes that 
can often come from secondary care. In Susan’s situation it seems that secondary 
care have told her that her tumour is unique, rather than being explicitly over 
optimistic about prognosis. Yet Susan has construed this information as good news 
about her illness, that it may potentially be treatable. The transcript highlights how 
difficult it is for health care professionals to engage patients in ACP when they have 
false hope. Despite this the GP gives Susan several opportunities to engage in 
preference discussions and enter the ACP process (resource). Feeling at peace with 
dying was scored variably by GPs and bereaved relatives who answered the related 
question in the QDDM (Curtis, Patrick et al. 2002). Palliative care, preference 
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discussions and ACP are difficult frameworks to operate within due to the sensitive 
nature of death and dying. However, if patients and their family members are able to 
express their holistic hopes and fears about death and dying through palliative 
preference discussions and use of the locality advance care plan this may start a 
process of acceptance. However, Susan is currently not ready to engage in this 
process. The GP therefore cannot currently help Susan in accepting her terminal 
diagnosis. Yet it is important that the GP continues to give Susan opportunities to 
engage in preference discussions (resource), as he does throughout the consultation. 
Susan does not seek information about her palliative or end-of-life care (reasoning), 
which is stereotypical of the blunting trait, as opposed to monitoring. Thus since 
Susan scored low for both monitoring and blunting it may be that her blunting trait 
is more predominant in this situation. As aforementioned, individuals with a 
blunting coping style use strategies such as distraction and denial when under stress 
(Miller 1980, Miller 1987, Bonk, France et al. 2001), thus Susan’s denial may be 
related to her predominant blunting trait (context). Susan may be worried that 
information will upset her or may not wish to be given information as she will not 
accept it due to the denial she is experiencing about her prognosis (reasoning).  
 
Outcome: Advance care planning does not occur  
Susan does not engage in preference discussions or the ACP process in general and 
therefore makes no plans for her end-of-life care.  
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Summary 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: CMOC3, low monitor and low blunter 
 
Susan’s blunting trait seems predominant in this consultation (context). The GP 
makes repeated and varied efforts to broach important preference discussions 
(resource) but Susan avoids the information (reasoning). This may be due to her 
denial. Therefore, in this context no ACP occurs (outcome). This CMOC is 
displayed diagrammatically in Figure 31. 
 
 
 
 
MECHANISM 
 
 
Reasoning: Patient is experiencing 
denial about their terminal illness  
 
 
OUTCOME: ACP does 
not occur 
 
Resources: GP’s 
understanding of 
ACP and the 
inherent importance 
of providing 
repeated 
opportunities for the 
patient to engage  
CONTEXT: Low 
monitoring and 
blunting scores: 
GP-C and patient 3 
(Susan) 
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Formulation of a new CMOC  
The data offers a valuable and rare insight into difficult conversations surrounding 
palliative and end-of-life care but is still very limited. However, from the data 
discussed the CMOC matrix can be revised (Table 13). This table takes into account 
that some of the patients and GPs scored high on both the monitoring and blunting 
scale (GP-B and John), or low on both the monitoring and blunting scale (GP-C and 
Susan). It would seem that this shouldn’t be possible, as high monitors would seek 
information and high blunters would avoid information. However, it may be that 
classifying people as either high or low is unhelpful, it may be that one trait is 
stronger in some circumstances than others, as in Susan’s case. Furthermore, it must 
be noted that the blunting score is not validated but the monitoring score is. This 
would suggest that participants’ monitoring scores are a more valid and robust 
representation of their disposition due to the scores predictive validity (Petersson, 
Nordin et al. 2002). Susan still scored low on the monitoring score so it may be that 
she would still avoid information.  
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Table 13: CMOC for monitoring and blunting based on data from the study. 
 
 
Chapter Summary 
This analysis indicates that GPs and patients who are both low blunters and high 
monitors may be more successful in partnership at engaging with preference 
discussions and using the locality advance care plan. Although a CMOC can be 
Context Mechanism   Outcomes   
Data 
Examples 
GP- 
patient are 
both: Resource Reasoning       
High 
monitor 
Health care 
professionals 
knowledge  
Patient is 
ready to 
engage with 
ACP and 
GP is 
willing to 
broach  
ACP 
broached  
ACP 
carried 
out  
GP-A and 
Mary 
Low 
monitor 
of preference 
discussions 
and ACP           
High 
monitor 
(but also a 
high score 
on the 
blunting 
scale) 
and their 
importance to 
patient care 
Patient does 
not wish to 
engage in 
ACP 
ACP not 
broached  
ACP 
not 
carried 
out 
GP-B and 
John 
Low 
Monitor 
(but also a 
low score 
on the 
blunting 
scale)   
Patient is 
experiencing 
denial and 
therefore 
does not 
wish to 
engage in 
ACP 
ACP 
broached   
ACP 
not 
carried 
out 
GP-C and 
Susan  
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formed based on monitoring and blunting scores and consultation outcomes, they 
offer little final explanatory potential. This is because patients are individual and 
their reasoning behind whether they wish to engage in ACP may change as their 
illness progresses. Alternatively, they may be open to ACP when it is first broached. 
Classifying patients as monitors or blunters does not allow for changes in context. 
Dr. Miller stated that monitoring and blunting are traits but that patients can be 
affected by situational factors (p.107). It may be that blunters are not willing to 
engage in ACP early in their terminal diagnosis but will become more open to 
information as their illness progresses. Thus classifying patients as monitors or 
blunters masks how context can change and impact on reasoning and thus patients’ 
behaviour changes over time. Furthermore, classifying patients poses the inherent 
risk of ignoring the individuality of patients; although information seeking and 
avoidance is important, the context of the person’s illness, their background and 
their general personality are also all important. GPs must react to the patient’s 
reasoning (which can change over time) and use this as a trigger for their own 
reasoning in order to ensure that ACP is entered into mutually. Monitoring and 
blunting scores may provide a framework to inform whether patients and GPs are 
likely to engage with or broach ACP when they are first presented with it, but they 
are not informative past this point due to interactive factors between the GP and 
patient and individual differences of both parties. Furthermore, it is unknown how 
many times these patients had been approached with ACP before the consultation 
recordings. It may be that the recording was taken when preference discussions 
were first broached, thus some patients (John and Susan) may not have been ready 
to engage; alternatively Mary may have had ACP attempted several times before 
she engaged and then reviewed them in her consultation recordings. Also, as 
discussed in a previous chapter (Chapter 6: Preference discussions and the locality 
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Advance Care Plan, p.199), health care professionals do not have a strong 
ownership of the locality advance care plan due to issues surrounding time 
constraints and capacity. Therefore the outcomes of consultations may also be 
affected by this lack of ownership.  
The findings do highlight the difficulties in being proactive and in engaging patients 
in shared decision making. Although shared decision making is promoted by the 
NHS there are difficulties in implementing this in practice that are not only 
attributable to professionals’ willingness to do so. Patients are sometimes not 
willing to engage and this may be due to their monitoring or blunting 
characteristics. However, repeated opportunities for patients to engage in ACP are 
crucial, as despite personal characteristics, desire for information is not static.  
The MBSS scale is subject to several different interpretations. If the MBSS 
creators’ standard approach is used, that of only using the monitoring scale and 
classifying participants as either high or low monitors, then the study results are 
extremely difficult to interpret given the literature base about information seeking 
and avoiding related to the disposition. For example, John is classified as a high 
monitor but avoids information.  
The initial programme theory (4) stated that innate coping style of the GP and 
patient (context) facilitates a consultation if matched (mechanism), making 
preference discussions and use of the locality advance care plan more likely to 
occur (outcome). The findings did not fully support the programme theory. Matched 
coping style may facilitate consultations including ACP when both the GP and 
patient are high monitors and low blunters. However, as discussed, patients are 
individual and their reasoning changes; as does health care professionals’ (as 
described in relation to preference discussions in the previous chapter) in response 
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to a change in context, when the patient’s condition, needs or psychological 
acceptance of their illness changes. This can affect whether they broach preference 
discussions and their monitoring and blunting can offer little facilitation to 
preference discussions and ACP in practice. Furthermore, the previous chapter 
suggests that health care professionals struggle to implement the locality advance 
care plan, thus this may not be the most effective tool to evaluate consultations with.  
In conclusion, the analysis offers interesting insights into attempts at and reviews of 
an advance care plan. The results of this analysis are limited by the low participant 
numbers. However, although the study suggests that the MBSS does not provide 
any coherent framework to improve consultation recordings, it does offer 
information on how we can understand communication issues better in a society that 
struggles to discuss death and dying, even in the health care domain. Palliative care 
consultation recordings are also rare in the literature. This chapter offers key 
insights into how flexible tools such as ACP need to be and how difficult they are to 
implement in practice, where each and every patient is unique and varies over time.  
Difficult conversations must take place in order to plan for a good death that is 
patient centred. ACP can help patients to identify where they wish to be cared for if 
their condition is to deteriorate and where they wish to die. Gomes, Calanzani et al. 
(2011) have identified that in the North of England and across England as a whole 
the most preferred place of death is in the person’s own home. The next chapter 
focuses on facilitating home deaths for patients in the community and in care homes 
(which are considered as their own home).  
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Chapter 8: Facilitating a home death  
 
This chapter describes CMOCs in relation to home deaths and avoidance of 
emergency admissions. In order to avoid unplanned admissions, a lot of 
responsibility is placed on those around the patient in their home environment, 
whether this is care home staff, carers or family members. This chapter will focus 
on facilitating a home death due to it being a preferable location of death. It will 
consider a home death as a quantifiable measure of the effectiveness of palliative 
care services in primary care, as others in the literature have done (Agar, Currow et 
al. 2008, Bower, Roderick et al. 2010).  
 
Initial question asked of the data 
The programme theory and subsidiary questions that this chapter focuses on were 
first stated in the methodology chapter as: 
 Programme theory 5: The ICP can facilitate preferred place of death 
(outcome) and prevent emergency admissions (outcomes) through 
identifying patient preferences (context) and using the locality advance care 
plan (mechanism).  
- Are home deaths increasing?  
- Are care home deaths increasing?  
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The CMOCs in this chapter focus on open communication strategies. CMOC1 
explains the increase in home deaths in the locality in reference to easily accessible 
palliative care expertise. CMOC2 explains the increase in both home and care home 
deaths using a multi component communication strategy, whereas CMOC3 
elucidates why care home deaths may not have increased significantly until 2011.  
 
CMOC1 – Caring for a loved one who is dying 
Outcome: Increase in home deaths  
A one-way repeated measures ANOVA was conducted to compare numbers of 
home deaths from 2007 to 2012, using Death Audit data. Mauchly’s Test of 
Sphericity was not significant (p > .05), meaning that sphericity was assumed and 
the relevant values are reported. There was a significant effect of time on home 
deaths (F(5, 55) = 2.47, p < .05, 2p = 0.18). Using the guidelines proposed by 
Cohen (1988) for the 2p  (0.01 = small, 0.06 = moderate, 0.14 = large effect), this 
result indicates a large effect size. The means and standard deviations for home 
deaths from 2007 to 2012 are presented in Table 14; the means show an overall 
increase in home deaths from 2007 to 2012, however there is not a steady increase 
in home deaths over time.  
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Table 14: Descriptive statistics for home deaths in the participating GP 
practices 
 
Time 
Period  N Mean 
Standard 
Deviation  
2007 12 12.17 6.82 
2008 12 10.83 7.35 
2009 12 11.75 5.72 
2010 12 11.75 7.23 
2011 12 9.83 4.24 
2012 12 15.17 6.53 
 
 
Figure 32: Mean number of home deaths in the fourteen GP practices between 
2007 and 2012, using Death Audit data. 
 
Figure 32 shows increases in home deaths in the year that the palliative care 
pathway was introduced (2008); this then plateaued from 2009 to 2010, followed by 
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a substantial drop from 2010 to 2011. Home deaths then increased from 2011 to 
2012.  
 
Mechanism: Easily accessible palliative expertise  
Rachel (bereaved relative) was provided with an OOH district nursing service 
immediate contact telephone number (resource) after she expressed her anxieties to 
health care professionals. This telephone number provided her with quick access to 
palliative and end-of-life expertise and eased her anxieties. She needed to know that 
she could telephone someone who knew about the process of dying, who could 
reassure her that the symptoms her husband had were normal, or do something 
about them by coming to her house and providing treatment (reasoning). Similarly, 
during the day she explained that her anxiety was eased by the knowledge that she 
could go to her local GP practice for immediate help (resource) if she were to need 
it, in the village where she lived.  
Rachel (bereaved relative): “And that was better because then I 
knew I could ring them at any time, through the night, because 
everything’s always worse through the night. And it was, you felt, 
alone, you know, on your own. Well when you had this number 
(OOH immediate contact) at least you knew you could ring 
somebody and you could speak to somebody straight away […] 
Erm, as I say it was mainly through the night the support, there 
was nothing till the last week, or until the Thursday. And that was 
when as I say I got a mobile number and that was when you felt 
better, I didn’t need to ring it on the Thursday night but definitely 
on the Friday night when he was pulling the drip out.” 
 
Rachel (bereaved relative): “Because at least you knew you could 
just go up (to the GP surgery) and, and I didn’t do that even. It 
was just knowing that you could, yes.”  
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Rachel (bereaved relative): “You know, so. So there’s just nothing 
from the surgery closing to the next morning, it’s just gone 
completely.”  
 
Rachel highlights that it was not just loneliness at night and weekends that caused 
her fear and anxiety by stating that contacting her family did not ease her negative 
emotions.  It was the knowledge of easy access to palliative and end-of-life advice 
(resource) she craved, the knowledge that she had it if and when she needed it was 
sufficient to ease her anxieties (reasoning).  
Rachel (bereaved relative): “You were just left as I say with this 
person that was dying and you didn’t know symptoms to look for, 
or, ahhh, I cannot explain it. Alone. That’s the feeling that you got. 
Alone. You know I had me family I could ring but they couldn’t 
diagnose anything or tell us what to do.” 
 
The family member’s reasoning was changed, as her anxieties were eased in 
response to the knowledge of easily accessible palliative and end-of-life advice: the 
GP surgery during the day and the OOH nursing telephone number (resources). This 
helped Rachel to keep her husband at home and not call the emergency services. 
This is supported by the literature; carers and patients take reassurance from 
knowing that they will receive skilled support quickly if they need help OOH 
(Ellershaw and Ward 2003, Eyre 2010).  
 
Context: Death is hidden 
Several of the participants discussed death and dying in their interviews and its 
relation to society, in terms of how death is often hidden away from the public. 
They also offered reasons as to why this might be and demonstrated that they 
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themselves had difficulty in discussing death and dying, which may be related to 
this taboo.  
Caroline (bereaved relative): “And, but there is, people don’t, 
because we hide the old away, urm, people don’t understand that 
people aren’t just alive and then die, you know there is this period 
of deterioration, and we’re not very good at it.” 
 
In the quote above Caroline describes how death is hidden from the public. She then 
states how she feels that the past has had an influence on how society deals with 
death and dying. She felt that prior to World War I death and dying was not as much 
of a taboo in British society, especially because death was experienced more often 
at younger ages and in the home.  
Caroline (bereaved relative): “The first World War resulted in us 
all not wanting to think about death. And there are lots of poetry 
about death, but the Victorians were very into death. I’ve got some 
wonderful mourning jewellery that (my husband’s) mother has 
given me that was her grandmothers, and people would wear 
specific types of of jewellery and, and there was a much, you know, 
because life was much, you know, life was hard and life was 
earnest. What is it, ‘Nasty, British and short’. Who was that? […] 
And so, families were always experiencing the loss of life, and the 
loss of life amongst lots of different ages and so death was very 
much a part of life. And death has become something that doesn’t 
happen at home, it happens in a hospital, it happens somewhere 
away, we don’t see it, we’re protected from it. And we need to 
debunk that somehow, without going back to the point of, you 
know, what was she called? Miss Havisham, who, you know. The 
rooms don’t change because somebody’s died, and, no body would 
move and we don’t need to go back to that but we do need to erm, 
accept that most of us don’t want to have that stroke and then 
shuffle round an old peoples home for the next 5 years, 10 years, 
15 years, whatever it is, not able to live our life to the full.” 
 
In the above quote Caroline provides an explanation as to why death may have 
become hidden, referring to World War I.  
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Caroline explains how death is hidden, which means that people are not used to 
providing care for dying relatives. However, the achievement of a home death 
heavily depends on a carer’s ability and willingness to provide home care (Gomes 
and Higginson 2006, Grande and Ewing 2008). Informal carers are essential to the 
achievement of end-of-life care and death at home, and to policy aims of facilitating 
patient choice towards end-of-life (Department of Health 2008, Grande, Stajduhar et 
al. 2009). However, since death has been removed from the community and 
hospitalised, the general public can be anxious about death and often have no 
experience of caring for a person whose care is being shaped by an understanding 
that they are dying. A GP in FG3 commented on how family carers assume a lot of 
responsibility for which they have no training when caring for a dying loved one.  
GP5 (FG3): When you’re talking about proactive-ness, you’re 
talking about giving someone some confidence which you cannot 
put on a tick box, you’re trying to give someone confidence to 
manage someone close to them dying, which is a huge achievement 
when they actually achieve it, if you think about it, dying in their 
own home, especially with difficult symptoms. So and to do it 
successfully and feel like they’ve been supported and dignity and 
you know, Macmillan nurses train for years to be able to do that 
and we’re expecting someone to do it in the space of a few months 
with all the emotions going on. So I think there’s this huge amount 
of subtlety about how you empower someone, how you get them 
confident.” 
 
Although health care professionals try to empower carers to look after their loved 
ones at home, anxiety and fear can increase as end-of-life approaches and symptoms 
worsen.  
Rachel (bereaved relative): “So you’re sent home with this person 
that’s dying and you don’t know what to do, at the weekend. So 
that’s another thing that you know that, there could be a little bit 
more help there. Erm, cos I said to the nurse in the hospital well 
what do I do if anything happens and she says well what do you 
mean if anything happens?” 
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Weekends were referred to by both Rachel (above) and Linda (below) as 
particularly fear and anxiety-provoking times. In both cases this was due to reduced 
health care professional contact.  
Linda (bereaved relative): “I’d say that’s the only time I felt 
vulnerable. Weekends.” 
 
Linda (bereaved relative): “That (weekends) was the only thing 
that rocked the boat a bit. At the end.” 
 
Linda (bereaved relative): “Yeah you feel vulnerable and I, during 
the week they came in three times a day, weekends it’s down to 
two.” 
 
Linda (bereaved relative): “But, erm, I would say the only thing in 
this whole, this… looking after someone at home, as the only 
breakthrough in that is weekends. Because weekends, obviously 
people are off, and they have err, a backup, or somebody who’s on 
call at week… or it’s the weekend nurse, or whoever and they 
don’t come in as often. And I had to call out at the end somebody 
in the middle of the night and they had to come from (name of 
place far away).” 
 
In the quote above Linda refers to the difficulties of not having easily accessible 
palliative expertise at the weekend and throughout the night. Rachel also felt 
vulnerable through the night.  
Rachel (bereaved relative): “You just felt by, it got dark and that 
was it.  It was the weirdest feeling you could ever have, you were 
alone with this person that was gunna die and you didn’t know, 
quite know when, or what was gunna happen. And if he was gunna 
take bad what was gunna happen when he took bad, you know 
nobody explained that, what could happen, if he did take bad.” 
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The literature identifies death and dying as a social taboo that is still prominent, 
despite its diminishing presence in comparison to the past (1980s). Interviewees 
discussed how death and dying was often hidden away from the public view, 
supporting the literatures’ claims. These societal factors create anxieties for those 
providing home care for relatives (context). These anxieties are heightened when 
access to palliative expertise is not available, in OOH times such as weekends or 
overnight. In order to facilitate home deaths, the ICP must provide patients with 
reassurance and confidence to provide palliative care at home. 
 
Summary  
 
 
 
 
 
 
 
 
 
Figure 33: CMOC1, caring for a loved one who is dying 
 
  
MECHANISM 
    
    Reasoning: Reduced anxiety when 
caring for a loved one with end-of-
life care needs  
 
 
OUTCOME: Increase in 
home deaths 
 
Resources: Easily 
accessible palliative 
expertise (access to 
the GP practice or an 
OOH district nursing 
telephone number)  
CONTEXT: Death 
is hidden from the 
general public 
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As displayed in Figure 33, CMOC1 identifies that the context of the social taboo of 
death and dying does make family members anxious about managing death at home. 
However, the data suggests that easily accessible palliative and end-of-life expertise 
(resource) which eased anxiety (reasoning) may have contributed to the increased 
numbers of home deaths. Thus it is important when preparing for a home death that 
carers are assured of where they can find easily accessible palliative and end-of-life 
help and expertise in order to reduce inappropriate hospital admissions. Although 
carers’ needs have been identified in the literature (National Cancer Research 
Institute (NCRI) 2004), there is a lack of good evidence on how these should best be 
addressed (Grande, Stajduhar et al. 2009). CMOC1 identifies that providing a 
telephone number for easily accessible palliative advice could address carers’ needs 
and reduce hospital admissions. 
 
 
CMOC2 – Open communication strategies to increase ‘home’ 
deaths 
Outcome: Increase in ‘home’ deaths 
Chapter 6 (Preference discussions and the locality advance care plan, p.199) 
identified that the patient’s own home or their care home can be considered as 
settings that are hospitable to open communication strategies (as opposed to 
hospital, where communication strategies can often break down). Therefore, it is 
important to include care homes in the outcome analysis. Thus, assessing how many 
‘home’ deaths, where ‘home’ refers to care home and own home deaths, is essential 
in this section of outcome analysis. Furthermore, death in the usual place of 
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residence has been highlighted as an important proxy marker for quality (National 
End of Life Care Intelligence Network 2013).  
A one-way repeated measures ANOVA was conducted to compare numbers of 
‘home’ (own home and care home) deaths from 2007 to 2012, using Death Audit 
data. Mauchly’s Test of Sphericity was not significant (p > .05), meaning that 
sphericity was assumed and relevant values are reported. There was a significant 
effect of time on ‘home’ deaths (F(5, 60) = 3.64, p > .05, 2p = 0.23). Using the 
guidelines proposed by (Cohen 1988) for the 2p  (0.01 = small, 0.06 = moderate, 
0.14 = large effect), this result suggests a large effect size. The means and standard 
deviations for ‘home’ deaths from 2007 to 2012 are presented in Table 15 and show 
a distinct increase in ‘home’ deaths from 2011 to 2012, which is expected from the 
previous analyses. Figure 34 also indicates that increases in home deaths each year 
have not been consecutive.  
 
Table 15: Descriptive statistics for ‘home’ deaths in the participating GP 
practices.  
Time 
Period  N Mean 
Standard 
Deviation  
2007 12 19.31 15.45 
2008 12 21.78 15.74 
2009 12 20.92 12.35 
2010 12 22.92 18.39 
2011 12 19.54 13.66 
2012 12 28.31 16.94 
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Figure 34: Mean number of ‘home’ deaths in the fourteen GP practices 
between 2007 and 2012, using Death Audit data. 
 
Figure 34 shows a sharp decrease in the number of ‘home’ deaths from 2010 to 
2011 and a sharp increase from 2011 to 2012. Hospital deaths have not significantly 
increased or decreased (F(2.63, 31.6) = 0.49, p > .05, 2p = 0.2) between 2007 and 
2012; Figure 35 highlights this steady trend. Thus hospice deaths (including the 
commissioned local palliative care unit and other local facilities) were investigated. 
Overall, from 2007 to 2012 hospice deaths have decreased significantly (F(5, 60) = 
2.57, p < .05, 2p = 0.18). However, there was a nearly significant increase in 
hospice deaths from 2010 to 2011 (F(1, 13) = 3.78, p = .074, 2p = 0.26), and a 
significant decrease in hospice deaths from 2011 to 2012 (F(1, 13) = 5.02, p > .05, 
2
p = 0.28). Thus the newly commissioned option available through the ICP (the 
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palliative care unit) may be giving patients extended choice and affecting the 
numbers of people who died at ‘home’ in 2011 and 2012; as when ‘home’ deaths 
decrease from 2010 to 2011, hospice deaths increase, and as ‘home’ deaths increase 
in 2011 to 2012, hospice deaths significantly decrease. The nearly significant 
increase in hospice deaths from 2010 to 2011 and the significant decrease in hospice 
deaths from 2011 to 2012 are displayed in Figure 36.  
 
Figure 35: Mean number of hospital deaths between 2007 and 2012, using 
Death Audit data. 
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Figure 36: Mean number of hospice deaths between 2007 and 2012, using 
Death Audit data. 
 
Data from the QDDM indicated that all GPs and bereaved relatives were very 
pleased with the location of their patient’s or loved one’s death. All patients’ deaths 
were at home, suggesting that this had been their desired place to die and this had 
been planned and executed well. This may be due to the GP’s knowledge of the 
patients’ preferences. 
To conclude, hospital deaths are not increasing or decreasing, but ‘home’ (own 
home and care home) deaths are increasing overall since ICP implementation. 
Hospice deaths including the locality palliative care unit may account for significant 
changes in the years 2011 and 2012. Location of death (home) was considered as 
extremely good by both GPs and bereaved relatives in the QDDM.  
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Mechanism: Open communication strategies (preference discussions and ACP) 
ACP (including preference discussions, the advance statement, DNACPR, EHCP, 
LPA-HW) is based on shared decision making. All the component parts of ACP can 
be considered as open communication strategies (resources) and are part of the ICP. 
They promote discussions about care with patients, such as what care they would 
like to receive and where they would like to be cared for. Discussions are open and 
comprehensive and can include the patient, their family and health care 
professionals. These discussions empower patients and their family members 
(reasoning) to have ownership of their palliative care plan. A ward staff nurse asked 
why people from nursing homes are admitted to hospital in FG2 and was answered 
by a GP.  
GP1 (FG2): “One of the reasons I would suggest is that the 
advance care plan discussion hasn’t happened.” 
 
The above quote highlights how preference discussions and ACP (resources) are 
integral to avoiding emergency admissions and facilitating a home death. A 
Macmillan nurse described how the process of ACP can result in patients having a 
better understanding about their care and they therefore feel more empowered to 
direct it (reasoning). This prompts them to ask questions and review their decisions, 
engaging in effective shared decision making.  
MacMillan nurse (FG1): “So if it’s (advance statement) in the 
house it gives them a chance to sit and read through it as well you 
know? Often people don’t like to look through things when 
someone’s, a professional’s there, but if they’ve got it to look at 
you can encourage them, and if they’ve got more questions they 
can understand more about what’s going on.”  
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Supporting the MacMillan nurse, GP1 described how communication about 
appropriate actions was essential, to enable planning.  
GP1 (FG2): “I suppose it’s really difficult to, to give one example, 
because all cases are so unique and so different and we’re coming 
to the story at all different places, it’s hard to really say isn’t it?... 
But in essence you want discussions and action that’s appropriate 
and timely, that’s what we’re trying to achieve isn’t it? So 
communication and appropriate action to ensure a good death is 
what all of this is trying to achieve”  
 
Comprehensive communication strategies such as ACP were also seen as an 
anticipatory mechanism that reduces patient and family stress.   
GP1 (FG2): “It’s what we expect to happen, this is what we, this is 
what we can do, if it’s like this, if it’s like that, and it takes the 
pressure off them, you’ve talked to the families, you’ve said 
remember when we talked about the plan, and remember when we 
said if, and they go, ah yeah, yeah.”  
 
Therefore, patients’ understanding of their illness, their preferences (reasoning) and 
their palliative care are enhanced through use of preference discussions and ACP 
(resources) which is likely to lead to less emergency admissions but clearly 
facilitates home deaths.  
However, if an emergency admission occurs, this three way open, honest and 
comprehensive communication system between the GP, patient and carer breaks 
down. The primary care health staff are not significantly involved during the 
patient’s hospital stay, patients are usually in a position where they are not able to 
comment on the care they receive as they are so unwell, and families become 
emotional, scared and disempowered. Supporting this, Ned and Caroline (bereaved 
 275 
 
relatives) explained how their mother had gone into hospital after a brain 
haemorrhage and had remained there for some time having futile investigative tests, 
against their will. 
Caroline (bereaved relative): “If you like that’s a bit like what they 
were doing with (Ned’s mother), to say well we know this lady’s 
had a brain haemorrhage, we want to know what’s happening, 
well we know there is something going on in her head that involves 
blood pressure and, so probably this but we need to prove, we 
need to prove what’s happening so we can do nothing.” 
 
Caroline and Ned were extremely upset by their mother’s extended hospital stay and 
futile tests but felt that they did not have the experience, knowledge or 
empowerment (reasoning) to challenge the medical staff at the hospital and request 
their mother’s discharge.  
Caroline (bereaved relative): “(You have less experience) than the 
medics do, and so inevitably you are going to be slightly shocked, 
and not certain whether there is going to be the possibility of, erm, 
some form of effective treatment, and, it was, it was clear when she 
came out four days later that no one had done anything, apart 
from, apart from find out what was happening.”  
 
Caroline (bereaved relative): “Perhaps we weren’t strong enough 
(to take her out of hospital). But realistically we have less 
experience of how someone is in that situation… 
Ned (bereaved relative): It’s knowledge, it’s coming back to 
knowledge.” 
 
Hospitals are not a favourable context for challenging discussions to happen. They 
have a dominant curative culture (context). In such an emotionally charged situation 
and with inevitably less technical knowledge than the medical staff, families rarely 
feel confident enough to challenge a consultant’s decisions about treatment and 
request their loved one’s discharge or refuse curative intervention. Furthermore, 
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families may not be given the chance to engage in decision making (as above with 
Ned and Caroline). Hospitals can be disempowering places which have a curative 
focus and less long term contact with patients. The structure means that symptoms 
are not reported by the patient or family, a very different approach to care compared 
to that of palliative care provided in the community, where there is increasing 
demand to be patient centred, and acknowledgement of the family and the patient’s 
expertise is paramount. Although patient centred care and shared decision making 
are aspired to in secondary care, they are more difficult to deliver. Supporting this, 
GP1 explained how she did not challenge the consultants when her own father was 
ill, thus questioning how families with no medical knowledge are supposed to be 
confident and empowered enough to challenge hospital procedures and the staff 
administering them.  
GP1 (FG2): “Well once you’re in a technical setting it’s very 
difficult to keep your brain straight. My dad was on ITU for 6 
weeks with an open abdomen, that’s crackers isn’t it? That’s 
crackers. But I lost the plot as well because you’re in such a 
technical setting that you lose the plot. I mean, I look back and I 
think, he was a corpse, for goodness sake what was anybody 
thinking, but you’re in a high tech setting where everybody’s doing 
things constantly for 6 weeks. You lose the plot, you really lose the 
plot. So I wish somebody would have given me some, some sort of 
common sense, but you do lose the plot yeah. I think families do 
that.”  
 
This GP was not given the opportunity to think about the situation in a rational way 
and was not consulted on her opinion about her father’s care, similar to Ned and 
Caroline. No options were presented for shared decision making to occur (resource) 
and therefore the open communication strategies mechanism did not ‘fire’. Thus 
hospital is an inhospitable context for this mechanism. Furthermore, the open 
communication strategies such as ACP are not recognised or used in hospitals, 
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suggesting fragmentation between primary and secondary care which can cause 
issues.  
Social care team lead (FG2): “I can’t help but think that there 
could be loads and loads of great work done before that person 
ends up in emergency care and then admitted, and they could have 
all of that bumf with them but unless someone at the receiving end 
takes the time to look and read and find out, all of that could have 
just been a waste of time. So it feels as if, we need more than just a 
document, there’s got to be a buy in to be discussing between 
professionals and I suppose who’s responsibility is that, is it the 
GP, is it the…?”  
 
Ward staff nurse (FG2): “If we had this (information, ACP) as the 
patients came through the door that would be really, really 
useful.”  
 
Additionally, if the patient does not die in hospital and is discharged, the ownership 
of the resources (ACP) can change. Patients and their family have been subjected to 
competing discourses about palliative care, and the predominant curative context 
has suggested that a high level of intervention is viable.  
GP1 (FG2): “The thing about the high interventions is that it 
makes it really difficult for the GPs because the, we, we don’t want 
them to be admitted but they get admitted, somehow, lots and lots 
and lots is done and they get sent home, so when they deteriorate 
again, it changes the, the families view of your ACP, because they 
suddenly want to like ditch it and say they want more of that, high 
input, intense, you know, it makes it very difficult to sell, sell your 
stall, because, (inaudible) in a whole host of people that admission 
shouldn’t have happened and yes we’ve prolonged life but so what, 
we’re going for quality here … it can skew the families ownership 
of the ACP because now they think that admission is a good thing 
because they can do things and they did live.”  
 
The related outcomes of prolonging life may not be appreciated as much in 
secondary care due the short term basis of interactions, thus primary care may be 
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more focused on quality of life for patients. Secondary care has more of a curative 
focus than primary care.  Thus primary care has an appreciation of a longer journey 
due to extended patient contact; they develop long term relationships with patients 
as they treat them over a longer period of time, in some cases a lifetime.  
Thus, knowledge of a patient’s preferences is an essential context in facilitating a 
home death. This allows preference discussions to open communication surrounding 
end-of-life care and ACP to occur (resources) which generates deeper understanding 
about palliative care and illness progression (reasoning) for all three parties 
involved: patient, carer and health care professional.  However, if an emergency 
admission does happen, the hospital is not a favourable context for open 
communication strategies, as it is not equipped to take into account the resources 
(preference discussions and ACP) provided by primary care and changes the 
patient’s and family’s ownership (reasoning) of the ACP. Thus, preference 
discussions and ACP are integral in the community setting: they can prevent an 
emergency admission, and once an emergency admission has occurred they cannot 
be enacted due to the inhospitable context of hospital.  
 
Context: Family and carers knowledge of the patient’s preferences 
The knowledge of patient preferences is an essential part of the ICP. Rachel and 
Linda (bereaved relatives) both explained how their husbands had expressed a 
strong preference to die at home and how these were stated very early in their 
palliative care journey.   
Linda (bereaved relative): “No, he made it very clear from the first 
visit of the, of the nurse, because she, the district nurse pointed out 
that there was erm, very nice 24 hour doctors beds in (local 
palliative care unit)? But he made it very clear from that moment 
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that was not for him, he wanted to die at home. If we could manage 
that, then that’s where he wanted to be.” 
 
Rachel (bereaved relative): “Ah when the, the night he was 
diagnosed he just turned to me and said I want to be at home.”  
 
Both women refused to accept any form of help that would result in their husband 
changing location, despite the difficulties they faced. Rachel turned down the offer 
of the palliative care unit when she was exhausted from caring for her husband; 
Linda refused to consider planning her husband’s death elsewhere despite the 
anticipation of difficult symptoms.  
Rachel (bereaved relative): “There was twice Dr. (name), she was 
lovely, she said, erm, it was the Saturday night she said would you 
like us to get him into (palliative care unit) for a couple of nights 
and I said no not now I've done the worst, you know.” 
 
Linda (bereaved relative): “But I don’t feel any resentment about 
what I didn’t do. Erm, I made it very clear, they were worried he 
was going to have a bleed, I said whatever he’s going to have he 
can have here, I’ll cope with it.” 
 
Both Rachel and Linda (bereaved relatives) explained that their dedication to their 
husbands’ home death was in part due to a pressure they felt to fulfil their dying 
husbands’ wishes.  
Rachel (bereaved relative): “Aha, that was his wish. Yes because 
it, you felt as if you were doing whatever you could for him, you 
know? […] Ah yes that was what he wanted. You know, but. That 
still isn’t the national health’s fault. That was what he wanted. But 
then I suppose it comes back to when somebody’s terminally ill, 
their last wishes is what they want so you’ve got to work round, 
yes […] That was his choice, it was probably harder for me but it 
was his choice. But what do you do? Do you go against their 
wishes when they’re dying? You can’t can you.”  
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Linda (bereaved relative): “That’s… I feel, erm, that was what 
(husband) wanted, and, I had to do everything I could to make that 
alright for him […] But he made it very clear from that moment 
that was not for him, he wanted to die at home. If we could manage 
that, then that’s where he wanted to be. And from that moment I 
realised how much it meant to him, so there was no way anybody 
was going to change that.” 
 
The experience described by the bereaved spouses - pressure, personal 
responsibility, dedication and loyalty - may not be felt as much by care home staff; 
although it is possible that they may develop relationships and bond with long term 
residents. Regardless, the dedication family members feel to their loved one’s dying 
wish to remain at home is a context that discourages emergency admissions and 
facilitates a home death.  
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Summary  
 
 
 
 
 
 
 
 
 
 
 
Figure 37: CMOC2, open communication strategies to increase ‘home’ deaths 
 
Having preference discussions and ACP (resources) as part of the ICP encourages 
discussions about care, including place of care and what kind of care a person 
wishes to receive which empowers them to adhere to their palliative care plan 
(reasoning). These discussions can take place between a triad of people, health care 
professionals, the family and the patient. If a family member or carer knows the 
palliative care persons preferences (context) and the patient remains in their own or 
care home (context), open communication strategies can be used with the GP and 
more ‘home’ deaths occur, as shown in Figure 37.  
 
 
MECHANISM 
    
 
   Reasoning: Enhanced 
understanding from all three parties 
about palliative care and individual 
preferences 
 
 
OUTCOME: Increase in 
‘home’ deaths 
 
Resources: Three way 
open communication 
strategy (between GP, 
patient and family/carers) 
through use of preference 
discussions and the 
locality advance care plan 
 
CONTEXT: 
Family and carers 
knowledge of the 
patient’s 
preferences 
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CMOC3 – Care home deaths 
Outcome: No significant increase in care home deaths  
In order to find whether care home deaths were increasing, a one-way repeated 
measures ANOVA was conducted. This compared numbers of care home deaths 
from 2007 to 2012, using Death Audit data. Mauchly’s Test of Sphericity was not 
significant (p > .05), meaning that sphericity was assumed and thus sphericity 
assumed values are reported. There was no significant effect of time on care home 
deaths (F(5, 45) = 1.78, p > .05, 2p = 0.17).  
The means and standard deviations for home deaths from 2007 to 2012 are 
presented in Table 16; the means show an increase in care home deaths since pre-
ICP implementation (2007) to most recent data (2012), but with variation between 
these two dates.  
Table 16: Care home deaths in the participating GP practices using Death 
Audit data. 
 
Time 
Period  N Mean 
Standard 
Deviation  
2007 12 10.6 9.61 
2008 12 11.8 9.66 
2009 12 10.9 9.53 
2010 12 13.2 12.88 
2011 12 11.8 11.35 
2012 12 15.7 14.42 
 
The means show small variation between years, with a large increase in the most 
recent data, 2011 to 2012. The standard deviations are increasing steadily for care 
home deaths from 2007 to 2012 (excluding 2010 to 2011). This means that the 
spread of numbers is becoming wider; they are not all as closely clustered around 
 283 
 
the mean as they were at the beginning of data collection (2007). Thus some 
practices have very few care home deaths, for example Practice M who had no care 
home deaths in 2012, and some practices have a lot more care home deaths in 
comparison, for example, Practice D who had 48 care home deaths in 2012. There is 
a wide range of values in the data, which increases with time. This could be 
attributed to some GP practices providing medical cover for more care homes than 
others. For example, Practice D provides the majority of care for residents in several 
care homes, whereas Practice M does not provide care for a specific care home in 
the locality. Thus as the negative contexts are replaced with more hospitable 
contexts (support from the family and deeper understanding about palliative care 
due to the ICPs efforts to discuss and plan death) and care home deaths increase, the 
mean increases (more patients die in their care home) and the scores vary more 
drastically, as practices who do not cover care homes cannot increase their score, 
whereas practices that do cover care homes increase their score substantially.   
Despite care home deaths not showing a statistically significant increase from 2007 
to 2012, they do show a large increase from 2011 to 2012, as shown in Figure 38. 
This may be due to the recently implemented end-of-life care plan in care homes.  
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Figure 38: Mean number of care home deaths in the fourteen GP practices 
between 2007 and 2012, using Death Audit data. 
 
Mechanism: Fear of reprimand and consequences of a ‘wrong’ decision 
Care home staff in the locality have a fear of reprimand. This was exemplified when 
a care home staff member explained how he and his colleagues feel that it is safer to 
call an ambulance in case of future questioning about their decision.  
Care home staff member (FG3): “Erm, but I guess it is a bit like 
litigation in that you’ve got to cover yourself and when somebody 
comes to you and says well why didn’t you get emergency 
(services), I mean it’s like erm, resuscitation. Years ago we 
wouldn’t have even considered resuscitating any residents but now 
you resuscitate somebody unless you’ve been told otherwise not 
to.” 
 
A GP from the locality also commented upon care home staff members’ fear of 
reprimand and consequences, using recent examples.  
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GP1 (FG2): “The ambulance control have very strict criteria, with 
you know, they start resuscitating and get them in an ambulance, 
you can’t say excuse me they’re very old and palliative, I mean 
there was a case, there’s been a case recently in (name of care 
home) of a very old lady who dropped down, and the staff got in 
trouble for not resuscitating her. It’s difficult.”  
 
GP1 (FG1): “There was a case in a nursing home of, I’ll just tell 
you briefly so you understand my issue, a colleague who was 
working in a nursing home was looking after a lady who was 
clearly very elderly, clearly very ill and the family said they would 
not want her to be resuscitated… but the lady did not have 
capacity, and the GP quite rightly was worried about signing the 
DNR, because she wasn’t imminently about to die but he could 
hear the families views that they would not want her resuscitated. 
He chose not to sign the DNR. Erm, because if you look at all of 
our GMC guidelines we are supposed to, erm, talk to the family 
about it and talk to the patient about it, and he sort of dilly dallied 
around, well lo and behold didn’t she go and literally clutch her 
chest and drop to the floor in the nursing home. The carer knew 
that the family has said that they wouldn’t want her resuscitated so 
she hesitated, phoned the ambulance and said this lady has 
arrested, but I know the family don’t want her resuscitated. The 
man, it was all recorded, and the operator said does this lady have 
a signed DNR? Well no she doesn’t but, well you will start CPR. 
The poor lady, the poor lady survived the CPR, ended up in 
hospital and died. The nurse was arrested and disciplined for not 
starting CPR. Erm, and the family were up in arms that she had 
been resuscitated.” 
 
The GP also stated that patients’ family support is extremely important when a 
crisis occurs and care home staff need to manage death in the care home as opposed 
to calling for an ambulance and having the patient admitted.  
GP1 (FG2): “I mean, it is part of the education we do with them 
(care home staff), but you have to remember some of the staff that, 
some of the staff are not, they’re just not paid to take that level of 
responsibility, because you’re actually deciding to, they can be, 
they can be just teenagers and it’s a hell of a responsibility isn’t it 
to ring up someone’s family and say your patient, you know, your 
mums deteriorated but we’re not doing anything, you know it’s 
very difficult for them, and I think, I think your back up then is the 
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family. It’s the family that need to be saying to the staff, please do 
not, you know, we’ve already discussed this and this is what we 
want to happen. Your protection is the family.”  
 
Fear of reprimand and responsibility for death were also commented upon by one of 
the bereaved relatives, Ned. He also felt that these two factors played crucial roles 
in the high number of emergency admissions for palliative care patients from care 
homes.  He referred to reprimand being not only institutional but also public, 
through the media.  
Ned (bereaved relative): “And, err, your mother. Erm, but then, 
then you’ve got this terrible fear, you know of, of, I’m gunna get 
sued or am I going to get in the Newspapers you know, somebody 
died at (residential home) that should have gone to hospital and 
that, also the impulse of the carers to… to care! To worry… to 
care… Ring an ambulance! You know? Let’s see if we can get her 
fixed.” 
 
Ned (bereaved relative): “And nobody wants to be responsible (for 
death) either.” 
 
Although it is not a formally recognised version of ACP as stated by Deciding Right 
(NHS North East 2012) (such as a locality advance care plan, advance statement or 
DNACPR), in 2011 care homes started to implement their own form of end-of-life 
care planning (resource) when people first become residents at the care home. This 
incentivised end-of-life care plan (Appendix 35) is completed with the resident and 
their family members whilst they complete their initial general care plan. This care 
plan asks residents to state their preferences surrounding location of end-of-life 
care, their preferences for medical intervention, if residents have a DNACPR form, 
a LPA-HW and also addresses spiritual requirements and funeral arrangements.  
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Care home staff member: “There has been more emphasis on 
doing end-of-life care plans in the past few years (in care homes). 
And actually in (locality) we get assessed by a local authority and 
it’s all linked to how much we get paid. And they’ve had a big 
emphasis on end-of-life care plans and basically you get marked 
down if you don’t have one. So there has been an increase in end-
of-life care planning” 
 
The care home end-of-life care planning may be a more effective way of achieving 
a statement of preferences that are active in the minds of carers. A GP in FG3 stated 
that they felt potentially care home staff were better equipped to discuss end-of-life 
care with residents due to their experience of witnessing previous patients’ journeys 
through palliative and end-of-life care.  
GP 6 (FG3): “Are we any more expert in discussing that 
(preferences) than you (care home staff)?... I mean you’ve seen 
patients who’ve come and gone through the home, you’ve seen 
good deaths and you’ve seen the benefits of having a care plan, 
you’ve seen the benefits of, the disadvantage of not having a 
DNAR, because they end up in hospital and things happen to them. 
Maybe people like you are the best people (to implement advance 
care plans).” 
 
Another GP in FG3 felt that the use of end-of-life care planning by care home staff 
may provide them with more ownership of the plan (reasoning) and avoid crises of 
confidence in actions when medical emergencies occur, as they have a familiar, care 
home completed plan to refer to.  
GP 4 (FG3): “That’s kind of giving the carers (care home staff) 
more ownership of this instead of being just medically driven.”  
 
As stated previously, the patient’s family is a strong source of support for care home 
workers when managing death. This end-of-life care plan is often carried out with 
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family members present and thus may provide care home workers with more 
reassurance of their support. Furthermore, care home staff reasoning is being 
changed to have more ownership of a resident’s preferences for end-of-life care 
through use of the recently implemented end-of-life care plan (resource) in care 
homes. This makes the residents’ preferences more active in the minds of those who 
care for them (care home staff) than if preferences are discussed with a health care 
professional, thus increasing their understanding and ownership of the plan for an 
end-of-life situation. This increased ownership from the care home end-of-life care 
plan may reduce care home staffs’ fear of reprimand and would explain the 
substantial increase in care home deaths from 2011 to 2012 as it was implemented 
in 2011.  
 
Context: Litigious society  
Health care professional-patient relationships produce potential civil, criminal and 
administrative liability (Selkin 2011). This poses an issue for those caring for 
palliative care patients, especially when they are caring in a professional setting and 
not regarded as a family member/carer (such as a care home worker). Discussions 
by participants in FG2 indicated that often emergency admissions are not initiated 
by a GP but by a member of the patient’s family or care home staff. This was 
highlighted as a concern, as when an emergency admission is initiated by anyone 
other than health care professionals that are significantly involved in the patient’s 
care, often important palliative care information is not conveyed to secondary care 
and patients receive unwanted procedures. FG2 and FG3 highlighted that care 
homes may initiate emergency admissions, as a result of staff shortages and lack of 
confidence to deal with end-of-life.  
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GP1 (FG2): “In some of the patients in care homes the reason it 
(emergency admission) happens is because of, erm, staffing levels 
on the weekend, and it can simply come down to that confidence 
and grade of staff in a nursing home who are not prepared to take 
responsibility and not paid to, and it can simply be down to that, a 
certain member of staff, on a weekend, in a care home, who 
doesn’t have confidence, and they ring, well they ring (emergency 
services) and then they’re triaged by the ambulance control…”  
 
GP 4 (FG3): “I think it also comes down to staffing levels in care 
homes because it does vary from home to home undoubtedly. I 
mean that would probably sway it one way or another whether 
people go to hospital or stay in the facility”.   
 
The care home is a location where an emergency admission is more likely to occur, 
with the participants of FG2 identifying that many emergency admissions come 
from care homes in the locality. Within the care home there are several contexts 
which make an emergency admission more probable: the reduced number of staff in 
care homes at weekends and the competence, confidence or responsibility of care 
home staff. Most care home staff do not have expertise in palliative care, leaving 
them with low confidence to take responsibility in an end-of-life emergency 
situation with a resident. A care home staff member’s job is usually related to basic 
care needs as opposed to decision making surrounding whether to attempt CPR on 
site or call an ambulance. However these staff members are regularly confronted 
with the need to make such decisions due to the population that they care for, 
despite their lack of knowledge and expertise (context).  
However, the introduction of the care home end-of-life care plan has lessened the 
effect of the litigious context; care home staff now have ownership of the end-of-
life care plan and thus have a heightened awareness to patients preferences, as 
identified as crucial previously in CMOC2. They also have increased support from 
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the family which can help them to keep the patient at home when an end-of-life 
crises occurs.  
 
Summary  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39: CMOC3, care home deaths 
 
It is important to note here the difference between CMOC1 and CMOC3, 
specifically the differences between paid carers and family members who act as 
carers. A family member who acts as a carer for a dying relative has less fear of 
reprimand than a paid carer. A paid carer is acting within a job role rather than as a 
loved one who values the patient’s interests above all else. Thus open 
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communication strategies between patients, family members (who act as carers) and 
health care professionals have the potential to be less formal (preference discussions 
as opposed to ACP) and the patient may still die in their preferred place, as their 
family member will ensure that this occurs. However, a paid carer, despite knowing 
the patient’s wishes, may not have as strong a will or remit to provide the patient’s 
preferred care. Thus inherent in the contexts in CMOC1 and CMOC3 are that the 
carers are family members or paid, respectively.  
It is important that the people who care for palliative care patients have this person’s 
preferences active in their mind and have some form of involvement and ownership 
of them. This means that if a crisis occurs, such as a sudden deterioration or 
collapse, the carer knows what to do. In care homes, staff need to have this 
heightened awareness. Care home staff have recently started to use end-of-life care 
plans (resource) which in a litigious society (context) gives them more ownership of 
the patient’s care in a crisis (reasoning), as they have use of a familiar, care home 
completed document. This may have accounted for the increase in care home deaths 
from 2011 (outcome). This is depicted in Figure 39. Despite often being young and 
not having a lot of training in palliative care, care home staff or one of their 
colleagues will have completed this end-of-life care plan with the patient which 
provides them with the patient’s family support and knowledge and ownership of 
patients’ preferences. The end-of-life care plan has only been implemented recently 
and may be the reason why care home deaths have increased a lot more between 
2011 and 2012, in comparison to earlier years, despite the ICP being implemented. 
Despite the care home end-of-life care plan not officially comprising part of the ICP 
its very existence contributes to care in this area. It is based on care planning 
principles and aims to identify patient preferences, thus it has the same ethos as the 
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ICP. It is also in line with national and local policy (Department of Health 2008, 
NHS North East 2012). However, the crucial difference is that it is created for use 
by and implemented by care home staff. The reality of practice is complex and this 
CMOC recognises this.  
 
Chapter Summary  
Three CMOCs have been established that result in varying outcomes. CMOC1 
identified that home deaths are increasing in the locality (outcome), despite death 
being hidden from society in hospital in more recent history (context), due to the 
access carers had to immediate clinical advice (mechanism). CMOC2 identified that 
‘home’ (own home and care home) deaths are increasing, with knowledge of patient 
preferences an essential context, which facilitates open communication strategies 
such as formal preference discussions and ACP (resources) that empower patients 
and their family members or carers (reasoning). However, if an emergency 
admission occurs, this CMOC is unable to ‘fire’ at all, as hospital is not a supportive 
context. CMOC1 and CMOC2 indicate that the ICP is achieving positive outcomes 
and keeping patients at home (care home and own home). However, CMOC3 
indicates that care home deaths alone are not significantly increasing over time 
(outcome). This could be due to the litigious society context which results in care 
home staff having a fear of reprimand (reasoning) when confronted with end-of-life 
crises due to no ownership of patients’ preferences for end-of-life care (reasoning). 
Yet, if the care home resident has a care home end-of-life care plan (resource) this 
can result in care home staff having a greater ownership of the residents preferences 
(reasoning) and less fear of reprimand. Thus the introduction of the care home end-
of-life care plan has resulted in less negative implications of the litigious context, as 
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care home staff are now more likely to be aware of patients’ preferences with 
support from their family. This has contributed to an increase in care home deaths 
from 2011 to 2012 (outcome). The care home end-of-life care plan is based on the 
same principles as the locality advance care plan and aims to identify preferences to 
ensure a good death.  
In answer to the research question initially posed, the ICP does work for patients 
who wish to have a home death. However, until 2011 the ICP may have worked 
better for those in their own homes (as opposed to care homes) due to factors such 
as easy access to palliative expertise and multi component open communication 
strategies involving family members which are stronger than with care home staff 
due to personal allegiances. The ICP works to keep patients at home through open 
communication strategies; in each CMOC this is the common theme. 
Communication with expertise in OOH (CMOC1), use of preference discussions 
and the locality advance care plan as communication strategies (CMOC2), and care 
home staff’s increased understanding (ownership) of residents’ preferences due to 
use of the end-of-life care plan in care homes (CMOC3).  
The programme theory initially stated was that the ICP can facilitate preferred place 
of death (outcome) and prevent emergency admissions (outcomes) by identifying 
patient preferences (context) and using ACP (mechanism). CMOCs identified that 
the ICP can facilitate home deaths, however, use of the ICP in care homes may have 
been laboured due to care home staff feeling disempowered to manage death and 
dying until implementation of the end-of-life care planning started in 2011. The 
programme theory should be modified to say that the ICP can facilitate ‘home’ 
death (outcomes) through use of open communication strategies (mechanism) in 
hospitable contexts (knowledge of patient preferences) that overcome societal issues 
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related to palliative care (death hidden from community, social taboo of death and 
dying and litigious society).  
This chapter concludes the results section of the thesis. The findings will be 
summarised in the next section and discussed in relation to relevant literature in the 
Discussion. Implications for practice and research will also be outlined. 
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Chapter 9: Discussion  
 
In this discussion the overall programme theory of the ICP will be explored, which 
identifies the ICP as a translational tool to implement shared decision making, 
patient centred care and proactivity in practice. Study findings will then be 
discussed in terms of the existing literature on ICPs. Implications for practice, 
challenges, limitations and future research will also be considered.  
 
The overall programme theory; the ICP as a translational tool  
The literature in the introduction highlighted translational problems between 
palliative care policies, the concepts they promote and practice (Chapter 1, p.6). 
This thesis highlighted various constraints to implementing proactive care, patient 
centred care and shared decision making, including the ageing population, time 
constraints in primary care and definitions of palliative and end-of-life care. 
Candidate theories that offer some explanation as to how translation might happen 
in practice despite these barriers were identified – CQI, diffusion of innovation and 
NPT. CQI was used to understand how the ICP worked in terms of PCQV; the visits 
provided motivation for health care professionals delivering the ICP and a non-
judgemental atmosphere to discuss and solve problems. The Diffusion of Innovation 
Theory offered exploratory avenues for embeddedness including relative advantage, 
opinion leads and champions. However, the NPT was not relied upon as this model 
focuses on the routinisation of a social programme and since the ICP had only been 
in place for 2 years when data collection took place its explanatory potential was 
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limited. All of the refined programme theories were combined in order to create 
Figure 40; the overall programme theory of the ICP explaining its success. This 
programme theory highlights the ICP as a translational tool underpinned by three 
key mechanisms - proactivity, patient centred care and shared decision making. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40: The overall programme theory of the ICP.  
 
The ICP is a tool that helps the translation of the political mandate into practice.  
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 297 
 
“Staff on the ground… do not stand to gain from pronouncements 
within policies and government reviews about the need for good 
communication. They also need to be provided with the 
resources… to implement good communication” (Parry 2013, p. 
2).  
 
The whole ICP can be construed as a CMOC encompassing the findings of all the 
programme theories refined throughout this thesis. A good, preference based death 
with the holistic needs of a palliative care patient addressed (outcome) is achieved 
when patients are identified early by a GP practice that collectively has a good 
comprehension of curative care, palliative care and end-of-life care (context). In 
Chapter 5 (p.162), CMOC 1 highlighted the importance of having consensual 
definitions within a GP practice in order to provide high quality palliative care and 
this was reflected in the refined programme theory for the chapter. This consensual 
definition is an essential context, as it allows palliative care patients to be identified 
early in their illness and have the input required for a good death. Furthermore, this 
context allows for the use of shared decision making in open communication 
strategies between health care professionals, patients and their family members, 
which results in planning for end-of-life and appropriate documentation (resources). 
This was exemplified in Chapters 7 and 8 (p.231 and p.262, respectively). Chapter 7 
highlighted how health care professionals’ attempts to engage patients in shared 
decision making can be blocked by the patient or their family members. In this 
circumstance no planning for a preference based death can occur. In Chapter 8 the 
refined programme theory highlighted the importance of shared decision making as 
an open communication strategy involving more than two experts - the patient’s 
family or carers should also be included to make it multi-component shared decision 
making. Furthermore, Chapter 4 (p.117) highlighted that communication between 
health care professionals could also be considered as shared decision making. These 
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resources allow for enhanced operationalisation of proactivity and patient 
centeredness (reasoning). In the context described above with the overall 
mechanisms described, a preference based death is more likely to occur. Thus, the 
initial programme theories have been refined throughout the study and in 
combination have contributed to this final overall programme theory (figure 40). 
Pragmatically, the overall programme theory was developed by undertaking a 
review of all the CMOC diagrams throughout the thesis and the final five refined 
programme theories from the end of each chapter. Commonalities and differences 
were searched for in order to find the overall ICP programme theory, which 
focusses on the implementation of national policy into the locality. The 
operationalisation of shared decision making, proactivity and patient centred care 
has been identified as difficult in the literature (see Chapter 1, pg.6). The overall 
programme theory for the ICP can be seen as a translational tool to convert national 
policy into local practice. The role of proactive care, patient centred care and shared 
decision making in the overall programme theory of the ICP are discussed further 
below.  
 
Shared Decision Making  
As with most practice development efforts, interpersonal relationships between 
health care professionals and patients embody the intervention and have the ability 
to bring about change (Entwistle and Cribb 2013). Accordingly, shared decision 
making has been referred to as the crux of patient centred care (Institute of 
Medicine 2001, Godolphin 2009, Ferrer and Gill 2013) and appears throughout the 
findings of this thesis. Policies to promote shared decision making are prominent in 
the United States, Canada and the UK (Elwyn, Laitner et al. 2010), thus the 
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characteristics of shared decision making have been well documented (Charles, 
Gafni et al. 1997, Godolphin 2009). It is known that most patients and their relatives 
prefer shared decision making over strict autonomy or health care professional 
directed decision making (Shields, Morrow et al. 2004, Murray, Pollack et al. 2007, 
Coulter 2010). Furthermore, the literature has indicated that involving patients in 
care decisions makes a potentially significant and lasting difference to health care 
outcomes (Stewart 1995, Elwyn, Edwards et al. 2000), as supported by this thesis 
(Chapter 8, p.262). However, the literature also highlights that quality shared 
decision making only occurs about 10% of the time (Braddock, Edwards et al. 1999, 
Godolphin 2009) and that it is often poorly implemented (Campion, Foulkes et al. 
2002, Elwyn, Edwards et al. 2003, Towle, Godolphin et al. 2006, Young, Bell et al. 
2008). This may be because shared decision making has been conceptualised and 
driven through a top down approach from national policy or (previously) a PCT. 
The shared decision making mechanism in the overall ICP programme theory is 
different; it is a local initiative implemented and driven by local health care 
professionals who appreciate the locality and its unique features, thus it is more 
likely to be used due to local ownership. Shared decision making can face 
difficulties in practice due to personal characteristics; Chapter 7 (p.231) highlighted 
that it is not only health care professionals who can form a barrier to shared decision 
making but patients also. Patients must be able to articulate their health problems 
and feelings and communicate with the health care professional in order to 
understand and share relevant information (Towle and Godolphin 1999). The 
consultation recordings evidenced that this is not always easy for patients, even 
when given the opportunity to engage in a preference or end-of-life conversation. 
Research has previously identified that successful communication is often frustrated 
by deficiencies in the patient’s ability to comprehend information presented to them 
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due to anxiety (Ley, Bradshaw et al. 1973) or denial (Gattellari, Butow et al. 1999). 
These are two psychological dispositions that can feature heavily in palliative care 
and featured in the thesis findings. Engaging patients in shared decision making in 
this context is very difficult. It is important to understand and explore the 
underlying associates of denial and information avoidance in palliative care as a 
shared decision making model in which one party pre-dominates (in this case the 
health care professional as the patient does not wish to engage) may result in a 
suboptimal decision. This is because neither partner (the health care professional or 
the patient) has the essential and adequate expertise required for making a shared 
decision (Gattellari, Butowa et al. 2001).  
However, it may be that the GP and the patient together still do not have adequate 
expertise for making a decision. A systematic review of the effects of shared 
decision making on patient satisfaction, treatment adherence and health status by 
Joosten, DeFuentes-Merillas et al. (2008) states that “the involvement of family 
members in shared decision-making may be important” (p.220). Godolphin (2009) 
suggest that shared decision making may also involve a team of health care 
professionals working collaboratively or significant others including family 
members and carers. Despite this, the literature still has a strong focus on shared 
decision making between only two experts – the patient and the health care 
professional (Charles, Gafni et al. 1997, Charles, Gafni et al. 1999, Murray, Charles 
et al. 2006). Evidence in the literature argues that health care professionals in 
primary care see an individual in the context of their family and wider social 
network and are thus aware of the impact of ill health on one individual on the rest 
of the patient’s social network (Cartwright and Anderson 1979, Murray, Charles et 
al. 2006), yet there are still no strong claims for family members (or significant 
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others providing care) to be involved in shared decision making about treatment 
decisions. Arguably, this might have particular significance in palliative and end-of-
life care. The findings from this study indicate that the involvement of the family 
and other significant individuals, such as care home staff, in shared decision making 
in palliative care can be crucial (Chapter 8, pg.262). A multi component 
communication strategy that involves not only the health care professional and 
patient but also those in close proximity is indeed essential in achieving patient 
focused palliative care aims, such as a home death. This shared decision making 
also needs to be placed in a context where the decisions reached are documented 
and communicated more broadly to those who are not so proximate but also require 
this valuable information - the OOH service, secondary and social care teams, for 
example. A partnership between the health care professional and patient only can 
result in family members or carers not being informed or consulted about plans or 
decisions. This can be detrimental as it is often family members or paid carers who 
provide the majority of care and thus may have a significant input into whether the 
plan is feasible. This study indicates that multidimensional shared decision making 
may be more effective as a mechanism in palliative and end-of-life care than the 
traditional model. Patients do not live in isolation and thus the family members and 
carers they live with are also experts who need to be involved in the shared decision 
making process. The need for paid carers’ involvement in shared decision making 
was further exemplified in that care home deaths increased when paid carers 
implemented the end-of-life care plan (Chapter 8, pg. 262), which involves patients 
making decisions about preferences for end-of-life, similar to the locality advance 
care plan. Although a health care professional was not present when the end-of-life 
care plan was completed, it meant that an open communication strategy was created 
between the care home resident (patient), their family members (if present) and the 
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carer. Furthermore, the patient may have then had their preferences discussed with a 
health care professional, thus reinforcing the decisions that they have previously 
made using the end-of-life care plan. Therefore it can be taken that shared decision 
making may benefit from being as multipartite as possible in order to constitute a 
successful mechanism in palliative care that triggers enhanced patient centeredness 
and proactivity.  
Policy makers perceive shared decision making as necessary due to its potential to 
sustain the health care system (Coulter 2006) and promote the right of patients to be 
involved in decisions concerning their health (Straub, Nebling et al. 2008, Légaré, 
Ratté et al. 2010). However, this thesis highlights that understanding the 
conversations that take place between health care professionals as shared decision 
making can play a crucial role in care planning. Chapter 4 (Embeddedness of the 
ICP as a new initiative, p.117) highlighted the importance of having the nursing 
team on site at the GP practice as it promotes informal contact, enhances 
professional relationships and facilitates MDT meetings. This communication 
between professionals is a crucial part of the shared decision making mechanism in 
the overall programme theory, as it allows for shared decision making to occur 
between health care professionals in relation to patients. Enhanced professional 
relationships mean that health care professionals work more comfortably with one 
another. This is enhanced by informal contact (short conversations in between 
surgeries) and more formal, frequent MDT meetings. Chapter 5 (p.163) highlighted 
that shared decision making between health care professionals is facilitated by use 
of the palliative care register as a framework, providing a structured way to discuss 
palliative care in MDT meetings, facilitating proactivity and patient centeredness 
(reasoning). This also contributed towards three of the practices being identified as 
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‘high performers’ in Chapter 4 (p117). Shared decision making between health care 
professionals has also been a facilitator in generating a shared understanding of the 
definition of ‘palliative care’, ‘end-of-life care’ and ‘curative care’, which forms the 
overall programme theory context. Once health care professionals in the locality 
were sensitised to the appropriate definitions through the creation of a consensus 
(context), they could then use their strengths in practice to improve palliative care 
registrations. This is extremely important as palliative care registrations can be the 
first step in using a palliative care framework with a patient. Thus, if a consensual 
definition is not present, palliative care registrations will not take place and the ICP 
is not implemented, hence making consensual definitions the essential overarching 
context for the overall programme theory of the ICP.  
This thesis thus highlights a new understanding of shared decision making, that 
between health care professionals. A lot of the same principles apply - the meeting 
of experts; developing a partnership; determining and acting in response to the other 
person’s ideas; identifying relevant choices and evaluating research evidence for the 
most appropriate course of action; making or negotiating a decision in partnership; 
and resolving conflict, agreeing an action plan and completing arrangements for 
follow up (Godolphin 2009).  
Although the ICP had some implementation tools (CQI PCQV, Palliative Care 
Partnership) more could have been provided to ensure it was implemented fully into 
all GP practices. Practices in which the overall programme theory carried more 
explanatory potential were those that had strong leaders and peer support (champion 
or opinion leads) and were therefore influenced to see the relative advantage of the 
ICP. Thus it is reasonable to assert that shared decision making between health care 
professionals in these practices may have been more likely. Thus, the programme 
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theory mechanism was more likely to fire. Strong communication within practices 
was through a cascade of information, dissemination of this information and 
knowledge transfer. A diagram outlining the types of implementation possible is 
provided from Greenhalgh, Robert et al. (2004). Their ‘Conceptual and Theoretical 
bases for the spread of innovation in service organisations’ figure can be used to 
help understand the findings related to implementation in this thesis.  
 
Figure 41: Greenhalgh, Robert et al., (2004) - Conceptual and Theoretical 
bases for the spread of innovation in service organisations, reproduced with 
permission from Wiley (Appendix 36).   
 
The Greenhalgh, Robert et al. (2004) diagram (Figure 41) explains how innovations 
may be implemented more readily when a technical or managerial factor is present. 
Thus, it explains why in some practices the overall programme theory worked better 
(due to enhanced shared decision making facilitated by peer opinion leaders and a 
champion). The champion and opinion leaders can be considered as technical and 
managerial – they have an expert knowledge of palliative care and are respected 
within their organisations so could be considered within a managerial role which 
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pushes the palliative agenda at MDT meetings. The need for not only clinical 
expertise in palliative care but also administrative and policy leadership in the 
implementation of new initiatives has been identified in the literature (Weissman 
2003, Murray, Barclay et al. 2008, Walshe, Caress et al. 2008). However, there is 
currently no literature on the effect that champions or peer opinion leads have on 
professional or clinical outcomes in palliative care provided by primary care, only 
the description of the need for them. The findings of this study contribute to the 
Greenhalgh model (Figure 41) in that they highlight the importance of champions 
and opinion leads in palliative and end-of-life care. The practices that had a 
champion or opinion lead had implemented the ICP in a more structured way; they 
can be considered to be closer to the ‘Make it happen’ end of the scale (Figure 41) 
and may have used shared decision making within the practice more frequently (in 
part also due to more frequent MDT meetings). Alternatively, the practices that did 
not have strong peer support can be considered to be in closer proximity to the ‘Let 
it happen’ end of the scale. Thus it is vital to understand as much as possible about 
opinion leaders and champions who have the potential to persuade other health care 
professionals to change their practice and how they work to aid implementation and 
embeddedness of new initiatives (Locock, Dopson et al. 2001). The presence of 
opinion leads or champions may mean that the overall programme theory can work 
better because shared decision making between health care professionals is 
improved and the agenda is directed to include discussions about the ICP. Shared 
decision making between health care professionals warrants further investigation 
and understanding in terms of the positive results it can have in practice.  
Shared decision making was conceptualised and implemented around twenty years 
ago and constituted one of the biggest reforms of the 1990s (Balster Liontos 1994). 
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However, it has been developed and understood more in recent times, with previous 
forms of shared decision making being more health care professional focused as 
opposed to an equal input from two experts. However, this thesis highlights that 
shared decision making in palliative care could advance further (to acknowledge the 
role of significant others surrounding patients and to recognise shared decision 
making between health care professionals) and is an essential mechanism in the 
overall programme theory for the ICP.  
 
Patient centred care  
Research focusing on advance directives and living wills (that are no longer in use 
now but have the same principles as ACP) has shown that although patients have 
positive attitudes towards these tools, they seldom complete them (Joos, Reuler et 
al. 1993, Kelner and Bourgeault 1993, Singer, Choudhry et al. 1995). The findings 
from this thesis support this, in that preference discussions occur more than is 
formally documented (Chapter 6, p.199). Furthermore in the past, interventions to 
increase advance directives only had modest effects (Luptak and Boult 1994, 
Markson, Fanale et al. 1994, Hanson, Tulsky et al. 1997). Related to this, ACP 
interventions have been found to have no impact on the number of DNACPR forms 
completed; patient-health care professional agreement on treatment options; days in 
the intensive care unit; pain or use of hospital resources (The SUPPORT Principal 
Investigators 1995). Furthermore, a review of ACP and advance directives 
concluded that advance treatment preferences are difficult to form, communicate 
and implement (Miles, Koepp et al. 1996). ACP is underpinned by theoretical 
concepts from law (Justice 2007) and ethics (autonomy and beneficence) (Gillon 
1994) and has a focus on stating preferences for those who may lose capacity 
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(Department of Health 2008, Robinson, Bamford et al. 2010). Thus the difference 
between ACP and care planning more generally is that ACP will usually take place 
when there is an anticipation of deterioration in the individual’s condition in the 
future, with associated loss of capacity for decisions and/or ability to communicate 
choices to others (Department of Health 2008). However, this thesis highlights that 
ACP was carried out with people who were unlikely to lose capacity, including 
those with cancer diagnoses, despite its main aim to capitalise on autonomy whilst it 
is present. This study suggests that preference discussions and use of the locality 
advance care plans were resources of the mechanism, to implement patient centred 
care into practice, through a multi component communication strategy that should 
include the patient’s family and/or carers. A model by Martin, Thiel et al. (1999) 
can be used to explain the mechanism of the programme theory. This model found 
that from the perspective of participants, the primary goal of ACP was preparation 
for death which consisted of three facets. Firstly, ACP was a way of facing death, it 
provides a tool to confront and accept death, plan goals and outline situations that 
the patient might wish to avoid. This provides the patient with a sense of fulfilment. 
Secondly, it allowed patients to express their treatment preferences, regardless of 
whether it was predicted that they would lose capacity, and provided patients with a 
sense of control. Finally, it allowed patients to communicate with loved ones about 
their death and relieved the burden of them potentially witnessing a prolonged death 
or having to make decisions for the patient (Martin, Thiel et al. 1999). The findings 
from this thesis suggest that a multi component communication strategy using ACP 
is the overall effective mechanism of the ICP which allows health care 
professionals, patients, family members and carers to plan for a good death. 
Although the findings suggested barriers to using the locality advance care plan 
(time constraints and fear of incorrect assessments of capacity), the model has 
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explanatory potential as to why preference discussions are sometimes perceived as 
sufficient for patients, as they allow for the three stages to occur without formal 
documentation. Additionally, the overall programme theory stated above (Figure 
40), with open communication strategies using shared decision making as a crucial 
mechanism would also support this, suggesting that preference discussions may (in 
some cases) be sufficient to support open communication strategies without formal 
documentation. Whilst it is recognised that documenting preferences (using the 
locality advance care plan or advance statement) is important in order to inform 
other care providers of patients’ preferences (for example, OOHs and ambulance 
services) and may strengthen the multicomponent shared decision making 
mechanism, it could be that the formal documentation of preferences may be more 
important for those at risk of losing capacity. Thus, the model by Martin, Thiel et al. 
(1999) switches the primary focus of the goals of ACP from ethical and lawful 
(where capitalising on capacity is the priority) to psychosocial. Using this model, 
and the overall programme theory stated at the beginning of this chapter, ACP is a 
translational tool/mechanism to encourage patient centred care through multipartite 
shared decision making. Furthermore, the Martin, Thiel et al. (1999) model is more 
in tune with the psychosocial ethos of palliative care. It has explanatory potential as 
to why GPs and patients often have positive attitudes towards advance care plans 
but do not complete one, as they can achieve their psychosocial goals without 
documenting them formally (just through preference discussions). Furthermore, 
Martin, Thiel et al. (1999) suggest that the goal of ACP should be to strengthen 
relationships with loved ones, not necessarily the health care professional – thus 
substantiating the claim earlier that shared decision making should be understood as 
a multi component communication strategy, which plays a key role as a mechanism 
in the overall programme theory. Thus the findings and overall programme theory 
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from this thesis build upon the Martin, Thiel et al. (1999) model, indicating that 
ACP is a tool to provide patient and family centred palliative care. As identified in 
this study, the reasoning behind initiating preference discussions was health care 
professionals’ desire to enhance their patient centred practice rather than to prepare 
for loss of capacity (Chapter 6, p.199). It is reasonable to assert that now that the 
use of the advance statement is in place (overcoming some time constraints) and 
training on capacity assessment has been provided, the reasoning behind the use of 
the advance statement will also be to provide patient centred care. The overall 
programme theory highlights that having preference discussions and completing a 
locality advance care plan, advance statement or DNACPR (collectively known as 
using ACP) is not an end in itself. It can be considered as a mechanism that can 
facilitate palliative care discussions and meet the overall psychosocial goals that the 
patient may have (Martin, Thiel et al. 1999), which then facilitates proactive and 
patient centred care. This model supports the mechanism of the overall programme 
theory in this study suggesting that ACP is a translational shared decision making 
mechanism for patient centred and proactive care. The thesis contributes to this 
model suggesting that patients’ family members and carers should always be 
involved in shared decision making and ACP.  
 
Proactivity  
The use of multicomponent shared decision making that includes ACP (mechanism) 
is also a way for health care professionals to work proactively as it allows for them 
to put in place the relevant requirements for the patient’s preferences. There is an 
inherent need for palliative care to be proactive through early identification and 
impeccable assessment and treatment (Froggatt and Hoult 2002, Norton, Hogan et 
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al. 2007, Burns, Johnson et al. 2008). Proactivity was identified as a common theme 
throughout the findings (for example, Chapter 4, Embeddedness, CMOC3 context 
focused on the drive to provide patient centred and proactive care; Chapter 5, 
Identifying and registering palliative care patients, CMOC2, health care 
professionals found it difficult to work proactively with those who had non-cancer 
illnesses; Chapter 6, Preference discussions and the locality advance care plan, 
CMOC1, the reasoning behind initiating preference discussions was to provide 
proactive care) and can be considered as an integral part of the mechanism in the 
overall programme theory; thus it is essential in the provision of successful 
palliative and end-of-life care. The GSF is centred on proactive and patient centred 
care (Thomas 2003, The National Gold Standards Framework Centre 2009) and the 
ICP uses some of the same tools. However, the GSF relates the tools’ beneficial 
effect to enhanced coordination and communication rather than proactivity 
(Hansford and Meehan 2007). However, the reasoning that these tools trigger in 
health care professionals has previously never been explored – the overall 
programme theory highlights that they provide enhanced confidence that a patient is 
appropriate for palliative care. Thus they are tools that can enhance proactive 
working in palliative care.  
The findings also identified barriers to working proactively: complexity of non-
cancer illnesses, time constraints, the avoidance of diminishing patients’ hopes, and 
lack of confidence in assessing capacity.  All of these barriers have an impact on 
whether the overall programme theory mechanism can fire and thus could be 
considered as inhibiting contexts.  
The unpredictable trajectory of non-cancer illnesses was a barrier to working 
proactively and the risk of ‘prognostic paralysis’ (Stewart and McMurray 2002), as 
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described in the literature, was confirmed in this thesis. Prognostic paralysis is 
exhibited by health care professionals for patients with uncertain illness trajectories 
and involved prevarication when considering palliative care issues (Stewart and 
McMurray 2002). Although estimating prognosis is an inexact science, health care 
professionals must avoid not prognosticating at all (prognostic paralysis) (Murray 
2005). The unpredictable trajectory of non-cancer patients is recognised in the 
literature and in practice; however this has not been related to the difficulties of 
placing palliative care patients on a register. Related to prognostics, health care 
professionals in this study identified a marker for change from curative care to 
palliative care; a change in patients’ condition or needs. The context of the overall 
programme theory requires healthcare professionals to have consensual definitions 
of active care, palliative care and end-of-life care. This marker can only be used in 
this conducive context. A change in the patient’s condition or needs is a non-time 
dependent marker that has not previously been explored in relation to how this 
affects the use of proactive palliative care tools (such as ACP). This marker allowed 
for national policy (palliative care for all regardless of diagnosis) (Department of 
Health 2008) to be translated into practice in a context conducive to the shared 
decision making mechanism. Thus, this informal marker, based on well-developed 
knowledge of a patient and their overall trajectory, is a valuable part of the context 
which allows palliative care conversations to be initiated and timely progression 
from curative care.   
A further barrier to health care professionals working proactively and broaching 
ACP is the false hope some patients have about their prognosis. Health care 
professionals then do not want to diminish these patients’ hopes. Thus, false hope 
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place. The literature suggests that information can be given to patients without 
negativity or instilling false hope using phrases such as “there is little chance of A 
or B but a real chance of C” (Penson 2000). It is thought that this approach puts 
emphasis on what the patient can hope for (Penson 2000). However, findings from 
this study (Chapter 6, pg. 199 and Chapter 7, pg. 231) highlight that it is not easy to 
engage patients who have false hope in ACP, thus suggesting that the technique 
suggested by Penson (2000) may not be effective. Thus although false hope has 
been explored in the literature, some of the techniques to overcome it may not be 
viable in practice. Furthermore, the root of false hope about prognosis, which these 
findings highlighted as secondary care, has not been previously investigated as a 
barrier to ACP in primary care. In order for health care professionals to be able to 
broach ACP and work proactively, secondary care must also acknowledge that the 
patient is appropriate for palliative as opposed to curative care. Thus consensual 
definitions between primary and secondary care may allow for less false hope to be 
instilled in patients and facilitate a conducive context which allows for the overall 
mechanism of shared decision making to fire. This is especially important due to 
ACP being previously identified in this discussion as a psychosocial mechanism 
that has value beyond capitalising on capacity.  
Another barrier to ACP was highlighted in relation to non-cancer patients in these 
findings; health care professionals have a fear of repercussions from inaccurately 
assessing mental capacity which is required for ACP. The literature states that if a 
non-cancer illness such as dementia is empathetically discussed at an early stage it 
would allow the patient to express their wishes whilst they had capacity (Robinson, 
Hughes et al. 2005), which may increase the use of advance statements to deliver 
more proactive and patient centred care (Hughes and Robinson 2004). However, 
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although the premise of ACP is meant to be to document preferences before 
capacity is unstable, in practice this is not always viable. This thesis highlighted that 
often preference discussions occur in the amber phase, when patients are declining 
and thus can have capacity issues, especially in those with non-cancer diagnoses. 
Since the premise of ACP is that it happens prior to a time when an assessment for 
capacity is needed there has been little research into the assessment of capacity as a 
barrier. The findings from this study are grounded in practice - they suggest that 
ACP can occur late and that in this case capacity will need assessment, which health 
care professionals have low confidence in doing and a fear of repercussions from an 
inaccurate assessment. However, the overall programme theory mechanism can still 
fire in these circumstances, in the form of preference discussions. Yet, formal 
documentation of these preferences, which is a more robust method, may not be 
possible. In order for health care professionals to work proactively they must have 
an understanding that even when patients are identified in the amber phase, efforts 
to document preferences are still valuable.  
 
Study findings in relation to the current literature on ICPs 
The limited literature on palliative care ICPs suggests that they result in positive 
outcomes for patients (increased home deaths, improved quality of life and mood, 
optimal symptom control) (Bakitas, Lyons et al. 2009, Bower, Roderick et al. 2010, 
Temel, Greer et al. 2010) and health care professionals (increased job satisfaction, 
ability to provide palliative care, communication and coordination) (Hall, Goddard 
et al. 2011, Reymond, Israel et al. 2011). However, they give limited understanding 
of the underlying reasons behind the success, no explanation of mechanism or 
context. The findings from this study, although drawn from one practice example, 
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highlight underlying mechanisms with more translational potential (implementation, 
shared decision making, patient centred care, and proactivity). They show the 
importance of identifying and understanding underlying mechanisms (resources and 
reasoning), alongside conducive contexts. Inhibitive contexts and mechanisms are 
also important to identify, as they highlight what could be changed to achieve 
positive outcomes in a specific situation. Collectively, the CMOCs identified in this 
thesis uncover general themes and needs (described above) to provide high quality 
palliative and end-of-life care in primary care. This highlights the potential of realist 
evaluation to contribute to the knowledge translation agenda of research findings 
into practice.  
 
Implications for practice  
The study findings highlight that new social programmes require active 
implementation strategies that encourage the innovation to become embedded into 
practice. They also indicate the importance of context and how this can affect the 
implementation and effectiveness of a social programme.  
The findings highlighted that shared decision making in palliative care should be a 
lot more inclusive in practice, involving more significant individuals than just the 
patient and the health care professional. This may allow for more realistic plans and 
less undesired outcomes (for example, emergency admissions). Building upon this, 
the role of ACP should be reconsidered as a psychosocial tool in practice to aid in 
shared decision making, rather than a tool with the main goal of capitalising on 
capacity in order to provide patient centred care to those who lose autonomy for 
health care decisions. This reconsideration of ACP may make it easier for health 
care professionals (and potentially care home staff) to engage with and aid 
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discussions surrounding death and dying which have previously been identified as 
difficult. Thus, as the End of Life Care Strategy (Department of Health 2008) states, 
palliative care is appropriate for all, as is ACP; it is not only for those who are likely 
to lose capacity. Furthermore there is scope for shared decision making to play a 
more explicit role between health care professionals forming the best care possible 
for a patient. It could be said that this already occurs in MDT meetings but 
conceptualising it as shared decision making in practice may facilitate 
communications and aid health care professionals in their interactions. Barriers to 
proactive care in palliative care still remain and these are areas that health care 
professionals need to focus on in order to provide higher quality palliative care for 
all. If these barriers are not addressed, issues related to ethical justice will continue 
to occur in terms of provision of palliative care to those with non-cancer diagnoses, 
especially those who lose capacity (Koffman 2012). Furthermore, in order to 
provide proactive care and avoid solely reactive care, health care professionals must 
be given time efficient tools. These implications are relevant to many individuals 
involved with the ICP - health care professionals, care home staff, care home 
managers, patients, family members, carers, OOH staff, and commissioners due to 
the broad scope of individuals involved with the ICP.  
 
Challenges  
Greenhalgh, Robert et al. (2004) highlight that drawing realist conclusions about the 
generative causality of particular programme theories can only be achieved though 
much negotiation and contestation. Developing and refining CMOCs in this study 
has been a time consuming and demanding process, and although it is presented in a 
logical and neat format in the thesis, the process was somewhat disordered. This 
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was due to the methodology (realist evaluation) and several forms of data collection 
and analysis that were used collectively and concurrently to form many CMOCs. 
However, the continuous refinement of CMOCs has resulted in findings that reflect 
the complexities of health care, primary care and palliative and end-of-life care. For 
example, the embeddedness CMOC4 (I) and CMOC4 (II) were developed over a 
long period of time throughout which they were constantly refined. Initially, I 
considered the MIQUEST and Death Audit data and what the numbers meant; use 
of more interventions and more ‘home’ deaths were undoubtedly positive outcomes. 
Following this my attendance at PCQV, the Palliative Care Partnership and 
integration into the field identified a difference between practices. There were those 
that were very involved, attended Palliative Care Partnership meetings, engaged in 
PCQV discussions enthusiastically, discussed issues as a team, and those that did 
not. This prompted me to wonder whether those GP practices that behaved in this 
positive way used more interventions and/or had more ‘home’ deaths. Looking at 
the MIQUEST and death audit data some practices did have higher numbers than 
others, but this was a very subjective observation. The cluster analysis transformed 
my observations from the field and of the data into a robust outcome – there were 
three high performing practices out of the fourteen under study. From here I needed 
to establish the common essential context and mechanism that led to increased 
embeddedness in these three practices. The shared nursing team on site was 
identified first. This was initially thought of as a mechanism. However, further 
consideration refined the shared nursing team on site into a context that facilitated 
MDT meetings. The mechanism was then identified using my own knowledge of 
the locality, conversations with the founder and confirmed in FG3. I knew of some 
key individuals who attended the Palliative Care Partnership regularly, took interest 
in the study and could be considered as a champion or an opinion lead. 
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Conversations with the founder and within FG3 confirmed (without prompt) that 
these people were key figures in pushing the palliative agenda in their practice. 
Hence the mechanism was formed, having a champion or opinion lead (resource) 
who pushes the palliative agenda within the team and highlights its relative 
advantage (reasoning). Although this seems fairly straightforward to explain it 
required a lot of thinking, sketching (using the CMOC diagrams) and collaborative 
working with the founder, the health care professionals in FG3 and my supervisors 
who offered methodological support. It also required adjudication between 
competing theories, i.e. was it the champions and opinion leads in the practices or 
was it that these teams generally had enhanced communication skills? This could 
have been the case but FG3 participants highlighted the champion and opinion leads 
in the three high performing practices as pivotal.  
Facilitating the refinement of CMOC was the increased understanding of contexts, 
mechanisms and outcomes as the project progressed. At first I found it difficult to 
decipher between contexts and mechanisms especially, a difficulty reported by other 
realists (Jagosh, Pluye et al. 2013). Deciding what constitutes a context and a 
mechanism requires intense thought and debate - the ICP offers a great variety of 
resources, used in an array of contexts impacting at a range of levels. However, I 
found as my time working with realist evaluation progressed, so did my knowledge 
of the ICP and I feel this facilitated my ability to formulate CMOCs with increasing 
explanatory potential. I also found that drawing several versions of a CMOC (using 
the CMOC figure framework used throughout this thesis) often helped me to 
decipher between context and mechanism and the exact formulation of each. 
Finally, understanding mechanisms in terms of resource and reasoning was 
extremely helpful, a technique suggested by Dr. Gill Westhorp on the Realist And 
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Meta-narrative Evidence Syntheses: Evolving Standards (RAMESES) Discussion 
list (RAMESES 2014). Using resources and reasoning allowed me to understand 
fully what tool was being used (resource), and whose decision making process this 
was changing (reasoning). This method was also helpful when discussing 
mechanisms with health care professionals in FG3. Identifying these two factors 
often made the mechanism more obvious, which in turn highlighted the context. 
Furthermore, throughout my time using realist evaluation I developed an 
understanding that the concept of mechanisms ‘firing’ in context did not always 
apply. This is because, at the individual level especially, reasoning is often on a 
continuum. People have enhanced patient centred practice or increase their 
confidence due to a resource. The resource in itself sometimes does not produce the 
reasoning but can instead enhance it, thus mechanisms often have increasing 
degrees of activation. However, at the system or practice level, it is sometimes more 
definitive; for example if the ICP is not present, it is not embedded into practice – 
the mechanism cannot fire. I feel that use of resources and reasoning highlights and 
explains the complexity of CMOCs; human volition is not often comprised of 
complete oppositions, and often there are spectrums. For example, different GPs 
will be situated at different points on the continuum of patient centred practice. 
Mechanisms can have degrees of activation as opposed to being categorical (‘firing’ 
or not ‘firing’).  
Not only was the understanding and refinement of CMOCs difficult but also the 
change from a positivist standpoint to realist logic of analysis. Sporadically I would 
feel a positivist mind frame creep back in and would have to pull myself back in to 
the realist evaluation world. Facilitating working within a realist logic and 
confirmation of its value was made apparent when I read non-realist literature. Time 
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and again, I was left wondering what made an intervention work, even when it was 
reported as successful.  
Undoubtedly realist evaluation is time consuming and can be frustrating to use. Yet 
these negatives are overcome by the satisfaction derived from creating refined and 
robust programme theories that provide credible explanations for observed 
outcomes. Those outcomes can collectively then inform practice more generally, for 
example in terms of shared decision making. Now I have become experienced with 
realist evaluation I feel that it offers a wealth of knowledge to the research field 
alongside a refreshing change from successive causality. It moves on from using a 
pure science technique with complex humans. Rather than trying to fit square boxes 
in to round holes it embraces human volition and understands that it is an inherent 
feature in the process of complex social programmes.  
 
Limitations  
An issue that is beyond the control of the study is the variability in recording of GP 
practice data (MIQUEST and Death Audit). Health care professionals could be 
using ICP tools such as palliative care registrations, preference discussions and 
advance care planning and not recording this use. However, the qualitative results 
seem to reflect health care professional and patient experiences. For example, most 
palliative care patients and bereaved relatives recalled preference discussions but 
few had completed locality advance care plans. Also, health care professionals 
described their dislike of the locality advance care plan format and the time 
consuming paper work it generated. In relation to palliative care registrations, the 
quantitative data identified less non-cancer registrations than cancer registrations, 
despite increases in non-cancer death registrations from 2011 to 2012. Not only 
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does the literature describe the difficulties in the non-cancer trajectory (Murray, 
Boyd et al. 2005) but health care professionals in focus groups commented on the 
difficulty they have when registering non-cancer patients on the palliative care 
register. Finally, the embeddedness chapter identified that there is an underlying 
context and mechanism to explain why some practices have embedded the ICP 
better than others, explaining that outcomes could not just be linked to a recording 
artefact. These examples and supporting evidence indicate that the recordings that 
health care professionals do on the data templates are representative of what 
actually happens in practice, although potential variability needs to be 
acknowledged.  
Another limitation is the self-selected or health care professional selected 
recruitment. Focus groups included motivated health care professionals prepared to 
give up their time to participate in the study. However, these individuals were very 
honest, for example, stating their dislike and neglect of the locality advance care 
plan. Patients and bereaved relatives participating in interviews, consultation 
recordings and the QDDM were selected by health care professionals. However, 
there was no other means of access to these potentially vulnerable people. All 
participants were very candid in their discussions and often would comment on 
negative issues that they had encountered, thus providing a balanced view of the 
service.  
A potential criticism of the study could be that the focus of the research has been on 
health care professionals’ decisions - decisions to use tools, register patients, and 
facilitate home deaths. However, focusing solely on patient experiences or 
outcomes would have happened if more traditional quantitative or qualitative 
research paradigms were used, assuming the causal relationship between 
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intervention and outcomes. The focus on health care professionals in this thesis is 
due to the use of realist logic; the search for underpinning mechanisms. Health care 
professionals embody these mechanisms and thus they were the primary focus of 
the study, as the aim was to discover if the ICP worked, how and in what 
circumstances. This is why some lines of enquiry were not pursed, such as bereaved 
relatives having feelings of allegiance to their loved ones wishes and not accepting 
end-of-life care in a hospice for example. The purpose of using interview data was 
to highlight their experience of the ICP and provide practical information to health 
care professionals concerning how it works and how it could potentially be used 
more efficiently. For example, quotes from bereaved relatives about guilt and 
allegiance to their loved ones highlighted that a bed in the palliative care unit had 
been offered when end-of-life was approaching. By this time, participants felt that 
they had lived through the worst of their loved one’s worsening health and had 
refused to use the service. Interviews with palliative care patients and bereaved 
relatives thus helped to understand the implementation of the pathway (for example, 
if the palliative care unit is offered late in the patient’s illness it is not accepted due 
to feelings of allegiance and guilt). It could be that people’s relationships and 
closeness will always form a context for services implementation, and it could be 
that allegiance and guilt are particularly salient in palliative and end-of-life care. 
However, exploring further the explanatory potential of such feelings in interviews 
would have caused additional emotional strain and been unethical. The interview of 
people in highly emotionally charged situations, such as a bereavement, is an 
acknowledged challenge in qualitative research and can only be conducted under 
very strict ethical guidance. Thus, this study highlights that guilt and allegiances 
may be overarching inhibitive contexts that health care professionals need to 
operate within in order to trigger shared decision making, and that early 
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implementation may minimise the impact of these feelings on poor uptake, but this 
could not ethically be tested with greater certainty.  
The ICP is adaptive, which is to its credit. The recognition of the locality advance 
care plan’s flaws from various sources resulted in the change to the advance 
statement to facilitate the documentation of patient preferences.  This makes this 
section of the ICP evaluation less relevant to the locality but still generates 
important findings in terms of underlying principles. The practicality of tool use in a 
time constrained primary health care environment needs consideration, as does the 
assessment of mental capacity in ACP.   
The data set in this study was complex and management of it was difficult. There 
would have been benefits in collecting and analysing data iteratively (for example, 
complete interview 1 and follow interview 1 issues up in interview 2 to confirm or 
dispute interview 1 claims). However, NHS ethics procedures meant that a semi-
structured interview schedule was required that could not be deviated from, apart 
from when this was initiated by participants. However, I always had previous 
interviews in mind throughout data collection and informal refinement occurred, so 
that for example, if a participant of their own accord discussed an issue that I had 
understood from a previous interview to have explanatory potential, I would follow 
that line of enquiry. The focus groups on the other hand were used explicitly to 
refine programme theories and all focus groups were used to make sense of data 
form different sources. For example, the focus groups provided explanation as to 
why some patients with a predictable illness trajectory may not have had ACP; false 
hope had prevented this. Additionally the breadth of data collection meant that all 
data triangulated to refine understanding. For example, early analysis of GP practice 
data highlighted that preference discussions were significantly increasing, but the 
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use of locality advance care plans was not. All patients and bereaved relatives 
interviewed reported not having locality advance care plans but all had engaged in 
preference discussions. In order to explain this, the focus groups highlighted that 
health care professionals did not like to use the locality advance care plan due to 
capacity assessment and time constraints. Consultation recordings also highlighted 
that sometimes professionals found it difficult to engage some patients in ACP 
altogether. The explanation (theory) that emerged from all these data strands was 
that often once a patient is ready to engage it is too late to use the locality advance 
care plan (due to time constraints and capacity issues) and this was further 
confirmed in the focus group. Thus programme theories were refined and tested 
through different data strands. There was also strength in exploring the explanatory 
potential of one idea (programme theory) in one data strand and then seeking 
explanation of this in other data strands, with the ICP founder or in PCQV. This 
process, at different stages of maturation, was then presented to health care 
professionals as collective sense makers during the focus groups to further refine 
theory development. This method of data collection and analysis did mean that at 
times decisions had to be made between different segments of evidence. Data was 
always chosen that had the strongest explanatory potential and was corroborated by 
alternative data sources, the ICPs founder, or the PCQVs.   
Finally, the interviews and focus groups provided data on interesting aspects of care 
which have not been presented here. Although interesting, this data did not offer 
sufficient explanatory potential to be presented in this thesis. For example, one 
patient had concerns regarding social care and her dislike of the lack of continuity in 
the carers that came to her house every day. Another example was the fear of end-
of-life paraphernalia including the syringe driver, which was referred to by a 
 324 
 
bereaved relative and one of the nurses in a focus group. This data did not possess 
enough explanatory potential because it could not be related to a component part of 
the CMOC. For example, the fear of end-of-life paraphernalia was never linked to 
emergency admissions or increased likelihood to call an ambulance. Furthermore, 
the social taboo of death and dying is an important overarching context, which 
participants commented on. They felt that this taboo needed to be ‘broken down’ for 
progression in palliative care to occur. Although the social taboo of death and dying 
did not bear direct influence on the mechanisms detailed in this thesis, it is 
nevertheless an important context to all social programmes implemented in 
palliative care, including the ICP. Furthermore, some CMOC include contexts that 
are inherently underpinned by this taboo (for example, death being hidden in 
CMOC1, Chapter 8, p.263; litigious society in CMOC3, Chapter 8, p.285).  
 
Future research 
Future research should focus on the role of active implementation strategies for new 
initiatives. This thesis supports Greenhalgh, Robert et al. (2004) in that active 
implementation may impact on the success of an intervention. Related to this, 
understanding how to identify and use champions’ energies in providing active 
implementation of interventions is pivotal, as the literature is currently sparse in this 
area (Greenhalgh, Robert et al. 2004). Further research about champions and peer 
opinions would generate a deeper understanding of how champions work and if they 
can be developed.  
ACP could be reconceptualised and therefore require further research. The 
traditional focus of ACP on capacity has meant that other important aspects of it 
have been ignored. This thesis makes a case for ACP to be a tool to implement 
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shared decision making, allowing the patient to face death and strengthen the 
relationships with their family. Furthermore, shared decision making needs to be 
investigated as a multi component communication strategy, as opposed to just the 
meeting of two experts. The role of shared decision making between health care 
professionals should be explored as a facilitator to MDT working. Following from 
this, the role of ACP should be researched. It could have a much broader role for all 
patients regardless of whether their capacity is likely to diminish. It could help 
patients face death, plan for it, discuss it with their family and generally take control 
of their care. This therefore supports the need to investigate shared decision making 
as a multi component communication strategy that also includes the patient’s 
family. Therefore the role of ACP in practice and its effect on patients requires 
further investigation.  
Barriers to proactive care were identified throughout this thesis; all of which could 
impact on participation and shared decision making (Burt, Rick et al. 2013). This 
could have a negative effect on ACP. The barriers to proactive care (and thus the 
barriers to ACP) need to be explored and ways to overcome them need to be 
identified. The insights developed in this thesis could be used to develop more 
understanding of how, why and in what circumstances ACP and care planning in 
general lead to successful outcomes.  
 
Conclusion 
This thesis occupies a currently important political space. The LCP has been subject 
to great media attention and review (BBC News 2013, Neuberger, Aaronovitch et 
al. 2013) and recent news articles have suggested that palliative care registers and 
advance care planning may be subject to the same scrutiny (Daily Mail 2013). A 
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recent article in The Daily Mail (2013) suggests that palliative care registers and 
advance care planning are carried out to reduce health costs rather than plan for a 
good death. Unarguably, the NHS does need to save money, and deaths at home 
may be a piece in this economic jigsaw, especially as they are the preference of 
many patients. In the article, Dr. Anthony Cole, acting chairman of the Medical 
Ethics Alliance, acknowledged the need to save money, but also highlighted a 
danger of uninformed patient choice leading to lack of wanted medical support in 
their final days of life. Although uninformed patients can lead to uninformed 
decisions about end-of-life care, the patients interviewed in this study were very 
aware of their preferences and decisions. They appreciated the conversations they 
had had about end-of-life care with health care professionals and valued their 
clinical advice. Unfortunately, referring to palliative care registers as ‘death lists’ 
and advance care planning as ‘end-of-life advanced care plans to reduce cost’ will 
only result in a poor public understanding of these tools, when this research 
demonstrates that they are actually helping people to die in their preferred place. 
Furthermore, some participants were acutely aware of this wider political and media 
context and expressed the need to open up a societal dialogue about death and 
dying. 
This research has highlighted important findings for the locality, some of which 
have already been fed back and acted upon, and for palliative care in primary care 
and the community in general. The findings surrounding implementation, shared 
decision making, patient centred care, and proactivity are informative, transferable 
and identify important issues that need to be addressed within practice and the 
academic literature.  
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The goal of palliative and end-of-life care should be to have good quality of life 
before a good death. When a person has a terminal disease and time to digest their 
prognosis, a good death should be planned, personalised, symptom controlled, 
peaceful and holistically assessed with needs met. This ICP attempts to do this in an 
organised process, with positive outcomes increasing since its implementation. It 
operationalises attempts to break down barriers to improve palliative and end-of-life 
care for care providers, patients, and their relatives.  
 
“How people die remains in the memory of those who live on” 
- Dame Cicely Saunders, Founder of the Modern Hospice Movement (1918-
2005) 
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Appendices 
Appendix 1 – Guidance on use of the Liverpool Care Pathway for 
the Dying Patient 
Dear Colleague, 
Liverpool Care Pathway (LCP): 
End of Life Network Regional Response 
You will be aware that the Neuberger Review has recommended the 
‘phasing out’ of the Liverpool Care Pathway (LCP) and its replacement by 
End of Life Care Plans that will be condition-specific. The Secretary of 
State has accepted this
 recommendation. This letter is intended to update 
practitioners on the current situation and offers guidance on the 
management of patients through this transition. 
While accepting the need for change we must all be careful that patients 
continue to benefit from high standards of care at the end of their lives.  
The national and regional guidance is clear that the "proper" use of the 
Liverpool Care pathway (or its equivalent) should continue until new care 
planning tools are introduced.  As an example, St Oswald's hospice is 
actively involved in the evaluation of one such care planning tool, though 
will continue to discharge patients on the LCP where this is appropriate. 
The enclosed guidance is intended to provide practical support in the use 
of the LCP at the present time.  It is understandable that patients and their 
relatives will have questions and concerns about the pathway and advice is 
offered in this regard. 
From a clinical point of view, this does not represent any change from what 
has been seen as good practice for a number of years. 
We are aware that use of the LCP - or its equivalent - now varies 
significantly across the region and so it is particularly important that good 
communication is part of any transfer or handover of care. 
Thank you for all your continued hard work in this 
difficult area. Yours sincerely 
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Dr E Kendrick Dr M Prentice Dr Mike Guy 
Chair End of Life Network Medical Director Medical Director 
Northern Clinical Networks CNTW Area Team DDT Area Team 
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End of Life Group Guidance 
 
The first priority is to maintain the excellent standards of care that tools such as 
the Liverpool Care Pathway, have enabled. The correct use of the Liverpool 
Care Pathway - or its equivalent - continues to be endorsed both nationally 
and regionally until such time as new care planning tolls are available. 
1) One of the criticisms of care at the end of life included in the Neuberger Report 
is the failure of staff adequately to inform patients and families that the patient is 
believed to be dying; families in distress may not understand nuances so it is 
important to communicate the message that death is likely over the next few 
hours/days explicitly, and to record this conversation in the case notes. We see 
lots of examples of good practice in this regard during our audits of end of life 
care, so do keep up this difficult but good work 
We suggest therefore that whether you are using the LCP or not: 
When the realistic possibility of the patient’s death within hours or days is 
realised by the caring team, a senior clinician should make this possibility known 
to the patient (if appropriate) and to the patient’s family/carers (unless permission 
is explicitly declined by the patient). The conversation must be recorded in the 
patient’s notes, and both the conversation and the record should include: 
•    Time, date and names of participants in discussion 
• That the patient is sick enough to die/dying appears inevitable (as 
appropriate) and how death might be expected to occur 
•    That patient (if applicable) and family/carers had an opportunity to ask 
questions 
• That care will be based on best comfort care as described by the LCP 
(possibly alongside resuscitative measures if there is a possibility of 
reversing the deterioration to 
death) 
• If family do not accept that the patient is dying, the clinician has explained 
the basis for that clinical judgement. This may include acknowledging that 
diagnosis of dying is an art rather than a science, thus sharing any 
uncertainty. 
2) The symptom management guidelines contained in the LCP that include 
prescribing of safe starting doses and careful titration of drugs to achieve best 
possible symptom relief with least possible side effects, should be followed 
regardless of whether the paper LCP document is in use.  Advice on the use of 
palliative care drugs can be found in the North of England Cancer Network 
Palliative and End of Life Care guidelines at http://www.gp- 
palliativecare.co.uk/files/north_england_cancer_network_palliative_care_guidelin
es_feb_09. pdf 
The effects of drugs being used to provide symptom relief, whether 
intermittently or by infusion, should be explained to patient (where 
appropriate) and family/carers. Families should be warned if sedation is a 
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possible consequence of comfort drugs used for eg breathlessness or 
anxiety. 
When symptoms do not settle quickly, or a prescriber would like advice for any 
reason, the palliative care team should be consulted as usual. 
3)  Any decisions made in advance e.g. ADRT, (Advance Decision to Refuse 
Treatment), DNACPR (Do Not Attempt Cardio Pulmonary Resuscitation), LPA 
(Lasting Power of Attorney), EHCP (emergency health care plan) must be 
identified, actioned, documented and shared with all members of the patients team 
in line with local policy and the Mental Capacity Act 2005. 
4)  A decision regarding current and any future investigations, treatments and 
medications has been made in partnership with the patient. Where this is not 
possible the ‘Best interests’ process should be followed as set out in Deciding 
Right which can be found at: http://www.cnne.org.uk/end-of-life-care---the-clinical-
network/Decidingright/plusresources 
5)  Any as required medication or equipment needed has been ordered and is in 
place. 
6)  For all dying patients there should be regular assessment and management 
of symptom control and comfort measures. 
7) Patients and their families should be communicated with regularly to ensure 
their needs are being addressed and that they know what is happening. 
8) All dying patients need a regular multidisciplinary review, including the senior 
clinician to re-assess the situation and make sure all their needs are being met. 
The decision to remain on the LCP or other documentation using the LCP 
principles must be reviewed and documented regularly. 
9) Offering oral fluids where the patient can swallow and good mouth care is 
an important part of managing comfort. 
10) All dying patients and their families must have the provision of psychological, 
social and spiritual support. 
11)  Following death the relative/carer must be supported in their 
understanding of what to do next and the patient’s death should be 
communicated to all appropriate services. 
12) For those patients, families or organisations that choose not to use 
the LCP, medical and nursing care plans should be documented on the 
normal paper/ electronic systems.  Staff need to ensure that exactly the 
same assessments, communication and regular reviews take place that would 
have been done on the LCP, to make sure that dying patients receive optimal 
care. 
Please note that NEAS will no longer accept someone being on the LCP as 
a surrogate DNACPR form and so all patients discharged on the LCP where 
resuscitation is not appropriate will need to have a regional DNACPR form 
completed. 
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Appendix 2 – Dalkin, Jones et al. (2012) 
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Appendix 3 
Invitation letter 9 for practices to provide their MIQUEST and death audit data  
Version 2 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Dear Practice Manager,  
Your practice is invited to take part in this research study. 
We would like you to provide your GP practice’s MIQUEST and death audit data. We 
are undertaking research into the new Palliative Care Integrated Care Pathway in [the 
locality]. It is a study funded by NHS North of Tyne Primary Care Trust and 
Northumbria University. 
This study is part of Sonia Dalkin’s PhD at Northumbria University which investigates 
the new palliative care system in [the locality]. It hopes to find out new and interesting 
things about the system, including how it works, and who it works for (for example, 
patients, family, carers, GPs, nurses). It will also help the system improve itself, 
therefore improving palliative care as the study is taking place. This research is 
important as its overall aim is to inform and improve palliative care practice on both a 
local and national level so that individuals have open and easy access to the supportive 
care they need, which will ultimately lead to a peaceful death. 
I would like to invite you to take the time to read the Information Sheet included with 
this letter. This will give you more information about the study and what you would do 
if you participated. If you would like to participate once reading the information sheet, 
please complete the consent form and email it back to 
sonia.dalkin@northumbria.ac.uk. As one of the researchers in this study I can be 
contacted if you would like to find out more information or ask questions. My contact 
details are at the end of this letter and in the information sheet. 
If you have decided you do not want to take part in the study, you do not need to do 
anything. 
Thank you for taking the time to read this letter. 
Dr. Bill Cunningham, GP and Chair of the Palliative Care Partnership  
Contact Details [Address, home and mobile phone number, email address] 
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Appendix 4 
Information Sheet 9 - Information sheet for practices to request MIQUEST and death 
audit data 
Version 2 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Information Sheet 
Dear Practice Manager,  
We would like to invite you to take part in this research project. Before you make a 
decision about taking part, please take the time to read the following information 
carefully and carefully and discuss this request and the study with GP colleagues in 
your practice.  
By taking part, you will be contributing to a local study that aims to make a real 
difference to life limiting illness and palliative care. This will be done through 
identification of pathway mechanisms that contribute to a successful outcome in an 
Integrated Care Pathway (ICP). This could then improve the quality of palliative care 
delivered in [the locality], and the rest of the county.  
What is the purpose of the study? 
[The locality] has created a new ICP which provides individuals who have life limiting 
illness with access to supportive palliative care including the best symptom control, 
shared decision making about treatment and generally increased choice about care, 
leading to a peaceful death with an individual’s needs fully met. This research aims to 
find out how the ICP works. For example, does it encourage better communication 
between patients and GPs, or better planning and co-ordination? We would also like to 
hear from patients, family members, carers and health professionals, in a variety of 
ways, about their experience of the ICP.  
Why has the practice been invited to take part in the study? 
You have been invited to take part as you have been identified as a GP practice in [the 
locality] using the life limiting illness and palliative care ICP, and providing 
MIQUEST and death audit data.  
Does the practice have to take part? 
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No, taking part in this study is voluntary and you do not have to take part. We would 
like the practice manager to give consent on behalf of the practice. If you decide you 
would like to take part, we will ask you to reply to this email in order to confirm your 
consent to us utilising the MIQUEST and death audit data from your practice.  
If you take part and decide that you have changed your mind and no longer wish to be 
involved you can stop taking part and withdraw at any time. You do not need to 
provide a reason. There will be no detrimental effects on the practice and your patients 
will still have access to services on the palliative are pathway. 
What will happen to the data if I consent to the study using it? 
If the practice consents to the use of its MIQUEST and death audit data, simple 
statistics will be performed on the data sets. This will allow the generation of 
knowledge such as the amount of individuals dying in their preferred place, and 
whether there is a significant difference between the amount of individuals on the 
palliative care register, in comparison to last year. If you consent to the practice 
MIQUEST and death audit data being used we would like the practice manager to 
reply to this email (email address: sonia.dalkin@northumbia.ac.uk) to confirm this and 
attach the completed consent form (attached to this email).  
Dr. Bill Cunningham is a member of the research steering group and will therefore 
ensure that all data is used appropriately and the individuals performing analysis on 
the data will have the ability to use it effectively.  
What will be the cost of taking part? 
There will be no financial cost to taking part. Additionally, this will not take any of 
your time; you will just provide the data.  
How might taking part affect the practice? 
The practice will not be required to spend any time with the researchers. They will 
simply be asked to give consent for their data to be used, similar to its current use by 
NHS North of Tyne PCT. 
Will taking part in the project be private and confidential? 
Yes. We will follow ethical and legal practice and all information the practice provides 
will be handled in confidence. This research is also for an educational project, as the 
chief investigator (Sonia Dalkin) is doing a PhD. All information the practice provides 
will be completely confidential in regards to this educational project and any future 
publications. Anything that you provide will not be able to be traced back to the 
practice in published reports. The researchers will not be able to access any 
information about the patients as the data will be anonymised before the researchers 
are given access. All information will be stored on a secure, password protected 
computer within Northumbria University. It will only be able to be accessed by Sonia 
Dalkin, (the chief investigator), Dr. Anna Jones (academic supervisor), Dr. Monique 
Lhussier (academic supervisor) and Dr. Bill Cunningham (academic supervisor and 
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GP). Any written and recorded information will be destroyed six years after the study 
ends. Practices will be provided with feedback from the analysis that is completed in 
order to help them improve their current performance.  
What will happen if the practice does not want to carry on with the research? 
The practice can withdraw from the research at any time they can and they do not need 
to provide a reason. There will be no detrimental effects on the practice and your 
patients will still have access to services on the palliative are pathway.  
Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given favourable opinion by Newcastle and North Tyneside 1  Research Ethics 
Committee. 
What if there is a problem? 
If you have any query, please feel free to contact the researcher (contact details 
provided below). We hope this is not the case, but would you wish to complain 
formally about the study, you can do this through the NHS complaints procedure or by 
contacting the Principal Supervisor, Dr. Anna Jones at Northumbria University. Both 
of their contact details are below: 
Dr. Anna Jones [contact information] 
NHS North of Tyne PCT complaints [contact information] 
 
Contact details 
Please feel free to contact the chief investigator if you have any further questions.  
Sonia Dalkin (Chief Investigator) [contact details] 
What happens now? 
Many thanks for taking time to read about this study. If you would like to take part 
please reply to this email within 2 weeks of receiving it. Consent should be given by 
the practice manager on behalf of the practice. You will then receive a confirmation 
email.  
Many Thanks,  
Dr. Bill Cunningham [contact details]  
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Appendix 5 
Consent form for Practices to agree to the use of MIQUEST and death audit data  
Version 1 – 7.10.11 
 
 
Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
 [A Research Study] 
CONSENT FORM 
 
Title of Project: Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
Name of Researcher: Sonia Dalkin 
 
Please tick the appropriate box   
              Yes   No 
1. I confirm that I have read and understand the information sheet 
dated 24/11/11 (version 2) for the above study. I have had the 
opportunity to consider the information, ask questions and have had 
these answered to my satisfaction.  
 Yes  No  
 
2. I understand that the participation is voluntary and that the 
practice is free to withdraw at any time without giving any reason, 
without legal rights being affected.  
 
 Yes  No 
3. I understand that relevant sections of the data collected  
during the study may be looked at by the chief investigator 
(Sonia Dalkin) and her supervisory team (Dr. Anna Jones, Dr.  
Monique Lhussier, Dr. Bill Cunningham). I give permission for 
these individuals to have access to the data I provide.  
   
 Yes    No 
4. I agree to take part in the above study.  
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Name of Participant _________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
 
 
Name of Researcher ________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
 
If you would like more details about the project, please do not hesitate to contact the 
researcher, Sonia Dalkin, by email: sonia.dalkin@northumbria.ac.uk or by telephone: 
07792768226.  
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Appendix 6 
Invitation letter for bereaved relatives for Quality of Death and Dying Measure  
Version 2 
 
 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
 
Dear Sir/Madam,  
Firstly may we say that we are extremely sorry for the recent loss of your loved one. 
We are contacting you as we are doing research into the new Palliative Care Integrated 
Care Pathway in [the locality] that your loved one had experience of. It is a study 
funded by NHS North of Tyne Primary Care Trust and Northumbria University and 
we think you could help contribute to the research.  
What will this study do? 
This study is part of Sonia Dalkin’s PhD at Northumbria University which investigates 
the new palliative care system in [the locality]. It hopes to find out new and interesting 
things about the system, including how it works, and who it works for (for example, 
patients, family, carers, GPs, nurses). It will also help the system improve itself, 
therefore improving palliative care as the study is taking place. This research is 
important as its overall aim is to inform and improve palliative care practice on both a 
local and national level so that individuals have open and easy access to the supportive 
care they need, which will ultimately lead to a peaceful death. 
How could you take part? 
If you are interested in taking part, we will ask you to fill in a short questionnaire 
which will ask questions about your relative’s death. This is so that we can find out 
how well the system is working and if it is helping individuals die peacefully. 
What to do if you are interested in taking part and want more information?  
If you would like to find out more information about the study, please take the time to 
read the Information Sheet included with this letter. This will give you more 
information about the study and what you would do if you participated. We would like 
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you to share the information sheet with your friends and family if you wish to, as they 
could possibly be involved also. You may also contact the researcher if you would like 
to find out more information or ask questions. The contact details of Sonia Dalkin are 
at the end of this letter and in the information sheet. 
If you have decided you do not want to take part in the study, you do not need to do 
anything. 
Thank you for taking the time to read this letter. 
 
Contact Details 
 
Sonia Dalkin, Principal Researcher. 
Room H007 
Coach Lane Campus East 
Northumbria University 
Newcastle upon Tyne 
NE7 7XA 
sonia.dalkin@northumbria.ac.uk  
07792768226 
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Appendix 7  
Information Sheet for bereaved relatives approached to complete the Quality of Death 
and Dying Measure  
Version 2  
 
 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Information Sheet 
Part 1 
We would like to invite you to take part in this research project. Before you make a 
decision about taking part we want to make sure you understand why the research is 
being done and what it would involve for you. Please take the time to read the 
following information carefully and talk to others about the study if you wish. Part 1 
will provide a brief summary of the research and part 2 will give more detailed 
information about the study.  
Below is a list of terms used in this document that you may not be familiar with:  Service user: This is any person who comes into contact with the National 
Health Service (NHS). This includes patients, carers, family members and 
advocates.  Integrated Care Pathway (ICP): An integrated care pathway involves many 
teams working together, for example the GP surgery, the community nurses, 
the North east ambulance service and Tynedale hospice at home all working 
together to provide the best possible care for patients.  
If you have any difficulties, or need help to understand the information please contact 
us and we will be happy to help. By taking part, you will be contributing to a local 
study that aims to make a real difference to life limiting illness and palliative care. 
This will be done through identification of pathway mechanisms that contribute to a 
successful outcome in an ICP. This could then improve the quality of palliative care 
delivered in [the locality], and the rest of the county. Please take time to decide 
whether you would like to take part.  
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What is the purpose of the study? 
[The locality] has created a new ICP which provides individuals who have life limiting 
illness with access to supportive palliative care including the best symptom control, 
shared decision making about treatment and generally increased choice about care, 
leading to a peaceful death with an individual’s needs fully met. The ICP is now in 
place and you will have experienced it in some way or form in your late loved ones 
care. This research wants to find out how the ICP works, for example, does it enable 
better communication between patients and GPs, or better planning and co-ordination? 
We also want to look at who the ICP is benefitting, does it benefit palliative care 
patients? Are families happy with it? Are health professionals happy with it? So, we 
would like to hear from patients, family members, carers and health professionals, in a 
variety of ways, about their experience of the ICP.   
Why have I been invited to take part in the study? 
You have been invited to take part as you have recently been bereaved and it is our 
understanding your loved one was a palliative care patient. We are very interested in 
hearing about your experience and how you found the ICP. We may also ask how you 
think your loved one felt about the care they received. Your loved one’s GP will fill in 
the same questionnaire as you so we can get an idea of how everybody felt the 
experience was. The GP will not see your answers to the questionnaire and you will 
not see their answers. Your loved one’s GP practice will have no access to the data 
you provide in this study. 
Do I have to take part? 
No, taking part in this study is voluntary and you do not have to take part. We will 
explain the study to you in this Information Sheet and if you have any questions or you 
are unsure whether you understand everything please feel free to contact us (our 
contact details are on the bottom of this information sheet). If you decide you would 
like to take part, we will ask you to sign the reply slip at the end of this Information 
Sheet to show you have agreed for a member of the research team to contact you to 
arrange the questionnaire to be posted to you.  
If you take part and decide that you have changed your mind and no longer wish to be 
involved you can stop taking part and withdraw at any time. You do not need to 
provide a reason. There will be no detrimental effects on you or your care form the 
NHS. You and your family will still have access to services on the palliative care 
pathway.  
What will happen to me if I take part? 
If you decide you would like to take part in this research, we would like you to fill in 
the reply slip at the end of this Information Sheet. The researcher (Sonia Dalkin) will 
then send you a questionnaire that you will fill in and send back. We will provide you 
with a stamped and addressed envelope. You will also receive a consent form which 
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will just make sure that you understand what we are doing with the information you 
give us.  
You will not be contacted again once you have returned the questionnaire and consent 
form in the stamped and addressed envelope provided.  
What will be the cost of taking part? 
There will be no financial cost to taking part. We will however ask for 30 minutes 
(maximum) of your time.  
How might taking part affect me? 
This study will not involve any physical risks, but answering questions about your 
experiences might be emotional or tiring. We cannot promise the study will help you 
but the information we get from this study will help improve the treatment of palliative 
care patients. If you do feel distressed or upset by the questionnaire you can contact 
Dr. Bill Cunningham who will be happy to talk to you about the study and provide 
support.  
This completes Part 1. If the information in Part 1 has interested you and you are 
considering participation, please read the additional information in Part 2 before 
making any decision. 
 
Part 2 
Will taking part in the project be private and confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. This research is also for an educational project, as the chief 
investigator (Sonia Dalkin) is doing a PhD. All information you provide will be 
completely confidential. Anything that you provide will not be able to be traced back 
to you as you will be given a number instead of using your name. Additionally, your 
loved one’s GP practice will not have access to any of the recorded data from this 
study. 
All information will be stored on a secure, password protected computer within 
Northumbria University. It will only be able to be accessed by Sonia Dalkin, (the chief 
investigator), Dr. Anna Jones (academic supervisor), Dr. Monique Lhussier (academic 
supervisor) and Dr. Bill Cunningham (academic supervisor and GP). All personal 
information will be destroyed when the study ends (names will already have been 
replaced with a number and addresses will be destroyed) and any written and recorded 
information will be destroyed six years after the study ends. 
Breaking confidentiality 
If you tell us something during the study that suggests you or someone else is at 
serious risk of harm we would then have to breach confidentiality. This means that we 
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would report the issue to someone who could help. We will however inform you that 
we are going to do this, and it will not affect the standard of care that you receive. 
What will happen if I don’t want to carry on with the research? 
If you wish to withdraw from the research at any time you can and you do not need to 
provide a reason. Please remember there will be no detrimental effects on you or your 
care from the NHS. You and your family will still have access to services on the 
palliative care pathway.  
Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given favourable opinion by Newcastle and North Tyneside 1  Research Ethics 
Committee. 
What if there is a problem? 
If there is a problem or you are not happy with the study please contact one of the 
researchers (contact details provided below) and we will do our best to answer any 
questions or queries you may have. We hope this is not the case, but if you are still 
unhappy and wish to complain formally, you can do this through the NHS complaints 
procedure or by contacting the Principal Supervisor, Dr. Anna Jones at Northumbria 
University. Both of their contact details are below:  
Dr. Anna Jones [contact details] 
NHS North of Tyne PCT complaints procedure [contact details] 
Additional Information  
This study aims to identify how palliative care can be improved and provide best 
support to people with life limiting illnesses. If, for any reason, you are no longer able 
to provide us with any feedback once your interview is completed, we would still 
really value being able to use the questionnaire data. This is so that your experiences 
may help improve palliative care for other people. By agreeing to take part in the 
study, you are also giving consent for us to use your interview data at any point in the 
future, in relation to studying palliative care. 
Contact details 
If you have any concerns or would like further information about the study, please feel 
free to contact us.  
Sonia Dalkin (Chief Investigator) [contact details]  
 
Dr. Bill Cunningham 
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GP and Chair of the Palliative Care Partnership [contact details] 
 
What happens now? 
Many thanks for taking time to read about this study. If you would like to take part 
please fill in the reply slip below within two weeks of receiving it and send it via the 
stamped and addressed envelope provided. The reply slip will then be securely passed 
on to Sonia Dalkin. If you need help to fill in the reply slip please contact us. When we 
receive the reply slip we will then post you a copy of the questionnaire.  
 
I would be interested in taking part in the study, and hereby give permission to be sent 
a questionnaire by the research team. I understand that before taking part, I will need 
to fill in a consent form and that if I want to I can withdraw from the study at any time, 
and that this will not affect my standard of care from the NHS.  
 
Name  __________________________ 
Signature __________________________ 
Date  __________________________ 
Home address for questionnaire to be sent to: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________ 
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Appendix 8  
Quality of Dying and Death Measure consent form for bereaved relatives 
Version 1 
Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
 [A Research Study] 
CONSENT FORM 
 
Title of Project: Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
Name of Researcher: Sonia Dalkin 
 
Please tick the appropriate box   
              Yes  No 
1. I confirm that I have read and understand the information sheet 
dated 24/11/11 (version 2) for the above study. I have had the 
opportunity to consider the information, ask questions and have had 
these answered to my satisfaction.  
 Yes  No  
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
my medical care or legal rights being affected.  
 
 Yes  No 
3. I understand that relevant sections of the data collected  
during the study may be looked at by the chief investigator 
(Sonia Dalkin) and her supervisory team (Dr. Anna Jones, Dr.  
Monique Lhussier, Dr. Bill Cunningham). I give permission for 
these individuals to have access to the data I provide.  
   
 Yes  No 
4. I agree to take part in the above study.  
 
 
 
Name of Participant _________________________ 
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Date _____________________________________ 
 
Signature _________________________________ 
 
Name of Researcher ________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
If you would like more details about the project, please do not hesitate to contact the 
researcher, Sonia Dalkin, by email: sonia.dalkin@northumbria.ac.uk or by telephone: 
07792768226.  
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Appendix 9 
Invitation letter for Quality of Death and Dying Measure for Health Professionals  
Version 2  
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Dear Health Professional, 
You are invited to take part in this research study. 
We are doing important research into the new Palliative Care Integrated Care Pathway 
in [the locality]. It is a study funded by NHS North of Tyne Primary Care Trust and 
Northumbria University. 
What will this study do? 
This study is part of Sonia Dalkin’s PhD at Northumbria University which investigates 
the new palliative care system in [the locality]. It hopes to find out new and interesting 
things about the system, including how it works, and who it works for (for example, 
patients, family, carers, GPs, nurses). It will also help the system improve itself, 
therefore improving palliative care as the study is taking place. This research is 
important as its overall aim is to inform and improve palliative care practice on both a 
local and national level so that individuals have open and easy access to the supportive 
care they need, which will ultimately lead to a peaceful death. 
How could you take part? 
If you are interested in taking part, we will ask you to fill in a short questionnaire 
which will ask questions about a palliative care patient’s death.  
What to do if you are interested in taking part and want more information?  
If you would like to find out more information about the study, please take the time to 
read the Information Sheet included with this letter. This will give you more 
information about the study and what you would do if you participated. You may also 
contact the researcher if you would like to find out more information or ask questions. 
The contact details of Sonia Dalkin are at the end of this letter and in the information 
sheet. 
If you have decided you do not want to take part in the study, you do not need to do 
anything. 
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Thank you for taking the time to read this letter. 
 
Contact Details 
 
Sonia Dalkin, [contact details] 
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Appendix 10 
Information sheet for health professionals approached to complete the Quality of 
Death and Dying Measure  
Version 2 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Information Sheet 
Part 1 
We would like to invite you to take part in this research project. Before you make a 
decision about taking part we want to make sure you understand why the research is 
being done and what it would involve for you. Please take the time to read the 
following information carefully and talk to others about the study if you wish. Part 1 
will provide a brief summary of the research and part 2 will give more detailed 
information about the study. 
If you have any difficulties, or need other help to understand the information please 
contact us and we will be happy to help. By taking part, you will be contributing to a 
local study that aims to make a real difference to life limiting illness and palliative 
care. This will be done through identification of pathway mechanisms that contribute 
to a successful outcome in an Integrated Care Pathway (ICP). This could then improve 
the quality of palliative care delivered in [the locality], and the rest of the county. 
Please take time to decide whether you would like to take part.  
What is the purpose of the study? 
[The locality] has created a new ICP which provides individuals who have life limiting 
illness with access to supportive palliative care including the best symptom control, 
shared decision making about treatment and generally increased choice about care, 
leading to a peaceful death with an individual’s needs fully met. The ICP is now in 
place and as a health professional in [the locality] you have been selected as a 
potential participant due to your involvement with the ICP. This research wants to find 
out how the ICP works, for example, is it better communication between patients and 
GPs, or is it better planning and co-ordination? We also want to look at who the ICP is 
benefitting; does it benefit palliative care patients? Are their families happy with it? 
Are health professionals happy with it? So, we would like to hear from patients, family 
members, carers and health professionals, in a variety of ways, about their experience 
of the ICP.   
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Why have I been invited to take part in the study? 
You have been invited to complete this questionnaire as the family of a previous 
palliative care patient you worked closely with have agreed to answer questions on the 
death of their loved one. It is hoped this will help us decipher whether the ICP is 
working to its full potential and identify areas where it could potentially be improved. 
The deceased palliative care patient’s family will not see your answers to the 
questionnaire, and you will not see their answers.  
Do I have to take part? 
No, taking part in this study is voluntary and you do not have to take part. We will 
explain the study to you in this Information Sheet and if you have any questions or you 
are unsure whether you understand everything please feel free to contact us (our 
contact details are on the bottom of this information sheet). If you decide you would 
like to take part, we will ask you to sign the reply slip at the end of this Information 
Sheet to show you have agreed for a member of the research team to contact you to 
arrange the questionnaire to be posted to you.  
If you take part and decide that you have changed your mind and no longer wish to be 
involved you can stop taking part and withdraw at any time. There will be no 
detrimental effects on you, your patients or your employment. Your patients will still 
have access to services on the palliative care pathway.   
What will happen to me if I take part? 
If you decide you would like to take part in this research, we would like you to fill in 
the reply slip at the end of this Information Sheet. The researcher (Sonia Dalkin) will 
then send you a questionnaire that you will fill in and send back. We will provide you 
with a stamped and addressed envelope. You will also receive a consent form which 
will just make sure that you understand what we are doing with the information you 
provide us with.  
You will not be contacted again in relation to this section of the research once you 
have returned the questionnaire and consent form in the stamped and addressed 
envelope provided. However, it is likely that you might be contacted and asked if you 
wish to take part in other parts of the research, such as focus groups. You do no have 
to participate in all or any of the research you are invited to take part in. You can take 
part in some sections and not others and you can withdraw from any section of 
research at any time. Please remember that there will be no detrimental effects on you, 
your patients or your employment if you choose to withdraw. Your patients will still 
have access to service on the palliative care pathway.  
What will be the cost of taking part? 
There will be no financial cost to taking part. We will however ask for 30 minutes 
(maximum) of your time.  
How might taking part affect me? 
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This study will not involve any physical risks, but answering questions about your 
experiences might be emotional or tiring. We cannot promise the study will help you 
but the information we get from this study will help improve the treatment of palliative 
care patients. If you do feel distressed or upset by the questionnaire you can contact 
Dr. Bill Cunningham who will be happy to talk to you about the study and provide 
support. 
This completes Part 1. If the information in Part 1 has interested you and you are 
considering participation, please read the additional information in Part 2 before 
making any decision. 
 
Part 2 
Will taking part in the project be private and confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. This research is also for an educational project, as the chief 
investigator (Sonia Dalkin) is doing a PhD. All information you provide will be 
completely confidential. Anything that you provide will not be able to be traced back 
to you as you will be given a number instead of using your name.  
All information will be stored on a secure, password protected computer within 
Northumbria University. It will only be able to be accessed by Sonia Dalkin, (the chief 
investigator), Dr. Anna Jones (academic supervisor), Dr. Monique Lhussier (academic 
supervisor) and Dr. Bill Cunningham (academic supervisor and GP). All personal 
information will be destroyed when the study ends (names will already have been 
replaced with a number and addresses will be destroyed) and any written and recorded 
information will be destroyed six years after the study ends. 
Breaking confidentiality 
If you tell us something during the study that suggests you or someone else is at 
serious risk of harm we would then have to breach confidentiality. This means that we 
would report the issue to someone who could help. We will however inform you that 
we are going to do this. 
What will happen if I don’t want to carry on with the research? 
If you wish to withdraw from the research at any time you can and you do not need to 
provide a reason. This will not affect your employment or your patient’s access to the 
palliative care pathway services.  
Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
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and given favourable opinion by Newcastle and North Tyneside 1  Research Ethics 
Committee. 
What if there is a problem? 
If there is a problem or you are not happy with the study please contact one of the 
researchers (contact details provided below) and we will do our best to answer any 
questions or queries you may have. We hope this is not the case, but if you are still 
unhappy and wish to complain formally, you can do this through the NHS complaints 
procedure or by contacting the Principal Supervisor, Dr. Anna Jones at Northumbria 
University. Both of their contact details are below: 
Dr. Anna Jones [contact details] 
NHS North of Tyne Complaints [contact details] 
Additional Information  
This study aims to identify how palliative care can be improved and provide best 
support to people with life limiting illnesses. If, for any reason, you are no longer able 
to provide us with any feedback once your interview is completed, we would still 
really value being able to use the questionnaire data. This is so that your experiences 
may help improve palliative care for other people. By agreeing to take part in the 
study, you are also giving consent for us to use your interview data at any point in the 
future, in relation to studying palliative care. 
Contact details 
If you have any concerns or would like further information about the study, please feel 
free to contact us.  
Sonia Dalkin (Chief Investigator) [contact details] 
Dr. Bill Cunningham, GP and Chair of the Palliative Care Partnership [contact details] 
What happens now? 
Many thanks for taking time to read about this study. If you would like to take part 
please fill in the reply slip below within two weeks of receiving it and post it to the 
address provided above for Sonia Dalkin. You will then be posted a copy of the 
questionnaire. Please return the questionnaire and the consent form that you have 
received to Sonia Dalkin as soon as possible.  
---------------------------------------------------------------------------------------- 
I would be interested in taking part in the study, and hereby give permission to be 
contacted by a member of the research team. I understand that before taking part, I 
will need to fill in a consent form and that if I want I can withdraw from the study at 
any time. I understand that this will not affect my employment or my patient’s access 
to services.  
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Name  __________________________ 
Signature __________________________ 
Date  __________________________ 
Address (for questionnaire to be sent to): 
_____________________________________________________________________
_____________________________________________________________________
_______________________________________ 
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Appendix 11  
 
Quality of Death and Dying Consent form for health professionals  
Version 1 
 
Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
 [A Research Study] 
CONSENT FORM 
 
Title of Project: Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
Name of Researcher: Sonia Dalkin 
 
Please tick the appropriate box   
              Yes  No 
1. I confirm that I have read and understand the information sheet 
dated 24/11/11 (version 2) for the above study. I have had the 
opportunity to consider the information, ask questions and have had 
these answered to my satisfaction.  
 Yes  No  
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
my medical care or legal rights being affected.  
 
 Yes  No 
3. I understand that relevant sections of the data collected  
during the study may be looked at by the chief investigator 
(Sonia Dalkin) and her supervisory team (Dr. Anna Jones, Dr.  
Monique Lhussier, Dr. Bill Cunningham). I give permission for 
these individuals to have access to the data I provide.    
 Yes  No 
4. I agree to take part in the above study.  
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Name of Participant _________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
 
Name of Researcher ________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
If you would like more details about the project, please do not hesitate to contact the 
researcher, Sonia Dalkin, by email: sonia.dalkin@northumbria.ac.uk or by telephone: 
07792768226.  
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Appendix 12 - The Quality of Dying and Death Measure 
 
In the box provided next to each statement please rate it from 0 to 10, where 0 was a 
“terrible experience” and 10 was an “almost perfect experience”. How would you 
rate the following aspect of your loved ones dying experience… 
1. Having pain under control. 
 
2. Having control of event. 
 
3. Being able to feed oneself. 
 
4. Having control of bladder, bowels. 
 
5. Being able to breathe comfortably. 
 
6. Having energy to do things one wants to do. 
 
7. Spend time with your children as much as you want. (or I have no children) 
 
8. Spend time with your friends and other family as much as you want. 
 
9. Spend time alone. 
 
10. Be touched and hugged by loved ones. 
 
Reminder: 0 = Terrible Experience, 10 = Almost perfect experience  
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11. Say goodbye to your loved ones. 
 
12. Have the means to end your life if you need to. 
 
13. Discuss your wishes for end-of-life care with your doctor and others. 
 
14. Feel at peace with dying. 
 
15. Avoid worry about strain on your loved ones. 
 
16. Be unafraid of dying. 
 
17. Find meaning and purpose in your life. 
 
18. Die with dignity and respect. 
 
19. Laugh and smile. 
 
20. Avoid being on dialysis or mechanical ventilation. 
 
21. Location of death (home, hospice, hospital). 
 
Reminder: 0 = Terrible Experience, 10 = Almost perfect experience  
 
22. Die with/without loved ones present. 
 
23. State at moment of death (awake, asleep). 
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24. Have a visit from a religious or spiritual advisor. 
 
25. Have a spiritual service or ceremony. 
 
26. Have health care costs provided. 
 
27. Have funeral arrangements in order. 
 
28. Spend time with spouse, partner. (or I have no spouse, partner) 
 
29. Spend time with pets. (or I have no pets) 
 
30. Clear up bad feelings. (or there were no bad feelings to clear up) 
 
31. Attend important events. (or there were no important events to attend) 
 
This is the end of the questionnaire. Thank you very much for filling it in. Please now 
return it using the stamped and addressed envelope provided.  
 
Statistics about the psychometric properties of the measure  
The Cronbach’s alpha is commonly used as an estimate of the reliability of 
a psychometric test (Pallant 2010). The Cronbach’s alpha for the QODD total score 
was 0.89 (Curtis, Patrick et al. 2002). A Cronbach’s alpha of 0.7 – 0.9 is good. A 
Cronbach’s alpha of >0.9 is excellent (Curtis, Patrick et al. 2002). A systematic review 
identified 6 published measure of the quality of death and dying (Hales, Zimmerman 
et al. 2010). Of the six published measures reviewed, the Quality of Dying and Death 
questionnaire (QODD) is the most widely studied and best validated (Hales, 
Zimmerman et al. 2010). 
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Appendix 13 - Research and Development approval  
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Appendix 14 - letter to charitable organisations 
Sonia Dalkin [contact details]  
27/02/12 
Dear Sir/Madam,  
I am a PhD student at Northumbria University working in collaboration with NHS 
North of Tyne PCT. I am currently developing a study to investigate and evaluate the 
new life limiting illness and palliative care integrated care pathway in [the locality]. In 
order to get a full understanding of how the Integrated Care Pathway (ICP) works we 
would like to host 3 focus groups in 2012 at Burn Brae Medical Group in Hexham, 
[the locality]. Since your organisation has been involved with the new ICP we would 
like to request approval for your staff to be approached to take part in the 
aforementioned focus groups.  
These focus groups will involve 8-12 people each time. Your staff can attend one, two 
or all of the focus groups, it is completely up to them. They will be contacted via email 
with an invitation and information sheet and then provided with a consent form. The 
focus groups will include a variety of health professionals involved with the ICP, 
including GPs, community matrons, Macmillan nurses district nurses, hospice staff, 
North East Ambulance Service staff, Northern Doctors Urgent care staff, charitable 
organisation staff and social workers.  
The focus groups will discuss the ICP and prompt collaborative discussion about how 
the ICP works, what is beneficial about it and what is not beneficial. It is hoped that 
not only will this focus group generate data for the evaluation of the ICP, but it will 
also help the ICP improve as information generated from the focus groups will be 
anonymously fed back in order to have continuous quality improvement.  
You and your staff would receive a short report at the end of the study detailing the 
information generated from the focus groups. The study has full ethical approval from 
the Newcastle North Tyneside 1 Committee. This approval was gained on 12.01.12 
If you would like more information please don’t hesitate to contact me via phone 
(07792768226) or email (sonia.dalkin@northumbria.ac.uk). If you feel you have 
sufficient information to make an informed decision could you please contact me via 
email giving permission for me to approach your staff to ask them if they would like to 
take part in the focus groups. Alternatively, you can just fill in the slip below and 
return it to the address below.  
Sonia Dalkin  
Room H007, School of Health, Education and Community Studies 
Coach Lane Campus, Northumbria University  
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Coach Lane  
Newcastle Upon Tyne  
NE7 7XA 
I look forward to hearing from you.  
Yours Sincerely 
Sonia Dalkin 
Post Graduate Research Student 
 
I hereby give my approval for staff at Charlotte Straker Hospice to be approached to 
take part in the focus groups for the study “Understanding Palliative Care Integrated 
Care Pathways – Context, Approaches, Outcomes”.  
 
Name: 
_____________________________________________________________________
_______ 
 
Signature: 
_____________________________________________________________________
____ 
 
Date: ______________________ 
 369 
 
Appendix 15 
Invitation  letter for focus groups to health care professionals  
Version 2 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Dear Health Professional, 
You are invited to take part in this research study. 
We are doing research into the new Palliative Care Integrated Care Pathway in [the 
locality]. It is a study funded by NHS North of Tyne Primary Care Trust and 
Northumbria University. 
What will this study do? 
This study is part of Sonia Dalkin’s PhD at Northumbria University which investigates 
the new palliative care system in [the locality]. It hopes to find out new and interesting 
things about the system, including how it works, and who it works for (for example, 
patients, family, carers, GPs, nurses). It will also help the system improve itself, 
therefore improving palliative care as the study is taking place. This research is 
important as its overall aim is to inform and improve palliative care practice on both a 
local and national level so that individuals have open and easy access to the supportive 
care they need, which will ultimately lead to a peaceful death. 
How could you take part? 
If you are interested in taking part, we will ask you to attend a focus group with a 
variety of health professionals to discuss the benefits and challenges of the new ICP.  
What to do if you are interested in taking part and want more information?  
If you would like to find out more information about the study, please take the time to 
read the Information Sheet included with this letter. This will give you more 
information about the study and what you would do if you participated. You may also 
contact the researcher if you would like to find out more information or ask questions. 
The contact details of Sonia Dalkin are at the end of this letter and in the information 
sheet. 
If you have decided you do not want to take part in the study, you do not need to do 
anything. 
Thank you for taking the time to read this letter. Contact Details [Sonia Dalkin] 
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Appendix 16 
 
Information sheet email to be sent to health professionals for focus groups 
Version 2 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Information Sheet 
Part 1 
We would like to invite you to take part in this research project. Before you make a 
decision about taking part we want to make sure you understand why the research is 
being done and what it would involve for you. Please take the time to read the 
following information carefully and talk to others about the study if you wish. Part 1 
will provide a brief summary of the research and part 2 will give more detailed 
information about the study. 
If you have any difficulties, or need other help to understand the information please 
contact us and we will be happy to help.  
By taking part, you will be contributing to a local study that aims to make a real 
difference to palliative care. This will be done through identification of pathway 
mechanisms that contribute to a successful outcome in an Integrated Care Pathway 
(ICP). This could then improve the quality of palliative care delivered in [the locality], 
and the rest of the county. Please take time to decide whether or not you would like to 
participate. 
What is the purpose of the study? 
[The locality] has created a new Integrated Care Pathway which provides individuals 
who have life limiting illness with access to supportive palliative care including the 
best symptom control, shared decision making about treatment and generally increased 
choice about care, leading to a peaceful death with an individual’s needs fully met. 
The ICP is now in place and as a health professional in [the locality] you have been 
selected as a potential participant due to your involvement with the ICP. This research 
wants to find out how the ICP works, for example, is it better communication between 
patients and GPs, or is it better planning and co-ordination? We also want to look at 
who the ICP is benefitting; does it benefit palliative care patients? Are their families 
happy with it? Are health professionals happy with it? So, we would like to hear from 
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patients, family members, carers and health professionals, in a variety of ways, about 
their experience of the ICP.   
Why have I been invited to take part in the study? 
You have been invited to take part as you have been identified as a health professional 
working within [the locality] who has experience of the palliative care ICP.  
Do I have to take part? 
No, taking part in this study is voluntary and you do not have to take part. We will 
explain the study to you in this Information Sheet and if you have any questions or you 
are unsure whether you understand everything please feel free to contact us (our 
contact details are on the bottom of this information sheet). If you decide you would 
like to take part, we will ask you to reply to this email in order to confirm your 
attendance at the focus group.  
If you take part and decide that you have changed your mind and no longer wish to be 
involved you can stop taking part and withdraw at any time. You do not need to 
provide a reason. There will be no detrimental effects on you, your patients or your 
employment. Your patients will still have access to services on the palliative care 
pathway.  
What will happen to me if I take part? 
If you decide you would like to take part in this research and the date, time and place 
of the focus group (stated in the email accompanying this letter) is convenient for you, 
we would like you to reply to this email (email address: 
sonia.dalkin@northumbia.ac.uk). The researcher, Sonia Dalkin, will then send you an 
email confirming she has received your reply and provide you with a consent form. 
This will ensure sure that you understand what we are doing with the information you 
provide us with in the focus groups. We ask that you fill in this consent form and bring 
it with you to the focus groups.  
The focus group will last approximately 1 hour. It will take place with around 8 – 12 
other health professionals form a variety of backgrounds. You do not have to 
contribute to any of the discussions if you do not wish to. Before the focus group, 
Sonia Dalkin will explain the study in person to all participants and answer any 
questions you may have. Your signed consent form will then be collected. Spare 
consent forms will also be available though we would prefer if you had ample time to 
read them before agreeing to participate. The interview will be recorded using a digital 
voice recorder and the chief investigator will also take notes.  
The focus group discussions will cover topics such as:  
 The ICP entails multidisciplinary work – how is this operationalised?  What do you think the benefits of the ICP are?  
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 Are there any ways in which you think the ICP can be improved?  
You may be contacted again about further focus groups, however attending one focus 
group does not mean you are have to attend the following future focus groups. It is 
also possible that you might be contacted and asked if you wish to take part in other 
parts of the research. You do not have to participate in all or any of the research you 
are invited to take part in. You can take part in some sections and not others.  
What will be the cost of taking part? 
There will be no financial cost to taking part in this study. We will however ask for 1 
hour (maximum) of your time.  
How might taking part affect me? 
This study will not involve any physical risks, but answering questions about your 
experiences might be emotional or tiring. We cannot promise the study will help you 
personally but the information we get from this study will help improve the treatment 
of palliative care patients and aid the health professionals who work in the field. If you 
do feel distressed or upset by the focus groups you can contact Dr. Bill Cunningham 
who will be happy to talk to you about the study and provide support. 
This completes Part 1. If the information in Part 1 has interested you and you are 
considering participation, please read the additional information in Part 2 before 
making any decision. 
Part 2 
Will taking part in the project be private and confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. This research is also for an educational project, as the chief 
investigator (Sonia Dalkin) is doing a PhD. All information you provide will be 
completely confidential in regards to this educational project. Anything that you 
provide will not be able to be traced back to you as you will be given a number instead 
of using your name. However, the researcher cannot guarantee confidentiality from 
others in the focus group.  
All information will be stored on a secure, password protected computer within 
Northumbria University. It will only be able to be accessed by Sonia Dalkin, (the chief 
investigator), Dr. Anna Jones (academic supervisor), Dr. Monique Lhussier (academic 
supervisor) and Dr. Bill Cunningham (academic supervisor and GP). All personal 
information will be destroyed when the study ends (names will already have been 
replaced with a number and addresses will be destroyed) and any written and recorded 
information will be destroyed six years after the study ends. 
Breaking confidentiality 
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If you tell us something during the study that suggests you or someone else is at 
serious risk of harm we would then have to breach confidentiality. This means that we 
would report the issue to someone who could help. We will however inform you that 
we are going to do this. 
What will happen if I don’t want to carry on with the research? 
If you wish to withdraw from the research at any time you can and you do not need to 
provide a reason.  
Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given favourable opinion by Newcastle and North Tyneside 1 Research Ethics 
Committee. 
What if there is a problem? 
If there is a problem or you are not happy with the study please contact one of the 
researchers (contact details provided below) and we will do our best to answer any 
questions or queries you may have. We hope this is not the case, but if you are still 
unhappy and wish to complain formally, you can do this through the NHS complaints 
procedure on the internet, or you can contact your local Primary Care Trust (PCT), 
NHS North of Tyne, or you can contact the Principal Supervisor, Dr. Anna Jones at 
Northumbria University. Dr. Anna Jones’s details and North of Tyne PCT details are 
below:  
Dr. Anna Jones [contact details] 
NHS North of Tyne PCT complaints procedure [contact details] 
Additional Information 
This study aims to identify how palliative care can be improved and provide the best 
support to people with life limiting illnesses. If, for any reason, you are no longer able 
to provide us with any feedback once your interview is completed, we would still 
really value being able to use the focus group data. This is so that your experiences 
may help improve palliative care for other people. By agreeing to take part in the 
study, you are also giving consent for us to use your interview data at any point in the 
future, in relation to studying palliative care. 
Contact details 
If you have any concerns or would like further information about the study, please feel 
free to contact us.  
Sonia Dalkin (Chief Investigator), [contact details]   
Dr. Bill Cunningham, GP and Chair of the Palliative Care Partnership [contact details] 
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What happens now? 
Many thanks for taking time to read about this study. If you would like to take part 
please reply to this email within 2 weeks of receiving it. You will then receive a 
confirmation email with the location of the focus group. A light lunch will be provided 
before the focus group commences.  
Many Thanks,  
Sonia Dalkin 
Chief Investigator  
 375 
 
Appendix 17 
Consent form for focus groups with health professionals  
Version 1 
Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
 [A Research Study] 
CONSENT FORM 
 
Title of Project: Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
Name of Researcher: Sonia Dalkin 
 
Please tick the appropriate box   
              Yes   No 
1. I confirm that I have read and understand the information sheet 
dated 24/11/11 (version 2) for the above study. I have had the 
opportunity to consider the information, ask questions and have had 
these answered to my satisfaction.  
 Yes  No  
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
my medical care or legal rights being affected.  
 
3. I agree to being recorded by a digital voice recorder.  YesNo 
 
4. I agree for the researcher to take notes.                     
 
  
 Yes  No       
5. I understand that relevant sections of the data collected  
during the study may be looked at by the chief investigator 
(Sonia Dalkin) and her supervisory team (Dr. Anna Jones, Dr.  
Monique Lhussier, Dr. Bill Cunningham). I give permission for 
these individuals to have access to the data I provide.  
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 Yes  No 
6. I agree to take part in the above study.  
 
 
Name of Participant _________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
 
Name of Researcher ________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
If you would like more details about the project, please do not hesitate to contact the 
researcher, Sonia Dalkin, by email: sonia.dalkin@northumbria.ac.uk or by telephone: 
07792768226.  
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Appendix 18 
Invitation letter for interviews with palliative care patients 
Version 2 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Dear Service User,  
You are invited to take part in this research study. 
We are doing important research into the new Palliative Care Integrated Care Pathway 
in [the locality]. It is a study funded by NHS North of Tyne Primary Care Trust and 
Northumbria University. 
What will this study do? 
This study is part of Sonia Dalkin’s PhD at Northumbria University which investigates 
the new palliative care system in [the locality]. It hopes to find out new and interesting 
things about the system, including how it works, and who it works for (for example, 
patients, family, carers, GPs, nurses). It will also help the system improve itself, 
therefore improving palliative care as the study is taking place. This research is 
important as its overall aim is to inform and improve palliative care practice on both a 
local and national level so that individuals have open and easy access to the supportive 
care they need, which will ultimately lead to a peaceful death. 
How could you take part? 
If you are interested in taking part, we will ask you to attend an interview to discuss 
your experience of Palliative care.   
What to do if you are interested in taking part and want more information?  
If you would like to find out more information about the study, please take the time to 
read the Information Sheet included with this letter. This will give you more 
information about the study and what you would do if you participated. We would like 
you to share the information sheet with your friends, family are carers if you wish to, 
as they could possibly be involved also. You may also contact the researcher if you 
would like to find out more information or ask questions. The contact details of Sonia 
Dalkin are at the end of this letter and in the information sheet. 
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If you have decided you do not want to take part in the study, you do not need to do 
anything. 
Thank you for taking the time to read this letter. 
Contact Details 
Sonia Dalkin, Principal Researcher [contact details] 
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Appendix 19  
Invitation letter for interviews with bereaved relatives and carers  
Version 2 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Dear Sir/Madam, 
Firstly may we say that we are extremely sorry for the recent loss of your loved one. 
We are contacting you as we are doing research into the new Palliative Care Integrated 
Care Pathway in [the locality] that your loved one had experience of. It is a study 
funded by NHS North of Tyne Primary Care Trust and Northumbria University and 
we think you could help contribute to the research.  
What will this study do? 
This study is part of Sonia Dalkin’s PhD at Northumbria University which investigates 
the new palliative care system in [the locality]. It hopes to find out new and interesting 
things about the system, including how it works, and who it works for (for example, 
patients, family, carers, GPs, nurses). It will also help the system improve itself, 
therefore improving palliative care as the study is taking place. This research is 
important as its overall aim is to inform and improve palliative care practice on both a 
local and national level so that individuals have open and easy access to the supportive 
care they need, which will ultimately lead to a peaceful death. 
How could you take part? 
You are invited to take part as you have recently lost a loved one who was a palliative 
care patient. If you are interested in taking part, we will ask you to attend an interview 
to discuss your experience of palliative care in [the locality].  
What to do if you are interested in taking part and want more information?  
If you would like to find out more information about the study, please take the time to 
read the Information Sheet included with this letter. This will give you more 
information about the study and what you would do if you participated. We would like 
you to share the information sheet with your friends and family if you wish to, as they 
could possibly be involved also. You may also contact the researcher if you would like 
to find out more information or ask questions. The contact details of Sonia Dalkin are 
at the end of this letter and in the information sheet. 
If you have decided you do not want to take part in the study, you do not need to do 
anything. Thank you for taking the time to read this letter.  
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Contact Details 
Sonia Dalkin, Principal Researcher [contact details] 
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Appendix 20 
Information sheet for interviews with palliative care patients’ relatives  
Version 2 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Information Sheet 
Part 1 
We would like to invite you to take part in this research project. Before you make a 
decision about taking part we want to make sure you understand why the research is 
being done and what it would involve for you. Please take the time to read the 
following information carefully and talk to others about the study if you wish. Part 1 
will provide a brief summary of the research and Part 2 will give more detailed 
information about the study. 
If you have any difficulties, or need other help to understand the information please 
contact us and we will be happy to help.  
Below is a list of terms used in this document that you may not be familiar with:  Service user: This is any person who comes into contact with the National 
Health Service (NHS). This includes patients, carers, family members and 
advocates. 
 Integrated Care Pathway (ICP): An integrated care pathway involves many 
teams working together, for example the GP surgery, the community nurses, 
the North east ambulance service and Tynedale hospice at home all working 
together to provide the best possible care for patients. 
By taking part, you will be contributing to a local study that aims to make a real 
difference to life limiting illness and palliative care. This will be done through 
identification of pathway mechanisms that contribute to a successful outcome in an 
ICP. This could then improve the quality of palliative care delivered in [the locality], 
and the rest of the county.  
What is the purpose of the study? 
[The locality] has created a new ICP which provides individuals who have life limiting 
illness with access to supportive palliative care including the best symptom control, 
shared decision making about treatment and generally increased choice about care, 
leading to a peaceful death with an individual’s needs fully met. The ICP is now in 
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place and as a palliative care patient’s relative in [the locality] you have been selected 
as a potential participant. This research wants to find out how the ICP works, for 
example, does it enable better communication between patients and GPs, or better 
planning and co-ordination? We also want to look at who the ICP is benefitting; does 
it benefit palliative care patients? Are families happy with it? Are health professionals 
happy with it? So, we would like to hear from patients, family members, carers and 
health professionals, in a variety of ways, about their experience of the ICP.   
Why have I been invited to take part in the study? 
You have been invited to take part as you are identified as a palliative care patient’s 
friend, relative or carer and they would like you to take part in the study with them.  
Do I have to take part? 
No, taking part in this study is voluntary and you do not have to take part. We will 
explain the study to you in this Information Sheet and if you have any questions or you 
are unsure whether you understand everything please feel free to contact us (our 
contact details are on the bottom of this information sheet). If you decide you would 
like to take part, we will ask you to fill in the reply slip at the bottom of this 
information sheet and return it to the chief investigator (Sonia Dalkin) with the 
stamped and addressed envelope provided.  
If you take part and decide that you have changed your mind and no longer wish to be 
involved you can stop taking part and withdraw at any time. You do not need to 
provide a reason. There will be no detrimental effects on you or your care from the 
NHS. You and your family will still have access to services on the palliative care 
pathway.   
What will happen to me if I take part? 
If you decide you would like to take part in this research we would like you to 
complete and return the reply slip at the bottom of this information sheet. The chief 
investigator (Sonia Dalkin) will then call your loved one to arrange a convenient time 
for an interview with you both. We will ask that you bring the consent form provided 
in this pack with you to the interview. This consent form will ensure sure that you 
understand what we are doing with the information you provide us with in the 
interview.  
Before the interview, Sonia Dalkin will explain the study in person and answer any 
questions you may have. Your signed consent form will then be collected. Spare 
consent forms will also be available though we would prefer if you had ample time to 
read them before agreeing to participate. The interview will be recorded using a digital 
voice recorder and the chief investigator will also take notes. 
The interview will last approximately 1 hour. You do not have to answer any question 
you do not wish to answer. The interview will cover topics such as:  
 What experience of palliative care have you had?  
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 Have there been any instances where you think your care could have been 
handled better?   Do you think the communication between all the different services is good? 
For example between the hospital and your GP?  
Throughout the interview, the researcher (Sonia Dalkin) will check that she 
understands your point of view and has recorded it correctly, and that you are happy 
with it. You will not be contacted again once the interview has taken place. However, 
you can contact the researcher and request a summary of what the research finds or a 
copy of the full report if you wish. If you forget to tell the researcher something, you 
can contact her after the interview (her contact details are below, but will also be 
provided after the interview for you to take home) and she will add it to your record. 
What will be the cost of taking part? 
There will be no financial cost to taking part. We will however ask for 1 hour 
(maximum) of your time. Any money you spend on travel will be reimbursed.      
How might taking part affect me? 
Answering questions about your experiences of your loved one’s care or your 
experience of the service might be emotional or tiring. You can stop for a break during 
the interview at any time, or stop the interview completely. You will not be at any 
physical risk in this study. We cannot promise the study will help you but the 
information we get from this study will help improve the treatment of palliative care 
patients. If you do feel distressed or upset by the questionnaire you can contact Dr. 
Bill Cunningham who will be happy to talk to you about the study and provide 
support. 
This completes Part 1. If the information in Part 1 has interested you and you are 
considering participation, please read the additional information in Part 2 before 
making any decision. 
 
Part 2 
Will taking part in the project be private and confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. This research is also for an educational project, as the chief 
investigator (Sonia Dalkin) is doing a PhD. All information you provide will be 
completely confidential in regards to this educational project. Anything that you 
provide will not be able to be traced back to you as you will be given a number instead 
of using your name. Your GP practice will not have access to any of the recorded data 
from this study. 
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All information will be stored on a secure, password protected computer within 
Northumbria University in Newcastle. It will only be able to be accessed by Sonia 
Dalkin (the chief investigator), Dr. Anna Jones (academic supervisor), Dr. Monique 
Lhussier (academic supervisor) and Dr. Bill Cunningham (academic supervisor and 
GP).All personal information will be destroyed when the study ends (names will have 
already been replaced with a number and addresses will be destroyed) and any written 
and recorded information will be destroyed six years after the study ends. 
Breaking confidentiality 
If you tell us something during the study that suggests you or someone else is at 
serious risk of harm we would then have to breach confidentiality. This means that we 
would report the issue to someone who could help. We will however inform you that 
we are going to do this. 
What will happen if I don’t want to carry on with the research? 
If you wish to withdraw from the research at any time you can and you do not need to 
provide a reason. Please remember that whether you decide to take part, not take part 
or take part then withdraw, the standard of care you receive from the NHS will no be 
affected.  
Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given favourable opinion by Newcastle and North Tyneside 1  Research Ethics 
Committee. 
What if there is a problem? 
If there is a problem or you are not happy with the study please contact one of the 
researchers (contact details provided below) and we will do our best to answer any 
questions or queries you may have. We hope this is not the case, but if you are still 
unhappy and wish to complain formally, you can do this through contacting the NHS 
North of Tyne PCT or by contacting the Principal Supervisor, Dr. Anna Jones at 
Northumbria University. Both of their contact details are below:  
Dr. Anna Jones [contact details]  
NHS North of Tyne complaints procedure [contact details] 
Additional Information  
This study aims to identify how palliative care can be improved and provide best 
support to people with life limiting illnesses. If, for any reason, you are no longer able 
to provide us with any feedback once your interview is completed, we would still 
really value being able to use the interview data. This is so that your experiences may 
help improve palliative care for other people. By agreeing to take part in the study, 
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you are also giving consent for us to use your interview data at any point in the future, 
in relation to studying palliative care. 
Contact details 
If you have any concerns or would like further information about the study, please feel 
free to contact us.  
Sonia Dalkin (Chief Investigator), [contact details]  
Dr. Bill Cunningham,GP and Chair of the Palliative Care Partnership, [contact 
details]. 
What happens now? 
Many thanks for taking time to read about this study. If you would like to take part 
please fill in the reply slip below and return it using the stamped and addressed 
envelope enclosed within 2 weeks. Sonia Dalkin (chief investigator) will then contact 
your relative, carer or friend to arrange a convenient time and place for the interview 
with both you and them. 
 
I would be interested in taking part in the study, and hereby give permission to be 
contacted by a member of the research team. I understand that before taking part, I 
will need to fill in a consent form and that if I want I can withdraw from the study at 
any time and this will not affect the care my family or I receive. 
Your Name      __________________________ 
Loves one’s name  __________________________ 
Signature      __________________________ 
Date       __________________________ 
Telephone number _______________________ 
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Appendix 21 
Information Sheet for interviews with bereaved relatives, friends and carers 
Version: 2 
 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Information Sheet 
Part 1 
We would like to invite you to take part in this research project. Before you make a 
decision about taking part we need you to make sure you understand why the research 
is being done and what it would involve for you. Please take the time to read the 
following information carefully and talk to others about the study if you wish. Part 1 
will provide a brief summary of the research and Part 2 will give more detailed 
information about the study. 
Below is a list of terms used in this document that you may not be familiar with:  Service user: This is any person who comes into contact with the National 
Health Service (NHS). This includes patients, carers, family members and 
advocates. 
 Integrated Care Pathway (ICP): An integrated care pathway involves many 
teams working together, for example the GP surgery, the community nurses, 
the North east ambulance service and Tynedale hospice at home all working 
together to provide the best possible care for patients. 
If you have any difficulties, or need other help to understand the information please 
contact us and we will be happy to help. By taking part, you will be contributing to a 
local study that aims to make a real difference to life limiting illness and palliative 
care. This will be done through identification of pathway mechanisms that contribute 
to a successful outcome in an ICP. This could then improve the quality of palliative 
care delivered in [the locality], and the rest of the county.  
What is the purpose of the study? 
[The locality] has created a new ICP which provides individuals who have life limiting 
illness with access to supportive palliative care including the best symptom control, 
shared decision making about treatment and generally increased choice about care, 
leading to a peaceful death with an individual’s needs fully met. The I
 387 
 
place and as a bereaved relative or carer in [the locality] you have been selected as a 
potential participant. This research wants to find out how the ICP works, for example, 
does it enable better communication between patients and GPs, or better planning and 
co-ordination? We also want to look at who the ICP is benefitting; does it benefit 
palliative care patients? Are families happy with it? Are health professionals happy 
with it? So, we would like to hear from patients, family members, carers and health 
professionals, in a variety of ways, about their experience of the ICP.   
Why have I been invited to take part in the study? 
You have been invited to take part as you are identified as a relative, friend or carer of 
someone who was a palliative care patient.   
Do I have to take part? 
No, taking part in this study is voluntary and you do not have to take part. We will 
explain the study to you in this Information Sheet and if you have any questions or you 
are unsure whether you understand everything please feel free to contact us (our 
contact details are on the bottom of this information sheet). If you decide you would 
like to take part, we will ask you to fill in the reply slip at the bottom of this 
information sheet and return it to the chief investigator (Sonia Dalkin) with the 
stamped and addressed envelope provided.  
If you take part and decide that you have changed your mind and no longer wish to be 
involved you can stop taking part and withdraw at any time. You do not need to 
provide a reason. There will be no detrimental effects on you or your care from the 
NHS. You and your family will still have access to the services on the palliative care 
pathway.  
What will happen to me if I take part? 
If you decide you would like to take part in this research we would like you to 
complete and return the reply slip at the bottom of this information sheet. The chief 
investigator (Sonia Dalkin) will then telephone call you to arrange a convenient time 
for an interview. We will ask that you bring the consent form provided in this pack 
with you to the interview. This consent form will ensure sure that you understand what 
we are doing with the information you provide us with in the interview.  
Before the interview, Sonia Dalkin will explain the study in person and answer any 
questions you may have. Spare consent forms will also be available though we would 
prefer if you had ample time to read them before agreeing to participate. The interview 
will be recorded using a digital voice recorder and the chief investigator will also take 
notes. 
The interview will last approximately 1 hour. You do not have to answer any question 
you do not wish to answer. The interview will cover topics such as:  
 What were yours and your loved one’s experience of life limiting illness and 
palliative care in [the locality]? 
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 Have there been any instances where you think their care could have been 
handled better?   Do you think the communication between all the different services is good? 
For example between the hospital and your GP?  
Throughout the interview, the researcher (Sonia Dalkin) will check that she 
understands your point of view and has recorded it correctly, and that you are happy 
with it. You will not be contacted again one the interview has taken place. However, 
you can contact the researcher and request a summary of what the research finds or a 
copy of the full report if you wish. If you forget to tell the researcher something, you 
can contact her after the interview (her contact details are below, but will also be 
provided after the interview for you to take home) and she will add this to your record. 
We would like to encourage you to bring along family, friends or carers to the 
interview if you wish to do so. Please let the researcher know if this is the case so she 
can provide an information pack for them also.  
What will be the cost of taking part? 
There will be no financial cost to taking part. We will however ask for 1 hour 
(maximum) of your time. Any money you spend on travel will be reimbursed.      
How might taking part affect me? 
Answering questions about your experiences might be emotional or tiring. You can 
stop for a break during the interview at any time, or stop the interview completely. 
You will not be at any physical risk in this study. We cannot promise the study will 
help you personally but the information we get from this study will help improve the 
treatment of life limiting illness and palliative care patients. If you do feel distressed or 
upset by the interview you can contact Dr. Bill Cunningham who will be happy to talk 
to you about the study and provide support. 
This completes Part 1. If the information in Part 1 has interested you and you are 
considering participation, please read the additional information in Part 2 before 
making any decision. 
 
Part 2 
Will taking part in the project be private and confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. This research is also for an educational project, as the chief 
investigator (Sonia Dalkin) is doing a PhD. All information you provide will be 
completely confidential in regards to this educational project. Anything that you 
provide will not be able to be traced back to you as you will be given a number instead 
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of using your name. Additionally, your loved one’s GP practice will not have access to 
any of the recorded data. 
All information will be stored on a secure, password protected computer within 
Northumbria University. It will only be able to be accessed by Sonia Dalkin, (the chief 
investigator), Dr. Anna Jones (academic supervisor), Dr. Monique Lhussier (academic 
supervisor) and Dr. Bill Cunningham (academic supervisor and GP). All personal 
information will be destroyed when the study ends (names will already have been 
replaced with a number and addresses will be destroyed) and any written and recorded 
information will be destroyed six years after the study ends. 
Breaking confidentiality 
If you tell us something during the study that suggests you or someone else is at 
serious risk of harm we would then have to breach confidentiality. This means that we 
would report the issue to someone who could help. We will however inform you that 
we are going to do this. 
What will happen if I don’t want to carry on with the research? 
If you wish to withdraw from the research at any time you can and you do not need to 
provide a reason. Please remember that whether you decide to take part, not take part 
or take part then withdraw, the standard of care you and our family receive from the 
NHS will not be affected. 
Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given favourable opinion by Newcastle and North Tyneside 1 Research Ethics 
Committee. 
What if there is a problem? 
If there is a problem or you are not happy with the study please contact one of the 
researchers (contact details provided below) and we will do our best to answer any 
questions or queries you may have. We hope this is not the case, but if you are still 
unhappy and wish to complain formally, you can do this by contacting NHS North of 
Tyne Primary Care Trust or by contacting the Principal Supervisor, Dr. Anna Jones at 
Northumbria University. Both of their details are below:  
Dr. Anna Jones [contact details] 
NHS North of Tyne complaints procedure [contact details] 
 
Additional Information  
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This study aims to identify how palliative care can be improved and provide best 
support to people with life limiting illnesses. If, for any reason, you are no longer able 
to provide us with any feedback once your interview is completed, we would still 
really value being able to use the interview data. This is so that your experiences may 
help improve palliative care for other people. By agreeing to take part in the study, 
you are also giving consent for us to use your interview data at any point in the future, 
in relation to studying palliative care. 
Contact details 
If you have any concerns or would like further information about the study, please feel 
free to contact us.  
Sonia Dalkin (Chief Investigator), [contact details] 
Dr. Bill Cunningham, GP and Chair of the Palliative Care Partnership [contact details] 
What happens now? 
Many thanks for taking time to read about this study. If you would like to take part 
please fill in the reply slip below and return it using the stamped and addressed 
envelope enclosed within 2 weeks. Sonia Dalkin (chief investigator) will then contact 
you to arrange a convenient time and place for the interview.   
 
I would be interested in taking part in the study, and hereby give permission to be 
contacted by a member of the research team. I understand that before taking part, I 
will need to fill in a consent form and that if I want I can withdraw from the study at 
any time and this will not affect the care my family or I receive.  
Name  __________________________ 
Signature __________________________ 
Date  __________________________ 
Telephone number for researcher to contact you on (to arrange an interview): 
_____________________________ 
 
 391 
 
Appendix 22 
Consent form for interviews with Palliative care patients 
Version 1 
Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
 [A Research Study] 
CONSENT FORM 
 
Title of Project: Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
Name of Researcher: Sonia Dalkin 
 
Please tick the appropriate box   
              Yes   No 
1. I confirm that I have read and understand the information sheet 
dated 24/11/11 (version 2) for the above study. I have had the 
opportunity to consider the information, ask questions and have had 
these answered to my satisfaction.  
 Yes  No  
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
my medical care or legal rights being affected.  
 
3. I agree to being recorded by a digital voice recorder                     YesNo       
 
 
 
4. I agree to the researcher taking notes 
 
 
 
 Yes  No      
5. I understand that relevant sections of the data collected  
during the study may be looked at by the chief investigator 
(Sonia Dalkin) and her supervisory team (Dr. Anna Jones, Dr.  
Monique Lhussier, Dr. Bill Cunningham). I give permission for 
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these individuals to have access to the data I provide.  
   
 Yes  No 
6. I agree to take part in the above study.  
 
 
 
Name of Participant _________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
 
Name of Researcher ________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
 
 
If you would like more details about the project, please do not hesitate to contact the 
researcher, Sonia Dalkin, by email: sonia.dalkin@northumbria.ac.uk or by telephone: 
07792768226.  
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Appendix 23 
Consent forms for interviews with bereaved relatives and carers of palliative patients.  
Version 1 
 
Understanding integrated care pathways in palliative care – context, approaches, 
outcomes. 
 [A Research Study] 
CONSENT FORM 
 
Title of Project: Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
Name of Researcher: Sonia Dalkin 
 
Please tick the appropriate box   
              Yes   No 
1. I confirm that I have read and understand the information sheet 
dated 24/11/11 (version 2) for the above study. I have had the 
opportunity to consider the information, ask questions and have had 
these answered to my satisfaction.  
 Yes  No  
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
my medical care or legal rights being affected.  
 
3. I agree to being recorded by a digital voice recorder                                       Yes  No 
 
4. I agree to the researcher taking notes.                                                                                               
 
 Yes  No      
5. I understand that relevant sections of the data collected  
during the study may be looked at by the chief investigator 
(Sonia Dalkin) and her supervisory team (Dr. Anna Jones, Dr.  
Monique Lhussier, Dr. Bill Cunningham). I give permission for 
these individuals to have access to the data I provide.  
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 Yes  No 
6. I agree to take part in the above study.  
 
 
Name of Participant _________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
 
Name of Researcher ________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
 
If you would like more details about the project, please do not hesitate to contact the 
researcher, Sonia Dalkin, by email: sonia.dalkin@northumbria.ac.uk or by telephone: 
07792768226.  
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Appendix 24  
Consent form for interviews with palliative care patients’ relatives 
Version 1 
 
Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
 [A Research Study] 
CONSENT FORM 
 
Title of Project: Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
Name of Researcher: Sonia Dalkin 
 
Please tick the appropriate box   
              Yes   No 
1. I confirm that I have read and understand the information sheet 
dated 24/11/11 (version 2) for the above study. I have had the 
opportunity to consider the information, ask questions and have had 
these answered to my satisfaction.  
 Yes     No  
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
my medical care or legal rights being affected.  
 
3. I agree to being recorded by a digital voice recorder.     Yes No 
 
 
 
4. I agree to the researcher taking notes   
 
 Yes  No      
5. I understand that relevant sections of the data collected  
during the study may be looked at by the chief investigator 
(Sonia Dalkin) and her supervisory team (Dr. Anna Jones, Dr.  
Monique Lhussier, Dr. Bill Cunningham). I give permission for 
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these individuals to have access to the data I provide.  
     
 Yes  No 
6. I agree to take part in the above study.  
 
 
Name of Participant _________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
 
Name of Researcher ________________________ 
 
Date _____________________________________ 
 
Signature _________________________________ 
 
 
If you would like more details about the project, please do not hesitate to contact the 
researcher, Sonia Dalkin, by email: sonia.dalkin@northumbria.ac.uk or by telephone: 
07792768226. 
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Appendix 25 
Invitation letter for coping style questionnaire and consultation recording for palliative 
care patients 
Version 2 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Dear Service User,  
You are invited to take part in this research study. 
We are doing research into the new Palliative Care Integrated Care Pathway in [the 
locality]. It is a study funded by NHS North of Tyne Primary Care Trust and 
Northumbria University. 
What will this study do? 
This study is part of Sonia Dalkin’s PhD at Northumbria University which investigates 
the new palliative care system in [the locality]. It hopes to find out new and interesting 
things about the system, including how it works, and who it works for (for example, 
patients, family, carers, GPs, nurses). It will also help the system improve itself, 
therefore improving palliative care as the study is taking place. This research is 
important as its overall aim is to inform and improve palliative care practice on both a 
local and national level so that individuals have open and easy access to the supportive 
care they need, which will ultimately lead to a peaceful death. 
How could you take part? 
If you are interested in taking part, we will ask you to fill in a questionnaire about how 
you cope with stressful health information. Your consultation with your GP will then 
be recorded.  
What to do if you are interested in taking part and want more information?  
If you would like to find out more information about the study, please take the time to 
read the Information Sheet included with this letter. This will give you more 
information about the study and what you would do if you participated. We would like 
you to share the information sheet with your friends, family are carers if you wish to, 
as they could possibly be involved also. You may also contact the researcher if you 
would like to find out more information or ask questions. The contact details of Sonia 
Dalkin are at the end of this letter and in the information sheet. 
If you have decided you do not want to take part in the study, you do not need to do 
anything. 
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Thank you for taking the time to read this letter. 
Contact Details 
Sonia Dalkin, Principal Researcher [contact details] 
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Appendix 26 
Information sheet for MBSS questionnaire and consultation recording for palliative 
care patients 
Version 3 
 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Information Sheet 
Part 1 
We would like to invite you to take part in this research project. Before you make a 
decision about taking part we want to make sure you understand why the research is 
being done and what it would involve for you. Please take the time to read the 
following information carefully and talk to others about the study if you wish. Part 1 
will provide a brief summary of the research and part 2 will give more detailed 
information about the study. 
Below is a list of terms used in this document that you may not be familiar with:  Service user: This is any person who comes into contact with the National 
Health Service (NHS). This includes patients, carers, family members and 
advocates. 
 Integrated Care Pathway (ICP): An integrated care pathway involves many 
teams working together, for example the GP surgery, the community nurses, 
the North East ambulance service and Tynedale hospice at home all working 
together to provide the best possible care for patients. 
If you have any difficulties, or need other help to understand the information please 
contact us and we will be happy to help. By taking part, you will be contributing to a 
local study that aims to make a real difference to life limiting illness and palliative 
care. This will be done through identification of pathway mechanisms that contribute 
to a successful outcome in an ICP. This could then improve the quality of palliative 
care delivered in [the locality], and the rest of the county. Please take time to decide 
whether you would like to take part.  
What is the purpose of the study? 
[the locality] has created a new ICP which provides individuals who have life limiting 
illness with access to supportive palliative care including the best symptom control, 
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shared decision making about treatment and generally increased choice about care, 
leading to a peaceful death with an individual’s needs fully met. The ICP is now in 
place and as a palliative care patient in [the locality] you have been selected as a 
potential participant. This research wants to find out how the ICP works, for example, 
does it allow for better communication between patients and GPs, or better planning 
and co-ordination? We also want to look at who the ICP is benefitting; does it benefit 
palliative care patients? Are families happy with it? Are health professionals happy 
with it? So, we would like to hear from patients, family members, carers and health 
professionals, in a variety of ways, about their experience of the ICP.   
Why have I been invited to take part in the study? 
You have been invited to take part as you are on the palliative care register at your GP 
surgery.  
Do I have to take part? 
No, taking part in this study is voluntary and you do not have to take part. We will 
explain the study to you in this Information Sheet and if you have any questions or you 
are unsure whether you understand everything please feel free to contact us (our 
contact details are on the bottom of this information sheet). If you decide you would 
like to take part, we will ask you to fill in the reply slip at the bottom of this 
information sheet and return it to the chief investigator (Sonia Dalkin) with the 
stamped and addressed envelope provided.  
If you take part and decide that you have changed your mind and no longer wish to be 
involved you can stop taking part and withdraw at any time. You do not need to 
provide a reason. There will be no detrimental effects on you or your care from the 
NHS. You and your family will still have access to services on the palliative care 
pathway.  
What will happen to me if I take part? 
If you decide you would like to take part in this research we would like you to 
complete and return the reply slip at the bottom of this information sheet, using the 
stamped and addressed envelope provided. The chief investigator (Sonia Dalkin) will 
then send you a questionnaire that asks questions about how you cope in various 
situations. It is well known that we are all different, and that different people cope in 
different ways. We are trying to find out if the way that people cope (for example, 
wanting to ask lots of questions or not wanting to know everything at once) affects 
how well a consultation goes between a GP and a patient.  
We will also ask you to tell us when our next consultation with your GP is as we will 
wish to audio record it. We would ask that you bring the consent form provided in this 
pack with you to the consultation. This consent form will ensure sure that you 
understand what we are doing with the information you provide us with in the study. 
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Before the consultation, Sonia Dalkin will explain the study in person and answer any 
questions you may have. Your signed consent form will then be collected. Spare 
consent forms will also be available though we would prefer if you had ample time to 
read them before agreeing to participate. The consultation between you and your GP 
will be recorded using a digital voice recorder. The researcher (Sonia Dalkin) will not 
be sitting in on the consultation but will listen to the recording afterwards. Your GP 
may ask you to take part in more than one consultation recording. This consultation 
will be one of your regular consultations that you would normally have with your GP. 
Your GP will ask for your consent to record the consultation a maximum of three 
times, and each time, they will check if you are still happy with that (meaning that a 
conversation will never be recorded without your prior agreement). Even if you agreed 
for one recording, just say if you would rather not have subsequent ones recorded. At 
the end of the study the GP will check that you are still happy with the recording being 
given to the researcher (Sonia Dalkin). Communication about palliative care has been 
reported as difficult by patients and GPs. So, we would like to see if this might be 
because professionals and patients might have a different approach to stressful 
situations. This questionnaire and audio recording of your consultation will help us 
discover this.  
You will not be contacted again by the researcher once the consultation has taken 
place. However, you can contact the researcher to ask any question, add any comment 
to what you have already told them, and/or request a summary of what the research 
finds or a copy of the full report if you wish.  
We would like to encourage you to bring along family, friends or carers to the 
consultation if you wish to do so. Please let the researcher know if this is the case so 
she can provide an information pack for them also.  
What will be the cost of taking part? 
There will be no financial cost to taking part. We will however ask for 1 hour 
(maximum) of your time.  
How might taking part affect me? 
You will not be at any physical risk in this study. The consultation between you and 
your GP will be a consultation that you would normally have any way so there should 
not be any questions that you will feel uncomfortable with. However, please remember 
you do not have to answer any questions you feel uncomfortable with. Also, please 
feel free to ask your GP questions, and use this consultation like any normal 
appointment you would usually have with your GP. We cannot promise the study will 
help you but the information we get from this study will help improve the treatment of 
palliative care patients. If you do feel distressed or upset by the questionnaire you can 
contact Dr. Bill Cunningham who will be happy to talk to you about the study and 
provide support. 
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This completes Part 1. If the information in Part 1 has interested you and you are 
considering participation, please read the additional information in Part 2 before 
making any decision. 
Part 2 
Will taking part in the project be private and confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. This research is also for an educational project, as the chief 
investigator (Sonia Dalkin) is doing a PhD. All information you provide will be 
completely confidential in regards to this educational project. Anything that you 
provide will not be able to be traced back to you as you will be given a number instead 
of using your name. Additionally, your GP practice will not have access to any of the 
recorded data. 
All information will be stored on a secure, password protected computer within 
Northumbria University. It will only be able to be accessed by Sonia Dalkin, (the chief 
investigator), Dr. Anna Jones (academic supervisor), Dr. Monique Lhussier (academic 
supervisor) and Dr. Bill Cunningham (academic supervisor and GP). All personal 
information will be destroyed when the study ends (names will already have been 
replaced with a number and addresses will be destroyed) and any written and recorded 
information will be destroyed six years after the study ends. 
Your GP will be told that you are taking part in the study, as they too will be invited to 
take part, as they will be recorded during your consultation also. They will not have 
access to your questionnaire answers though.  
Breaking confidentiality 
If you tell us something during the study that suggests you or someone else is at 
serious risk of harm we would then have to breach confidentiality. This means that we 
would report the issue to someone who could help. We will however inform you that 
we are going to do this. 
What will happen if I don’t want to carry on with the research? 
If you wish to withdraw from the research at any time you can and you do not need to 
provide a reason. Please remember that there will be no detrimental effects on you or 
your care from the NHS. You and your family will still have access to services on the 
palliative care pathway.   
Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given favourable opinion by Newcastle and North Tyneside 1 Research Ethics 
Committee. 
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What if there is a problem? 
If there is a problem or you are not happy with the study please contact one of the 
researchers (contact details provided below) and we will do our best to answer any 
questions or queries you may have. We hope this is not the case, but if you are still 
unhappy and wish to complain formally, you can do this through the NHS complaints 
procedure or by contacting the Principal Supervisor, Dr. Anna Jones at Northumbria 
University.  
Dr. Anna Jones [contact details] 
NHS North of Tyne Complaints Procedure [contact details] 
Additional Information  
This study aims to identify how palliative care can be improved and provide best 
support to people with life limiting illnesses. If, for any reason, you are no longer able 
to provide us with any feedback once your interview is completed, we would still 
really value being able to use the questionnaire and consultation recording data. This is 
so that your experiences may help improve palliative care for other people. By 
agreeing to take part in the study, you are also giving consent for us to use your 
interview data at any point in the future, in relation to studying palliative care. 
Contact details 
If you have any concerns or would like further information about the study, please feel 
free to contact us.  
Sonia Dalkin (Chief Investigator), [contact details] 
Dr. Bill Cunningham, GP and Chair of the Palliative Care Partnership [contact details] 
What happens now? 
Many thanks for taking time to read about this study. If you would like to take part 
please fill in the reply slip below and return it using the stamped and addressed 
envelope enclosed within 2 weeks. Sonia Dalkin (chief investigator) will then send 
you the questionnaire and ask you to return it using the stamped and addressed 
envelope that we will provide. You will then meet with the researcher (Sonia Dalkin) 
before your consultation for her to explain the study in person, answer any questions 
you may have and collect your consent form.  
 
I would be interested in taking part in the study, and hereby give permission to be 
contacted by a member of the research team. I understand that before taking part, I 
will need to fill in a consent form and that if I want I can withdraw from the study at 
any time. This will not affect my care from the NHS.   
Name  __________________________ 
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Signature __________________________ 
Date  __________________________ 
Home address to send questionnaire to: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_________ 
Name of GP ___________________________________________________ 
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Appendix 27 
Consent forms for MBSS and consultation recording for palliative care patients  
Version 2 
 
Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
 [A Research Study] 
CONSENT FORM 
 
Title of Project: Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
Name of Researcher: Sonia Dalkin 
 
Please tick the appropriate box   
              Yes   No 
1. I confirm that I have read and understand the information sheet 
dated 16/12/11 (version 3) for the above study. I have had the 
opportunity to consider the information, ask questions and have had 
these answered to my satisfaction.  
 Yes  No  
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
my medical care or legal rights being affected.  
 
 
3. I agree to having my next consultation recorded by a digital voice recorder.                                              
 
 
 
 Yes  No      
4. I understand that relevant sections of the data collected  
during the study may be looked at by the chief investigator 
(Sonia Dalkin) and her supervisory team (Dr. Anna Jones, Dr.  
Monique Lhussier, Dr. Bill Cunningham). I give permission for 
these individuals to have access to the data I provide.  
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 Yes  No 
5. I agree to my GP being informed of my participation in the 
study.  
 
 
 
6. I understand that my GP may ask me to take part in a  Yes  No 
further 2 consultation recordings but I do not have to   
take part if I do not want to.  
 
 
 Yes  No 
7. I agree to take part in the above study.  
 
 
Name of Participant _________________________ 
Date _____________________________________ 
Signature _________________________________ 
 
Name of Researcher ________________________ 
Date _____________________________________ 
Signature _________________________________ 
 
If you would like more details about the project, please do not hesitate to contact the 
researcher, Sonia Dalkin, by email: sonia.dalkin@northumbria.ac.uk or by telephone: 
07792768226.  
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Appendix 28 
Invitation letter for MBSS and consultation recording for health care professional  
Version 2 
 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Dear Health Professional, 
You are invited to take part in this research study. 
We are doing research into the new Palliative Care Integrated Care Pathway in [the 
locality]. It is a study funded by NHS North of Tyne Primary Care Trust and 
Northumbria University. 
What will this study do? 
This study is part of Sonia Dalkin’s PhD at Northumbria University which investigates 
the new palliative care system in [the locality]. It hopes to find out new and interesting 
things about the system, including how it works, and who it works for (for example, 
patients, family, carers, GPs, nurses). It will also help the system improve itself, 
therefore improving palliative care as the study is taking place. This research is 
important as its overall aim is to inform and improve palliative care practice on both a 
local and national level so that individuals have open and easy access to the supportive 
care they need, which will ultimately lead to a peaceful death. 
How could you take part? 
If you are interested in taking part, we will ask you to fill in a questionnaire about how 
you cope with stressful health information. A recording of a consultation with a 
palliative care patient (who has also filled in the questionnaire and given their consent 
to be recorded) will then be taken.  
What to do if you are interested in taking part and want more information?  
If you would like to find out more information about the study, please take the time to 
read the Information Sheet included with this letter. This will give you more 
information about the study and what you would do if you participated. You may also 
contact the researcher if you would like to find out more information or ask questions. 
The contact details of Sonia Dalkin are at the end of this letter and in the information 
sheet. 
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If you have decided you do not want to take part in the study, you do not need to do 
anything. 
Thank you for taking the time to read this letter. 
Sonia Dalkin, Principal Researcher [contact details] 
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Appendix 29 
Information sheet for MBSS and consultation recording for health professionals 
Version 3  
 
Understanding integrated care pathways in palliative care – 
context, approaches, outcomes. 
 [A Research Study] 
Information Sheet 
Part 1 
We would like to invite you to take part in this research project. Before you make a 
decision about taking part we want to make sure you understand why the research is 
being done and what it would involve for you. Please take the time to read the 
following information carefully and talk to others about the study if you wish. Part 1 
will provide a brief summary of the research and part 2 will give more detailed 
information about the study. 
If you have any difficulties, or need other help to understand the information please 
contact us and we will be happy to help. By taking part, you will be contributing to a 
local study that aims to make a real difference to life limiting illness and palliative 
care. This will be done through identification of pathway mechanisms that contribute 
to a successful outcome in an Integrated Care Pathway (ICP). This could then improve 
the quality of palliative care delivered in [the locality], and the rest of the county. 
Please take time to decide whether you would like to take part.  
What is the purpose of the study? 
[The locality] has created a new ICP which provides individuals who have life limiting 
illness with access to supportive palliative care including the best symptom control, 
shared decision making about treatment and generally increased choice about care, 
leading to a peaceful death with an individual’s needs fully met. The ICP is now in 
place and as a health professional in [the locality] you have been selected as a 
potential participant due to your involvement with the ICP. This research wants to find 
out how the ICP works, for example, does it enable better communication between 
patients and GPs, or better planning and co-ordination? We also want to look at who 
the ICP is benefitting; does it benefit palliative care patients? Are families happy with 
it? Are health professionals happy with it? So, we would like to hear from patients, 
family members, carers and health professionals, in a variety of ways, about their 
experience of the ICP.   
 410 
 
Why have I been invited to take part in the study? 
You have been invited to take part as you are identified as a health professional in [the 
locality] who has worked closely with a palliative care patient who has agreed to take 
part in this study also.  
Do I have to take part? 
No, taking part in this study is voluntary and you do not have to take part. We will 
explain the study to you in this Information Sheet and if you have any questions or you 
are unsure whether you understand everything please feel free to contact us (our 
contact details are on the bottom of this information sheet). If you decide you would 
like to take part, we will ask you to fill in the reply slip at the bottom of this 
information sheet and return it to the chief investigator (Sonia Dalkin) with the 
stamped and addressed envelope provided.  
If you take part and decide that you have changed your mind and no longer wish to be 
involved you can stop taking part and withdraw at any time. You do not need to 
provide a reason. There will be no detrimental effects on you, your patients, or your 
employment. Your pati9ents will still have access to the services on the palliative care 
pathway.  
What will happen to me if I take part? 
If you decide that you would like to take part in this research we would like you to 
complete and return the reply slip at the bottom of this information sheet. The chief 
investigator (Sonia Dalkin) will then send you a questionnaire that asks questions 
about how you cope in various situations. It is well known that we are all different, 
and that different people cope in different ways. We are trying to find out if the way 
that people cope (for example, wanting to ask lots of questions or not wanting to know 
everything at once) affects how successful a consultation is between a GP and a 
patient.  
We will also ask you to confirm with us when your next consultation with your 
palliative care patient is (we will inform you which patient has agreed to take part in 
this study, and they will have already told us when their appointment with you is). We 
wish to know when this appointment is as we would like to digitally voice record it. 
We would ask that you bring the consent form provided in this pack with you to the 
consultation. This consent form will ensure sure that you understand what we are 
doing with the information you provide us with in the study. 
Before the consultation, Sonia Dalkin will explain the study in person and answer any 
questions you or the patient may have. Your signed consent form will then be 
collected. Spare consent forms will also be available though we would prefer if you 
had ample time to read them before agreeing to participate. The interview will be 
recorded using a digital voice recorder. The consultation between you and your 
palliative care patient will be recorded using a digital voice recorder. The researcher 
(Sonia Dalkin) will not be sitting in on the consultation but will listen to the recording 
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afterwards. We understand that conversations about palliative care and death do not 
occur in one consultation, therefore you may ask to record up to 3 consultations 
(maximum) with one patient. The patient will give written consent at the beginning to 
the chief investigator (Sonia Dalkin) and there after you will confirm with the patient, 
whilst the audio recorder is taping, that they are still happy to be recorded and 
participate in the research. Additionally, at the end of the last recording you will have 
to confirm that they are still happy to participate and that it is ok to pass on the 
recording to the research team. Communication about palliative care has been reported 
as difficult by patients and GPs. So, we would like to see if this might be because 
professionals and patients might have a different approach to stressful situations. This 
questionnaire and audio recording of your consultation will help us discover this. 
What will be the cost of taking part? 
There will be no financial cost to taking part in this study. We will however ask for 1 
hour (maximum) of your time.  
How might taking part affect me? 
You will not be at any physical risk in this study. The consultation between you and 
your palliative care patient will be a consultation that you would normally have any 
way. We would like you to please use this consultation like any normal appointment 
you would usually have with your palliative care patient. We cannot promise the study 
will help you personally but the information we get from this study will help improve 
the treatment of palliative care patients. If you do feel distressed or upset by the 
questionnaire you can contact Dr. Bill Cunningham who will be happy to talk to you 
about the study and provide support. 
This completes Part 1 of the information sheet. If the information in Part 1 has 
interested you and you are considering participation, please read the additional 
information in Part 2 before making any decision. 
 
Part 2 
Will taking part in the project be private and confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. This research is also for an educational project, as the chief 
investigator (Sonia Dalkin) is doing a PhD. All information you provide will be 
completely confidential in regards to this educational project. Anything that you 
provide will not be able to be traced back to you as you will be allocated a number 
instead of using your name in the study write up.  
All information will be stored on a secure, password protected computer within 
Northumbria University. It will only be able to be accessed by Sonia Dalkin, (the chief 
investigator), Dr. Anna Jones (academic supervisor), Dr. Monique Lhussier (academic 
supervisor) and Dr. Bill Cunningham (academic supervisor and GP). All personal 
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information will be destroyed when the study ends (names will already have been 
replaced with a number and addresses will be destroyed) and any written and recorded 
information will be destroyed six years after the study ends. 
Your palliative care patient will be told that you are taking part in the study, as they 
will be recorded during your consultation also.  
Breaking confidentiality 
If you tell us something during the study that suggests you or someone else is at 
serious risk of harm we would then have to breach confidentiality. This means that we 
would report the issue to someone who could help. We will however inform you that 
we are going to do this. 
What will happen if I don’t want to carry on with the research? 
If you wish to withdraw from the research at any time you can and you do not need to 
provide a reason. There will be no detrimental effects on you, your patients or your 
employment. Your patients will still have access to services on the palliative care 
pathway.  
Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given favourable opinion by Newcastle and North Tyneside 1 Research Ethics 
Committee. 
What if there is a problem? 
If there is a problem or you are not happy with the study please contact one of the 
researchers (contact details provided below) and we will do our best to answer any 
questions or queries you may have. We hope this is not the case, but if you are still 
unhappy and wish to complain formally, you can do this through the NHS complaints 
procedure or by contacting the Principal Supervisor, Dr. Anna Jones at Northumbria 
University. Both of their contact details are below:  
Dr. Anna Jones [contact details]  
NHS North of Tyne PCT compaints procedure [contact details] 
Additional Information  
This study aims to identify how palliative care can be improved and provide best 
support to people with life limiting illnesses. If, for any reason, you are no longer able 
to provide us with any feedback once your interview is completed, we would still 
really value being able to use the questionnaire and consultation recording data. This is 
so that your experiences may help improve palliative care for other people. By 
agreeing to take part in the study, you are also giving consent for us to use your 
interview data at any point in the future, in relation to studying palliative care. 
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Contact details 
If you have any concerns or would like further information about the study, please feel 
free to contact us.  
Sonia Dalkin (Chief Investigator), [contact details] 
Dr. Bill Cunningham, GP and Chair of the Palliative Care Partnership [contact details] 
What happens now? 
Many thanks for taking time to read about this study. If you would like to take part 
please fill in the reply slip below and return it using the stamped and addressed 
envelope enclosed within 2 weeks. Sonia Dalkin (chief investigator) will then send 
you the questionnaire and you will return it using the stamped and addressed envelope 
we will provide. You will then meet with the researcher before your consultation for 
her to explain the study in person, answer any questions you may have and collect 
your consent form.  
 
I would be interested in taking part in the study, and hereby give permission to be 
contacted by a member of the research team. I understand that before taking part, I 
will need to fill in a consent form and that if I want I can withdraw from the study at 
any time. If I withdraw this will have no effect on my employment or my patient’s 
access to palliative care pathway services.  
Name  __________________________ 
Signature __________________________ 
Date  __________________________ 
Address to send questionnaire to: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________ 
Date of next consultation with GP __________________________________ 
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Appendix 30 
 
Consent form for MBSS and consultation recording for health professional. 
Version 1 
 
Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
 [A Research Study] 
CONSENT FORM 
 
Title of Project: Understanding integrated care pathways in palliative care – context, 
approaches, outcomes. 
Name of Researcher: Sonia Dalkin 
 
Please tick the appropriate box   
              Yes   No 
1. I confirm that I have read and understand the information sheet 
dated 16/12/11 (version 3) for the above study. I have had the 
opportunity to consider the information, ask questions and have had 
these answered to my satisfaction.  
 Yes  No  
 
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
my medical care or legal rights being affected.  
 
3. I agree to having my next palliative care consultation being recorded by a digital 
voice recorder.                                                                                                    
                                                                                                                              Yes No 
 
 
 
 Yes  No 
4. I agree for the researcher to take notes 
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 Yes  No 
5. I understand that relevant sections of the data collected  
during the study may be looked at by the chief investigator 
(Sonia Dalkin) and her supervisory team (Dr. Anna Jones, Dr.  
Monique Lhussier, Dr. Bill Cunningham). I give permission for 
these individuals to have access to the data I provide.  
   
                                                                                                                                          Yes   No 
6. I agree to _______________ (palliative care patient) being 
informed of my participation in the study.  
 
 Yes     No 
7. I agree to take part in the above study.  
 
 
 
Name of Participant _________________________ 
Date _____________________________________ 
Signature _________________________________ 
 
 
Name of Researcher ________________________ 
Date _____________________________________ 
Signature _________________________________ 
 
If you would like more details about the project, please do not hesitate to contact the 
researcher, Sonia Dalkin, by email: sonia.dalkin@northumbria.ac.uk or by telephone: 
07792768226.  
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Appendix 31- Miller Behavioural Style Scale 
Miller Behavioural Style Scale (MBSS) 
Version 1 
Monitor/Blunter Style Scale 
1.    Vividly imagine that you are afraid of the dentist and have to get some dental 
work done.  Which of the following would you do?  Check all of the statements that 
might apply to you. 
I would ask the dentist exactly what work was going to be done. 
I would take a tranquilizer or have a drink before going. 
I would try to think about pleasant memories. 
I would want the dentist to tell me when I would feel pain. 
I would try to sleep. 
I would watch all the dentist's movements and listen for the sound of the drill. 
I would watch the flow of water from my mouth to see if it contained blood. 
I would do mental puzzles in my mind. 
2.    Vividly imagine that you are being held hostage by a group of armed terrorists 
in a public building. Which of the following would you do?  Check all of the 
statements that might apply to you. 
I would sit by myself and have as many daydreams and fantasies as I could. 
I would stay alert and try to keep myself from falling asleep. 
I would exchange life stories with the other hostages. 
If there was a radio present, I would stay near it and listen to the bulletins about what the 
police were doing. 
I would watch every movement of my captors and keep an eye on their weapons. 
I would try to sleep as much as possible. 
I would think about how nice it's going to be when I get home. 
I would make sure I knew where every possible exit was.  
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3.    Vividly imagine that, due to a large drop in sales, it is rumored that several 
people in your department at work will be laid off. Your supervisor has turned in an 
evaluation of your work for the past year.  The decision about lay-offs has been made 
and will be announced in several days. Check all of the statements that might apply 
to you. 
I would talk to my fellow workers to see if they knew anything about what the supervisor 
evaluation of me said. 
I would review the list of duties for my present job and try to figure out if I had fulfilled them all. 
I would go to the movies to take my mind off things. 
I would try to remember any arguments or disagreements I might have had that would 
have resulted in the supervisor having a lower opinion of me. 
I would push all thoughts of being laid off out of my mind. 
I would tell my spouse that I'd rather not discuss my chances of being laid off. 
I would try to think which employees in my department the supervisor might have thought 
had done the worst job. 
I would continue doing my work as if nothing special was happening. 
4.    Vividly imagine that you are on an airplane, thirty minutes from your 
destination, when the plane unexpectedly goes into a deep dive and then suddenly 
levels off.  After a short time, the pilot announces that nothing is wrong, although the 
rest of the ride may be rough.  You, however, are not convinced that all is well.  
Check all of the statements that might apply to you. 
I would carefully read the information provided about safety features in the plane and               
make sure I knew where the emergency exits were. 
I would make small talk with the passenger beside me. 
I would watch the end of the movie, even if I had seen it before. 
I would call for the flight attendant and ask what exactly the problem was. 
I would order a drink from the flight attendant or take a tranquilizer. 
I would listen carefully to the engines for unusual noises and would watch the crew to see 
if their behaviour was out of the ordinary. 
I would talk to the passenger beside me about what might be wrong. 
I would settle down and read a book or magazine or write a letter.  
This is the end of the questionnaire. Thank you very much for taking the time to fill it in. 
Could you now please give the questionnaire back to the researcher via email or post. 
Again, thank you for your time. 
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Sonia Dalkin [contact details]  
Questionnaire validation  
Results from an MBSS validation study showed that coping-style scores accurately 
predicted informational strategy, particularly with the monitoring dimension (Miller, 
1987).  
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Appendix 32 - Correspondence with Dr. Miller 
Hi: 
I have been on travel and facing deadlines. 
I am most interested in your study and would love to hear more. 
I am ccing my assistant who will answer your questions. 
Generally it is stable over time, if the situation remains consistent. So, yes it is a trait.  
If there are changes in the situation, then  monitors especially may react with more 
anxiety and less adaptive responding. 
TheǇ doŶ͛t ĐhaŶge hoǁ theǇ ƌespoŶd to the iteŵs oŶ the ƋuestioŶŶaiƌe, ďut theiƌ 
strategies may change over time as the situation changes. 
Also some people are in the middle (a subset, perhaps a quarter) so that they are 
more influenced by changes in the situation. 
Hope this helps for now. 
Please give us any further details.  That would be helpful. 
Dr. Suzanne Miller 
Professor, Senior Member  
Director,  Psychosocial and BioBehavioral Medicine Department  
Fox Chase Cancer Center  
Robert C. Young Pavilion - Room 4149  
333 Cottman Avenue  
Philadelphia, Pennsylvania 19111  
Tel:  (215) 728-4069 
Fax: (215) 214-1651 
Email: suzanne.miller@fccc.edu 
Administrative Assistant: Mary Anne Ryan 
email: (maryanne.ryan@fccc.edu) Tel: (215)728-5296 
FCCC webpage: http://www.fccc.edu/research/pid/miller/ 
Adjunct Professor, Department of Psychiatry, University of Pennsylvania  
Adjunct Professor, Department of Medicine, Obstetrics and Gynecology, and 
Public Health, Temple University  
Adjunct Professor, Institute for Health, Health Care Policy, and Aging 
Research, Rutgers University 
  
420 
 
420 
 
Appendix 33 - University ethical approval  
 
 
 
Professor Kathleen McCourt FRCN Dean 
This matter is being dealt with by: 
Research and Enterprise Office 
School of Health, Community & Education Studies 
Room H007 
Coach Lane Campus East 
Newcastle upon Tyne 
NE7 7XA 
Tel: 0191 215 6701 
Fax: 0191 215 6083 
E-mail: julie.blackwell@northumbria.ac.uk 
28th September 2011 
 
Dear Sonia 
 
School of HCES Research Ethics Sub Committee 
Title: Understanding integrated care pathways in palliative care - context, 
approaches, outcomes 
 
Following independent peer review of the above proposal, I am pleased to inform you that 
University approval has been granted on the basis of this proposal and subject to 
compliance with the University policies on ethics and consent and any other policies 
applicable to your individual research. You should also have recent CRB and occupational 
health clearance if your research involves working with children and/or vulnerable adults.    
 
The University’s Policies and Procedures are available from the following web link: 
http://www.northumbria.ac.uk/researchandconsultancy/sa/ethgov/policies/?view=Standard  
 
It is recommended that you submit the additional information regarding the 
clinical database to the NHS REC committee.  Both the University and 
NRES strongly advise that the supervisor accompany the student when 
attending an external REC. 
Sonia Dalkin 
17 The Orchard  
Hepscott 
Morpeth 
Northumberland 
NE61 6HT 
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You may now also proceed with your application (if applicable) to:  NHS R&D organisations for approval. Please check with the NHS 
Trust whether you require a Research Passport, Letter(s) of Access 
or Honorary contract(s).   NHS Research Ethics Committee (REC).  [They will require a copy 
of this letter plus the ethics panel comments and your response to 
those comments]. If your research is subject to external REC 
approval, a ‘favourable opinion’ must be obtained prior to 
commencing your research. You must notify the University of the 
date of that favourable opinion.  
 
All researchers must also notify this office of the following:  Commencement of the study;  Actual completion date of the study;  Any significant changes to the study design;  Any incidents which have an adverse effect on participants, researchers 
or study outcomes;  Any suspension or abandonment of the study;  All funding, awards and grants pertaining to this study, whether 
commercial or non-commercial;  All publications and/or conference presentations of the findings of the 
study. 
 
We wish you well in your research endeavours. 
 
Yours sincerely 
 
 
Professor David Stanley 
Chair, School Research Ethics Review Panel 
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Appendix 34 - NHS ethical approval  
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Appendix 35 - Care home end-of-life care plan 
 
`                                                                                                                                                                                                                                                                                   
RESIDENT’S FULL NAME:   
 
We aim to care for people for the remainder of their lives.  We are keen that we 
respect Resident’s and Relatives wishes with all aspects of their care and life 
during their time at here.  It is particularly important that we have plans in place 
to ensure that we respect and meet the wishes of the Resident and Relatives during 
the final stages of their life. Because we cannot predict when this will be it is 
important that we consider this in advance in order that we have plans in place. 
 
 
RESUSCITATION:   
Is there a ‘Do Not Attempt Resuscitation’ (DNAR) Form in Place?    Yes / No 
If  no is it you decision that you wish us to attempt Resuscitation?   Yes / No 
 
 
 
If it is the wish of the Resident and their Relative every effort will be made by staff 
to care for the Resident at Burn Brae Lodge in the final stages of their life. This 
will include obtaining the support from community services such as the GP, 
District Nurses and MacMillan Nurses. 
 Where would you like to be cared for at this time?    Burn Brae Lodge  /  
Hospital  /  Hospice 
Do you have a living will / advance directive?     Yes  /  No   
If yes please give details and where this is held 
If the medical opinion is that treatment is unlikely to be effective would you 
wish that: 
(a) Every effort is made to treat the condition 
Or 
(b) Medical intervention is limited to relieving pain and keeping me / the 
resident comfortable 
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(Delete which does not apply) 
Do you have any other wishes about medical intervention (for example no 
blood products etc.)? 
Yes / No 
If yes please give details 
We hope that relatives and family feel able to be involved at this time if this is the 
residents and relatives wish.  
Please detail below any particular wishes for family involvement and who you 
wish to be contacted: 
Are there any religious issues that you would like to be observed during and / 
or after your life has ended?  If so give details: 
What are your final wishes?  Burial / Cremation / Medical Science 
Does anyone have Enduring Power of Attorney for you?  If yes please give 
details: 
Who will make the final arrangements for you? 
Are there any other wishes or comments you would like to make for your care 
at this time? 
 
 
SIGNED: 
NAME: 
STATUS: 
IF RELATIVE DO YOU HAVE POWER 
OF ATTORNEY FOR CARE?  YES / NO 
STAFF SIGNATURE: 
NAME: 
POSITION: 
 
DATE 
 
 
 
 
 
 
 
DATE 
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Appendix 36 – permission to use Greenghalgh, Robert et al., (2004) 
figure 
 
Dear Sonia, 
Thank you for your request.  
Permission is granted for you to use the material requested for your 
thesis/dissertation subject to the usual acknowledgements and on the understanding 
that you will reapply for permission if you wish to distribute or publish your 
thesis/dissertation commercially. 
Permission is granted solely for use in conjunction with the thesis, and the material 
may not be posted online separately. 
Any third party material is expressly excluded from this permission. If any material 
appears within the article with credit to another source, authorisation from that 
source must be obtained. 
Kind Regards 
Emma Willcox 
 
Permissions Assistant 
Description: Description: cid:image003.jpg@01CD4E24.F19D75F0
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Appendix 37 – Soft System Methodology Map
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